source_id,evidence_count,source_title,source_type,publication_year,journal,evidence_types,evidence_share_percent
1264,87,Genotype-phenotype correlations in von Hippel-Lindau disease.,PUBMED,2007,Hum Mutat,"DIAGNOSTIC, PREDISPOSING",0.7688229056203606
2174,80,Identification and in silico analysis of novel von Hippel-Lindau (VHL) gene variants from a large population.,PUBMED,2011,Ann Hum Genet,PREDISPOSING,0.7069635913750442
4356,69,Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.,PUBMED,1999,Cancer Res,FUNCTIONAL,0.6097560975609756
2650,67,Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients.,PUBMED,2017,Oncotarget,PREDISPOSING,0.5920820077765996
2285,63,Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.,PUBMED,2004,Hum Mutat,PREDISPOSING,0.5567338282078473
1532,62,Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations.,PUBMED,2009,Blood,PREDICTIVE,0.5478967833156593
4271,57,Tumour p53 mutations exhibit promoter selective dominance over wild type p53.,PUBMED,2002,Oncogene,FUNCTIONAL,0.503711558854719
1278,56,Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.,PUBMED,1998,Hum Mutat,PREDISPOSING,0.49487451396253096
2179,53,Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.,PUBMED,2002,Invest Ophthalmol Vis Sci,PREDISPOSING,0.46836337928596683
1529,52,"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.",PUBMED,2009,J Clin Oncol,PREDICTIVE,0.45952633439377877
2186,52,Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.,PUBMED,1995,Hum Mutat,PREDISPOSING,0.45952633439377877
76,52,"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.",PUBMED,2010,Lancet Oncol,PREDICTIVE,0.45952633439377877
2495,51,Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.,PUBMED,2014,N Engl J Med,"DIAGNOSTIC, ONCOGENIC, PREDICTIVE",0.4506892895015907
4058,50,Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.,PUBMED,2010,Mol Cancer Res,FUNCTIONAL,0.44185224460940264
2193,49,Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.,PUBMED,1998,Hum Mutat,PREDISPOSING,0.4330151997172146
1622,48,"Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations.",PUBMED,2006,Blood,PREDICTIVE,0.4241781548250266
3161,46,Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.,PUBMED,2015,Nat Med,"PREDICTIVE, PROGNOSTIC",0.40650406504065045
1479,45,Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.,PUBMED,2009,Br J Cancer,"PREDICTIVE, PROGNOSTIC",0.39766702014846234
2240,45,Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families.,PUBMED,2000,Jpn J Cancer Res,PREDISPOSING,0.39766702014846234
1370,44,Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.,PUBMED,2001,Pharmacogenetics,"DIAGNOSTIC, ONCOGENIC",0.38882997525627433
2042,43,Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.37999293036408627
1997,43,Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure.,PUBMED,2012,Blood,PREDICTIVE,0.37999293036408627
4473,43,Genotype-phenotype correlation in von Hippel-Lindau disease.,PUBMED,2021,Acta Ophthalmol,PREDISPOSING,0.37999293036408627
2611,42,Von Hippel-Lindau disease: an evaluation of natural history and functional disability.,PUBMED,2016,Neuro Oncol,PREDISPOSING,0.3711558854718982
2655,42,Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.,PUBMED,2014,J Hum Genet,PREDISPOSING,0.3711558854718982
2324,42,The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.,PUBMED,1999,J Neurol Neurosurg Psychiatry,PREDISPOSING,0.3711558854718982
2096,42,Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.,PUBMED,2006,N Engl J Med,PREDICTIVE,0.3711558854718982
2286,41,Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.,PUBMED,2012,Urol Int,PREDISPOSING,0.36231884057971014
2610,41,Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.,PUBMED,2016,Head Neck,PREDISPOSING,0.36231884057971014
2192,41,"Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification.",PUBMED,2007,Clin Genet,PREDISPOSING,0.36231884057971014
1329,40,Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.,PUBMED,1994,Hum Mol Genet,PREDISPOSING,0.3534817956875221
1251,38,Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.,PUBMED,2014,J Pathol,ONCOGENIC,0.335807705903146
5168,37,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,PUBMED,2022,Acta Neuropathol,"DIAGNOSTIC, PREDICTIVE, PREDISPOSING",0.32697066101095795
3875,37,A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.,PUBMED,2011,Hum Mol Genet,FUNCTIONAL,0.32697066101095795
2657,37,Mutations of the VHL tumour suppressor gene in renal carcinoma.,PUBMED,1994,Nat Genet,"ONCOGENIC, PREDISPOSING",0.32697066101095795
2187,33,Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.,PUBMED,1994,Am J Hum Genet,PREDISPOSING,0.29162248144220576
2002,33,Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.,PUBMED,2015,Nature,PREDICTIVE,0.29162248144220576
3351,32,Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.,PUBMED,1997,Am J Hum Genet,PREDISPOSING,0.2827854365500177
1996,32,Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.,PUBMED,2011,Blood,PREDICTIVE,0.2827854365500177
1998,31,Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.,PUBMED,2007,Blood,PREDICTIVE,0.27394839165782964
1589,31,Targeted therapy in GIST: in silico modeling for prediction of resistance.,PUBMED,2011,Nat Rev Clin Oncol,PREDICTIVE,0.27394839165782964
1230,30,"Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",PUBMED,2013,Sci Transl Med,PREDICTIVE,0.2651113467656416
965,30,Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.2651113467656416
2245,30,Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.,PUBMED,2010,Endocr Relat Cancer,PREDISPOSING,0.2651113467656416
2239,29,Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe.,PUBMED,1996,Hum Genet,PREDISPOSING,0.2562743018734535
2414,29,"Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.",PUBMED,2018,J Clin Oncol,PREDICTIVE,0.2562743018734535
4202,29,A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity.,PUBMED,2013,Cancer Res,FUNCTIONAL,0.2562743018734535
1941,29,Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.2562743018734535
2486,29,Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.,PUBMED,2008,Cancer Res,PREDICTIVE,0.2562743018734535
1435,29,Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.,PUBMED,2010,Clin Cancer Res,PREDICTIVE,0.2562743018734535
1259,28,"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.",PUBMED,1996,Hum Mutat,PREDISPOSING,0.24743725698126548
3005,28,Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.,PUBMED,2017,Nature,"FUNCTIONAL, PREDICTIVE",0.24743725698126548
4099,28,"Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab.",PUBMED,2020,Int J Cancer,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.24743725698126548
3389,27,Retinal angiomatosis and von Hippel-Lindau disease.,PUBMED,2000,Graefes Arch Clin Exp Ophthalmol,PREDISPOSING,0.23860021208907742
1531,27,In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.,PUBMED,2005,Cancer Res,PREDICTIVE,0.23860021208907742
1621,26,"Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines.",PUBMED,2008,Leuk Res,PREDICTIVE,0.22976316719688938
176,26,PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.,PUBMED,2009,Cancer Res,"PREDICTIVE, PROGNOSTIC",0.22976316719688938
258,25,Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.,PUBMED,2011,Nature,"DIAGNOSTIC, ONCOGENIC",0.22092612230470132
3522,25,Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.,PUBMED,2000,Surgery,PREDISPOSING,0.22092612230470132
3671,24,"Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.",PUBMED,2008,Pancreas,PREDISPOSING,0.2120890774125133
1696,24,Identifying the determinants of response to MDM2 inhibition.,PUBMED,2015,Oncotarget,"FUNCTIONAL, PREDICTIVE",0.2120890774125133
1368,24,Genetic analysis of von Hippel-Lindau disease.,PUBMED,2010,Hum Mutat,PREDISPOSING,0.2120890774125133
4276,24,A high-throughput functional complementation assay for classification of BRCA1 missense variants.,PUBMED,2013,Cancer Discov,FUNCTIONAL,0.2120890774125133
1994,24,Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.,PUBMED,2009,Leukemia,PREDICTIVE,0.2120890774125133
1541,24,ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.,PUBMED,2013,Haematologica,PREDICTIVE,0.2120890774125133
1503,24,"Effectiveness of tyrosine kinase inhibitors on ""uncommon"" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer.",PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.2120890774125133
2269,24,High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil.,PUBMED,2003,J Med Genet,PREDISPOSING,0.2120890774125133
170,23,Activating HER2 mutations in HER2 gene amplification negative breast cancer.,PUBMED,2013,Cancer Discov,"FUNCTIONAL, PREDICTIVE",0.20325203252032523
4020,23,Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.,PUBMED,2019,Clin Genet,PREDISPOSING,0.20325203252032523
3974,23,Evidence for genetic anticipation in vonHippel-Lindau syndrome.,PUBMED,2018,J Med Genet,PREDISPOSING,0.20325203252032523
4823,23,"Futibatinib, an Irreversible FGFR1-4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study.",PUBMED,2022,Cancer Discov,PREDICTIVE,0.20325203252032523
2672,23,Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.20325203252032523
3784,22,Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan.,PUBMED,1995,Hum Mol Genet,PREDISPOSING,0.19441498762813716
2190,22,Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.,PUBMED,1996,J Med Genet,PREDISPOSING,0.19441498762813716
2241,22,Germ-line mutations in nonsyndromic pheochromocytoma.,PUBMED,2002,N Engl J Med,PREDISPOSING,0.19441498762813716
2090,22,Extreme mutational selectivity of axitinib limits its potential use as a targeted therapeutic for BCR-ABL1-positive leukemia.,PUBMED,2016,Leukemia,PREDICTIVE,0.19441498762813716
3683,21,Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study.,PUBMED,2020,Mod Pathol,PREDISPOSING,0.1855779427359491
3026,21,Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.,PUBMED,2019,J Clin Oncol,PREDICTIVE,0.1855779427359491
4746,21,Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.,PUBMED,2020,Carcinogenesis,"ONCOGENIC, PREDICTIVE",0.1855779427359491
2605,21,Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.,PUBMED,2014,Endocr Relat Cancer,PREDISPOSING,0.1855779427359491
1406,21,Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.1855779427359491
2216,21,Germline mutations in the von Hippel-Lindau gene in Italian patients.,PUBMED,2009,Eur J Med Genet,PREDISPOSING,0.1855779427359491
1530,21,"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.",PUBMED,2003,Blood,PREDICTIVE,0.1855779427359491
3870,20,In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.,PUBMED,2018,J Clin Endocrinol Metab,PREDISPOSING,0.17674089784376104
4229,20,The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity.,PUBMED,2012,PLoS One,FUNCTIONAL,0.17674089784376104
1528,20,Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.17674089784376104
2282,20,Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.,PUBMED,2004,Hum Mutat,PREDISPOSING,0.17674089784376104
1480,20,"KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.",PUBMED,2009,Br J Cancer,PREDICTIVE,0.17674089784376104
2243,20,DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.,PUBMED,2001,Hum Genet,PREDISPOSING,0.17674089784376104
2498,20,Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.,PUBMED,2017,Blood,"DIAGNOSTIC, ONCOGENIC",0.17674089784376104
4994,20,Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.17674089784376104
3973,20,Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.,PUBMED,2008,J Cancer Res Clin Oncol,PREDISPOSING,0.17674089784376104
4879,19,"Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial.",PUBMED,2023,J Clin Oncol,PREDICTIVE,0.167903852951573
665,19,"AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.",PUBMED,2014,Cancer Discov,PREDICTIVE,0.167903852951573
1407,19,Hyperactive Ras in developmental disorders and cancer.,PUBMED,2007,Nat Rev Cancer,PREDICTIVE,0.167903852951573
4938,19,Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.,PUBMED,2019,Blood,ONCOGENIC,0.167903852951573
3919,19,Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.,PUBMED,1999,J Urol,PREDISPOSING,0.167903852951573
4949,18,Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.,PUBMED,2020,Blood,"ONCOGENIC, PROGNOSTIC",0.15906680805938495
2625,18,Risk of new tumors in von Hippel-Lindau patients depends on age and genotype.,PUBMED,2016,Genet Med,PREDISPOSING,0.15906680805938495
2904,18,A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation.,PUBMED,2018,Mol Cell,FUNCTIONAL,0.15906680805938495
2514,18,von Hippel-Lindau development in children and adolescents.,PUBMED,2017,Am J Med Genet A,PREDISPOSING,0.15906680805938495
412,18,Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.,PUBMED,2003,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.15906680805938495
2043,18,Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.15906680805938495
1372,18,Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene.,PUBMED,2002,J Med Genet,PREDISPOSING,0.15906680805938495
3489,18,New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations.,PUBMED,2019,J Endocr Soc,PREDISPOSING,0.15906680805938495
4378,18,Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma.,PUBMED,2021,Cancers (Basel),PREDISPOSING,0.15906680805938495
3543,17,The incidence of consecutive manifestations in Von Hippel-Lindau disease.,PUBMED,2019,Fam Cancer,PREDISPOSING,0.15022976316719688
3665,17,Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.,PUBMED,2011,Hum Mol Genet,PREDISPOSING,0.15022976316719688
4361,17,Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations.,PUBMED,2021,Mol Cancer Ther,PREDICTIVE,0.15022976316719688
4965,17,Genetic and Functional Drivers of Diffuse Large B¬†Cell Lymphoma.,PUBMED,2017,Cell,ONCOGENIC,0.15022976316719688
4951,17,"Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).",PUBMED,2022,Neuro Oncol,PREDICTIVE,0.15022976316719688
2207,17,"ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.",PUBMED,2017,Cell Rep,PREDICTIVE,0.15022976316719688
922,17,Crizotinib-resistant mutants of EML4-ALK identified through an accelerated mutagenesis screen.,PUBMED,2011,Chem Biol Drug Des,PREDICTIVE,0.15022976316719688
4968,17,Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.,PUBMED,2018,Nat Med,ONCOGENIC,0.15022976316719688
1161,17,Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.,PUBMED,2004,Cell,"FUNCTIONAL, ONCOGENIC",0.15022976316719688
2645,16,Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.,PUBMED,2016,Eur J Endocrinol,PREDISPOSING,0.14139271827500885
3253,16,Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.,PUBMED,2020,Cancer Res,PREDICTIVE,0.14139271827500885
3429,16,Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families.,PUBMED,2014,Cancer Res,PREDISPOSING,0.14139271827500885
1452,16,A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.,PUBMED,2009,Int J Mol Med,PREDICTIVE,0.14139271827500885
2634,16,PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.,PUBMED,2016,Retina,PREDISPOSING,0.14139271827500885
4404,16,Polyglobulia in patients with hemangioblastomas is related to tumor size but not to serum erythropoietin.,PUBMED,2018,Hered Cancer Clin Pract,PREDISPOSING,0.14139271827500885
2448,15,Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.,PUBMED,2014,Nat Genet,"DIAGNOSTIC, PREDICTIVE, PROGNOSTIC",0.1325556733828208
2266,15,Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.,PUBMED,2012,N Engl J Med,"DIAGNOSTIC, ONCOGENIC, PREDISPOSING",0.1325556733828208
3554,15,Olaparib for Metastatic Castration-Resistant Prostate Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.1325556733828208
3714,15,Hemangioblastomas and neurogenic polyglobulia.,PUBMED,2013,Neurosurgery,PREDISPOSING,0.1325556733828208
3409,15,Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.,PUBMED,2018,N Engl J Med,"ONCOGENIC, PROGNOSTIC",0.1325556733828208
3357,15,Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma.,PUBMED,2014,BMC Res Notes,PREDISPOSING,0.1325556733828208
1468,15,"Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.1325556733828208
966,15,The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.,PUBMED,2016,Blood,"DIAGNOSTIC, PROGNOSTIC",0.1325556733828208
1373,15,Improved detection of germline mutations in Korean VHL patients by multiple ligation-dependent probe amplification analysis.,PUBMED,2009,J Korean Med Sci,PREDISPOSING,0.1325556733828208
3828,14,Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.,PUBMED,2009,Am J Surg Pathol,PREDISPOSING,0.12371862849063274
3456,14,Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.,PUBMED,2009,J Clin Invest,"ONCOGENIC, PREDICTIVE",0.12371862849063274
924,14,The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.12371862849063274
2913,14,Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies.,PUBMED,2011,Mol Cancer Ther,PREDICTIVE,0.12371862849063274
3044,14,The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.12371862849063274
2328,13,Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.,PUBMED,2012,J Hum Genet,PREDISPOSING,0.11488158359844469
4727,13,"Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.",PUBMED,2022,J Clin Oncol,PREDICTIVE,0.11488158359844469
4167,13,FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors.,PUBMED,2017,Oncotarget,"ONCOGENIC, PREDICTIVE",0.11488158359844469
592,13,Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.11488158359844469
2488,13,VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.,PUBMED,2016,Genet Test Mol Biomarkers,PREDISPOSING,0.11488158359844469
2649,13,Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.,PUBMED,2018,Fam Cancer,PREDISPOSING,0.11488158359844469
1510,13,"Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.",PUBMED,2012,Lancet Oncol,PREDICTIVE,0.11488158359844469
1009,13,Genomic Classification and Prognosis in Acute Myeloid Leukemia.,PUBMED,2016,N Engl J Med,"DIAGNOSTIC, ONCOGENIC, PREDICTIVE, PROGNOSTIC",0.11488158359844469
1143,13,ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.,PUBMED,2016,Eur Urol,PREDICTIVE,0.11488158359844469
2431,13,Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.,PUBMED,1995,Int J Cancer,"DIAGNOSTIC, PREDISPOSING",0.11488158359844469
3487,12,Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.,PUBMED,2009,J Clin Endocrinol Metab,PREDISPOSING,0.10604453870625664
3472,12,Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors.,PUBMED,2013,Leukemia,PREDICTIVE,0.10604453870625664
3512,12,Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.,PUBMED,2001,J Neurol Neurosurg Psychiatry,PREDISPOSING,0.10604453870625664
1644,12,Oncogenic ERBB3 mutations in human cancers.,PUBMED,2013,Cancer Cell,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.10604453870625664
3074,12,Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.,PUBMED,2014,Cancer Biol Ther,"ONCOGENIC, PREDICTIVE",0.10604453870625664
2757,12,"The dominant-negative interplay between p53, p63 and p73: A family affair.",PUBMED,2016,Oncotarget,FUNCTIONAL,0.10604453870625664
4442,12,"Retinal haemangioblastomas in von Hippel-Lindau germline mutation carriers: progression, complications and treatment outcome.",PUBMED,2020,Acta Ophthalmol,PREDISPOSING,0.10604453870625664
490,12,Oncogenic RIT1 mutations in lung adenocarcinoma.,PUBMED,2014,Oncogene,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.10604453870625664
1508,12,Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.,PUBMED,2010,N Engl J Med,PREDICTIVE,0.10604453870625664
2246,12,Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup.,PUBMED,2010,J Urol,PREDISPOSING,0.10604453870625664
2365,12,Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.,PUBMED,2015,Fam Cancer,PREDISPOSING,0.10604453870625664
1358,12,"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.",PUBMED,2010,Lancet Oncol,PREDICTIVE,0.10604453870625664
122,12,KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.,PUBMED,2008,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.10604453870625664
3391,11,Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.,PUBMED,2018,Blood,PREDISPOSING,0.09720749381406858
3376,11,"Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations.",PUBMED,2020,Blood,PREDICTIVE,0.09720749381406858
1999,11,Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.09720749381406858
1328,11,"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.09720749381406858
1289,11,What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).,PUBMED,2016,Ann Oncol,PREDICTIVE,0.09720749381406858
4142,11,Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.,PUBMED,2016,Oncotarget,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.09720749381406858
3669,11,Epididymal cystadenomas in von Hippel-Lindau disease.,PUBMED,1997,Urology,PREDISPOSING,0.09720749381406858
3657,11,Genetic testing in pheochromocytoma or functional paraganglioma.,PUBMED,2005,J Clin Oncol,PREDISPOSING,0.09720749381406858
4870,11,Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors.,PUBMED,2020,J Med Genet,"ONCOGENIC, PREDICTIVE",0.09720749381406858
4374,11,VHL-Related Neuroendocrine Neoplasms And Beyond: An Israeli Specialized Center Real-Life Report.,PUBMED,2020,Endocr Pract,PREDISPOSING,0.09720749381406858
2534,11,"Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.",PUBMED,2018,Cancer Discov,PREDICTIVE,0.09720749381406858
2480,11,Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance.,PUBMED,2005,Proc Natl Acad Sci U S A,PREDICTIVE,0.09720749381406858
1608,11,Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.,PUBMED,2006,PLoS Med,"FUNCTIONAL, PREDICTIVE",0.09720749381406858
1630,11,Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.,PUBMED,2006,Blood,PREDICTIVE,0.09720749381406858
3398,10,Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.,PUBMED,2010,BMC Med Genet,PREDISPOSING,0.08837044892188052
262,10,Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.,PUBMED,2012,Sci Transl Med,PREDICTIVE,0.08837044892188052
4559,10,Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.,PUBMED,2010,Cancer Res,FUNCTIONAL,0.08837044892188052
811,10,HER2 activating mutations are targets for colorectal cancer treatment.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.08837044892188052
493,10,Smoothened variants explain the majority of drug resistance in basal cell carcinoma.,PUBMED,2015,Cancer Cell,PREDICTIVE,0.08837044892188052
2445,10,Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.,PUBMED,2018,N Engl J Med,PREDICTIVE,0.08837044892188052
2978,10,"Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.",PUBMED,2019,Ann Oncol,PREDICTIVE,0.08837044892188052
3131,10,Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.,PUBMED,2013,Nat Genet,"PREDICTIVE, PROGNOSTIC",0.08837044892188052
2323,10,Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.,PUBMED,1999,Arch Ophthalmol,PREDISPOSING,0.08837044892188052
2001,10,Overriding imatinib resistance with a novel ABL kinase inhibitor.,PUBMED,2004,Science,PREDICTIVE,0.08837044892188052
2049,10,"Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants.",PUBMED,2014,Cancer Sci,PREDICTIVE,0.08837044892188052
2212,10,Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.,PUBMED,2009,Eur J Endocrinol,PREDISPOSING,0.08837044892188052
567,10,Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.,PUBMED,2016,N Engl J Med,"PREDICTIVE, PREDISPOSING",0.08837044892188052
3677,10,Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.,PUBMED,2013,Endocr Relat Cancer,PREDISPOSING,0.08837044892188052
3867,10,ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.,PUBMED,2019,Clin Cancer Res,FUNCTIONAL,0.08837044892188052
2644,10,Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-Œ± binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.,PUBMED,2016,BMC Med Genet,PREDISPOSING,0.08837044892188052
2784,10,Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.,PUBMED,2011,Lancet,"PREDICTIVE, PROGNOSTIC",0.08837044892188052
2626,10,Risk factors for survival in patients with von Hippel-Lindau disease.,PUBMED,2018,J Med Genet,PREDISPOSING,0.08837044892188052
2134,10,Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC.,PUBMED,2016,Mol Cancer Ther,"ONCOGENIC, PREDICTIVE",0.08837044892188052
1926,10,Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.,PUBMED,2007,Br J Cancer,PREDICTIVE,0.08837044892188052
68,9,DNMT3A mutations in acute myeloid leukemia.,PUBMED,2010,N Engl J Med,"DIAGNOSTIC, PROGNOSTIC",0.07953340402969247
1924,9,RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.07953340402969247
3866,9,Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-Œ± protein turnover.,PUBMED,2015,Cell Death Dis,FUNCTIONAL,0.07953340402969247
1942,9,Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.,PUBMED,2015,Cancer Cell,PREDICTIVE,0.07953340402969247
3988,9,Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis.,PUBMED,2021,Blood Adv,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.07953340402969247
3223,9,High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.,PUBMED,2017,J Clin Oncol,"DIAGNOSTIC, PROGNOSTIC",0.07953340402969247
3445,9,Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax.,PUBMED,2020,Blood,PREDICTIVE,0.07953340402969247
3569,9,Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.,PUBMED,1999,J Natl Cancer Inst,PREDISPOSING,0.07953340402969247
1332,9,Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.,PUBMED,2016,Oncotarget,"FUNCTIONAL, PREDICTIVE",0.07953340402969247
1991,9,Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain.,PUBMED,2007,Mol Cancer,PREDICTIVE,0.07953340402969247
1546,9,Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.,PUBMED,2005,J Clin Oncol,PREDICTIVE,0.07953340402969247
1689,9,"Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).",PUBMED,2017,Cancer Discov,PREDICTIVE,0.07953340402969247
62,9,Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.,PUBMED,2006,J Clin Oncol,PREDICTIVE,0.07953340402969247
2081,9,Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.,PUBMED,2010,World J Surg Oncol,PREDICTIVE,0.07953340402969247
3571,9,Management of solid renal tumour associated with von Hippel-Lindau disease.,PUBMED,2007,Chin Med J (Engl),PREDISPOSING,0.07953340402969247
1710,9,Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.,PUBMED,1996,J Pathol,PREDISPOSING,0.07953340402969247
3845,9,Natural history of supratentorial hemangioblastomas in von Hippel-Lindau disease.,PUBMED,2010,Neurosurgery,PREDISPOSING,0.07953340402969247
4010,9,Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.,PUBMED,2018,Clin Cancer Res,"ONCOGENIC, PREDICTIVE",0.07953340402969247
4436,9,"Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.",PUBMED,2021,Endocrine,PREDISPOSING,0.07953340402969247
4417,9,Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.,PUBMED,2020,Front Endocrinol (Lausanne),PREDISPOSING,0.07953340402969247
4463,9,Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome.,PUBMED,2021,Mol Vis,PREDISPOSING,0.07953340402969247
1491,9,Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.,PUBMED,2010,Nature,PREDICTIVE,0.07953340402969247
1509,9,"EGF receptor gene mutations are common in lung cancers from ""never smokers"" and are associated with sensitivity of tumors to gefitinib and erlotinib.",PUBMED,2004,Proc Natl Acad Sci U S A,PREDICTIVE,0.07953340402969247
887,9,Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.07953340402969247
4826,9,"Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.",PUBMED,2020,Target Oncol,PREDICTIVE,0.07953340402969247
3167,9,Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.,PUBMED,2002,Oncogene,PREDISPOSING,0.07953340402969247
2509,9,Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma.,PUBMED,2005,Clin Cancer Res,PREDISPOSING,0.07953340402969247
3272,9,The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.,PUBMED,2019,Nature,PREDICTIVE,0.07953340402969247
2640,9,Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system.,PUBMED,2014,J Neuropathol Exp Neurol,PREDISPOSING,0.07953340402969247
1586,8,Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.07069635913750442
5358,8,"US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Locally Advanced or Metastatic Breast Cancer.",PUBMED,2025,J Clin Oncol,PREDICTIVE,0.07069635913750442
81,8,Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).,PUBMED,2013,Blood,"DIAGNOSTIC, PROGNOSTIC",0.07069635913750442
3546,8,Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease.,PUBMED,2008,Arch Ophthalmol,PREDISPOSING,0.07069635913750442
746,8,The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.07069635913750442
3529,8,Efficacy of gene testing for von Hippel-Lindau disease.,PUBMED,1998,Med J Aust,PREDISPOSING,0.07069635913750442
3447,8,Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.07069635913750442
108,8,Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.,PUBMED,2012,Cancer Res,PREDICTIVE,0.07069635913750442
2123,8,Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.,PUBMED,2015,Science,PREDICTIVE,0.07069635913750442
1396,8,Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib.,PUBMED,2011,PLoS One,PREDICTIVE,0.07069635913750442
507,8,Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.07069635913750442
868,8,Molecular Changes Associated with Acquired Resistance to Crizotinib in ROS1-Rearranged Non-Small Cell Lung Cancer.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.07069635913750442
2261,8,Molecular basis of von Hippel-Lindau syndrome in Chinese patients.,PUBMED,2011,Chin Med J (Engl),PREDISPOSING,0.07069635913750442
1463,8,"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.",PUBMED,2012,N Engl J Med,PREDICTIVE,0.07069635913750442
1447,8,Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.,PUBMED,2011,Breast Cancer Res Treat,PREDICTIVE,0.07069635913750442
2927,8,Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.,PUBMED,2019,N Engl J Med,PREDICTIVE,0.07069635913750442
1485,8,Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.,PUBMED,2006,Cancer Res,PREDICTIVE,0.07069635913750442
1416,8,PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients.,PUBMED,2006,J Thorac Oncol,PREDICTIVE,0.07069635913750442
4350,8,The genomic landscape of phaeochromocytoma.,PUBMED,2015,J Pathol,PREDISPOSING,0.07069635913750442
4006,8,Systematic Functional Annotation of Somatic Mutations in Cancer.,PUBMED,2018,Cancer Cell,FUNCTIONAL,0.07069635913750442
2799,8,FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.,PUBMED,2007,J Exp Med,"FUNCTIONAL, PREDISPOSING",0.07069635913750442
399,8,Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.,PUBMED,2013,Nat Med,"PREDICTIVE, PROGNOSTIC",0.07069635913750442
409,8,DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.07069635913750442
171,8,ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.,PUBMED,2013,Nat Genet,"FUNCTIONAL, PREDICTIVE",0.07069635913750442
179,8,Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.,PUBMED,2011,Cancer Discov,PREDICTIVE,0.07069635913750442
687,8,K-ras mutations and benefit from cetuximab in advanced colorectal cancer.,PUBMED,2008,N Engl J Med,PREDICTIVE,0.07069635913750442
3676,8,Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomas.,PUBMED,2004,Hered Cancer Clin Pract,PREDISPOSING,0.07069635913750442
3643,8,"Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 ""Gatekeeper"" F691L Mutation with PLX3397.",PUBMED,2015,Cancer Discov,PREDICTIVE,0.07069635913750442
1937,8,Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).,PUBMED,2012,J Thorac Oncol,PREDICTIVE,0.07069635913750442
1935,8,KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.,PUBMED,2015,Future Oncol,PREDICTIVE,0.07069635913750442
2030,8,A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.,PUBMED,2005,Blood,PREDICTIVE,0.07069635913750442
54,7,Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.,PUBMED,2012,Blood,"DIAGNOSTIC, PROGNOSTIC",0.06185931424531637
1931,7,"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.",PUBMED,2011,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.06185931424531637
1934,7,Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.,PUBMED,2009,N Engl J Med,PREDICTIVE,0.06185931424531637
1946,7,Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients.,PUBMED,2016,Oncotarget,PREDICTIVE,0.06185931424531637
1936,7,KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.,PUBMED,2013,J Cancer Res Clin Oncol,PREDICTIVE,0.06185931424531637
1025,7,Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.,PUBMED,2016,Nature,PREDICTIVE,0.06185931424531637
1040,7,Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.06185931424531637
2859,7,First results from the primary analysis population of the phase 2 study of erdafitinib (ERDA; JNJ-42756493) in patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) and <i>FGFR</i> alterations (FGFRalt).,ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 4503)",PREDICTIVE,0.06185931424531637
2816,7,Pediatric low-grade gliomas can be molecularly stratified for risk.,PUBMED,2018,Acta Neuropathol,PROGNOSTIC,0.06185931424531637
174,7,KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.,PUBMED,2006,Cancer Res,PREDICTIVE,0.06185931424531637
2135,7,Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.06185931424531637
3872,7,Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.,PUBMED,1999,Oncogene,FUNCTIONAL,0.06185931424531637
3793,7,Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.,PUBMED,2002,Endocr Pathol,PREDISPOSING,0.06185931424531637
2302,7,Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by Southern blot and direct genomic DNA sequencing.,PUBMED,1998,Hum Mutat,PREDISPOSING,0.06185931424531637
2628,7,"Genotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience.",PUBMED,2017,Clin Med Insights Endocrinol Diabetes,PREDISPOSING,0.06185931424531637
2086,7,EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.,PUBMED,2016,Cancer Discov,"FUNCTIONAL, PREDICTIVE",0.06185931424531637
3607,7,Three novel VHL germline mutations in Korean patients with von Hippel-Lindau disease and pheochromocytomas.,PUBMED,2005,Oncol Rep,PREDISPOSING,0.06185931424531637
1297,7,Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.06185931424531637
1993,7,Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry.,PUBMED,2011,Oncogene,PREDICTIVE,0.06185931424531637
1557,7,Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.,PUBMED,2003,Mol Pathol,PREDICTIVE,0.06185931424531637
1337,7,"Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.",PUBMED,2017,J Clin Oncol,PREDICTIVE,0.06185931424531637
856,7,Ceritinib in ALK-rearranged non-small-cell lung cancer.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.06185931424531637
3402,7,"Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.",PUBMED,2012,Horm Cancer,PREDISPOSING,0.06185931424531637
3377,7,EGFR blockade in GBM brain tumor stem cells synergizes with JAK2/STAT3 pathway inhibition to abrogate compensatory mechanisms in vitro and in vivo.,PUBMED,2020,Neurooncol Adv,PREDICTIVE,0.06185931424531637
1525,7,"BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.",PUBMED,2008,Oncogene,PREDICTIVE,0.06185931424531637
1160,7,Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.,PUBMED,2012,Proc Natl Acad Sci U S A,"FUNCTIONAL, ONCOGENIC",0.06185931424531637
3047,7,Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.,PUBMED,2015,Cancer,FUNCTIONAL,0.06185931424531637
2467,7,"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.",PUBMED,2018,Lancet Oncol,PREDICTIVE,0.06185931424531637
1433,7,Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.,PUBMED,2011,Anticancer Res,"PREDICTIVE, PROGNOSTIC",0.06185931424531637
864,7,Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.,PUBMED,2013,Nat Genet,"DIAGNOSTIC, ONCOGENIC",0.06185931424531637
3017,7,Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.06185931424531637
1423,7,Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.,PUBMED,2001,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.06185931424531637
1412,7,Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.,PUBMED,2008,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.06185931424531637
927,7,Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.,PUBMED,2013,Cancer Discov,"FUNCTIONAL, ONCOGENIC, PREDICTIVE",0.06185931424531637
2992,7,A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.,PUBMED,2019,Science,FUNCTIONAL,0.06185931424531637
2888,7,"Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.",PUBMED,2019,N Engl J Med,PREDICTIVE,0.06185931424531637
4419,7,"Pathogenic Germline Variants in 10,389 Adult Cancers.",PUBMED,2018,Cell,PREDISPOSING,0.06185931424531637
3511,7,Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.,PUBMED,2016,J Clin Endocrinol Metab,PREDISPOSING,0.06185931424531637
4070,7,"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.",PUBMED,2011,Blood,FUNCTIONAL,0.06185931424531637
1988,7,Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.06185931424531637
925,6,Activity of second-generation ALK inhibitors against crizotinib-resistant mutants in an NPM-ALK model compared to EML4-ALK.,PUBMED,2015,Cancer Med,PREDICTIVE,0.05302226935312832
3023,6,EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer.,PUBMED,2019,BMC Cancer,PREDICTIVE,0.05302226935312832
2484,6,Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.05302226935312832
3009,6,Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib.,PUBMED,2017,Oncotarget,PREDICTIVE,0.05302226935312832
2229,6,Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.,PUBMED,2010,Pathol Int,PREDISPOSING,0.05302226935312832
1388,6,Prediction and prioritization of rare oncogenic mutations in the cancer Kinome using novel features and multiple classifiers.,PUBMED,2014,PLoS Comput Biol,"FUNCTIONAL, PREDICTIVE",0.05302226935312832
3741,6,Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.,PUBMED,2015,Blood,"ONCOGENIC, PREDICTIVE",0.05302226935312832
2624,6,Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumours.,PUBMED,2016,Nat Commun,PREDISPOSING,0.05302226935312832
2031,6,SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.,PUBMED,2003,Blood,PREDICTIVE,0.05302226935312832
2677,6,Selective RET kinase inhibition for patients with RET-altered cancers.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.05302226935312832
4398,6,AKT mutant allele-specific activation dictates pharmacologic sensitivities.,PUBMED,2022,Nat Commun,PREDICTIVE,0.05302226935312832
2067,6,Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).,PUBMED,2016,PLoS One,PREDICTIVE,0.05302226935312832
1940,6,KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.05302226935312832
3972,6,"Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.",PUBMED,2014,Ophthalmic Genet,PREDISPOSING,0.05302226935312832
3666,6,Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.,PUBMED,2007,Hum Mutat,PREDISPOSING,0.05302226935312832
2277,6,Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes.,PUBMED,2003,J Med Genet,PREDISPOSING,0.05302226935312832
3855,6,Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.,PUBMED,2001,Genes Chromosomes Cancer,PREDISPOSING,0.05302226935312832
2616,6,Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.,PUBMED,2016,Fam Cancer,PREDISPOSING,0.05302226935312832
2627,6,Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.,PUBMED,2017,J Pediatr Endocrinol Metab,PREDISPOSING,0.05302226935312832
1138,6,"A molecularly annotated platform of patient-derived xenografts (""xenopatients"") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.",PUBMED,2011,Cancer Discov,PREDICTIVE,0.05302226935312832
1389,6,Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.05302226935312832
3815,6,Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.05302226935312832
3823,6,Pancreatic lesions in von Hippel-Lindau disease.,PUBMED,2002,Clin Endocrinol (Oxf),PREDISPOSING,0.05302226935312832
1933,6,Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab.,PUBMED,2010,Ann Surg,PREDICTIVE,0.05302226935312832
2133,6,"Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.",PUBMED,2016,Cancer Cell,"FUNCTIONAL, PREDICTIVE",0.05302226935312832
607,6,The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.,PUBMED,2014,Cell Death Differ,"ONCOGENIC, PREDICTIVE, PROGNOSTIC",0.05302226935312832
1932,6,"Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.",PUBMED,2009,J Clin Oncol,PREDICTIVE,0.05302226935312832
1925,6,KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab.,PUBMED,2008,Ann Oncol,PREDICTIVE,0.05302226935312832
1938,6,"Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.",PUBMED,2011,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.05302226935312832
3039,6,Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia.,PUBMED,2017,Oncotarget,"DIAGNOSTIC, ONCOGENIC, PROGNOSTIC",0.05302226935312832
2175,6,Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.,PUBMED,1998,Int J Cancer,PREDISPOSING,0.05302226935312832
5182,6,Extensive functional evaluation of exon 20 insertion mutations of EGFR.,PUBMED,2021,Lung Cancer,"ONCOGENIC, PREDICTIVE",0.05302226935312832
826,6,Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.05302226935312832
2196,6,PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.05302226935312832
2211,6,"Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.",PUBMED,2009,J Surg Res,PREDISPOSING,0.05302226935312832
4325,6,"Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.05302226935312832
3195,6,"Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.",PUBMED,2009,J Pathol,"DIAGNOSTIC, PROGNOSTIC",0.05302226935312832
729,6,Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.05302226935312832
720,6,Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.,PUBMED,2013,Blood,PREDICTIVE,0.05302226935312832
2102,6,FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.,PUBMED,2017,Oncogene,PREDICTIVE,0.05302226935312832
1702,6,Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.,PUBMED,2008,Am J Pathol,"DIAGNOSTIC, PROGNOSTIC",0.05302226935312832
2334,6,Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.,PUBMED,2015,Scand J Gastroenterol,PREDISPOSING,0.05302226935312832
2376,6,Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.,PUBMED,2010,J Clin Endocrinol Metab,PREDISPOSING,0.05302226935312832
4646,6,Efficacy of MEK inhibition in patients with histiocytic neoplasms.,PUBMED,2019,Nature,PREDICTIVE,0.05302226935312832
2320,6,Sequence variations in the von Hippel-Lindau tumor suppressor gene in patients with intracranial aneurysms.,PUBMED,2013,J Stroke Cerebrovasc Dis,PREDISPOSING,0.05302226935312832
4800,6,A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.,PUBMED,2016,Am J Surg Pathol,"DIAGNOSTIC, PROGNOSTIC",0.05302226935312832
859,6,Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.,PUBMED,2013,Lancet Oncol,PREDICTIVE,0.05302226935312832
3092,6,Solitary juxtapapillary capillary retinal angioma and von Hippel-Lindau disease.,PUBMED,2007,Can J Ophthalmol,PREDISPOSING,0.05302226935312832
2585,6,Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients.,PUBMED,2009,Hum Mutat,PREDISPOSING,0.05302226935312832
2612,6,Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome.,PUBMED,2016,Chin J Cancer,PREDISPOSING,0.05302226935312832
3093,6,Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.,PUBMED,2006,J Neurosurg,PREDISPOSING,0.05302226935312832
3136,6,Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.,PUBMED,2013,Cancer Res,"ONCOGENIC, PREDICTIVE",0.05302226935312832
1244,6,Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.05302226935312832
4375,6,Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.,PUBMED,2020,Cancer Genet,PREDISPOSING,0.05302226935312832
1415,6,Prognostic significance of K-ras mutations in colorectal carcinoma.,PUBMED,1993,Gastroenterology,PREDICTIVE,0.05302226935312832
1413,6,KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.,PUBMED,2007,Oncogene,PREDICTIVE,0.05302226935312832
3010,6,Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer.,PUBMED,2019,Clin Cancer Res,"FUNCTIONAL, PREDICTIVE",0.05302226935312832
1414,6,ras oncogenes in human cancer: a review.,PUBMED,1989,Cancer Res,PREDICTIVE,0.05302226935312832
4438,6,Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.,PUBMED,2020,Endocrinol Metab (Seoul),PREDISPOSING,0.05302226935312832
911,6,A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.,PUBMED,2014,Cancer Discov,"FUNCTIONAL, PREDICTIVE",0.05302226935312832
4454,6,Germline mutations in the new E1' cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma.,PUBMED,2020,J Med Genet,PREDISPOSING,0.05302226935312832
4402,5,Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma.,PUBMED,2015,PLoS One,PREDISPOSING,0.04418522446094026
4400,5,Absence of BRAF mutation in pheochromocytoma and paraganglioma.,PUBMED,2017,Neoplasma,PREDISPOSING,0.04418522446094026
1005,5,"Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.",PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.04418522446094026
997,5,Recurrent mutations refine prognosis in chronic lymphocytic leukemia.,PUBMED,2015,Leukemia,PROGNOSTIC,0.04418522446094026
2745,5,"A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with <i>RET</i>-altered cancers.",ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 102)",PREDICTIVE,0.04418522446094026
4560,5,Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.,PUBMED,2017,Gynecol Oncol,PREDICTIVE,0.04418522446094026
4541,5,Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.,PUBMED,2021,N Engl J Med,PREDICTIVE,0.04418522446094026
2758,5,Gain of function mutations in p53.,PUBMED,1993,Nat Genet,ONCOGENIC,0.04418522446094026
4518,5,Gastrointestinal malignancies harbor actionable MET exon 14 deletions.,PUBMED,2015,Oncotarget,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
2675,5,Clinical effect of point mutations in myelodysplastic syndromes.,PUBMED,2011,N Engl J Med,PROGNOSTIC,0.04418522446094026
2617,5,Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system.,PUBMED,2017,Neuro Oncol,PREDISPOSING,0.04418522446094026
2646,5,Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.,PUBMED,2018,Int J Neurosci,PREDISPOSING,0.04418522446094026
2317,5,Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.,PUBMED,2013,Endocr Relat Cancer,PREDISPOSING,0.04418522446094026
3983,5,"Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2.",PUBMED,2021,J Clin Oncol,PREDICTIVE,0.04418522446094026
3711,5,Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation.,PUBMED,2011,FASEB J,PREDISPOSING,0.04418522446094026
3755,5,Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.,PUBMED,2021,Ann Oncol,PREDICTIVE,0.04418522446094026
2128,5,Somatically mutated ABL1 is an actionable and essential NSCLC survival gene.,PUBMED,2016,EMBO Mol Med,PREDICTIVE,0.04418522446094026
166,5,EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.,PUBMED,2010,N Engl J Med,PREDICTIVE,0.04418522446094026
3821,5,Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients.,PUBMED,2000,Am J Pathol,PREDISPOSING,0.04418522446094026
2054,5,Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.,PUBMED,2014,JAMA Dermatol,"ONCOGENIC, PREDICTIVE",0.04418522446094026
116,5,"The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.",PUBMED,2008,Blood,"DIAGNOSTIC, PROGNOSTIC",0.04418522446094026
2065,5,Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.04418522446094026
1920,5,FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.,PUBMED,2015,Clin Colorectal Cancer,PREDICTIVE,0.04418522446094026
156,5,BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.,PUBMED,2010,Leuk Res,"DIAGNOSTIC, PREDICTIVE",0.04418522446094026
688,5,Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.04418522446094026
2180,5,"Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma.",PUBMED,2013,BMC Med Genet,PREDISPOSING,0.04418522446094026
3625,5,The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.,PUBMED,2016,Acta Neuropathol,DIAGNOSTIC,0.04418522446094026
1951,5,BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.04418522446094026
2045,5,Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.04418522446094026
2040,5,TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.,PUBMED,2016,Oncotarget,PREDICTIVE,0.04418522446094026
4337,5,FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.,PUBMED,2005,Oncogene,PREDICTIVE,0.04418522446094026
233,5,"The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.",PUBMED,2006,Clin Cancer Res,PROGNOSTIC,0.04418522446094026
2264,5,Mutations in the VHL gene in sporadic apparently congenital polycythemia.,PUBMED,2003,Blood,PREDISPOSING,0.04418522446094026
1425,5,IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.,PUBMED,2010,Neurology,PREDICTIVE,0.04418522446094026
1175,5,Specificity of fusion genes in adipocytic tumors.,PUBMED,2010,Anticancer Res,DIAGNOSTIC,0.04418522446094026
2599,5,A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect.,PUBMED,2009,J Mol Med (Berl),PREDISPOSING,0.04418522446094026
338,5,BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.,PUBMED,2012,Cancer Discov,PREDICTIVE,0.04418522446094026
4576,5,Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis.,PUBMED,2016,Acta Neuropathol,"DIAGNOSTIC, PROGNOSTIC",0.04418522446094026
2560,5,Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.,PUBMED,2012,Nat Genet,DIAGNOSTIC,0.04418522446094026
2536,5,High-throughput Phenotyping of Lung Cancer Somatic Mutations.,PUBMED,2016,Cancer Cell,ONCOGENIC,0.04418522446094026
2478,5,Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.04418522446094026
1236,5,Identification of ALK as a major familial neuroblastoma predisposition gene.,PUBMED,2008,Nature,PREDISPOSING,0.04418522446094026
2464,5,Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.,PUBMED,2010,Proc Natl Acad Sci U S A,"DIAGNOSTIC, PREDICTIVE, PROGNOSTIC",0.04418522446094026
4333,5,"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II.",PUBMED,1996,Mol Cell Biol,FUNCTIONAL,0.04418522446094026
4352,5,"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.",PUBMED,2020,Mod Pathol,ONCOGENIC,0.04418522446094026
3084,5,Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.,PUBMED,2009,Endocr Relat Cancer,PREDISPOSING,0.04418522446094026
3123,5,"Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All).",PUBMED,2018,Biochem Pharmacol,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
2458,5,Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.,PUBMED,2012,Cancer Cell,"DIAGNOSTIC, PREDICTIVE",0.04418522446094026
4376,5,Intrafamilial Variability of Ocular Manifestations of von Hippel-Lindau Disease.,PUBMED,2022,Ophthalmol Retina,PREDISPOSING,0.04418522446094026
4881,5,First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.,PUBMED,2024,Nat Med,PREDICTIVE,0.04418522446094026
1475,5,PIK3CA mutations predict local recurrences in rectal cancer patients.,PUBMED,2009,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
2231,5,Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.,PUBMED,2010,Fam Cancer,PREDISPOSING,0.04418522446094026
2879,5,Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.,PUBMED,2017,Sci Rep,PREDICTIVE,0.04418522446094026
4433,5,"A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.",PUBMED,2021,Front Endocrinol (Lausanne),PREDISPOSING,0.04418522446094026
2235,5,Molecular genetic diagnosis of von Hippel-Lindau disease: analysis of five Japanese families.,PUBMED,1996,Jpn J Cancer Res,PREDISPOSING,0.04418522446094026
2894,5,Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.,PUBMED,2016,J Clin Invest,PREDICTIVE,0.04418522446094026
229,5,Clinical and biological significance of RAS mutations in multiple myeloma.,PUBMED,2008,Leukemia,PROGNOSTIC,0.04418522446094026
1464,5,Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation.,PUBMED,1998,Mol Cell Biol,PREDICTIVE,0.04418522446094026
234,5,Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.,PUBMED,1998,Br J Cancer,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
4837,5,Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.04418522446094026
4855,5,Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis.,PUBMED,2023,NPJ Genom Med,PREDICTIVE,0.04418522446094026
494,5,Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.,PUBMED,2014,Cancer Cell,"DIAGNOSTIC, PREDICTIVE",0.04418522446094026
3336,5,"Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.",PUBMED,2017,Blood,PREDICTIVE,0.04418522446094026
508,5,Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer.,PUBMED,2013,J Thorac Oncol,PREDICTIVE,0.04418522446094026
5293,5,Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway.,PUBMED,2018,Acta Neuropathol,DIAGNOSTIC,0.04418522446094026
30,5,Activating ESR1 mutations in hormone-resistant metastatic breast cancer.,PUBMED,2013,Nat Genet,PREDICTIVE,0.04418522446094026
82,5,Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate.,PUBMED,2006,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
80,5,Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.04418522446094026
2019,5,Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.,PUBMED,2007,Cancer Res,PREDICTIVE,0.04418522446094026
2008,5,Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.,PUBMED,2012,Nature,PREDICTIVE,0.04418522446094026
2215,5,Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease.,PUBMED,2012,Int J Mol Med,PREDISPOSING,0.04418522446094026
3903,5,Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.,PUBMED,2017,J Invest Dermatol,"DIAGNOSTIC, ONCOGENIC",0.04418522446094026
1632,5,Genomic and biological characterization of exon 4 KRAS mutations in human cancer.,PUBMED,2010,Cancer Res,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
3203,5,Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide.,PUBMED,2014,Ann Surg Oncol,"PREDICTIVE, PROGNOSTIC",0.04418522446094026
4764,5,Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.,PUBMED,2020,Breast Cancer Res,PREDICTIVE,0.04418522446094026
2265,5,A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.,PUBMED,2015,Mod Pathol,DIAGNOSTIC,0.04418522446094026
3305,5,Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.04418522446094026
4326,5,Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.,PUBMED,2000,Am J Hum Genet,FUNCTIONAL,0.04418522446094026
4645,5,High-Throughput Functional Evaluation of Variants of Unknown Significance in ERBB2.,PUBMED,2018,Clin Cancer Res,"FUNCTIONAL, PREDICTIVE",0.04418522446094026
2307,5,An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.,PUBMED,2016,Nat Med,"ONCOGENIC, PREDICTIVE, PROGNOSTIC",0.04418522446094026
4185,5,Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.,PUBMED,2011,J Biol Chem,FUNCTIONAL,0.04418522446094026
4178,5,Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.,PUBMED,2017,Brain Tumor Pathol,DIAGNOSTIC,0.04418522446094026
2204,5,Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.,PUBMED,2008,Blood,PREDISPOSING,0.04418522446094026
1336,5,Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.04418522446094026
2316,5,Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green.,PUBMED,2013,Fam Cancer,PREDISPOSING,0.04418522446094026
2311,5,Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease.,PUBMED,2013,Clin Transl Oncol,PREDISPOSING,0.04418522446094026
1341,5,"Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.",PUBMED,2015,J Clin Oncol,PREDICTIVE,0.04418522446094026
3517,5,Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.,PUBMED,2000,J Med Genet,PREDISPOSING,0.04418522446094026
3615,5,Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms.,PUBMED,2020,Blood,"ONCOGENIC, PREDICTIVE",0.04418522446094026
4175,5,H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.,PUBMED,2018,Clin Neuropathol,DIAGNOSTIC,0.04418522446094026
4176,5,Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.,PUBMED,2012,Cancer Cell,DIAGNOSTIC,0.04418522446094026
2093,5,"In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants.",PUBMED,2016,BMC Cancer,PREDICTIVE,0.04418522446094026
2124,5,Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.04418522446094026
152,5,Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.,PUBMED,2001,Blood,"DIAGNOSTIC, PROGNOSTIC",0.04418522446094026
154,5,U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.,PUBMED,2012,PLoS One,"DIAGNOSTIC, PROGNOSTIC",0.04418522446094026
60,5,Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.04418522446094026
2143,4,"Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers.",PUBMED,2017,Cancer Discov,PREDICTIVE,0.03534817956875221
3401,4,Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion.,PUBMED,2002,Oncogene,PREDISPOSING,0.03534817956875221
3386,4,von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.,PUBMED,2001,Hum Mol Genet,FUNCTIONAL,0.03534817956875221
818,4,Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.03534817956875221
819,4,Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.,PUBMED,2010,N Engl J Med,PREDICTIVE,0.03534817956875221
4689,4,Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.,PUBMED,2019,Anticancer Drugs,PREDICTIVE,0.03534817956875221
1670,4,Characteristics of lung cancers harboring NRAS mutations.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.03534817956875221
1679,4,Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.03534817956875221
1132,4,The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.03534817956875221
2195,4,CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.,PUBMED,2012,Mod Pathol,DIAGNOSTIC,0.03534817956875221
522,4,The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.,PUBMED,2016,Clin Transl Oncol,"PREDICTIVE, PROGNOSTIC",0.03534817956875221
1136,4,Comprehensive mutation profiling of mucinous gastric carcinoma.,PUBMED,2016,J Pathol,PROGNOSTIC,0.03534817956875221
3662,4,Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.,PUBMED,2000,J Clin Endocrinol Metab,PREDISPOSING,0.03534817956875221
506,4,A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.,PUBMED,2011,Cancer Res,PREDICTIVE,0.03534817956875221
4261,4,Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.,PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.03534817956875221
2620,4,Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.,PUBMED,2016,Haematologica,PREDISPOSING,0.03534817956875221
4200,4,Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.,PUBMED,2017,Proc Natl Acad Sci U S A,ONCOGENIC,0.03534817956875221
850,4,Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.,PUBMED,2012,Lancet Oncol,PREDICTIVE,0.03534817956875221
846,4,The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.,PUBMED,2012,BMC Cancer,PREDICTIVE,0.03534817956875221
2632,4,Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T).,PUBMED,2017,Curr Genomics,PREDISPOSING,0.03534817956875221
186,4,"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.",PUBMED,2014,PLoS Genet,PREDICTIVE,0.03534817956875221
3128,4,Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.03534817956875221
3103,4,The genomic landscape of hepatoblastoma and their progenies with HCC-like features.,PUBMED,2014,J Hepatol,DIAGNOSTIC,0.03534817956875221
192,4,Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.03534817956875221
3083,4,Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.03534817956875221
4487,4,Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.,PUBMED,2012,Proc Natl Acad Sci U S A,"FUNCTIONAL, ONCOGENIC",0.03534817956875221
514,4,Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.,PUBMED,2005,N Engl J Med,PREDICTIVE,0.03534817956875221
686,4,Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.,PUBMED,2014,Cell Rep,PREDICTIVE,0.03534817956875221
337,4,CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.,PUBMED,2009,Oncogene,PREDICTIVE,0.03534817956875221
2060,4,"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.",PUBMED,2006,Blood,PREDICTIVE,0.03534817956875221
2079,4,Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations.,PUBMED,2012,J Thorac Oncol,PREDICTIVE,0.03534817956875221
661,4,Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu.,PUBMED,2012,Lung Cancer,PREDICTIVE,0.03534817956875221
3626,4,"Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.",PUBMED,2015,Cancer Cell,"DIAGNOSTIC, PROGNOSTIC",0.03534817956875221
2092,4,Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.,PUBMED,2016,Cell Commun Signal,PREDICTIVE,0.03534817956875221
3622,4,Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.,PUBMED,2016,Nat Commun,"DIAGNOSTIC, ONCOGENIC, PREDICTIVE, PROGNOSTIC",0.03534817956875221
708,4,"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.",PUBMED,2010,Lancet,PREDICTIVE,0.03534817956875221
2366,4,Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients.,PUBMED,2005,Haematologica,PREDISPOSING,0.03534817956875221
3576,4,Novel genotype-phenotype correlations in five Chinese families with Von Hippel-Lindau disease.,PUBMED,2018,Endocr Connect,PREDISPOSING,0.03534817956875221
3580,4,VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.,PUBMED,2007,Brain,PREDISPOSING,0.03534817956875221
3562,4,Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.,PUBMED,2009,Blood,PROGNOSTIC,0.03534817956875221
4718,4,"Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.",PUBMED,2021,Acta Neuropathol Commun,DIAGNOSTIC,0.03534817956875221
3559,4,New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.,PUBMED,2016,Cell,"DIAGNOSTIC, ONCOGENIC",0.03534817956875221
3528,4,Molecular analysis of two uncharacterized sequence variants of the VHL gene.,PUBMED,2006,J Hum Genet,PREDISPOSING,0.03534817956875221
2109,4,Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6.,PUBMED,2016,Blood,PREDICTIVE,0.03534817956875221
2105,4,Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors.,PUBMED,2013,Med Oncol,PREDICTIVE,0.03534817956875221
744,4,"ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.",PUBMED,2012,Oncology,PROGNOSTIC,0.03534817956875221
2113,4,Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.03534817956875221
739,4,SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.,PUBMED,1998,N Engl J Med,"DIAGNOSTIC, PROGNOSTIC",0.03534817956875221
4201,4,Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.,PUBMED,2010,Nat Genet,FUNCTIONAL,0.03534817956875221
4183,4,Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes.,PUBMED,2015,Acta Neuropathol,"DIAGNOSTIC, ONCOGENIC, PROGNOSTIC",0.03534817956875221
4177,4,Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity.,PUBMED,2016,Acta Neuropathol,DIAGNOSTIC,0.03534817956875221
2517,4,"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.",PUBMED,2018,Lancet Oncol,PREDICTIVE,0.03534817956875221
178,4,CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.,PUBMED,2014,Cancer Cell,PREDICTIVE,0.03534817956875221
3428,4,Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations.,PUBMED,2020,Blood Adv,PREDICTIVE,0.03534817956875221
3553,4,Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.,PUBMED,2016,Blood,"DIAGNOSTIC, PROGNOSTIC",0.03534817956875221
4462,4,The Endothelial Landscape and Its Role in Von Hippel-Lindau Disease.,PUBMED,2021,Cells,PREDISPOSING,0.03534817956875221
1421,4,Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: implications for disease progression and therapeutic response.,PUBMED,2002,Oncogene,PREDICTIVE,0.03534817956875221
1420,4,"Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.",PUBMED,2000,Blood,PREDICTIVE,0.03534817956875221
1419,4,Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors.,PUBMED,2005,Blood,PREDICTIVE,0.03534817956875221
1418,4,High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.,PUBMED,2001,Hum Mutat,PREDICTIVE,0.03534817956875221
4424,4,The integrated landscape of driver genomic alterations in glioblastoma.,PUBMED,2013,Nat Genet,"ONCOGENIC, PREDICTIVE",0.03534817956875221
1417,4,"Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation.",PUBMED,2009,J Exp Clin Cancer Res,PREDICTIVE,0.03534817956875221
4416,4,Germline Pathogenic Variants Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma.,PUBMED,2021,J Kidney Cancer VHL,PREDISPOSING,0.03534817956875221
1444,4,PIK3CA mutation associates with improved outcome in breast cancer.,PUBMED,2009,Clin Cancer Res,PROGNOSTIC,0.03534817956875221
4414,4,Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma.,PUBMED,2021,Cancers (Basel),PREDISPOSING,0.03534817956875221
1432,4,"Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.",PUBMED,2011,PLoS One,PREDICTIVE,0.03534817956875221
1424,4,An integrated genomic analysis of human glioblastoma multiforme.,PUBMED,2008,Science,PREDICTIVE,0.03534817956875221
2876,4,PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.,PUBMED,2019,Nat Genet,"DIAGNOSTIC, ONCOGENIC",0.03534817956875221
212,4,"PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.",PUBMED,2013,Anticancer Res,PREDICTIVE,0.03534817956875221
2867,4,Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.,PUBMED,2018,N Engl J Med,PREDICTIVE,0.03534817956875221
2855,4,Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.,PUBMED,2018,Science,PREDICTIVE,0.03534817956875221
2680,4,Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.,PUBMED,2014,Nat Genet,DIAGNOSTIC,0.03534817956875221
1020,4,"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.",PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.03534817956875221
1004,4,"The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.",PUBMED,2013,J Transl Med,PREDICTIVE,0.03534817956875221
1006,4,"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.",PUBMED,2016,Blood,PROGNOSTIC,0.03534817956875221
4762,4,Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.03534817956875221
4821,4,Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.03534817956875221
2705,4,PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.,PUBMED,2002,J Clin Oncol,"DIAGNOSTIC, PROGNOSTIC",0.03534817956875221
1027,4,Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.,PUBMED,2016,Oncology,"PREDICTIVE, PROGNOSTIC",0.03534817956875221
275,4,Integrated molecular analysis of clear-cell renal cell carcinoma.,PUBMED,2013,Nat Genet,"PREDISPOSING, PROGNOSTIC",0.03534817956875221
1036,4,Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.03534817956875221
257,4,Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.,PUBMED,2012,Proc Natl Acad Sci U S A,ONCOGENIC,0.03534817956875221
2863,4,"The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers.",ASCO,2017,"J Clin Oncol 35, 2017 (suppl; abstr LBA2501)",PREDICTIVE,0.03534817956875221
4964,4,Genetic heterogeneity of diffuse large B-cell lymphoma.,PUBMED,2013,Proc Natl Acad Sci U S A,ONCOGENIC,0.03534817956875221
882,4,Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.,PUBMED,2016,Nat Genet,"DIAGNOSTIC, ONCOGENIC, PROGNOSTIC",0.03534817956875221
4533,4,KDM6 Demethylases Integrate DNA Repair Gene Regulation: Loss of KDM6A Sensitizes AML to PARP Inhibition and Potentiates with BCL2 Blockade,ASH,2021,Blood,PREDICTIVE,0.03534817956875221
1555,4,Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.,PUBMED,2000,Cancer Res,PREDICTIVE,0.03534817956875221
476,4,BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.03534817956875221
468,4,Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.,PUBMED,2016,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.03534817956875221
4353,4,Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging F√∂rster resonance energy transfer.,PUBMED,2015,Acc Chem Res,FUNCTIONAL,0.03534817956875221
4329,4,Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.,PUBMED,2018,Mod Pathol,DIAGNOSTIC,0.03534817956875221
4330,4,Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.,PUBMED,2018,Structure,FUNCTIONAL,0.03534817956875221
3032,4,Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.,PUBMED,2012,Blood,PREDICTIVE,0.03534817956875221
919,4,The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.03534817956875221
1488,4,Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.03534817956875221
1501,4,Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.,PUBMED,2010,J Clin Oncol,PREDICTIVE,0.03534817956875221
2889,4,Effectiveness of EGFR-TKIs in a Patient with Lung Adenocarcinoma Harboring an EGFR-RAD51 Fusion.,PUBMED,2019,Oncologist,"ONCOGENIC, PREDICTIVE",0.03534817956875221
2973,4,"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.03534817956875221
2961,4,TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 5005)",PREDICTIVE,0.03534817956875221
2967,4,"Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization.",PUBMED,2019,Clin Cancer Res,PROGNOSTIC,0.03534817956875221
2956,4,Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.,PUBMED,2019,Eur Urol,PREDICTIVE,0.03534817956875221
1422,4,"Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.",PUBMED,2006,Blood,PREDICTIVE,0.03534817956875221
4858,4,The genomic landscape of pediatric acute lymphoblastic leukemia.,PUBMED,2022,Nat Genet,"DIAGNOSTIC, ONCOGENIC",0.03534817956875221
926,4,Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.,PUBMED,2015,JAMA Otolaryngol Head Neck Surg,PREDICTIVE,0.03534817956875221
932,4,Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.,PUBMED,2014,Pigment Cell Melanoma Res,PREDICTIVE,0.03534817956875221
2303,4,Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients.,PUBMED,1998,Hum Mutat,PREDISPOSING,0.03534817956875221
2925,4,The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.,PUBMED,2018,Cancer,PREDICTIVE,0.03534817956875221
220,4,"Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.",PUBMED,1999,J Pathol,PROGNOSTIC,0.03534817956875221
231,4,Alterations of the Notch pathway in lung cancer.,PUBMED,2009,Proc Natl Acad Sci U S A,PROGNOSTIC,0.03534817956875221
984,4,"Taselisib (GDC-0032), a Potent Œ≤-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.03534817956875221
1066,4,"PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs.",PUBMED,2011,Oncogene,PREDICTIVE,0.03534817956875221
2397,4,An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.,PUBMED,2017,Cancer Discov,PREDICTIVE,0.03534817956875221
1316,4,"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.",PUBMED,2015,Nat Genet,"FUNCTIONAL, PREDISPOSING",0.03534817956875221
3879,4,Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.,PUBMED,2019,Blood,"PREDICTIVE, PROGNOSTIC",0.03534817956875221
1233,4,"Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models.",PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.03534817956875221
568,4,Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.03534817956875221
594,4,Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial.,PUBMED,2012,Lancet Oncol,PREDICTIVE,0.03534817956875221
53,4,Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.,PUBMED,2011,Oncotarget,"DIAGNOSTIC, PREDICTIVE, PROGNOSTIC",0.03534817956875221
136,4,Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.,PUBMED,2009,Blood,PROGNOSTIC,0.03534817956875221
134,4,Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.,PUBMED,2011,Leukemia,PROGNOSTIC,0.03534817956875221
1331,4,Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.03534817956875221
86,4,Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.,PUBMED,2012,J Clin Oncol,PROGNOSTIC,0.03534817956875221
2044,4,"Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.",PUBMED,2013,Lancet,PREDICTIVE,0.03534817956875221
4038,4,Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors.,PUBMED,1999,J Natl Cancer Inst,FUNCTIONAL,0.03534817956875221
2388,4,Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.03534817956875221
2046,4,Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.03534817956875221
2499,4,"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.",PUBMED,2010,Blood,"ONCOGENIC, PROGNOSTIC",0.03534817956875221
2033,4,An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.,PUBMED,2003,Clin Cancer Res,PREDICTIVE,0.03534817956875221
2403,4,BAP1 loss defines a new class of renal cell carcinoma.,PUBMED,2012,Nat Genet,"PREDICTIVE, PREDISPOSING",0.03534817956875221
38,4,IDH1 and IDH2 mutations in gliomas.,PUBMED,2009,N Engl J Med,PROGNOSTIC,0.03534817956875221
1272,4,CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.,PUBMED,2015,Int J Clin Exp Med,PREDISPOSING,0.03534817956875221
2022,4,Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.,PUBMED,2016,Oncotarget,PREDICTIVE,0.03534817956875221
1270,4,Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.,PUBMED,2014,Hepatology,"DIAGNOSTIC, PREDICTIVE",0.03534817956875221
4029,4,Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.,PUBMED,2017,Orphanet J Rare Dis,PREDISPOSING,0.03534817956875221
103,4,Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.03534817956875221
5199,4,CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.,PUBMED,2024,Nature,PREDICTIVE,0.03534817956875221
1208,4,Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.03534817956875221
1324,4,Recurrent PTPRB and PLCG1 mutations in angiosarcoma.,PUBMED,2014,Nat Genet,"DIAGNOSTIC, FUNCTIONAL, PREDICTIVE",0.03534817956875221
1239,4,"Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.",PUBMED,2011,Lancet Oncol,PREDICTIVE,0.03534817956875221
3826,4,Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.,PUBMED,2014,APMIS,PREDISPOSING,0.03534817956875221
3949,4,"Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report.",PUBMED,2020,Ther Adv Respir Dis,PREDICTIVE,0.03534817956875221
118,4,"The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.",PUBMED,2010,Blood,"PREDICTIVE, PROGNOSTIC",0.03534817956875221
113,4,Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).,PUBMED,2006,Blood,"DIAGNOSTIC, PROGNOSTIC",0.03534817956875221
3827,4,Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.,PUBMED,2010,Cancer Genet Cytogenet,PREDISPOSING,0.03534817956875221
3965,4,Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.,PUBMED,2012,Nature,DIAGNOSTIC,0.03534817956875221
3786,4,Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors.,PUBMED,2021,Clin Cancer Res,PREDICTIVE,0.03534817956875221
5183,4,Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin.,PUBMED,2020,Cancers (Basel),PREDICTIVE,0.03534817956875221
119,4,Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.,PUBMED,2011,Sci Transl Med,PREDICTIVE,0.03534817956875221
1477,3,Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.,PUBMED,2009,N Engl J Med,PREDICTIVE,0.02651113467656416
3144,3,"Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09).",PUBMED,2020,J Clin Oncol,PREDICTIVE,0.02651113467656416
1482,3,"PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.",PUBMED,2010,Pigment Cell Melanoma Res,PREDICTIVE,0.02651113467656416
1064,3,Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.02651113467656416
4470,3,Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity.,PUBMED,2021,Transl Oncol,PREDICTIVE,0.02651113467656416
2226,3,Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico.,PUBMED,2010,Clin Exp Ophthalmol,PREDISPOSING,0.02651113467656416
2230,3,Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma.,PUBMED,2011,Clin Genet,PREDISPOSING,0.02651113467656416
2642,3,VHL gene mutation analysis of a Chinese family with non- syndromic pheochromocytomas and patients with apparently sporadic pheochromocytoma.,PUBMED,2015,Asian Pac J Cancer Prev,PREDISPOSING,0.02651113467656416
2234,3,Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.,PUBMED,2017,Eur Urol,PREDICTIVE,0.02651113467656416
3006,3,Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.,PUBMED,2017,Br J Cancer,"FUNCTIONAL, PREDICTIVE",0.02651113467656416
3155,3,"Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial.",PUBMED,2020,Lancet Respir Med,PREDICTIVE,0.02651113467656416
4562,3,Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.,PUBMED,2004,J Med Genet,FUNCTIONAL,0.02651113467656416
2999,3,Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.02651113467656416
1492,3,COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.,PUBMED,2010,Nature,PREDICTIVE,0.02651113467656416
3812,3,Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.,PUBMED,2017,J Natl Cancer Inst,PREDICTIVE,0.02651113467656416
1393,3,The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.02651113467656416
6,3,Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.,PUBMED,2014,J Clin Invest,PREDICTIVE,0.02651113467656416
1495,3,The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.,PUBMED,2012,Cancer,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
1494,3,BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.,PUBMED,2008,J Clin Endocrinol Metab,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
5135,3,Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3Œ≤/FBW7-mediated Mcl-1 destabilization.,PUBMED,2020,Cell Death Dis,PREDICTIVE,0.02651113467656416
2975,3,Durable Response to Afatinib in Lung Adenocarcinoma¬†Harboring NRG1 Gene Fusions.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.02651113467656416
943,3,Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.02651113467656416
142,3,TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.,PUBMED,2012,J Clin Oncol,PROGNOSTIC,0.02651113467656416
2959,3,"NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.02651113467656416
1474,3,PIK3CA mutation is predictive of poor survival in patients with colorectal cancer.,PUBMED,2007,Int J Cancer,PROGNOSTIC,0.02651113467656416
3929,3,Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.,PUBMED,2015,PLoS One,DIAGNOSTIC,0.02651113467656416
3862,3,Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.,PUBMED,2007,Neoplasma,PREDISPOSING,0.02651113467656416
2347,3,Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.,PUBMED,2015,Urol Oncol,PREDISPOSING,0.02651113467656416
210,3,Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.,PUBMED,2007,Lung Cancer,PROGNOSTIC,0.02651113467656416
2473,3,Routine EGFR molecular analysis in non-small-cell lung cancer patients is feasible: exons 18-21 sequencing results of 753 patients and subsequent clinical outcomes.,PUBMED,2013,Lung,PREDICTIVE,0.02651113467656416
3065,3,Optimization of Next-Generation Sequencing Technologies for von Hippel Lindau (VHL) Mosaic Mutation Detection and Development of Confirmation Methods.,PUBMED,2019,J Mol Diagn,PREDISPOSING,0.02651113467656416
3066,3,Exploring the hereditary background of renal cancer in Denmark.,PUBMED,2019,PLoS One,PREDISPOSING,0.02651113467656416
1369,3,Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.,PUBMED,2005,BMC Cancer,ONCOGENIC,0.02651113467656416
204,3,IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.,PUBMED,2012,Ann Hematol,PROGNOSTIC,0.02651113467656416
866,3,Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors.,PUBMED,2015,Proc Natl Acad Sci U S A,PREDICTIVE,0.02651113467656416
867,3,PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations.,PUBMED,2015,Proc Natl Acad Sci U S A,PREDICTIVE,0.02651113467656416
595,3,"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.",PUBMED,2012,Lancet Oncol,PREDICTIVE,0.02651113467656416
3049,3,Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.,PUBMED,2017,JCO Precis Oncol,PREDICTIVE,0.02651113467656416
3045,3,Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.,PUBMED,2014,Nat Commun,PREDICTIVE,0.02651113467656416
2343,3,Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.,PUBMED,2014,PLoS One,PREDISPOSING,0.02651113467656416
602,3,Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer.,PUBMED,2014,Cancer,PREDICTIVE,0.02651113467656416
1547,3,"Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.",PUBMED,2011,J Clin Oncol,PREDICTIVE,0.02651113467656416
4540,3,Inhibition of the¬†deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2.,PUBMED,2022,Leukemia,FUNCTIONAL,0.02651113467656416
1919,3,Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer.,PUBMED,2014,Sci Transl Med,PREDICTIVE,0.02651113467656416
4538,3,Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.,PUBMED,2008,Proc Natl Acad Sci U S A,FUNCTIONAL,0.02651113467656416
4349,3,Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.,PUBMED,2002,Eur J Hum Genet,ONCOGENIC,0.02651113467656416
4351,3,Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.,PUBMED,2002,Cancer Cell,"DIAGNOSTIC, ONCOGENIC",0.02651113467656416
3101,3,Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.,PUBMED,2016,Haematologica,"ONCOGENIC, PREDICTIVE",0.02651113467656416
2475,3,Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.02651113467656416
4338,3,Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.,PUBMED,2006,J Clin Invest,FUNCTIONAL,0.02651113467656416
4345,3,Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.,PUBMED,2020,Lancet Oncol,PREDICTIVE,0.02651113467656416
1960,3,Trametinib with or without vemurafenib in BRAF mutated non-small cell lung cancer.,PUBMED,2015,PLoS One,PREDICTIVE,0.02651113467656416
1210,3,Improved survival with MEK inhibition in BRAF-mutated melanoma.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.02651113467656416
51,3,"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia.",PUBMED,2005,Blood,DIAGNOSTIC,0.02651113467656416
472,3,Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer.,PUBMED,2012,Nat Med,PREDICTIVE,0.02651113467656416
1446,3,PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.,PUBMED,2007,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
114,3,Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.,PUBMED,2005,Blood,"DIAGNOSTIC, PROGNOSTIC",0.02651113467656416
2869,3,"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.",PUBMED,2013,Lancet,PREDICTIVE,0.02651113467656416
133,3,CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.,PUBMED,2004,J Clin Oncol,PROGNOSTIC,0.02651113467656416
130,3,Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.,PUBMED,2005,N Engl J Med,"DIAGNOSTIC, PREDICTIVE, PROGNOSTIC",0.02651113467656416
1470,3,Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.02651113467656416
1253,3,Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.,PUBMED,2013,Clin Pharmacol Ther,PREDICTIVE,0.02651113467656416
4954,3,"Re: ""A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion"" by Wijewardene et al.",PUBMED,2023,Thyroid,PREDICTIVE,0.02651113467656416
124,3,Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.,PUBMED,2008,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
1742,3,Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.,PUBMED,2015,Cancer Res,PREDICTIVE,0.02651113467656416
1268,3,"Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.",PUBMED,2013,Blood,PREDICTIVE,0.02651113467656416
4431,3,Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.,PUBMED,2021,Eur J Med Genet,PREDISPOSING,0.02651113467656416
4427,3,Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.,PUBMED,2016,Cancer Res,PREDICTIVE,0.02651113467656416
4426,3,Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report.,PUBMED,2021,Front Oncol,PREDICTIVE,0.02651113467656416
1735,3,"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.",PUBMED,2005,Proc Natl Acad Sci U S A,PREDICTIVE,0.02651113467656416
139,3,Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.,PUBMED,2000,N Engl J Med,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
1434,3,IDH1 inhibitor shows promising early results.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.02651113467656416
1043,3,Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.02651113467656416
2740,3,Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.02651113467656416
2752,3,"IRS2 copy number gain, KRAS and BRAF mutation status as predictive biomarkers for response to the IGF-1R/IR inhibitor BMS-754807 in colorectal cancer cell lines.",PUBMED,2015,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
2751,3,"Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.",PUBMED,2019,J Clin Oncol,PREDICTIVE,0.02651113467656416
123,3,Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.,PUBMED,2010,JAMA,PREDICTIVE,0.02651113467656416
4816,3,Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.,PUBMED,2016,Genes Chromosomes Cancer,DIAGNOSTIC,0.02651113467656416
100,3,Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.02651113467656416
2251,3,Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.,PUBMED,2011,World J Surg,PREDISPOSING,0.02651113467656416
4799,3,Clinicopathologic features and molecular spectrum of spindle cell and sclerosing rhabdomyosarcomas in the head and neck region.,PUBMED,2018,Int J Clin Exp Pathol,"DIAGNOSTIC, PROGNOSTIC",0.02651113467656416
2819,3,Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways.,PUBMED,2017,Oncotarget,PREDICTIVE,0.02651113467656416
2840,3,Polymorphisms of CDKN1A gene and risk of retinoblastoma.,PUBMED,2013,Carcinogenesis,PREDISPOSING,0.02651113467656416
4786,3,Integrative clinical and molecular characterization of translocation renal cell carcinoma.,PUBMED,2022,Cell Rep,DIAGNOSTIC,0.02651113467656416
93,3,Both BRAF V600E mutation and older age (‚â• 65 years) are associated with recurrent papillary thyroid cancer.,PUBMED,2011,Ann Surg Oncol,"DIAGNOSTIC, PROGNOSTIC",0.02651113467656416
1002,3,"Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.02651113467656416
1021,3,Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition.,PUBMED,2014,Ann Oncol,PREDICTIVE,0.02651113467656416
117,3,Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.,PUBMED,2009,Haematologica,"DIAGNOSTIC, PREDICTIVE, PROGNOSTIC",0.02651113467656416
1028,3,Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.02651113467656416
2917,3,A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib.,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.02651113467656416
232,3,Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.,PUBMED,2012,Clin Cancer Res,PROGNOSTIC,0.02651113467656416
2035,3,Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment.,PUBMED,2013,Genomics,PREDICTIVE,0.02651113467656416
2924,3,SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.02651113467656416
2921,3,Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.,PUBMED,2017,Oncotarget,PREDICTIVE,0.02651113467656416
2934,3,Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation.,PUBMED,2018,JCO Precis Oncol,PREDICTIVE,0.02651113467656416
2654,3,Higher prevalence of novel mutations in VHL gene in Chinese Von Hippel-Lindau disease patients.,PUBMED,2014,Urology,PREDISPOSING,0.02651113467656416
1953,3,Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?,PUBMED,2015,Cancer Chemother Pharmacol,PREDICTIVE,0.02651113467656416
4851,3,NTRK fusions in osteosarcoma are rare and non-functional events.,PUBMED,2020,J Pathol Clin Res,ONCOGENIC,0.02651113467656416
78,3,ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.02651113467656416
1085,3,"Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.",PUBMED,2015,N. Engl. J. Med.,"DIAGNOSTIC, PROGNOSTIC",0.02651113467656416
2300,3,"Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.",PUBMED,1997,Hum Mol Genet,PREDISPOSING,0.02651113467656416
1076,3,Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.,PUBMED,2009,Cancer Res,PREDICTIVE,0.02651113467656416
937,3,The p110Œ± and p110Œ≤ isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.,PUBMED,2012,Genes Dev,PREDICTIVE,0.02651113467656416
79,3,Activating mutations in ALK provide a therapeutic target in neuroblastoma.,PUBMED,2008,Nature,PREDICTIVE,0.02651113467656416
1502,3,Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.,PUBMED,2009,N Engl J Med,PREDICTIVE,0.02651113467656416
1276,3,Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.,PUBMED,2013,Oncotarget,PREDICTIVE,0.02651113467656416
4914,3,"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.",PUBMED,1998,Blood,"DIAGNOSTIC, PROGNOSTIC",0.02651113467656416
4451,3,"Clinical diagnosis, treatment and screening of the VHL gene in three von Hippel-Lindau disease pedigrees.",PUBMED,2020,Exp Ther Med,PREDISPOSING,0.02651113467656416
4466,3,The somatic genomic landscape of glioblastoma.,PUBMED,2013,Cell,ONCOGENIC,0.02651113467656416
2873,3,Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.,PUBMED,2018,Lancet Oncol,PREDICTIVE,0.02651113467656416
4901,3,"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.",PUBMED,2016,Acta Neuropathol,DIAGNOSTIC,0.02651113467656416
2671,3,Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.02651113467656416
2878,3,Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.,PUBMED,2016,Am J Surg Pathol,"DIAGNOSTIC, ONCOGENIC",0.02651113467656416
242,3,A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.,PUBMED,2015,Cancer Cell,PREDICTIVE,0.02651113467656416
2281,3,Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.02651113467656416
2908,3,Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.,PUBMED,2017,J Clin Oncol,PREDICTIVE,0.02651113467656416
963,3,Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.02651113467656416
982,3,Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.,PUBMED,2010,Cell,PREDICTIVE,0.02651113467656416
2295,3,Genetic screening for von Hippel-Lindau gene mutations in non-syndromic pheochromocytoma: low prevalence and false-positives or misdiagnosis indicate a need for caution.,PUBMED,2012,Horm Metab Res,PREDISPOSING,0.02651113467656416
241,3,RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.,PUBMED,2011,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
986,3,A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.02651113467656416
985,3,Elucidating distinct roles for NF1 in melanomagenesis.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.02651113467656416
2890,3,Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.,PUBMED,2008,Cancer Res,"DIAGNOSTIC, FUNCTIONAL, ONCOGENIC",0.02651113467656416
4071,3,Cancer-associated mutations in the protrusion-targeting region of p190RhoGAP impact tumor cell migration.,PUBMED,2016,J Cell Biol,FUNCTIONAL,0.02651113467656416
4077,3,Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.,PUBMED,2021,J Clin Oncol,PROGNOSTIC,0.02651113467656416
2576,3,Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.,PUBMED,2007,Eur J Clin Invest,PREDISPOSING,0.02651113467656416
4143,3,A novel variant of FGFR3 causes proportionate short stature.,PUBMED,2015,Eur J Endocrinol,"FUNCTIONAL, PREDISPOSING",0.02651113467656416
2538,3,ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.,PUBMED,2006,Ann Oncol,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
2529,3,Primary and Metastatic Melanoma With NTRK Fusions.,PUBMED,2018,Am J Surg Pathol,PREDICTIVE,0.02651113467656416
4062,3,Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.,PUBMED,2010,Breast Cancer Res,PREDISPOSING,0.02651113467656416
3381,3,RET Solvent Front Mutations Mediate Acquired¬†Resistance to Selective RET Inhibition in¬†RET-Driven Malignancies.,PUBMED,2020,J Thorac Oncol,PREDICTIVE,0.02651113467656416
2020,3,PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients.,PUBMED,2009,Ann Oncol,PREDICTIVE,0.02651113467656416
2122,3,A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.02651113467656416
3514,3,Characterization of hemangioblastomas of spinal nerves.,PUBMED,2005,Neurosurgery,PREDISPOSING,0.02651113467656416
3525,3,Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.,PUBMED,1997,Ann Oncol,PREDISPOSING,0.02651113467656416
4582,3,,ASCO,,,PREDICTIVE,0.02651113467656416
4016,3,Receptor tyrosine kinases activate canonical WNT/Œ≤-catenin signaling via MAP kinase/LRP6 pathway and direct Œ≤-catenin phosphorylation.,PUBMED,2012,PLoS One,FUNCTIONAL,0.02651113467656416
2116,3,"EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.",PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
747,3,Association studies of FcŒ≥ receptor polymorphisms with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) Trial N9831.,PUBMED,2014,Cancer Immunol Res,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
4628,3,Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial.,PUBMED,2022,Nat Med,PREDICTIVE,0.02651113467656416
2152,3,Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.,PUBMED,2016,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
3369,3,Varying responses of PML-RARA with different genetic mutations to arsenic trioxide.,PUBMED,2016,Blood,PREDICTIVE,0.02651113467656416
1973,3,Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.,PUBMED,2016,Cancer Sci,PREDICTIVE,0.02651113467656416
1174,3,PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3KŒ± Inhibition.,PUBMED,2016,Cancer Cell,PREDICTIVE,0.02651113467656416
1179,3,Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma.,PUBMED,2015,Mol Oncol,PREDICTIVE,0.02651113467656416
2139,3,Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.,PUBMED,2017,Oncotarget,PREDICTIVE,0.02651113467656416
2142,3,Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.,PUBMED,2017,Nat Commun,PREDICTIVE,0.02651113467656416
3699,3,Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.,PUBMED,2004,Blood,"ONCOGENIC, PREDICTIVE",0.02651113467656416
172,3,Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.,PUBMED,2012,Blood,PREDICTIVE,0.02651113467656416
1141,3,"Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling.",PUBMED,2015,Clin Lung Cancer,PREDICTIVE,0.02651113467656416
4734,3,MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.,PUBMED,2011,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
3457,3,Endocrine Manifestations of Von Hippel-Landau Disease.,PUBMED,2019,Indian J Endocrinol Metab,PREDISPOSING,0.02651113467656416
5036,3,A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy.,PUBMED,2019,Transl Oncol,PREDICTIVE,0.02651113467656416
3449,3,Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer.,PUBMED,2018,Cell Rep,PREDICTIVE,0.02651113467656416
3463,3,A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.,PUBMED,1998,Nat Genet,"DIAGNOSTIC, ONCOGENIC",0.02651113467656416
3693,3,Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.02651113467656416
4059,3,Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.,PUBMED,2015,Nat Med,"FUNCTIONAL, PREDICTIVE",0.02651113467656416
3708,3,Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.,PUBMED,2012,Oncotarget,DIAGNOSTIC,0.02651113467656416
356,3,BRAF inhibitor activity in V600R metastatic melanoma.,PUBMED,2013,Eur J Cancer,PREDICTIVE,0.02651113467656416
1286,3,Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.02651113467656416
3620,3,Exploring the role of defective fibronectin matrix assembly in the VHL-associated CNS hemangioblastoma.,PUBMED,2018,Drug Metab Pers Ther,PREDISPOSING,0.02651113467656416
2091,3,BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase.,PUBMED,2015,Leukemia,PREDICTIVE,0.02651113467656416
3966,3,High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts.,PUBMED,2020,Neuro Oncol,DIAGNOSTIC,0.02651113467656416
2095,3,Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.,PUBMED,2007,Haematologica,PREDICTIVE,0.02651113467656416
662,3,HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.,PUBMED,2009,Proc Natl Acad Sci U S A,PREDICTIVE,0.02651113467656416
582,3,Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.,PUBMED,2014,Oncotarget,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
669,3,In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.02651113467656416
2064,3,Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.,PUBMED,2005,PLoS Med,PREDICTIVE,0.02651113467656416
344,3,Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.,PUBMED,2012,Nature,PREDICTIVE,0.02651113467656416
2051,3,Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance.,PUBMED,2011,World J Gastroenterol,PREDICTIVE,0.02651113467656416
3667,3,Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.02651113467656416
3664,3,Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort.,PUBMED,2009,Can Urol Assoc J,PREDISPOSING,0.02651113467656416
3670,3,Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases.,PUBMED,2010,Otol Neurotol,PREDISPOSING,0.02651113467656416
2056,3,A phase 2 trial of dasatinib in advanced melanoma.,PUBMED,2011,Cancer,PREDICTIVE,0.02651113467656416
3968,3,Novel germline mutations in Swedish von Hippel-Lindau disease patients.,PUBMED,1997,Int J Oncol,PREDISPOSING,0.02651113467656416
4747,3,Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.,PUBMED,2018,Mod Pathol,"DIAGNOSTIC, ONCOGENIC, PREDISPOSING",0.02651113467656416
2506,3,Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms.,PUBMED,2017,Head Neck,PREDISPOSING,0.02651113467656416
3534,3,Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre.,PUBMED,2004,Eur J Cancer Prev,PREDISPOSING,0.02651113467656416
3533,3,Ser80Ile mutation and a concurrent Pro25Leu variant of the VHL gene in an extended Hungarian von Hippel-Lindau family.,PUBMED,2008,BMC Med Genet,PREDISPOSING,0.02651113467656416
2004,3,Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.,PUBMED,2010,J Clin Endocrinol Metab,PREDICTIVE,0.02651113467656416
3542,3,von Hippel-Lindau gene mutation in non-syndromic familial pheochromocytomas.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.02651113467656416
2504,3,Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease.,PUBMED,2016,Intern Med,"PREDICTIVE, PREDISPOSING",0.02651113467656416
3898,3,CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic.,PUBMED,2017,Oncogene,FUNCTIONAL,0.02651113467656416
353,3,Improved overall survival in melanoma with combined dabrafenib and trametinib.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.02651113467656416
1731,3,Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells.,PUBMED,2004,Blood,PREDICTIVE,0.02651113467656416
1706,3,Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib.,PUBMED,2016,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
3586,3,Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.,PUBMED,2018,Pathol Res Pract,PREDISPOSING,0.02651113467656416
1708,3,Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.,PUBMED,2016,Oncotarget,PREDICTIVE,0.02651113467656416
1290,3,In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.,PUBMED,2002,Blood,PREDISPOSING,0.02651113467656416
351,3,"RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.",PUBMED,2010,Cancer Res,PREDICTIVE,0.02651113467656416
690,3,Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.02651113467656416
352,3,"Inhibition of mutated, activated BRAF in metastatic melanoma.",PUBMED,2010,N Engl J Med,PREDICTIVE,0.02651113467656416
1315,3,Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.,PUBMED,2015,Nat Genet,PREDISPOSING,0.02651113467656416
2348,3,"A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.",PUBMED,2016,Cancer Res Treat,"DIAGNOSTIC, PREDISPOSING",0.02651113467656416
4657,3,"FIGHT-203, an Ongoing Phase 2 Study of Pemigatinib in Patients With Myeloid/Lymphoid Neoplasms (MLNs) With Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLNFGFR1): A Focus on Centrally Reviewed Clinical and Cytogenetic Responses in Previously Treated Patients",ASH,2022,Blood,PREDICTIVE,0.02651113467656416
5339,3,Anti-Tumor Effects of Gilteritinib on FLT3 Mutations: Insights into Resistance Mechanisms in Ba/F3 Cell Models.,PUBMED,2025,Onco Targets Ther,PREDICTIVE,0.02651113467656416
3323,3,Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.,PUBMED,2016,Blood Cancer J,DIAGNOSTIC,0.02651113467656416
1683,3,2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.,PUBMED,2017,Sci Transl Med,PREDICTIVE,0.02651113467656416
4222,3,Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.,PUBMED,2000,Hum Genet,PREDISPOSING,0.02651113467656416
1681,3,Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.02651113467656416
2363,3,"Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.02651113467656416
2622,3,"Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases.",PUBMED,2018,Oncol Lett,PREDISPOSING,0.02651113467656416
74,3,"Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.",PUBMED,2009,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
4258,3,RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.,PUBMED,2022,Clin Cancer Res,ONCOGENIC,0.02651113467656416
4212,3,The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.,PUBMED,2016,Am J Cancer Res,PREDICTIVE,0.02651113467656416
3244,3,Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma.,PUBMED,2020,J Cell Physiol,PROGNOSTIC,0.02651113467656416
1603,3,Gastrointestinal stromal tumours: origin and molecular oncology.,PUBMED,2011,Nat Rev Cancer,PREDICTIVE,0.02651113467656416
3778,3,Management of renal cell carcinoma in von Hippel-Lindau disease.,PUBMED,1999,Eur J Clin Invest,PREDISPOSING,0.02651113467656416
3780,3,The strength and cooperativity of KIT ectodomain contacts determine normal ligand-dependent stimulation or oncogenic activation in cancer.,PUBMED,2015,Mol Cell,"FUNCTIONAL, PREDICTIVE",0.02651113467656416
640,3,Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212.,PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.02651113467656416
2191,3,"Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.",PUBMED,2016,Lancet Gastroenterol Hepatol,PROGNOSTIC,0.02651113467656416
844,3,KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.,PUBMED,2006,Eur J Cancer,PREDICTIVE,0.02651113467656416
4622,3,"Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.",PUBMED,2016,N Engl J Med,PREDICTIVE,0.02651113467656416
1602,3,Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase.,PUBMED,2004,J Mol Graph Model,PREDICTIVE,0.02651113467656416
1601,3,Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.,PUBMED,2006,Oncogene,PREDICTIVE,0.02651113467656416
1587,3,Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors.,PUBMED,2010,J Cancer Res Clin Oncol,PREDICTIVE,0.02651113467656416
524,3,"Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.",PUBMED,2013,BMC Cancer,PREDICTIVE,0.02651113467656416
1526,3,Non-small-cell lung cancer and Ba/F3 transformed cells harboring the ERBB2 G776insV_G/C mutation are sensitive to the dual-specific epidermal growth factor receptor and ERBB2 inhibitor HKI-272.,PUBMED,2006,Cancer Res,PREDICTIVE,0.02651113467656416
2636,3,Identification of the von Hippel-Lindau disease tumor suppressor gene.,PUBMED,1993,Science,PREDISPOSING,0.02651113467656416
4937,3,The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.,PUBMED,2022,Blood,DIAGNOSTIC,0.02651113467656416
792,3,A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.,PUBMED,2012,Nature,PREDICTIVE,0.02651113467656416
793,3,Prognostic and Predictive Effect of TP53 Mutations in¬†Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials:¬†A LACE-Bio Pooled Analysis.,PUBMED,2016,J Thorac Oncol,"PREDICTIVE, PROGNOSTIC",0.02651113467656416
3787,3,"ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.",PUBMED,2021,Proc Natl Acad Sci U S A,PREDICTIVE,0.02651113467656416
3673,3,Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.,PUBMED,2014,Cancer Res,PREDISPOSING,0.02651113467656416
3349,3,Whole-exome sequencing and immunohistochemistry findings in von Hippel-Lindau disease.,PUBMED,2019,Mol Genet Genomic Med,PREDISPOSING,0.02651113467656416
5355,3,Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer.,PUBMED,2025,N Engl J Med,PREDICTIVE,0.02651113467656416
3348,3,Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.,PUBMED,2017,Oncogene,PREDICTIVE,0.02651113467656416
4939,3,Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.,PUBMED,2018,Nat Commun,ONCOGENIC,0.02651113467656416
3759,3,Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3.,PUBMED,2005,Br J Haematol,"ONCOGENIC, PREDISPOSING",0.02651113467656416
2349,3,Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.,PUBMED,2015,Int J Endocrinol,PREDISPOSING,0.02651113467656416
4946,3,The whole-genome landscape of Burkitt lymphoma subtypes.,PUBMED,2019,Blood,ONCOGENIC,0.02651113467656416
3356,3,Somatic mutations in VHL germline deletion kindred correlate with mild phenotype.,PUBMED,2004,Ann Neurol,PREDISPOSING,0.02651113467656416
1363,2,"AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.",PUBMED,2017,Cancer Discov,PREDICTIVE,0.017674089784376106
2372,2,TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer.,PUBMED,2018,Clin Pharmacol Ther,PREDICTIVE,0.017674089784376106
1367,2,A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.,PUBMED,2016,Nat Commun,PROGNOSTIC,0.017674089784376106
2357,2,Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.017674089784376106
2350,2,Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.,PUBMED,2014,Nature,PREDICTIVE,0.017674089784376106
2383,2,Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).,PUBMED,2015,Oncologist,PREDICTIVE,0.017674089784376106
1334,2,Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs.,PUBMED,2016,Cold Spring Harb Mol Case Stud,"FUNCTIONAL, PREDISPOSING",0.017674089784376106
2384,2,Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.017674089784376106
4752,2,DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.,PUBMED,2017,Gynecol Oncol,"DIAGNOSTIC, PREDISPOSING",0.017674089784376106
1371,2,VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.,PUBMED,2001,Oncogene,ONCOGENIC,0.017674089784376106
267,2,"Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.",PUBMED,2015,Mod Pathol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
269,2,Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.,PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.017674089784376106
2355,2,Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).,PUBMED,2013,PLoS One,PREDICTIVE,0.017674089784376106
2435,2,EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib.,PUBMED,2009,J Cancer Res Clin Oncol,PREDICTIVE,0.017674089784376106
2344,2,Novel mutations in the von Hippel-Lindau gene associated with congenital polycythemia.,PUBMED,2015,Pediatr Blood Cancer,PREDISPOSING,0.017674089784376106
2341,2,VHL mosaicism can be detected by clinical next-generation sequencing and is not restricted to patients with a mild phenotype.,PUBMED,2014,Eur J Hum Genet,PREDISPOSING,0.017674089784376106
1304,2,Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations.,PUBMED,2015,J Immunother Cancer,PREDICTIVE,0.017674089784376106
279,2,Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.,PUBMED,2012,JAMA,PROGNOSTIC,0.017674089784376106
283,2,The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.,PUBMED,2013,Genes Chromosomes Cancer,PROGNOSTIC,0.017674089784376106
2402,2,A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.017674089784376106
1288,2,Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.017674089784376106
4626,2,The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.,PUBMED,2021,Nature,PREDICTIVE,0.017674089784376106
1323,2,Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.,PUBMED,2016,Blood,PREDISPOSING,0.017674089784376106
2359,2,"EGFR Exon 19 Deletion in Pancreatic Adenocarcinoma Responds to Erlotinib, Followed by T790M-Mediated Resistance.",PUBMED,2017,J Natl Compr Canc Netw,PREDICTIVE,0.017674089784376106
1305,2,Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
272,2,The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.,PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.017674089784376106
2417,2,[A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dub√© syndrome treated with molecular-targeting agents].,PUBMED,2013,Hinyokika Kiyo,PREDICTIVE,0.017674089784376106
2369,2,Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.017674089784376106
1283,2,Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
2421,2,RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition.,PUBMED,2018,Clin Cancer Res,PREDICTIVE,0.017674089784376106
4817,2,EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.,PUBMED,2019,Hum Pathol,DIAGNOSTIC,0.017674089784376106
294,2,Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.,PUBMED,2013,Leukemia,PROGNOSTIC,0.017674089784376106
2326,2,Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).,PUBMED,2013,Eur J Haematol,PREDISPOSING,0.017674089784376106
4733,2,Tyrosine receptor kinase B is a drug target in astrocytomas.,PUBMED,2017,Neuro Oncol,"FUNCTIONAL, ONCOGENIC",0.017674089784376106
4673,2,Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test.,PUBMED,2022,Cell Oncol (Dordr),"FUNCTIONAL, ONCOGENIC",0.017674089784376106
2329,2,Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.017674089784376106
2393,2,FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.,PUBMED,2017,Clin Cancer Res,"DIAGNOSTIC, PREDICTIVE",0.017674089784376106
1379,2,Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.,PUBMED,2005,Gastroenterology,"PREDICTIVE, PREDISPOSING",0.017674089784376106
2318,2,Mutation screening in a Norwegian cohort with pheochromocytoma.,PUBMED,2013,Fam Cancer,PREDISPOSING,0.017674089784376106
1330,2,T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.017674089784376106
2310,2,p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees.,PUBMED,2013,Mol Med Rep,PREDISPOSING,0.017674089784376106
1374,2,Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.,PUBMED,2014,Oncogene,PREDICTIVE,0.017674089784376106
2267,2,VHL2C phenotype in a German von Hippel-Lindau family with concurrent VHL germline mutations P81S and L188V.,PUBMED,2002,J Clin Endocrinol Metab,PREDISPOSING,0.017674089784376106
2385,2,EGFR-RAD51 fusion variant in lung adenocarcinoma and response to erlotinib: A case report.,PUBMED,2018,Lung Cancer,PREDICTIVE,0.017674089784376106
2405,2,"Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.",PUBMED,2018,Cancer,PREDICTIVE,0.017674089784376106
2389,2,Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.,PUBMED,2014,Br J Cancer,PREDICTIVE,0.017674089784376106
2387,2,Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib.,PUBMED,2016,J Natl Compr Canc Netw,PREDICTIVE,0.017674089784376106
4719,2,C11orf95-RELA fusions drive oncogenic NF-Œ∫B signalling in ependymoma.,PUBMED,2014,Nature,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
4709,2,MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report.,PUBMED,2022,Transl Lung Cancer Res,PREDICTIVE,0.017674089784376106
2406,2,Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.,PUBMED,2018,Eur J Cancer,PREDICTIVE,0.017674089784376106
2373,2,The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations.,PUBMED,1998,J Intern Med,PREDISPOSING,0.017674089784376106
4688,2,Efficacy of pembrolizumab for patients with both high PD-L1 expression and an MET exon 14 skipping mutation: A case report.,PUBMED,2019,Thorac Cancer,PREDICTIVE,0.017674089784376106
1397,2,High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
1403,2,Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.,PUBMED,2015,JAMA Oncol,PROGNOSTIC,0.017674089784376106
1386,2,Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.017674089784376106
4831,2,Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations: Results From the TAPUR Study.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.017674089784376106
1357,2,Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.,PUBMED,2015,Nature,PREDICTIVE,0.017674089784376106
4741,2,The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.017674089784376106
1345,2,Targeting Akt3 signaling in triple-negative breast cancer.,PUBMED,2014,Cancer Res,PREDICTIVE,0.017674089784376106
4630,2,"Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.",PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1346,2,CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.,PUBMED,2017,Nat Commun,PREDICTIVE,0.017674089784376106
1351,2,Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.,PUBMED,2000,Cancer Res,"FUNCTIONAL, PREDISPOSING",0.017674089784376106
2279,2,Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.,PUBMED,2003,Am J Hum Genet,PREDISPOSING,0.017674089784376106
2338,2,Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.017674089784376106
316,2,Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.,PUBMED,2014,Nat Genet,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
2288,2,Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.,PUBMED,2012,Endocr Relat Cancer,PREDISPOSING,0.017674089784376106
290,2,Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.,PUBMED,2005,Science,DIAGNOSTIC,0.017674089784376106
319,2,TERT promoter mutations in primary and secondary glioblastomas.,PUBMED,2013,Acta Neuropathol,"ONCOGENIC, PROGNOSTIC",0.017674089784376106
4638,2,"Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.017674089784376106
2325,2,Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.,PUBMED,2000,Hum Mutat,PREDISPOSING,0.017674089784376106
308,2,Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.,PUBMED,2011,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
310,2,FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.,PUBMED,2007,Br J Cancer,PROGNOSTIC,0.017674089784376106
296,2,Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.,PUBMED,2004,N Engl J Med,PREDICTIVE,0.017674089784376106
300,2,Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.,PUBMED,2013,Breast Cancer Res Treat,PROGNOSTIC,0.017674089784376106
4647,2,Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib.,PUBMED,2020,Pediatr Blood Cancer,PREDICTIVE,0.017674089784376106
303,2,The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.,PUBMED,2012,Thyroid,PROGNOSTIC,0.017674089784376106
4658,2,"Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.",PUBMED,2020,Am J Hematol,PREDICTIVE,0.017674089784376106
2293,2,Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.,PUBMED,1996,J Med Genet,PREDISPOSING,0.017674089784376106
289,2,Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.,PUBMED,2013,Hum Pathol,DIAGNOSTIC,0.017674089784376106
2287,2,Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial.,PUBMED,2013,Ann Oncol,PREDICTIVE,0.017674089784376106
4995,2,Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.,PUBMED,2024,N Engl J Med,PREDICTIVE,0.017674089784376106
4997,2,Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.,PUBMED,2024,JCO Precis Oncol,PREDICTIVE,0.017674089784376106
4986,2,APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells.,PUBMED,2015,Cell Death Dis,PREDICTIVE,0.017674089784376106
2125,2,Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.017674089784376106
2118,2,Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma.,PUBMED,2014,J Am Acad Dermatol,PREDICTIVE,0.017674089784376106
2107,2,Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.017674089784376106
2110,2,Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors.,PUBMED,2013,Mol Cancer Res,PREDICTIVE,0.017674089784376106
1725,2,Afatinib: first global approval.,PUBMED,2013,Drugs,PREDICTIVE,0.017674089784376106
1730,2,CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.,PUBMED,2017,Cancer Res,PREDICTIVE,0.017674089784376106
1549,2,Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.,PUBMED,1999,J Clin Oncol,PREDICTIVE,0.017674089784376106
1697,2,"Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1700,2,Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
1704,2,Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation.,PUBMED,2015,Cancer Immunol Res,PREDICTIVE,0.017674089784376106
1705,2,Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.,PUBMED,2017,Cancer Discov,PREDICTIVE,0.017674089784376106
1690,2,TRK Inhibitor Shows Early Promise.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
1691,2,An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.017674089784376106
1693,2,Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
1695,2,Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.,PUBMED,2007,Cancer Res,PREDICTIVE,0.017674089784376106
2070,2,Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
1724,2,U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.,PUBMED,2014,Oncologist,PREDICTIVE,0.017674089784376106
2157,2,Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.017674089784376106
2158,2,Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.017674089784376106
2149,2,Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.,PUBMED,2014,Nat Genet,DIAGNOSTIC,0.017674089784376106
2136,2,,PUBMED,,,PREDICTIVE,0.017674089784376106
2137,2,CRAF R391W is a melanoma driver oncogene.,PUBMED,2016,Sci Rep,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
5072,2,Differentiation of NUT midline carcinoma by epigenomic reprogramming.,PUBMED,2011,Cancer Res,PREDICTIVE,0.017674089784376106
5075,2,HER kinase inhibition in patients with HER2- and HER3-mutant cancers.,PUBMED,2018,Nature,PREDICTIVE,0.017674089784376106
5048,2,Prognostic Value of BRAF¬†and¬†KRAS¬†Mutations in MSI and MSS Stage III Colon Cancer.,PUBMED,2017,J Natl Cancer Inst,PROGNOSTIC,0.017674089784376106
181,2,EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.,PUBMED,2004,Science,PREDICTIVE,0.017674089784376106
5018,2,Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.,PUBMED,2010,Blood,DIAGNOSTIC,0.017674089784376106
159,2,Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.,PUBMED,2010,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
160,2,Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.,PUBMED,1999,Cancer Res,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
161,2,"Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.",PUBMED,2012,Clin Cancer Res,DIAGNOSTIC,0.017674089784376106
163,2,PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.017674089784376106
164,2,Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.,PUBMED,2002,Oncogene,PREDICTIVE,0.017674089784376106
165,2,The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase.,PUBMED,2004,Biochem Biophys Res Commun,PREDICTIVE,0.017674089784376106
150,2,Advanced ovarian cancer: what should be the standard of care?,PUBMED,2013,J Gynecol Oncol,PREDICTIVE,0.017674089784376106
157,2,Cyclin D1 in breast cancer pathogenesis.,PUBMED,2005,J Clin Oncol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
5025,2,Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.,PUBMED,2014,Am J Surg Pathol,DIAGNOSTIC,0.017674089784376106
5014,2,Chromothripsis in acute myeloid leukemia: biological features and impact on survival.,PUBMED,2018,Leukemia,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
173,2,Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.,PUBMED,2008,J Natl Cancer Inst,PREDICTIVE,0.017674089784376106
3921,2,Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.,PUBMED,2015,Blood Cancer J,PREDICTIVE,0.017674089784376106
5137,2,The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.,PUBMED,2012,Cancer Discov,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
1755,2,Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1921,2,The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.,PUBMED,2011,J Clin Endocrinol Metab,PREDICTIVE,0.017674089784376106
1922,2,"Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity.",PUBMED,2011,Int J Cancer,PREDICTIVE,0.017674089784376106
5129,2,Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.,PUBMED,2019,Nat Commun,DIAGNOSTIC,0.017674089784376106
5130,2,Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.,PUBMED,2023,Leukemia,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
5088,2,"A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.",PUBMED,2006,Leukemia,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
5117,2,Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.,PUBMED,2021,J Clin Invest,PREDICTIVE,0.017674089784376106
2048,2,Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
148,2,Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.,PUBMED,2009,Cancer,PROGNOSTIC,0.017674089784376106
149,2,Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.,PUBMED,2008,J Clin Oncol,PROGNOSTIC,0.017674089784376106
137,2,Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.,PUBMED,2008,N Engl J Med,PROGNOSTIC,0.017674089784376106
141,2,Impact of FLT3(ITD) mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia.,PUBMED,2014,Blood,PROGNOSTIC,0.017674089784376106
128,2,Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.,PUBMED,2011,Blood,PREDICTIVE,0.017674089784376106
129,2,Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia.,PUBMED,2014,Blood Cancer J,PREDICTIVE,0.017674089784376106
132,2,Genome sequencing identifies a basis for everolimus sensitivity.,PUBMED,2012,Science,PREDICTIVE,0.017674089784376106
121,2,FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).,PUBMED,2005,Blood,PREDICTIVE,0.017674089784376106
5376,2,Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.,PUBMED,2021,Cell Death Dis,PREDICTIVE,0.017674089784376106
144,2,Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.,PUBMED,2005,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
2050,2,c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.,PUBMED,2016,Mol Clin Oncol,PREDICTIVE,0.017674089784376106
1753,2,Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.,PUBMED,2017,Br J Cancer,PREDICTIVE,0.017674089784376106
5181,2,"Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small Molecule Reactivator.",PUBMED,2025,Cancer Discov,PREDICTIVE,0.017674089784376106
5172,2,Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer.,PUBMED,2025,N Engl J Med,PREDICTIVE,0.017674089784376106
5169,2,Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.,PUBMED,2021,Cancer Discov,PREDICTIVE,0.017674089784376106
5160,2,A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.,PUBMED,2009,Cancer Res,"ONCOGENIC, PROGNOSTIC",0.017674089784376106
5147,2,Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study.,PUBMED,2024,J Clin Oncol,PREDICTIVE,0.017674089784376106
5139,2,Fanconi anemia associated protein 20 (FAAP20) plays an essential role in homology-directed repair of DNA double-strand breaks.,PUBMED,2023,Commun Biol,PREDICTIVE,0.017674089784376106
2003,2,Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.017674089784376106
3916,2,"Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.",PUBMED,2014,Endocr Relat Cancer,PREDISPOSING,0.017674089784376106
2007,2,Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade.,PUBMED,2013,Oncogene,PREDICTIVE,0.017674089784376106
1989,2,Erlotinib as first line treatment in a NSCLC patient with choroidal metastasis and with EGFR exon 19 deletion.,PUBMED,2016,J BUON,PREDICTIVE,0.017674089784376106
1992,2,Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET.,PUBMED,2015,EJNMMI Res,PREDICTIVE,0.017674089784376106
1979,2,Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.017674089784376106
5354,2,Trastuzumab deruxtecan for the treatment of metastatic non-small cell lung cancer harboring HER2 non-exon 19/20 mutations: four case reports.,PUBMED,2025,Front Immunol,PREDICTIVE,0.017674089784376106
5356,2,Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer.,PUBMED,2019,Nat Commun,PREDICTIVE,0.017674089784376106
5332,2,"FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.",PUBMED,2021,Breast Cancer Res,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
72,2,DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.,PUBMED,2014,Blood Cells Mol Dis,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
73,2,The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.,PUBMED,2010,Cancer Res,PREDICTIVE,0.017674089784376106
77,2,"CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.",PUBMED,2011,Cancer Cell,PREDICTIVE,0.017674089784376106
2006,2,"Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1.",PUBMED,2012,Proc Natl Acad Sci U S A,PREDICTIVE,0.017674089784376106
239,2,The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.,PUBMED,2002,N Engl J Med,DIAGNOSTIC,0.017674089784376106
222,2,Cyclin E in human cancers.,PUBMED,1999,FASEB J,PROGNOSTIC,0.017674089784376106
4884,2,Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 Gene.,PUBMED,2021,JTO Clin Res Rep,PREDICTIVE,0.017674089784376106
4850,2,A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation.,PUBMED,2014,Mol Cancer Ther,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
4841,2,Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.,PUBMED,2022,J Clin Oncol,PREDICTIVE,0.017674089784376106
4843,2,Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.,PUBMED,2014,Cancer Discov,DIAGNOSTIC,0.017674089784376106
4844,2,Evolving classification of rhabdomyosarcoma.,PUBMED,2022,Histopathology,DIAGNOSTIC,0.017674089784376106
4825,2,Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.,PUBMED,2019,JCO Precis Oncol,PREDICTIVE,0.017674089784376106
1513,2,First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.017674089784376106
1657,2,"Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.",PUBMED,2016,J Pathol,DIAGNOSTIC,0.017674089784376106
1499,2,"Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.",PUBMED,2012,Neuro Oncol,PREDICTIVE,0.017674089784376106
1500,2,"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.",PUBMED,2012,Lancet,PREDICTIVE,0.017674089784376106
1481,2,BRAF mutation in metastatic colorectal cancer.,PUBMED,2009,N Engl J Med,PREDICTIVE,0.017674089784376106
2232,2,Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.,PUBMED,2017,Blood,PREDICTIVE,0.017674089784376106
2236,2,"Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.",PUBMED,2017,J Natl Compr Canc Netw,PREDICTIVE,0.017674089784376106
2219,2,Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.,PUBMED,2009,J Clin Endocrinol Metab,PREDISPOSING,0.017674089784376106
2208,2,MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.,PUBMED,2016,Nat Commun,PREDICTIVE,0.017674089784376106
2210,2,Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.,PUBMED,2009,Neurol Res,PREDISPOSING,0.017674089784376106
1561,2,LKB1 regulated pathways in lung cancer invasion and metastasis.,PUBMED,2010,J Thorac Oncol,PREDICTIVE,0.017674089784376106
1515,2,"PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib.",PUBMED,2007,Cancer Res,PREDICTIVE,0.017674089784376106
256,2,Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.,PUBMED,2010,Nat Genet,DIAGNOSTIC,0.017674089784376106
259,2,Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.,PUBMED,2014,N Engl J Med,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
4808,2,BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.,PUBMED,2016,Am J Surg Pathol,DIAGNOSTIC,0.017674089784376106
4811,2,Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.,PUBMED,2013,Cancer Sci,DIAGNOSTIC,0.017674089784376106
4814,2,Recurrent rearrangements of FOS and FOSB define osteoblastoma.,PUBMED,2018,Nat Commun,DIAGNOSTIC,0.017674089784376106
4815,2,Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.,PUBMED,1994,Br J Cancer,DIAGNOSTIC,0.017674089784376106
4801,2,Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.017674089784376106
4804,2,Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor.,PUBMED,2020,Clin Sarcoma Res,"DIAGNOSTIC, PREDICTIVE",0.017674089784376106
4806,2,Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.,PUBMED,2014,Genes Chromosomes Cancer,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
235,2,Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.,PUBMED,2013,Am J Hematol,PROGNOSTIC,0.017674089784376106
4782,2,Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.,PUBMED,2018,Pathol Oncol Res,DIAGNOSTIC,0.017674089784376106
4785,2,TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.,PUBMED,2016,Am J Surg Pathol,DIAGNOSTIC,0.017674089784376106
2260,2,Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.,PUBMED,2011,Am J Med Genet A,PREDISPOSING,0.017674089784376106
2249,2,Conservative management of endolymphatic sac tumors in von Hippel-Lindau disease: case report.,PUBMED,2011,Acta Neurochir (Wien),PREDISPOSING,0.017674089784376106
4900,2,MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.,PUBMED,2010,Acta Neuropathol,DIAGNOSTIC,0.017674089784376106
4905,2,Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.,PUBMED,2020,Acta Neuropathol,DIAGNOSTIC,0.017674089784376106
4906,2,A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.,PUBMED,2019,Acta Neuropathol,DIAGNOSTIC,0.017674089784376106
249,2,Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.,PUBMED,2013,Clin Cancer Res,PROGNOSTIC,0.017674089784376106
250,2,TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.,PUBMED,2011,J Clin Oncol,PROGNOSTIC,0.017674089784376106
251,2,Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.,PUBMED,1997,Blood,PROGNOSTIC,0.017674089784376106
4790,2,YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.,PUBMED,2021,Mod Pathol,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
4952,2,Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.,PUBMED,2013,Proc Natl Acad Sci U S A,ONCOGENIC,0.017674089784376106
4953,2,Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene.,PUBMED,1997,Oncogene,ONCOGENIC,0.017674089784376106
4958,2,Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.,PUBMED,2024,JCO Precis Oncol,PREDICTIVE,0.017674089784376106
4919,2,A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.,PUBMED,2021,Cancers (Basel),PREDICTIVE,0.017674089784376106
4907,2,Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.,PUBMED,2013,Proc Natl Acad Sci U S A,DIAGNOSTIC,0.017674089784376106
1544,2,Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.,PUBMED,2010,Br J Cancer,ONCOGENIC,0.017674089784376106
1519,2,"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.",PUBMED,2010,Nat Rev Cancer,PREDICTIVE,0.017674089784376106
1520,2,Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain.,PUBMED,2005,PLoS Med,PREDICTIVE,0.017674089784376106
1521,2,Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.,PUBMED,2005,J Natl Cancer Inst,PREDICTIVE,0.017674089784376106
1562,2,Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.,PUBMED,2002,Cancer Res,PREDICTIVE,0.017674089784376106
1612,2,Targeting targeted therapy.,PUBMED,2004,N Engl J Med,PREDICTIVE,0.017674089784376106
2188,2,Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.,PUBMED,1995,J Med Genet,PREDISPOSING,0.017674089784376106
2194,2,Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.,PUBMED,2017,Blood,PREDICTIVE,0.017674089784376106
2184,2,Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations.,PUBMED,1995,Cancer Res,PREDISPOSING,0.017674089784376106
2167,2,Drug-sensitive FGFR3 mutations in lung adenocarcinoma.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.017674089784376106
2168,2,Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA.,PUBMED,2015,Oncotarget,PREDICTIVE,0.017674089784376106
1687,2,NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.,PUBMED,2015,Nat Med,PREDICTIVE,0.017674089784376106
1688,2,SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1672,2,PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer.,PUBMED,2015,J Thorac Oncol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
1624,2,A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.,PUBMED,2013,N Engl J Med,PREDICTIVE,0.017674089784376106
1563,2,Somatic mutations affect key pathways in lung adenocarcinoma.,PUBMED,2008,Nature,PREDICTIVE,0.017674089784376106
1569,2,Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.,PUBMED,2010,Cancer Res,PREDICTIVE,0.017674089784376106
1574,2,Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684.,PUBMED,2011,Biochem J,PREDICTIVE,0.017674089784376106
1580,2,Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1548,2,Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.,PUBMED,1999,J Natl Cancer Inst,PREDICTIVE,0.017674089784376106
1241,2,"Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA.",PUBMED,2014,Exp Hematol,PREDICTIVE,0.017674089784376106
1550,2,K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.,PUBMED,1990,N Engl J Med,PREDICTIVE,0.017674089784376106
1559,2,LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.,PUBMED,2009,Br J Cancer,PREDICTIVE,0.017674089784376106
1560,2,Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.,PUBMED,2004,Oncogene,PREDICTIVE,0.017674089784376106
191,2,L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.,PUBMED,2007,Int J Cancer,PREDICTIVE,0.017674089784376106
4978,2,Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.,PUBMED,2016,Genes Chromosomes Cancer,ONCOGENIC,0.017674089784376106
4967,2,Inactivating mutations of acetyltransferase genes in B-cell lymphoma.,PUBMED,2011,Nature,ONCOGENIC,0.017674089784376106
4973,2,Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.,PUBMED,2001,Nature,ONCOGENIC,0.017674089784376106
4960,2,Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.,PUBMED,2017,Nat Genet,DIAGNOSTIC,0.017674089784376106
216,2,The prognostic significance of IDH2 mutations in AML depends on the location of the mutation.,PUBMED,2011,Blood,PROGNOSTIC,0.017674089784376106
202,2,Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis.,PUBMED,2012,Leuk Lymphoma,PROGNOSTIC,0.017674089784376106
193,2,Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.,PUBMED,2008,Nat Med,PREDICTIVE,0.017674089784376106
194,2,MGMT gene silencing and benefit from temozolomide in glioblastoma.,PUBMED,2005,N Engl J Med,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
195,2,The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.017674089784376106
199,2,p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.,PUBMED,2012,Cancer Cell,PREDICTIVE,0.017674089784376106
4991,2,The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.,PUBMED,2024,Nat Med,PREDICTIVE,0.017674089784376106
791,2,Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer.,PUBMED,2015,Br J Cancer,PREDICTIVE,0.017674089784376106
778,2,A novel BRCA1 mutation in a patient with breast and ovarian cancer: A case report.,PUBMED,2013,Oncol Lett,PREDISPOSING,0.017674089784376106
783,2,Lapatinib plus capecitabine for HER2-positive advanced breast cancer.,PUBMED,2006,N Engl J Med,PREDICTIVE,0.017674089784376106
769,2,Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.,PUBMED,2015,Mol Cancer,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
774,2,CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine.,PUBMED,2016,Oncotarget,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
775,2,MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.,PUBMED,2015,Carcinogenesis,PROGNOSTIC,0.017674089784376106
764,2,KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.,PUBMED,2009,Cancer Res,PREDICTIVE,0.017674089784376106
3384,2,Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas.,PUBMED,2008,Aviat Space Environ Med,PREDISPOSING,0.017674089784376106
3378,2,MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.,PUBMED,2016,Mod Pathol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
801,2,Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.,PUBMED,2016,Oncotarget,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
5097,2,Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer.,PUBMED,2024,Cancer Cell,PREDICTIVE,0.017674089784376106
794,2,Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.,PUBMED,2016,Nat Commun,PREDICTIVE,0.017674089784376106
796,2,MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
3308,2,ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.,PUBMED,2017,J Cancer,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3317,2,Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-Œ∫B activation.,PUBMED,2020,J Exp Clin Cancer Res,PROGNOSTIC,0.017674089784376106
3332,2,"Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia.",PUBMED,2017,Invest New Drugs,PREDICTIVE,0.017674089784376106
3333,2,,PUBMED,,,PREDICTIVE,0.017674089784376106
3337,2,"A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations.",PUBMED,2018,Blood,PREDICTIVE,0.017674089784376106
3338,2,MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer.,PUBMED,2012,Cancer Biol Ther,PREDICTIVE,0.017674089784376106
3302,2,Mutational processes shape the landscape of TP53 mutations in human cancer.,PUBMED,2018,Nat Genet,FUNCTIONAL,0.017674089784376106
3245,2,"HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor.",PUBMED,2015,J Natl Compr Canc Netw,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3215,2,A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure.,PUBMED,2018,Onco Targets Ther,PREDICTIVE,0.017674089784376106
803,2,Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
731,2,PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.017674089784376106
3502,2,Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma.,PUBMED,2019,Br J Haematol,PREDICTIVE,0.017674089784376106
3482,2,Sequencing of Von Hippel-Lindau (VHL) Gene from Genomic DNA for Mutation Detection in Italian Patients.,PUBMED,2006,EJIFCC,PREDISPOSING,0.017674089784376106
4186,2,The DNA-binding domain mediates both nuclear and cytosolic functions of p53.,PUBMED,2014,Nat Struct Mol Biol,FUNCTIONAL,0.017674089784376106
4173,2,High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.,PUBMED,2015,Acta Neuropathol,DIAGNOSTIC,0.017674089784376106
556,2,CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
558,2,MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.,PUBMED,2015,Br J Cancer,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
551,2,KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.,PUBMED,2015,Cancer Res,PREDICTIVE,0.017674089784376106
543,2,ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy.,PUBMED,2015,J Urol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
544,2,A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.,PUBMED,2016,Int J Cancer,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
535,2,Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.,PUBMED,2011,Br J Cancer,PREDICTIVE,0.017674089784376106
790,2,Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.,PUBMED,2013,Nature,PREDICTIVE,0.017674089784376106
4168,2,Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome.,PUBMED,2014,Cancer Lett,ONCOGENIC,0.017674089784376106
4169,2,Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.,PUBMED,2008,Hum Pathol,DIAGNOSTIC,0.017674089784376106
4145,2,A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia.,PUBMED,2020,Blood Adv,PREDICTIVE,0.017674089784376106
4147,2,NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.,PUBMED,2011,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
4102,2,Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.,PUBMED,2021,Nat Commun,PREDICTIVE,0.017674089784376106
4072,2,Development of a steady-state FRET-based assay to identify inhibitors of the Keap1-Nrf2 protein-protein interaction.,PUBMED,2013,Protein Sci,FUNCTIONAL,0.017674089784376106
3460,2,A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease.,PUBMED,2018,Cancer Biol Ther,PREDISPOSING,0.017674089784376106
3462,2,Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.,PUBMED,2004,Leukemia,PROGNOSTIC,0.017674089784376106
3455,2,"Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.",PUBMED,2014,Cell Cycle,ONCOGENIC,0.017674089784376106
785,2,Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.,PUBMED,2011,Leukemia,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
787,2,Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.017674089784376106
4166,2,Cyclin D1 gene (CCND1) mutations in endometrial cancer.,PUBMED,2003,Oncogene,FUNCTIONAL,0.017674089784376106
3133,2,Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.,PUBMED,2019,Int J Cancer,PREDICTIVE,0.017674089784376106
3119,2,Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS.,PUBMED,2015,Oncotarget,PREDICTIVE,0.017674089784376106
3100,2,Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.017674089784376106
3096,2,Results of randomized phase II trial of dabrafenib versus dabrafenib plus trametinib in BRAF-mutated papillary thyroid carcinoma.,ASCO,2017,"J Clin Oncol 35, 2017 (suppl; abstr 6022)",PREDICTIVE,0.017674089784376106
3080,2,Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.,PUBMED,2019,N Engl J Med,PREDICTIVE,0.017674089784376106
3088,2,Difficult diagnosis of atypical cystic pancreatic lesions in von Hippel-Lindau disease.,PUBMED,2010,J Comput Assist Tomogr,PREDISPOSING,0.017674089784376106
3070,2,Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.,PUBMED,2015,Cancer Res,ONCOGENIC,0.017674089784376106
3072,2,Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma.,PUBMED,2020,Clin Cancer Res,PROGNOSTIC,0.017674089784376106
3075,2,Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.,PUBMED,2018,Cancer Cell,"FUNCTIONAL, ONCOGENIC",0.017674089784376106
3061,2,"Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.",PUBMED,2016,Cancer,PREDICTIVE,0.017674089784376106
3067,2,Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.,PUBMED,2009,Horm Metab Res,PREDISPOSING,0.017674089784376106
4334,2,A New Method to Study Heterodimerization of Membrane Proteins and Its Application to Fibroblast Growth Factor Receptors.,PUBMED,2017,J Biol Chem,FUNCTIONAL,0.017674089784376106
889,2,High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma.,PUBMED,2013,BMC Cancer,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
891,2,Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.017674089784376106
3048,2,Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.017674089784376106
3050,2,Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.017674089784376106
3041,2,The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.017674089784376106
488,2,Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.,PUBMED,2016,Int J Cancer,PREDICTIVE,0.017674089784376106
478,2,Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
473,2,Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.,PUBMED,2015,BMC Cancer,PREDICTIVE,0.017674089784376106
475,2,Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.,PUBMED,2013,Pigment Cell Melanoma Res,PREDICTIVE,0.017674089784376106
462,2,"Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.",PUBMED,2015,PLoS One,PREDICTIVE,0.017674089784376106
463,2,Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.017674089784376106
885,2,A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.,PUBMED,2012,Nat Med,PREDICTIVE,0.017674089784376106
4318,2,Novel fusion sarcomas including targetable NTRK and ALK.,PUBMED,2021,Ann Diagn Pathol,"ONCOGENIC, PREDICTIVE",0.017674089784376106
4322,2,A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.,PUBMED,1999,Am J Hum Genet,FUNCTIONAL,0.017674089784376106
521,2,Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.,PUBMED,1998,J Natl Cancer Inst,PROGNOSTIC,0.017674089784376106
523,2,Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.,PUBMED,2014,Mol Cancer,PREDICTIVE,0.017674089784376106
525,2,Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.,PUBMED,2015,JAMA Oncol,PREDICTIVE,0.017674089784376106
495,2,Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.017674089784376106
500,2,"First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors.",PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
4267,2,BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency.,PUBMED,2017,Nat Immunol,FUNCTIONAL,0.017674089784376106
4239,2,Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.,PUBMED,2021,Front Oncol,PROGNOSTIC,0.017674089784376106
4240,2,Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.,PUBMED,2015,Future Oncol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
4233,2,Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.017674089784376106
3143,2,Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131).,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.017674089784376106
4204,2,"Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.",PUBMED,2022,Lancet Oncol,PREDICTIVE,0.017674089784376106
4213,2,Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression.,PUBMED,2018,Theranostics,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3222,2,Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.,PUBMED,2015,Br J Haematol,DIAGNOSTIC,0.017674089784376106
3201,2,Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia.,PUBMED,2019,Haematologica,PREDICTIVE,0.017674089784376106
3204,2,Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.,PUBMED,2019,Ann Med,PROGNOSTIC,0.017674089784376106
849,2,"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.",PUBMED,2013,Lancet Oncol,PREDICTIVE,0.017674089784376106
835,2,BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.,PUBMED,2015,Oncotarget,PREDICTIVE,0.017674089784376106
836,2,Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.,PUBMED,2014,JAMA,PREDICTIVE,0.017674089784376106
3184,2,"Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.",PUBMED,2017,Mol Cancer Ther,PREDICTIVE,0.017674089784376106
3168,2,A Combinatorial Strategy for Targeting BRAF V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.017674089784376106
3160,2,P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.,PUBMED,2016,EBioMedicine,PREDICTIVE,0.017674089784376106
4216,2,Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.,PUBMED,2013,Mod Pathol,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
58,2,MEK1 mutations confer resistance to MEK and B-RAF inhibition.,PUBMED,2009,Proc Natl Acad Sci U S A,PREDICTIVE,0.017674089784376106
5389,2,MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.,PUBMED,2021,Gynecol Oncol,PREDICTIVE,0.017674089784376106
39,2,Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.,PUBMED,2012,N Engl J Med,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3902,2,B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.,PUBMED,2014,Mod Pathol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
3915,2,Pheochromocytoma and multifocal functioning paraganglioma in a 9-year-old boy with von Hippel-Lindau disease.,PUBMED,2002,Urol Int,PREDISPOSING,0.017674089784376106
623,2,KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer.,PUBMED,2013,J Gastroenterol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3881,2,Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.,PUBMED,2020,Blood Adv,DIAGNOSTIC,0.017674089784376106
3868,2,Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.,PUBMED,2011,Nat Chem Biol,FUNCTIONAL,0.017674089784376106
3876,2,"Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.",PUBMED,2021,Lancet Haematol,PROGNOSTIC,0.017674089784376106
3820,2,Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.,PUBMED,2000,J Natl Cancer Inst,PREDISPOSING,0.017674089784376106
3824,2,Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.,PUBMED,1999,Acta Neurochir (Wien),PREDISPOSING,0.017674089784376106
738,2,Fusions of the SYT and SSX genes in synovial sarcoma.,PUBMED,2001,Oncogene,DIAGNOSTIC,0.017674089784376106
3783,2,Phaeochromocytoma in black South Africans - a 30-year audit.,PUBMED,2011,S Afr Med J,PREDISPOSING,0.017674089784376106
3790,2,Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors.,PUBMED,2006,J Urol,PREDISPOSING,0.017674089784376106
650,2,EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.,PUBMED,2011,Ann Oncol,PREDICTIVE,0.017674089784376106
643,2,C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.017674089784376106
641,2,First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.017674089784376106
3766,2,Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML).,PUBMED,2005,Blood,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
3734,2,Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.,PUBMED,2016,J Natl Cancer Inst,"ONCOGENIC, PREDICTIVE",0.017674089784376106
3736,2,Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.,PUBMED,2014,Nat Commun,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
3737,2,Identification of a novel oncogenic mutation of FGFR4 in gastric cancer.,PUBMED,2019,Sci Rep,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
3738,2,Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.,PUBMED,2009,J Clin Invest,PREDICTIVE,0.017674089784376106
3742,2,Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.,PUBMED,2019,Blood Adv,PREDICTIVE,0.017674089784376106
3814,2,Pheochromocytoma and Von Hippel-Lindau in pregnancy.,PUBMED,2010,Am J Perinatol,PREDISPOSING,0.017674089784376106
5311,2,"Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome.",PUBMED,2024,World J Surg Oncol,ONCOGENIC,0.017674089784376106
98,2,Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.,PUBMED,2014,Cancer Res,PREDICTIVE,0.017674089784376106
104,2,The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations.,PUBMED,2013,J Clin Pathol,"DIAGNOSTIC, PREDICTIVE",0.017674089784376106
90,2,Anti-tumor activity of motesanib in a medullary thyroid cancer model.,PUBMED,2012,J Endocrinol Invest,PREDICTIVE,0.017674089784376106
85,2,"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.",PUBMED,2013,J Clin Oncol,PREDICTIVE,0.017674089784376106
5279,2,Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.,PUBMED,2023,Cancer Res,ONCOGENIC,0.017674089784376106
5258,2,Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma.,PUBMED,2024,Genes Chromosomes Cancer,"DIAGNOSTIC, PREDICTIVE",0.017674089784376106
5211,2,EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature.,PUBMED,2022,Transl Lung Cancer Res,PREDICTIVE,0.017674089784376106
5207,2,Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy.,PUBMED,2024,Front Oncol,PREDICTIVE,0.017674089784376106
5126,2,CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.,PUBMED,2021,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
5089,2,Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.,PUBMED,2014,Br J Haematol,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
18,2,CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.,PUBMED,2012,Diagn Mol Pathol,PROGNOSTIC,0.017674089784376106
1923,2,HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.,PUBMED,2014,Head Neck,PREDICTIVE,0.017674089784376106
1745,2,AKT Inhibition in Solid Tumors With AKT1 Mutations.,PUBMED,2017,J Clin Oncol,PREDICTIVE,0.017674089784376106
1957,2,A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survival.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.017674089784376106
1950,2,RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).,PUBMED,2011,Nature,PREDICTIVE,0.017674089784376106
1952,2,Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.,PUBMED,2008,Proc Natl Acad Sci U S A,PREDICTIVE,0.017674089784376106
2041,2,"Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.",PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.017674089784376106
2034,2,"ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.",PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.017674089784376106
2038,2,Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.,PUBMED,2016,PLoS One,PREDICTIVE,0.017674089784376106
2021,2,Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.017674089784376106
67,2,NRAS-mutant melanoma: response to chemotherapy.,PUBMED,2011,Arch Dermatol,PREDICTIVE,0.017674089784376106
19,2,The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.,PUBMED,2009,Blood,DIAGNOSTIC,0.017674089784376106
5069,2,YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancers.,PUBMED,2020,Cancer Sci,PREDICTIVE,0.017674089784376106
663,2,"A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.",PUBMED,2012,Breast Cancer Res Treat,PREDICTIVE,0.017674089784376106
3628,2,Segmental congenital hemangiomas: Three cases of a rare entity.,PUBMED,2020,Pediatr Dermatol,PROGNOSTIC,0.017674089784376106
3632,2,Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment.,PUBMED,2007,J Korean Neurosurg Soc,PREDISPOSING,0.017674089784376106
717,2,HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.,PUBMED,2010,Am J Pathol,PROGNOSTIC,0.017674089784376106
719,2,Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.,PUBMED,2006,Nat Med,PREDICTIVE,0.017674089784376106
722,2,Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.,PUBMED,2012,Nature,PREDICTIVE,0.017674089784376106
707,2,Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.,PUBMED,2016,JAMA Oncol,PREDICTIVE,0.017674089784376106
712,2,"Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.",PUBMED,2012,Am J Hematol,PROGNOSTIC,0.017674089784376106
3602,2,Identification of two sporadically derived mutations in the Von Hippel-Lindau gene.,PUBMED,1996,Hum Mutat,PREDISPOSING,0.017674089784376106
3606,2,Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.,PUBMED,2000,Am J Hum Genet,PREDISPOSING,0.017674089784376106
3608,2,Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.,PUBMED,2015,J Clin Endocrinol Metab,PREDISPOSING,0.017674089784376106
3690,2,Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.017674089784376106
3581,2,An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.,PUBMED,2012,Cancer Cell,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
3587,2,Paediatric pancreatic neuroendocrine tumours in von Hippel-Lindau disease.,PUBMED,2018,Endocr Relat Cancer,PREDISPOSING,0.017674089784376106
3588,2,The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.,PUBMED,2018,Nat Med,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
3579,2,Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.,PUBMED,2012,Horm Metab Res,PREDISPOSING,0.017674089784376106
3572,2,"Two pediatric patients with Von Hippel-Lindau disease type 2b: from patient to screening, from screening to patient.",PUBMED,2011,J Pediatr Endocrinol Metab,PREDISPOSING,0.017674089784376106
3560,2,Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.,PUBMED,2019,Acta Neuropathol Commun,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
752,2,Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.,PUBMED,2011,Blood,PREDICTIVE,0.017674089784376106
754,2,MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.017674089784376106
741,2,Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.,PUBMED,2000,Mod Pathol,DIAGNOSTIC,0.017674089784376106
742,2,Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.,PUBMED,2002,Cancer Res,PROGNOSTIC,0.017674089784376106
732,2,Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.017674089784376106
3591,2,Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.,PUBMED,1995,J Med Genet,PREDISPOSING,0.017674089784376106
3694,2,Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b.,PUBMED,2006,Carcinogenesis,ONCOGENIC,0.017674089784376106
4046,2,CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.,PUBMED,2015,Cancer Sci,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
578,2,AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.017674089784376106
570,2,P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer.,PUBMED,2014,BMC Cancer,PREDICTIVE,0.017674089784376106
574,2,RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.,PUBMED,2013,PLoS One,PREDICTIVE,0.017674089784376106
577,2,"Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.",PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
565,2,SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.,PUBMED,2016,Clin Cancer Res,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
566,2,Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.,PUBMED,2013,Nat Genet,"ONCOGENIC, PROGNOSTIC",0.017674089784376106
3995,2,Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.,PUBMED,2018,EMBO Mol Med,PREDICTIVE,0.017674089784376106
4009,2,Characterization of rare transforming KRAS mutations in sporadic colorectal cancer.,PUBMED,2014,Cancer Biol Ther,ONCOGENIC,0.017674089784376106
3986,2,Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.017674089784376106
672,2,Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.,PUBMED,2016,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
3971,2,Endolymphatic sac tumor in von Hippel-Lindau disease.,PUBMED,2003,Otol Neurotol,PREDISPOSING,0.017674089784376106
3945,2,SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome.,PUBMED,2021,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
3696,2,Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.,PUBMED,2009,Oncogene,ONCOGENIC,0.017674089784376106
3698,2,Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.,PUBMED,2019,Eur J Haematol,PREDICTIVE,0.017674089784376106
3661,2,Functioning thoracic paraganglioma: association with Von Hippel-Lindau syndrome.,PUBMED,1997,J Clin Endocrinol Metab,PREDISPOSING,0.017674089784376106
3668,2,Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.,PUBMED,2005,Neurosurgery,PREDISPOSING,0.017674089784376106
685,2,RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.,PUBMED,2014,Cell Rep,PREDICTIVE,0.017674089784376106
675,2,"TERT mutation in glioma: Frequency, prognosis and risk.",PUBMED,2016,J Clin Neurosci,"DIAGNOSTIC, PREDISPOSING",0.017674089784376106
678,2,An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.,PUBMED,2013,Science,PREDICTIVE,0.017674089784376106
679,2,"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.",PUBMED,2014,Lancet Oncol,PREDICTIVE,0.017674089784376106
667,2,AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.017674089784376106
3978,2,Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.,PUBMED,2017,Blood,PREDICTIVE,0.017674089784376106
4484,2,Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.,PUBMED,2017,Sci Rep,"DIAGNOSTIC, FUNCTIONAL",0.017674089784376106
4493,2,Whole-Exome Sequencing Reveals Novel Variations in Patients with Familial Von Hippel-Lindau Syndrome.,PUBMED,2021,World Neurosurg,PREDISPOSING,0.017674089784376106
4475,2,Biological and clinical impact of central nervous system hemangioblastomas in Chinese patients with von Hippel-Lindau disease: implications for treatment.,PUBMED,2020,Hered Cancer Clin Pract,PREDISPOSING,0.017674089784376106
4471,2,"Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.",PUBMED,2020,Histopathology,DIAGNOSTIC,0.017674089784376106
4458,2,A Rare EGFR-SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib.,PUBMED,2020,Oncologist,PREDICTIVE,0.017674089784376106
2633,2,"Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).",PUBMED,2017,Endocr Pathol,PREDISPOSING,0.017674089784376106
2637,2,Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.,PUBMED,2003,Int J Cancer,PREDISPOSING,0.017674089784376106
2629,2,Response to Somatostatin Analog Therapy in a Patient With von Hippel-Lindau Disease and Multiple Pancreatic Neuroendocrine Tumors.,PUBMED,2017,Pancreas,"DIAGNOSTIC, PREDISPOSING",0.017674089784376106
2621,2,Molecular Characterization of a Novel Germline VHL Mutation by Extensive In Silico Analysis in an Indian Family with Von Hippel-Lindau Disease.,PUBMED,2016,Genet Res Int,PREDISPOSING,0.017674089784376106
1133,2,BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.,PUBMED,2016,Gynecol Oncol,PROGNOSTIC,0.017674089784376106
1134,2,Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.,PUBMED,2014,Lancet Oncol,PREDICTIVE,0.017674089784376106
465,2,Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.,PUBMED,2014,Mol Cancer,PREDICTIVE,0.017674089784376106
1124,2,Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.017674089784376106
1126,2,The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.,PUBMED,2016,Int J Cancer,PREDICTIVE,0.017674089784376106
1127,2,Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.017674089784376106
1128,2,Heterogeneity of resistance mutations detectable by nextgeneration sequencing in TKI-treated lung adenocarcinoma.,PUBMED,2016,Oncotarget,PREDICTIVE,0.017674089784376106
1123,2,Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.,PUBMED,2016,Nat Med,PREDICTIVE,0.017674089784376106
2608,2,Characteristics of pheochromocytoma in a 4- to 20-year-old population.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.017674089784376106
2609,2,Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene.,PUBMED,2002,Ann Neurol,PREDISPOSING,0.017674089784376106
2592,2,A novel Von Hippel-Lindau case with germline mutation at codon 167 (CGG to TGG) having endocrine microadenomatosis of the pancreas.,PUBMED,2007,Dig Dis Sci,PREDISPOSING,0.017674089784376106
2582,2,,PUBMED,,,PREDISPOSING,0.017674089784376106
2589,2,A novel germline mutation in the von Hippel-Lindau gene in patients in Kuwait.,PUBMED,2004,Med Princ Pract,PREDISPOSING,0.017674089784376106
1158,2,"Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary.",PUBMED,2014,Case Rep Oncol,PREDICTIVE,0.017674089784376106
1137,2,TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.017674089784376106
2648,2,"Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.",PUBMED,2018,J Clin Res Pediatr Endocrinol,PREDISPOSING,0.017674089784376106
2651,2,Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma.,PUBMED,2017,Res Rep Urol,PREDISPOSING,0.017674089784376106
1084,2,Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.,PUBMED,2017,Leukemia,PROGNOSTIC,0.017674089784376106
1075,2,Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report.,PUBMED,2016,Onco Targets Ther,PREDICTIVE,0.017674089784376106
1078,2,Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.,PUBMED,2016,Cancer Res,PREDICTIVE,0.017674089784376106
1081,2,Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.017674089784376106
1082,2,Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection.,PUBMED,2016,PLoS One,PROGNOSTIC,0.017674089784376106
1067,2,PI3K pathway dependencies in endometrioid endometrial cancer cell lines.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1074,2,Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.017674089784376106
1057,2,Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.,PUBMED,2010,Cancer Res,PREDICTIVE,0.017674089784376106
4550,2,EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.,PUBMED,2012,Nature,PREDICTIVE,0.017674089784376106
4503,2,FGFR1 is a potential therapeutic target in neuroblastoma.,PUBMED,2022,Cancer Cell Int,"FUNCTIONAL, ONCOGENIC",0.017674089784376106
4536,2,Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication.,PUBMED,2014,Genome Res,FUNCTIONAL,0.017674089784376106
4537,2,Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.,PUBMED,2019,Mol Cell,FUNCTIONAL,0.017674089784376106
420,2,"A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.",PUBMED,2012,Oncogene,PREDICTIVE,0.017674089784376106
411,2,Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.,PUBMED,2003,Gastroenterology,PREDICTIVE,0.017674089784376106
413,2,BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.,PUBMED,2014,J Clin Oncol,PROGNOSTIC,0.017674089784376106
414,2,Highly prevalent TERT promoter mutations in aggressive thyroid cancers.,PUBMED,2013,Endocr Relat Cancer,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
4528,2,"CTX-712, a Novel Clk Inhibitor Targeting Myeloid Neoplasms with SRSF2 Mutation",ASH,2021,Blood,PREDICTIVE,0.017674089784376106
4530,2,Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.,PUBMED,2018,Cancer Discov,FUNCTIONAL,0.017674089784376106
4517,2,Comprehensive molecular profiling of lung adenocarcinoma.,PUBMED,2014,Nature,DIAGNOSTIC,0.017674089784376106
4519,2,MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis.,PUBMED,2016,Clin Cancer Res,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
4520,2,Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.017674089784376106
4551,2,Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma.,PUBMED,2021,Cancer Sci,PREDICTIVE,0.017674089784376106
4564,2,Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis.,PUBMED,2016,J Invest Dermatol,FUNCTIONAL,0.017674089784376106
4567,2,Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis.,PUBMED,2009,Leuk Res,PREDICTIVE,0.017674089784376106
4568,2,The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.,PUBMED,2002,Blood,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
4552,2,Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.,PUBMED,2021,Cancer Sci,PREDICTIVE,0.017674089784376106
4557,2,Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.,PUBMED,2018,Am J Hematol,PREDICTIVE,0.017674089784376106
2510,2,Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.,PUBMED,2014,Lancet Oncol,PREDICTIVE,0.017674089784376106
2501,2,NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.017674089784376106
2489,2,Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.,PUBMED,2018,J Clin Neurosci,"PREDICTIVE, PREDISPOSING",0.017674089784376106
2490,2,"Treatment of multiple synchronous misdiagnosed renal cell cancers in a young patient affected by a ""de novo"" Von Hippel-Lindau syndrome.",PUBMED,2017,Urologia,"DIAGNOSTIC, PREDISPOSING",0.017674089784376106
2493,2,Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair Genes.,PUBMED,2018,Am J Hum Genet,"DIAGNOSTIC, FUNCTIONAL",0.017674089784376106
2483,2,Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.,PUBMED,2007,Clin Cancer Res,PROGNOSTIC,0.017674089784376106
1147,2,Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.,PUBMED,2014,Clin Lymphoma Myeloma Leuk,PREDICTIVE,0.017674089784376106
1225,2,Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.,PUBMED,2010,JAMA,PREDISPOSING,0.017674089784376106
2468,2,"Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer.",PUBMED,2018,Cancer Discov,PREDICTIVE,0.017674089784376106
2465,2,Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.017674089784376106
2442,2,A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic BRAF-Mutant Colorectal Cancer.,PUBMED,2017,Cancer Discov,PREDICTIVE,0.017674089784376106
2444,2,CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.,PUBMED,2014,PLoS One,PREDICTIVE,0.017674089784376106
2446,2,A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib.,PUBMED,2016,Invest New Drugs,PREDICTIVE,0.017674089784376106
1279,2,Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.,PUBMED,2007,Br J Cancer,PREDICTIVE,0.017674089784376106
1267,2,Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer.,PUBMED,2016,Oncotarget,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
1252,2,"Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.",PUBMED,2016,J Clin Pharmacol,PREDICTIVE,0.017674089784376106
1255,2,A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.,PUBMED,2011,Genes Chromosomes Cancer,DIAGNOSTIC,0.017674089784376106
1238,2,Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors.,PUBMED,2009,Cancer Res,PREDICTIVE,0.017674089784376106
1222,2,De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes.,PUBMED,2005,Hum Mutat,PREDISPOSING,0.017674089784376106
1148,2,Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.,PUBMED,2013,Cancer,PROGNOSTIC,0.017674089784376106
2580,2,Benefits of screening in von Hippel-Lindau disease--comparison of morbidity associated with initial tumours in affected parents and children.,PUBMED,2006,Horm Res,PREDISPOSING,0.017674089784376106
2570,2,Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.,PUBMED,2013,Nat Genet,DIAGNOSTIC,0.017674089784376106
2557,2,The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma.,PUBMED,2014,Nat Genet,DIAGNOSTIC,0.017674089784376106
2527,2,Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.,PUBMED,2015,Leukemia,PROGNOSTIC,0.017674089784376106
2530,2,Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.,PUBMED,2018,J Clin Invest,PREDICTIVE,0.017674089784376106
2523,2,MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis.,PUBMED,2015,Genes Chromosomes Cancer,PREDICTIVE,0.017674089784376106
2503,2,A case of 3p deletion syndrome associated with cerebellar hemangioblastoma.,PUBMED,2016,Brain Dev,PREDISPOSING,0.017674089784376106
4627,2,Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.017674089784376106
4613,2,"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.",PUBMED,2021,Lancet Diabetes Endocrinol,PREDICTIVE,0.017674089784376106
4616,2,"Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.",PUBMED,2018,JAMA Oncol,PREDICTIVE,0.017674089784376106
326,2,Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.,PUBMED,2011,Clin Cancer Res,PROGNOSTIC,0.017674089784376106
4591,2,IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.,PUBMED,2011,J Pathol,DIAGNOSTIC,0.017674089784376106
4571,2,Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.,PUBMED,2019,Mod Pathol,"DIAGNOSTIC, PREDISPOSING",0.017674089784376106
4579,2,Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.,PUBMED,2011,J Pathol,ONCOGENIC,0.017674089784376106
372,2,Response and acquired resistance to everolimus in anaplastic thyroid cancer.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.017674089784376106
376,2,A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.,PUBMED,2003,N Engl J Med,PREDICTIVE,0.017674089784376106
381,2,Acquired resistance to crizotinib from a mutation in CD74-ROS1.,PUBMED,2013,N Engl J Med,PREDICTIVE,0.017674089784376106
385,2,"A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas.",PUBMED,2014,Eur J Cancer,PREDICTIVE,0.017674089784376106
354,2,Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.017674089784376106
359,2,Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.,PUBMED,2009,N Engl J Med,PREDICTIVE,0.017674089784376106
345,2,"Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.",PUBMED,2012,Lancet,PREDICTIVE,0.017674089784376106
325,2,"TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.",PUBMED,2001,Radiother Oncol,PROGNOSTIC,0.017674089784376106
4590,2,Mutant IDH is sufficient to initiate enchondromatosis in mice.,PUBMED,2015,Proc Natl Acad Sci U S A,ONCOGENIC,0.017674089784376106
950,2,Characterization of the novel and specific PI3KŒ± inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.017674089784376106
946,2,Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain.,PUBMED,2015,JAMA Oncol,PREDICTIVE,0.017674089784376106
947,2,"Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study.",PUBMED,2014,Lancet Oncol,PREDICTIVE,0.017674089784376106
933,2,Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.017674089784376106
938,2,A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.,PUBMED,2007,Cancer Cell,PREDICTIVE,0.017674089784376106
939,2,"PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.",PUBMED,2010,Am J Pathol,PREDICTIVE,0.017674089784376106
940,2,"Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.",PUBMED,2014,Blood,PROGNOSTIC,0.017674089784376106
941,2,Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.,PUBMED,2013,N Engl J Med,DIAGNOSTIC,0.017674089784376106
929,2,I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.017674089784376106
2944,2,Mutant p53 gain of function induces HER2 over-expression in cancer cells.,PUBMED,2018,BMC Cancer,FUNCTIONAL,0.017674089784376106
2933,2,Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.,PUBMED,2004,Oncogene,FUNCTIONAL,0.017674089784376106
2647,2,Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing.,PUBMED,2017,Mol Genet Genomic Med,PREDISPOSING,0.017674089784376106
2911,2,Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study.,PUBMED,2018,J Clin Oncol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
2914,2,Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.,PUBMED,2019,N Engl J Med,PREDICTIVE,0.017674089784376106
2915,2,Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.017674089784376106
2918,2,Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.,PUBMED,2009,N Engl J Med,PROGNOSTIC,0.017674089784376106
988,2,Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.,PUBMED,2011,PLoS One,PREDICTIVE,0.017674089784376106
977,2,Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors.,PUBMED,2013,Cancer Res,PREDICTIVE,0.017674089784376106
959,2,Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.017674089784376106
960,2,SF3B1 mutations constitute a novel therapeutic target in breast cancer.,PUBMED,2015,J Pathol,PREDICTIVE,0.017674089784376106
2909,2,"Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.017674089784376106
2898,2,Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.,PUBMED,2019,J Clin Oncol,PREDICTIVE,0.017674089784376106
2880,2,Palbociclib (P) in patients (Pts) with pancreatic cancer (PC) and gallbladder or bile duct cancer (GBC) with <i>CDKN2A</i> alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.,ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 2532)",PREDICTIVE,0.017674089784376106
2926,2,ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.,PUBMED,2018,Mol Cancer Ther,PREDICTIVE,0.017674089784376106
4360,2,Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).,PUBMED,2020,Mod Pathol,PREDICTIVE,0.017674089784376106
4354,2,Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion.,PUBMED,2019,Target Oncol,PREDICTIVE,0.017674089784376106
4328,2,Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.,PUBMED,2015,Cold Spring Harb Mol Case Stud,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
3046,2,Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.,PUBMED,2004,Oncogene,FUNCTIONAL,0.017674089784376106
3031,2,Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcS√© phase II trial.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.017674089784376106
3021,2,Single agent ONC201 in adult recurrent H3 K27M-mutant glioma.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3005)",PREDICTIVE,0.017674089784376106
3025,2,"Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.",PUBMED,2019,N Engl J Med,PREDICTIVE,0.017674089784376106
920,2,"Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.",PUBMED,2009,Mol Cancer Res,PREDICTIVE,0.017674089784376106
923,2,A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.,PUBMED,2016,Lung Cancer,PREDICTIVE,0.017674089784376106
900,2,In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.,PUBMED,2005,Clin Cancer Res,PREDICTIVE,0.017674089784376106
904,2,Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer.,PUBMED,2012,J Oncol,PROGNOSTIC,0.017674089784376106
2954,2,Dabrafenib and trametinib in patients with tumors with BRAF V600E/K mutations: Results from the molecular analysis for therapy choice (MATCH) Arm H.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3002)",PREDICTIVE,0.017674089784376106
893,2,KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.,PUBMED,2016,Clin Transl Gastroenterol,PROGNOSTIC,0.017674089784376106
3013,2,Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.017674089784376106
3014,2,EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.017674089784376106
3011,2,V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon Cancer.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.017674089784376106
3004,2,Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.,PUBMED,2003,Oncogene,FUNCTIONAL,0.017674089784376106
2989,2,Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.,PUBMED,2015,Oncol Rep,PROGNOSTIC,0.017674089784376106
2990,2,Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain.,PUBMED,2006,Blood,"FUNCTIONAL, PREDICTIVE",0.017674089784376106
2996,2,Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.,PUBMED,2018,Blood Adv,"ONCOGENIC, PROGNOSTIC",0.017674089784376106
2982,2,Functional consequences of mutations in a putative Akt phosphorylation motif of B-raf in human cancers.,PUBMED,2005,Mol Carcinog,ONCOGENIC,0.017674089784376106
2984,2,"Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.017674089784376106
2988,2,"FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective.",PUBMED,2019,Lung Cancer,PREDICTIVE,0.017674089784376106
892,2,Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.,PUBMED,2013,J Gastroenterol,PROGNOSTIC,0.017674089784376106
2783,2,"Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.",PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.017674089784376106
2764,2,"CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.",PUBMED,2013,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
2766,2,Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau disease.,PUBMED,2019,Eur J Med Genet,PREDISPOSING,0.017674089784376106
2767,2,Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation.,PUBMED,2018,Case Rep Endocrinol,"FUNCTIONAL, PREDISPOSING",0.017674089784376106
2750,2,Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program.,PUBMED,2018,J Thorac Oncol,PREDICTIVE,0.017674089784376106
2741,2,Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: A retrospective real world study.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl 4; abstr 113)",PREDICTIVE,0.017674089784376106
2724,2,Are meningeal hemangiopericytoma and mesenchymal chondrosarcoma the same?: a study of HEY1-NCOA2 fusion.,PUBMED,2013,Am J Clin Pathol,DIAGNOSTIC,0.017674089784376106
2725,2,Detection of HEY1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.,PUBMED,2012,Pathol Int,DIAGNOSTIC,0.017674089784376106
2728,2,"Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.017674089784376106
2729,2,NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.,PUBMED,2014,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
1050,2,MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.017674089784376106
2886,2,Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib.,PUBMED,2017,N Engl J Med,PREDICTIVE,0.017674089784376106
1037,2,Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.,PUBMED,2015,Pigment Cell Melanoma Res,PREDICTIVE,0.017674089784376106
1026,2,"Phase I Study of Apitolisib (GDC-0980), Dual Phosphatidylinositol-3-Kinase and Mammalian Target of Rapamycin Kinase Inhibitor, in Patients with Advanced Solid Tumors.",PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.017674089784376106
1031,2,"PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.",PUBMED,2009,Breast Cancer Res,PREDICTIVE,0.017674089784376106
2721,2,"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.",PUBMED,2010,J Clin Oncol,PREDICTIVE,0.017674089784376106
2692,2,Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.,PUBMED,1999,Cancer Res,DIAGNOSTIC,0.017674089784376106
2682,2,AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.,PUBMED,2005,Proc Natl Acad Sci U S A,PREDICTIVE,0.017674089784376106
2683,2,"Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.",PUBMED,2015,Mol Cell Endocrinol,PROGNOSTIC,0.017674089784376106
2667,2,Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme.,PUBMED,2017,Oncol Lett,PROGNOSTIC,0.017674089784376106
2676,2,Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.,PUBMED,2015,Blood,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
2661,2,Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.,PUBMED,2018,Gut,PREDICTIVE,0.017674089784376106
2662,2,ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.,PUBMED,2018,Blood,"ONCOGENIC, PREDICTIVE",0.017674089784376106
1052,2,"Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.017674089784376106
2871,2,"Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.017674089784376106
455,2,Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.,PUBMED,2013,Lancet Oncol,PREDICTIVE,0.017674089784376106
457,2,"HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report.",PUBMED,2016,Int J Colorectal Dis,PREDICTIVE,0.017674089784376106
458,2,Mutant HRAS as novel target for MEK and mTOR inhibitors.,PUBMED,2015,Oncotarget,PREDICTIVE,0.017674089784376106
446,2,Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.017674089784376106
447,2,Crizotinib in ROS1-rearranged non-small-cell lung cancer.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.017674089784376106
4439,2,Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.,PUBMED,2020,BMC Med Genet,PREDISPOSING,0.017674089784376106
4425,2,RNA-sequencing of IDH-wild-type glioblastoma with chromothripsis identifies novel gene fusions with potential oncogenic properties.,PUBMED,2021,Transl Oncol,ONCOGENIC,0.017674089784376106
4423,2,ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.,PUBMED,2018,Pediatr Blood Cancer,"DIAGNOSTIC, PROGNOSTIC",0.017674089784376106
4397,2,Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.,PUBMED,2015,Nat Commun,"DIAGNOSTIC, ONCOGENIC",0.017674089784376106
4384,2,177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma.,PUBMED,2020,Endocr Connect,PREDISPOSING,0.017674089784376106
2812,2,Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.,PUBMED,2019,J Exp Med,PREDICTIVE,0.017674089784376106
2875,2,"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.",PUBMED,2018,Proc Natl Acad Sci U S A,DIAGNOSTIC,0.017674089784376106
2857,2,Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.,PUBMED,2011,Br J Haematol,"ONCOGENIC, PREDICTIVE",0.017674089784376106
2849,2,Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.,PUBMED,2014,Eur J Haematol,"PREDICTIVE, PROGNOSTIC",0.017674089784376106
1016,2,"Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.",PUBMED,2013,J Clin Oncol,PROGNOSTIC,0.017674089784376106
1018,2,High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.017674089784376106
992,2,The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.,PUBMED,2013,Blood,PROGNOSTIC,0.017674089784376106
995,2,Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.,PUBMED,2014,J Thorac Oncol,PREDICTIVE,0.017674089784376106
2836,2,Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.,PUBMED,2016,JAMA Oncol,"FUNCTIONAL, PROGNOSTIC",0.017674089784376106
2830,2,Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.017674089784376106
2821,2,Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.,PUBMED,2013,Nat Genet,DIAGNOSTIC,0.017674089784376106
2824,2,Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.,PUBMED,2016,Cancer Cell,"DIAGNOSTIC, PREDICTIVE",0.017674089784376106
4392,2,Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.,PUBMED,2019,Oncotarget,PREDISPOSING,0.017674089784376106
22,1,Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.,PUBMED,2014,Science,DIAGNOSTIC,0.008837044892188053
35,1,The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.,PUBMED,2012,Cell,PREDICTIVE,0.008837044892188053
44,1,Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.,PUBMED,2008,J Clin Endocrinol Metab,DIAGNOSTIC,0.008837044892188053
46,1,Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.,PUBMED,2011,N Engl J Med,PROGNOSTIC,0.008837044892188053
52,1,A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential.,PUBMED,2004,Lab Invest,DIAGNOSTIC,0.008837044892188053
55,1,A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms.,PUBMED,2009,Nat Genet,DIAGNOSTIC,0.008837044892188053
56,1,RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.,PUBMED,2014,BMC Cancer,DIAGNOSTIC,0.008837044892188053
57,1,NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.,PUBMED,2013,PLoS One,DIAGNOSTIC,0.008837044892188053
61,1,"PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.",PUBMED,2005,J Clin Oncol,PREDICTIVE,0.008837044892188053
5295,1,Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer.,PUBMED,2018,JAMA Oncol,PREDICTIVE,0.008837044892188053
5296,1,Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs.,PUBMED,2024,J Clin Invest,ONCOGENIC,0.008837044892188053
5298,1,ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.,PUBMED,2017,Haematologica,DIAGNOSTIC,0.008837044892188053
5299,1,Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance.,PUBMED,2024,Front Oncol,PREDICTIVE,0.008837044892188053
5301,1,Identification of BRAF Kinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy.,PUBMED,2016,JAMA Oncol,PREDICTIVE,0.008837044892188053
5303,1,BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper.,PUBMED,2012,J Neuropathol Exp Neurol,ONCOGENIC,0.008837044892188053
5304,1,"BRAF in Lung Cancers: Analysis of Patient Cases Reveals Recurrent BRAF Mutations, Fusions, Kinase Duplications, and Concurrent Alterations.",PUBMED,2018,JCO Precis Oncol,ONCOGENIC,0.008837044892188053
5306,1,"Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.",PUBMED,2024,Histopathology,DIAGNOSTIC,0.008837044892188053
5281,1,The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice.,PUBMED,2000,Oncogene,DIAGNOSTIC,0.008837044892188053
5282,1,NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1 Mutant Melanoma.,PUBMED,2025,Cancer Res,PREDICTIVE,0.008837044892188053
5284,1,"Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia.",PUBMED,2024,Cell Commun Signal,PREDICTIVE,0.008837044892188053
5289,1,Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia.,PUBMED,2025,Nature,PROGNOSTIC,0.008837044892188053
5290,1,"Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.",PUBMED,2024,Lancet Oncol,PREDICTIVE,0.008837044892188053
5291,1,Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group.,PUBMED,2021,Leukemia,DIAGNOSTIC,0.008837044892188053
5292,1,Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.,PUBMED,2021,Int J Lab Hematol,DIAGNOSTIC,0.008837044892188053
5294,1,Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.,PUBMED,2016,JAMA Oncol,PREDICTIVE,0.008837044892188053
105,1,"Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma.",PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
106,1,A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.,PUBMED,2013,Cancer Cell,PREDICTIVE,0.008837044892188053
107,1,Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
109,1,The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?,PUBMED,2014,Clin Endocrinol (Oxf),PROGNOSTIC,0.008837044892188053
110,1,BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.,PUBMED,2014,PLoS One,PROGNOSTIC,0.008837044892188053
111,1,Prognostic value of BRAF mutations in localized cutaneous melanoma.,PUBMED,2014,J Am Acad Dermatol,PROGNOSTIC,0.008837044892188053
112,1,Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma.,PUBMED,2014,Oncol Lett,PROGNOSTIC,0.008837044892188053
5280,1,Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor.,PUBMED,2020,Onco Targets Ther,ONCOGENIC,0.008837044892188053
91,1,AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines.,PUBMED,2012,PLoS One,PREDICTIVE,0.008837044892188053
92,1,Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.,PUBMED,1998,Jpn J Clin Oncol,PROGNOSTIC,0.008837044892188053
94,1,Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers.,PUBMED,2014,Horm Metab Res,DIAGNOSTIC,0.008837044892188053
96,1,BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy.,PUBMED,2014,PLoS One,PROGNOSTIC,0.008837044892188053
97,1,Regorafenib in metastatic colorectal cancer.,PUBMED,2014,Expert Rev Anticancer Ther,PREDICTIVE,0.008837044892188053
99,1,Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
101,1,Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.,PUBMED,2013,J Thorac Oncol,PREDICTIVE,0.008837044892188053
102,1,BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation.,PUBMED,2010,Sci Signal,PREDICTIVE,0.008837044892188053
2028,1,ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition.,PUBMED,2014,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
2036,1,Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK.,PUBMED,2011,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
2037,1,De novo ALK kinase domain mutations are uncommon in kinase inhibitor-na√Øve ALK rearranged lung cancers.,PUBMED,2016,Lung Cancer,PREDICTIVE,0.008837044892188053
2039,1,Expanded Circulating Tumor Cells from a Patient with ALK-Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1939,1,"Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.",PUBMED,2015,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
1945,1,"Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.",PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
1947,1,EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.,PUBMED,2012,Cancer Discov,PREDICTIVE,0.008837044892188053
1948,1,BRAF V600E inhibition in anaplastic thyroid cancer.,PUBMED,2013,N Engl J Med,PREDICTIVE,0.008837044892188053
1990,1,Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.,PUBMED,2016,Respir Investig,PREDICTIVE,0.008837044892188053
1995,1,Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation.,PUBMED,2006,Nat Clin Pract Oncol,PREDICTIVE,0.008837044892188053
2005,1,Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.,PUBMED,2012,Nat Commun,PREDICTIVE,0.008837044892188053
2023,1,Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.,PUBMED,2016,Oncol Lett,PREDICTIVE,0.008837044892188053
2024,1,Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations.,PUBMED,2012,Oncol Rep,PREDICTIVE,0.008837044892188053
2025,1,Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.,PUBMED,2015,Nat Commun,PREDICTIVE,0.008837044892188053
2026,1,"Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.",PUBMED,2016,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
2027,1,Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo.,PUBMED,2012,Oncol Lett,PREDICTIVE,0.008837044892188053
1980,1,Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.,PUBMED,2016,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
1981,1,The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).,PUBMED,2011,Biochem Biophys Res Commun,PREDICTIVE,0.008837044892188053
1982,1,c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition.,PUBMED,2016,Mol Carcinog,PREDICTIVE,0.008837044892188053
1983,1,Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
1984,1,Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.,PUBMED,2015,Invest New Drugs,PREDICTIVE,0.008837044892188053
1985,1,Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.,PUBMED,2014,Neurology,PREDICTIVE,0.008837044892188053
1986,1,A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.008837044892188053
1987,1,"Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.",PUBMED,2010,Lancet Oncol,PREDICTIVE,0.008837044892188053
1970,1,Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience.,PUBMED,2015,J Clin Endocrinol Metab,PREDICTIVE,0.008837044892188053
1971,1,Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation.,PUBMED,2013,Thyroid,PREDICTIVE,0.008837044892188053
1972,1,Src inhibitors in suppression of papillary thyroid carcinoma growth.,PUBMED,2014,Head Neck,PREDICTIVE,0.008837044892188053
1974,1,Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent.,PUBMED,2014,J Transl Med,PREDICTIVE,0.008837044892188053
1975,1,Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib.,PUBMED,2016,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
1976,1,BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.,PUBMED,2015,Invest New Drugs,PREDICTIVE,0.008837044892188053
1977,1,BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.,PUBMED,2014,Lung Cancer,PREDICTIVE,0.008837044892188053
1978,1,Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
1749,1,Follicular thyroid carcinoma with NRAS Q61K and GNAS R201H mutations that had a good (131)I treatment response.,PUBMED,2016,Endocrinol Diabetes Metab Case Rep,PREDICTIVE,0.008837044892188053
1750,1,Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.,PUBMED,2017,J Clin Oncol,PROGNOSTIC,0.008837044892188053
1751,1,Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.,PUBMED,2017,Cancer Biomark,PROGNOSTIC,0.008837044892188053
1752,1,Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.,PUBMED,2012,Cancer Lett,DIAGNOSTIC,0.008837044892188053
1754,1,ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.,PUBMED,2015,Cancer Res,PREDICTIVE,0.008837044892188053
2055,1,Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.,PUBMED,2011,Lung Cancer,PREDICTIVE,0.008837044892188053
2058,1,An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2059,1,Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.,PUBMED,2009,Leuk Res,PREDICTIVE,0.008837044892188053
1734,1,Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor.,PUBMED,2011,Case Rep Oncol,PREDICTIVE,0.008837044892188053
1736,1,Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.,PUBMED,2012,Med Oncol,PREDICTIVE,0.008837044892188053
1737,1,Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD.,PUBMED,2007,Leukemia,DIAGNOSTIC,0.008837044892188053
1738,1,BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
1739,1,Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.,PUBMED,2007,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1740,1,"AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells.",PUBMED,2007,Leukemia,PREDICTIVE,0.008837044892188053
1741,1,Association of Oncogenic Mutations in Patients With Advanced Cutaneous Squamous Cell Carcinomas Treated With Cetuximab.,PUBMED,2017,JAMA Dermatol,PREDICTIVE,0.008837044892188053
1746,1,"p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.",PUBMED,2002,Cancer Epidemiol Biomarkers Prev,PROGNOSTIC,0.008837044892188053
1963,1,BRAF inhibition in refractory hairy-cell leukemia.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
1964,1,Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.,PUBMED,2013,Haematologica,PREDICTIVE,0.008837044892188053
1965,1,Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.,PUBMED,2013,Br J Haematol,PREDICTIVE,0.008837044892188053
1966,1,Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.,PUBMED,2015,Oncoscience,PREDICTIVE,0.008837044892188053
1967,1,Response of relapsed central nervous system hairy cell leukemia to vemurafenib.,PUBMED,2016,Leuk Lymphoma,PREDICTIVE,0.008837044892188053
1968,1,Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.,PUBMED,2014,BMC Cancer,PREDICTIVE,0.008837044892188053
1969,1,Pilomyxoid astrocytoma treated successfully with vemurafenib.,PUBMED,2014,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
1733,1,Amplification of EGFR Wild-Type Alleles in Non-Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors.,PUBMED,2017,Cancer Res,PREDICTIVE,0.008837044892188053
1949,1,Sustained Response to Vemurafenib in a BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Patient.,PUBMED,2016,Thyroid,PREDICTIVE,0.008837044892188053
1954,1,Management of a patient with advanced BRAF-mutant melanoma.,PUBMED,2014,J Natl Compr Canc Netw,PREDICTIVE,0.008837044892188053
1955,1,The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial.,PUBMED,2015,Contemp Oncol (Pozn),PREDICTIVE,0.008837044892188053
1956,1,Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.,PUBMED,2011,Neoplasia,PREDICTIVE,0.008837044892188053
1958,1,Vemurafenib treatment of BRAF V600E-mutated malignant peripheral nerve sheath tumor.,PUBMED,2013,J Natl Compr Canc Netw,PREDICTIVE,0.008837044892188053
1959,1,BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells.,PUBMED,2008,Mol Cancer Res,PREDICTIVE,0.008837044892188053
1961,1,Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.,PUBMED,2010,Cancer Res,PREDICTIVE,0.008837044892188053
1962,1,"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.",PUBMED,2011,Acta Neuropathol,PREDICTIVE,0.008837044892188053
2097,1,"FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib.",PUBMED,2009,Leukemia,PREDICTIVE,0.008837044892188053
2098,1,Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation.,PUBMED,2012,Cancer Res,PREDICTIVE,0.008837044892188053
2099,1,Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.,PUBMED,2016,Leukemia,PREDICTIVE,0.008837044892188053
2100,1,Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.,PUBMED,2011,Cancer Res,PREDICTIVE,0.008837044892188053
2101,1,Combination of In Silico Analysis and In Vitro Assay to Investigate Drug Response to Human Epidermal Growth Factor Receptor 2 Mutations in Lung Cancer.,PUBMED,2016,Mol Inform,PREDICTIVE,0.008837044892188053
2103,1,Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib.,PUBMED,2014,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2104,1,Dasatinib induces complete cytogenetic response and loss of F359C in an imatinib resistant chronic myelocytic leukemia patient.,PUBMED,2009,Am J Hematol,PREDICTIVE,0.008837044892188053
2106,1,Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1709,1,Melanoma-intrinsic Œ≤-catenin signalling prevents anti-tumour immunity.,PUBMED,2015,Nature,PREDICTIVE,0.008837044892188053
1711,1,Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma.,PUBMED,2011,Int J Cancer,PREDICTIVE,0.008837044892188053
1717,1,MERTK receptor tyrosine kinase is a therapeutic target in melanoma.,PUBMED,2013,J Clin Invest,PREDICTIVE,0.008837044892188053
1726,1,Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.,PUBMED,2017,JAMA,PREDICTIVE,0.008837044892188053
1727,1,Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy.,PUBMED,2017,J Clin Oncol,PROGNOSTIC,0.008837044892188053
1728,1,Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1729,1,Assessment of Molecular Markers in AML Patients: A Hospital-Based Study in Lebanon.,PUBMED,2015,Clin Lymphoma Myeloma Leuk,DIAGNOSTIC,0.008837044892188053
1732,1,"Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms.",PUBMED,2013,Mol Cancer,PREDICTIVE,0.008837044892188053
2088,1,Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2094,1,Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutation.,PUBMED,2015,J Hematol Oncol,PREDICTIVE,0.008837044892188053
1692,1,Inhibition of BRD4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma.,PUBMED,2017,Cell Physiol Biochem,PREDICTIVE,0.008837044892188053
1694,1,Identification of a FGFR3-TACC3 fusion in esophageal cancer.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.008837044892188053
1699,1,Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).,PUBMED,2015,Breast Cancer Res Treat,PREDICTIVE,0.008837044892188053
1701,1,The DCC protein and prognosis in colorectal cancer.,PUBMED,1996,N Engl J Med,PROGNOSTIC,0.008837044892188053
1703,1,"JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.",PUBMED,2014,Blood,PREDICTIVE,0.008837044892188053
1707,1,Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.,PUBMED,2015,Nat Med,PREDICTIVE,0.008837044892188053
2061,1,"Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.",PUBMED,2010,J Transl Med,PREDICTIVE,0.008837044892188053
2062,1,Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis.,PUBMED,2013,JAMA Dermatol,PREDICTIVE,0.008837044892188053
2071,1,Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer.,PUBMED,2007,Lung Cancer,PREDICTIVE,0.008837044892188053
2074,1,"ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.",PUBMED,2016,Lung Cancer,PREDICTIVE,0.008837044892188053
2078,1,Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
2083,1,Erlotinib in lung cancer - molecular and clinical predictors of outcome.,PUBMED,2005,N Engl J Med,PREDICTIVE,0.008837044892188053
2084,1,Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2087,1,First case of A859T epidermal growth factor receptor mutation responding to erlotinib.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2151,1,Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2153,1,Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.,PUBMED,2013,Endocr Relat Cancer,PREDICTIVE,0.008837044892188053
2154,1,Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.,PUBMED,2017,Oncotarget,PROGNOSTIC,0.008837044892188053
2155,1,Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.,PUBMED,2017,PLoS One,PROGNOSTIC,0.008837044892188053
2156,1,PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data.,PUBMED,2017,Immunotherapy,PREDICTIVE,0.008837044892188053
2159,1,A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced¬†Non-Small Cell Lung Cancer.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1653,1,GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.,PUBMED,2005,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1656,1,"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).",PUBMED,2014,Rare Dis,DIAGNOSTIC,0.008837044892188053
2140,1,Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi.,PUBMED,2017,Genes Chromosomes Cancer,PREDICTIVE,0.008837044892188053
2141,1,"Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.",PUBMED,2017,J Clin Oncol,PREDICTIVE,0.008837044892188053
2144,1,"Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
2145,1,Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.,PUBMED,2016,JAMA Oncol,PREDICTIVE,0.008837044892188053
2146,1,"Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors.",PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
2147,1,Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.,PUBMED,2017,Oncogene,PREDICTIVE,0.008837044892188053
2148,1,Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis.,PUBMED,2017,Breast J,PROGNOSTIC,0.008837044892188053
2150,1,Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.008837044892188053
2121,1,A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.,PUBMED,2013,Eur J Cancer,PREDICTIVE,0.008837044892188053
2126,1,MET Exon 14 Skipping in Non-Small Cell Lung Cancer.,PUBMED,2016,Oncologist,PREDICTIVE,0.008837044892188053
2127,1,Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation.,PUBMED,2015,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
2129,1,The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.,PUBMED,2014,BMC Cancer,PREDICTIVE,0.008837044892188053
2130,1,Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma.,PUBMED,2013,JAMA Dermatol,PREDICTIVE,0.008837044892188053
2131,1,MET Mutation Associated with Responsiveness to Crizotinib.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2132,1,MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
2138,1,Complete Response of Anaplastic Lymphoma Kinase-Mutated Refractory Extranodal Natural Killer/T-Cell Lymphoma to Crizotinib.,PUBMED,2016,Mayo Clin Proc,PREDICTIVE,0.008837044892188053
2108,1,Response to sunitinib of a gastrointestinal stromal tumor with a rare exon 12 PDGFRA mutation.,PUBMED,2015,Clin Sarcoma Res,PREDICTIVE,0.008837044892188053
2111,1,Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib.,PUBMED,2014,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2112,1,Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma.,PUBMED,2014,J Cancer Res Clin Oncol,PREDICTIVE,0.008837044892188053
2114,1,BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.,PUBMED,2013,Mol Oncol,PREDICTIVE,0.008837044892188053
2115,1,Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA.,PUBMED,2016,Lung Cancer,PREDICTIVE,0.008837044892188053
2117,1,Segmental basal cell naevus syndrome caused by an activating mutation in smoothened.,PUBMED,2016,Br J Dermatol,PREDICTIVE,0.008837044892188053
2119,1,EGFR delE709_T710insD: a rare but potentially EGFR inhibitor responsive mutation in non-small-cell lung cancer.,PUBMED,2012,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2120,1,A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.,PUBMED,2014,Med Oncol,PREDICTIVE,0.008837044892188053
2162,1,KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma.,PUBMED,2017,Cancer Immunol Immunother,PREDICTIVE,0.008837044892188053
2163,1,"A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer.",PUBMED,2016,Invest New Drugs,PREDICTIVE,0.008837044892188053
2164,1,A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)‚Ä†.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
2165,1,Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.008837044892188053
2170,1,Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].,PUBMED,2003,J Clin Oncol,PREDICTIVE,0.008837044892188053
2173,1,Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer.,PUBMED,2004,J Clin Oncol,PREDICTIVE,0.008837044892188053
2176,1,"Is the P25L a ""real"" VHL mutation?",PUBMED,2001,Mol Diagn,PREDISPOSING,0.008837044892188053
2177,1,RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome.,PUBMED,2003,J Clin Endocrinol Metab,DIAGNOSTIC,0.008837044892188053
1678,1,Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1680,1,ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression.,PUBMED,2012,Haematologica,PROGNOSTIC,0.008837044892188053
1682,1,Targeting mutant NRAS signaling pathways in melanoma.,PUBMED,2016,Pharmacol Res,PREDICTIVE,0.008837044892188053
1684,1,MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.,PUBMED,2015,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1685,1,Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
1686,1,"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
2160,1,Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
2161,1,Association between PD-L1 expression and driven gene status in NSCLC: A meta-analysis.,PUBMED,2017,Eur J Surg Oncol,PREDICTIVE,0.008837044892188053
1666,1,O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.,PUBMED,2011,Brain Tumor Pathol,PREDICTIVE,0.008837044892188053
1667,1,O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1668,1,The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer.,PUBMED,2013,Cancer Biomark,PREDICTIVE,0.008837044892188053
1669,1,S768I Mutation in EGFR in Patients with Lung Cancer.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1673,1,AEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanoma.,PUBMED,2013,Cell Death Dis,PREDICTIVE,0.008837044892188053
1674,1,CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.,PUBMED,2017,Oncol Rep,PREDICTIVE,0.008837044892188053
1675,1,When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?,PUBMED,2009,Ann Surg Oncol,PREDISPOSING,0.008837044892188053
1676,1,Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.,PUBMED,2006,Oncogene,PREDISPOSING,0.008837044892188053
1658,1,GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.,PUBMED,2009,Pharmacogenomics J,PREDICTIVE,0.008837044892188053
1659,1,The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.,PUBMED,2006,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1660,1,The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.,PUBMED,2006,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1661,1,GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma.,PUBMED,2010,Eur J Med Res,PROGNOSTIC,0.008837044892188053
1662,1,Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.,PUBMED,2007,J Clin Oncol,PREDICTIVE,0.008837044892188053
1663,1,Inhibition of hTERT expression by MAP kinase inhibitor induces cell death in renal cell carcinoma.,PUBMED,2017,Urol Oncol,PREDICTIVE,0.008837044892188053
1664,1,O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.,PUBMED,2011,PLoS One,PREDICTIVE,0.008837044892188053
1665,1,Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.,PUBMED,2006,Cancer,PREDICTIVE,0.008837044892188053
1516,1,EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
1524,1,Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1527,1,"Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models.",PUBMED,2012,Int J Cancer,PREDICTIVE,0.008837044892188053
1570,1,Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations.,PUBMED,2014,Exp Hematol,PREDICTIVE,0.008837044892188053
1585,1,Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2209,1,"Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.",PUBMED,2015,J Clin Oncol,PREDICTIVE,0.008837044892188053
2213,1,Bilateral papillary cystadenoma of the mesosalpinx: a rare manifestation of Von Hippel-Lindau disease.,PUBMED,2010,Arch Gynecol Obstet,PREDISPOSING,0.008837044892188053
2214,1,Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease.,PUBMED,2009,Pediatr Blood Cancer,PREDISPOSING,0.008837044892188053
1635,1,Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1645,1,Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.,PUBMED,2014,Nat Genet,ONCOGENIC,0.008837044892188053
1647,1,Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.,PUBMED,2010,Pigment Cell Melanoma Res,PROGNOSTIC,0.008837044892188053
1648,1,Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.,PUBMED,2009,Int J Cancer,PREDICTIVE,0.008837044892188053
1649,1,"Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation.",PUBMED,2008,Pigment Cell Melanoma Res,PREDICTIVE,0.008837044892188053
1650,1,Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan.,PUBMED,2003,Kaohsiung J Med Sci,DIAGNOSTIC,0.008837044892188053
1651,1,"Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.",PUBMED,2011,Blood,DIAGNOSTIC,0.008837044892188053
1652,1,The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.,PUBMED,2005,Cancer Epidemiol Biomarkers Prev,PROGNOSTIC,0.008837044892188053
1598,1,Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.,PUBMED,2002,Mol Cancer Ther,FUNCTIONAL,0.008837044892188053
1610,1,Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.,PUBMED,2004,N Engl J Med,PREDICTIVE,0.008837044892188053
1613,1,Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.,PUBMED,2008,Oncologist,PREDICTIVE,0.008837044892188053
1614,1,Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer.,PUBMED,2005,J Clin Oncol,PREDICTIVE,0.008837044892188053
1615,1,Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants.,PUBMED,2006,Oncogene,PREDICTIVE,0.008837044892188053
1620,1,Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report.,PUBMED,2015,Exp Ther Med,PREDICTIVE,0.008837044892188053
1629,1,"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.",PUBMED,2009,Cancer Cell,PREDICTIVE,0.008837044892188053
1634,1,Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.,PUBMED,2009,Pathol Res Pract,DIAGNOSTIC,0.008837044892188053
2178,1,Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma.,PUBMED,2014,Melanoma Res,PREDICTIVE,0.008837044892188053
2181,1,"von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma.",PUBMED,2013,Intern Med,PREDISPOSING,0.008837044892188053
2182,1,Pheochromocytoma--analysis of 15 consecutive cases from one centre.,PUBMED,2013,Endokrynol Pol,PREDISPOSING,0.008837044892188053
2183,1,A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.,PUBMED,2015,Genet Mol Res,PREDISPOSING,0.008837044892188053
2185,1,[von Hippel-Lindau hereditary tumor syndrome. Mutational analysis may improve prognosis].,PUBMED,1995,Lakartidningen,PREDISPOSING,0.008837044892188053
2189,1,Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
1588,1,Molecular basis and management of gastrointestinal stromal tumors.,PUBMED,2010,World J Gastroenterol,PREDICTIVE,0.008837044892188053
1593,1,KIT as a therapeutic target in metastatic melanoma.,PUBMED,2011,JAMA,PREDICTIVE,0.008837044892188053
2244,1,Pheochromocytoma in a 2.75-year-old-girl with a germline von Hippel-Lindau mutation Q164R.,PUBMED,2010,Am J Med Genet A,PREDISPOSING,0.008837044892188053
2247,1,Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with analysis of von Hippel-Lindau gene and review.,PUBMED,2010,Ann Diagn Pathol,PREDISPOSING,0.008837044892188053
2248,1,"Bilateral renal tumors; conventional clear cell carcinoma and contralateral t(6;11)/t(X;17)-like tumor Histomorphologic, immunohistochemical, ultrastructural and molecular genetic studies including the report of a novel mutation in the VHL gene.",PUBMED,2011,Ann Diagn Pathol,PREDISPOSING,0.008837044892188053
2252,1,BET bromodomain inhibition as a therapeutic strategy to target c-Myc.,PUBMED,2011,Cell,PREDICTIVE,0.008837044892188053
2253,1,Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma.,PUBMED,2009,Oncogene,PREDICTIVE,0.008837044892188053
2256,1,Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.,PUBMED,2017,Medicine (Baltimore),PROGNOSTIC,0.008837044892188053
2257,1,Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer.,PUBMED,2007,Int J Cancer,PREDICTIVE,0.008837044892188053
2258,1,Effect of Œ≤-catenin alterations in the prognosis of patients with sporadic colorectal cancer.,PUBMED,2014,J Cancer Res Ther,PROGNOSTIC,0.008837044892188053
1497,1,BRAF is a therapeutic target in aggressive thyroid carcinoma.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1498,1,Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing Program.,PUBMED,2010,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
1514,1,A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer.,PUBMED,2014,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
1405,1,The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma.,PUBMED,2007,Breast Cancer Res Treat,PROGNOSTIC,0.008837044892188053
1410,1,"High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.",PUBMED,2009,Blood,PREDISPOSING,0.008837044892188053
1445,1,Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.,PUBMED,2007,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1471,1,Rare cancer-specific mutations in PIK3CA show gain of function.,PUBMED,2007,Proc Natl Acad Sci U S A,FUNCTIONAL,0.008837044892188053
2242,1,Molecular genetic analysis and mutation screening of the VHL gene in a Japanese family with von Hippel-Lindau disease.,PUBMED,2000,Kobe J Med Sci,PREDISPOSING,0.008837044892188053
2233,1,Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2237,1,DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.,PUBMED,2016,Histopathology,DIAGNOSTIC,0.008837044892188053
1476,1,A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.,PUBMED,2011,Clin Cancer Res,FUNCTIONAL,0.008837044892188053
1484,1,Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.,PUBMED,2005,Cancer Res,PREDICTIVE,0.008837044892188053
1487,1,BRAF mutation predicts sensitivity to MEK inhibition.,PUBMED,2006,Nature,PREDICTIVE,0.008837044892188053
1489,1,The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1493,1,Inhibitory effects of the mitogen-activated protein kinase kinase inhibitor CI-1040 on the proliferation and tumor growth of thyroid cancer cells with BRAF or RAS mutations.,PUBMED,2007,J Clin Endocrinol Metab,PREDICTIVE,0.008837044892188053
1496,1,BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus.,PUBMED,2010,Int J Cancer,PREDICTIVE,0.008837044892188053
2217,1,Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.,PUBMED,2009,Fam Cancer,PREDISPOSING,0.008837044892188053
2218,1,Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.,PUBMED,2009,JOP,PREDISPOSING,0.008837044892188053
2220,1,"Local-regional recurrence of sporadic or syndromic abdominal extra-adrenal paraganglioma: incidence, characteristics, and outcome.",PUBMED,2009,Surgery,PREDISPOSING,0.008837044892188053
2221,1,Bilateral pheochromocytoma as first presentation of von Hippel-Lindau disease in a Chinese family.,PUBMED,2009,Chin Med Sci J,PREDISPOSING,0.008837044892188053
2222,1,Combination of right nephrectomy and total pancreaticoduodenectomy for Von Hippel-Lindau disease.,PUBMED,2010,JOP,PREDISPOSING,0.008837044892188053
2224,1,Midostaurin approved for FLT3-mutated AML.,PUBMED,2017,Blood,PREDICTIVE,0.008837044892188053
2227,1,"Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.",PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
2228,1,Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.,PUBMED,2013,Cancer Cell,PREDICTIVE,0.008837044892188053
2301,1,Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.,PUBMED,1997,Am J Pathol,PREDISPOSING,0.008837044892188053
2304,1,Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes.,PUBMED,1997,Clin Endocrinol (Oxf),PREDISPOSING,0.008837044892188053
2305,1,Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.,PUBMED,2012,PLoS One,PROGNOSTIC,0.008837044892188053
2306,1,Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.,PUBMED,2015,Hum Pathol,PROGNOSTIC,0.008837044892188053
1375,1,Dual disruption of DNA repair and telomere maintenance for the treatment of head and neck cancer.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1376,1,Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.008837044892188053
1377,1,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.008837044892188053
1378,1,Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERŒ± in breast cancer.,PUBMED,2014,Oncogene,PREDICTIVE,0.008837044892188053
2290,1,Von hippel-lindau disease and erythrocytosis.,PUBMED,2012,J Clin Oncol,PREDISPOSING,0.008837044892188053
2291,1,Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene.,PUBMED,1996,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
2292,1,Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.,PUBMED,1996,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
2294,1,Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.,PUBMED,2012,J Xray Sci Technol,PREDISPOSING,0.008837044892188053
2296,1,Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma.,PUBMED,1997,Clin Endocrinol (Oxf),PREDISPOSING,0.008837044892188053
2297,1,A mutation at IVS1 + 5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer?: case report.,PUBMED,2012,BMC Med Genet,PREDISPOSING,0.008837044892188053
2298,1,Endolymphatic sac tumor and angiomatous lesions of the nasal and pharyngeal mucosa as a first manifestation of von Hippel-Lindau disease.,PUBMED,2012,Laryngoscope,PREDISPOSING,0.008837044892188053
2299,1,A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma.,PUBMED,2013,Clin Endocrinol (Oxf),PREDISPOSING,0.008837044892188053
2274,1,A novel germline mutation of the VHL gene in a Greek family with Von Hippel-Lindau disease.,PUBMED,2009,BMJ Case Rep,PREDISPOSING,0.008837044892188053
2275,1,Cauda equina hemangioblastoma at L5 vertebral level related to von Hippel-Lindau disease.,PUBMED,2012,Br J Neurosurg,PREDISPOSING,0.008837044892188053
2276,1,Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?,PUBMED,2011,Surgery,PREDISPOSING,0.008837044892188053
2278,1,Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant.,PUBMED,2017,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
2280,1,Role of cortical sparing adrenalectomy and novel variant of mutation in patient with von Hippel-Lindau disease.,PUBMED,2011,Indian J Endocrinol Metab,PREDISPOSING,0.008837044892188053
2283,1,[Surgical treatment of a pheocromocytoma bilateral in a 5 year old patient with the von Hippel-Lindau disease].,PUBMED,2004,Cir Pediatr,PREDISPOSING,0.008837044892188053
2284,1,Genetic study of a large Chinese kindred with von Hippel-Lindau disease.,PUBMED,2004,Chin Med J (Engl),PREDISPOSING,0.008837044892188053
2289,1,Von Hippel-Lindau disease and aggressive GH-PRL pituitary adenoma in a young boy.,PUBMED,2012,Ann Endocrinol (Paris),PREDISPOSING,0.008837044892188053
2259,1,Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors.,PUBMED,2017,J Clin Oncol,PREDICTIVE,0.008837044892188053
2262,1,A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL gene.,PUBMED,2011,Neurol Sci,PREDISPOSING,0.008837044892188053
2263,1,Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
2268,1,Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.,PUBMED,2002,Nat Genet,PREDISPOSING,0.008837044892188053
2270,1,An elusive phaeochromocytoma.,PUBMED,2011,Med J Aust,PREDISPOSING,0.008837044892188053
2271,1,Molecular cytogenetic characterization in four pediatric pheochromocytomas and paragangliomas.,PUBMED,2011,Pathol Oncol Res,PREDISPOSING,0.008837044892188053
2272,1,Long-term effect of external beam radiotherapy of optic disc hemangioma in a patient with von Hippel-Lindau disease.,PUBMED,2011,Acta Med Okayama,PREDISPOSING,0.008837044892188053
2273,1,Serous cystic neoplasms of the whole pancreas in a patient with von Hippel-Lindau disease.,PUBMED,2011,Intern Med,PREDISPOSING,0.008837044892188053
2321,1,Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.,PUBMED,2013,Blood,PREDISPOSING,0.008837044892188053
2322,1,"New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?",PUBMED,2016,Onco Targets Ther,PREDICTIVE,0.008837044892188053
2327,1,Acute myeloid leukemia in a 38-year-old hemodialyzed patient with von Hippel-Lindau disease.,PUBMED,2013,Hered Cancer Clin Pract,PREDISPOSING,0.008837044892188053
2331,1,Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
2332,1,Identification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome.,PUBMED,2014,Genet Mol Res,PREDISPOSING,0.008837044892188053
2333,1,Metastatic phaeochromocytoma in a 23-year-old woman with an unclassified variant in the von Hippel Lindau disease gene: how can the pathogenicity of this variant be determined?,PUBMED,2015,Clin Endocrinol (Oxf),PREDISPOSING,0.008837044892188053
2335,1,Clinical and genetic investigation of a multi-generational Chinese family afflicted with Von Hippel-Lindau disease.,PUBMED,2015,Chin Med J (Engl),PREDISPOSING,0.008837044892188053
2336,1,Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma.,PUBMED,2012,Mod Pathol,PROGNOSTIC,0.008837044892188053
1404,1,GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.,PUBMED,2007,Neoplasia,PROGNOSTIC,0.008837044892188053
2308,1,P.Arg82Leu von Hippel-Lindau (VHL) gene mutation among three members of a family with familial bilateral pheochromocytoma in India: molecular analysis and in silico characterization.,PUBMED,2013,PLoS One,PREDISPOSING,0.008837044892188053
2309,1,Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family.,PUBMED,2014,Endocrine,PREDISPOSING,0.008837044892188053
2312,1,A c.464T>a mutation in VHL gene in a Chinese family with VHL syndrome.,PUBMED,2013,J Neurooncol,PREDISPOSING,0.008837044892188053
2313,1,"A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.",PUBMED,2013,Fam Cancer,PREDISPOSING,0.008837044892188053
2314,1,Bilateral pheochromocytomas in a child who had hemihypertrophy and alteration in the VHL gene.,PUBMED,2013,J Pediatr Endocrinol Metab,PREDISPOSING,0.008837044892188053
2315,1,Mosaicism in von Hippel-Lindau disease with severe renal manifestations.,PUBMED,2013,Clin Genet,PREDISPOSING,0.008837044892188053
2319,1,Bilateral pheochromocytoma as first manifestation of von Hippel-Lindau disease: a case report.,PUBMED,2012,Turk J Pediatr,PREDISPOSING,0.008837044892188053
1391,1,Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.,PUBMED,2016,PLoS One,PREDICTIVE,0.008837044892188053
1392,1,hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1394,1,Phase II study on lapatinib in advanced EGFR-positive chordoma.,PUBMED,2013,Ann Oncol,PREDICTIVE,0.008837044892188053
1395,1,Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
1398,1,Personalized Medicine Approach for an Exceptional Response to Multiple-recurrent and Metastatic HER2-positive Oropharyngeal Squamous Cell Carcinoma.,PUBMED,2017,Ann Otol Rhinol Laryngol,PREDICTIVE,0.008837044892188053
1399,1,HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF.,PUBMED,2017,Clin Colorectal Cancer,PREDICTIVE,0.008837044892188053
1400,1,GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.,PUBMED,2016,J Transl Med,PROGNOSTIC,0.008837044892188053
1401,1,[Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status].,PUBMED,2014,Zhongguo Fei Ai Za Zhi,PREDICTIVE,0.008837044892188053
1380,1,Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1381,1,Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
1382,1,Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
1383,1,Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.,PUBMED,1994,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
1384,1,Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
1385,1,ROS1 amplification mediates resistance to gefitinib in glioblastoma cells.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
1387,1,Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.,PUBMED,1993,N Engl J Med,PROGNOSTIC,0.008837044892188053
1390,1,A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.,PUBMED,2013,Nature,PREDICTIVE,0.008837044892188053
2346,1,Rathke's cleft cysts in twins with type 2C von Hippel-Lindau disease.,PUBMED,2014,J Neurosurg Pediatr,PREDISPOSING,0.008837044892188053
2351,1,Pembrolizumab for the treatment of non-small-cell lung cancer.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
2352,1,Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.,PUBMED,2015,JAMA Oncol,PREDICTIVE,0.008837044892188053
2353,1,Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
2354,1,Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient.,PUBMED,2017,Med Oncol,PREDICTIVE,0.008837044892188053
2356,1,Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.008837044892188053
2358,1,Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.,PUBMED,2015,Science,PREDICTIVE,0.008837044892188053
2360,1,BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.,PUBMED,2017,J Clin Oncol,PROGNOSTIC,0.008837044892188053
1356,1,PTEN hamartoma tumor syndrome and Gorham-Stout phenomenon.,PUBMED,2012,Am J Med Genet A,PREDISPOSING,0.008837044892188053
1360,1,Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer.,PUBMED,2018,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
1361,1,Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
1365,1,A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.,PUBMED,2015,Anticancer Drugs,PREDICTIVE,0.008837044892188053
1366,1,Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.008837044892188053
2340,1,Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel-Lindau disease.,PUBMED,2014,J Chin Med Assoc,PREDISPOSING,0.008837044892188053
2342,1,A novel mutation in the von hippel-lindau tumor suppressor gene identified in a patient presenting with gestational diabetes mellitus.,PUBMED,2013,Endocrinol Metab (Seoul),PREDISPOSING,0.008837044892188053
2345,1,De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.,PUBMED,2014,J Neurosurg,PREDISPOSING,0.008837044892188053
1347,1,Activating Smoothened mutations in sporadic basal-cell carcinoma.,PUBMED,1998,Nature,DIAGNOSTIC,0.008837044892188053
1348,1,Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.,PUBMED,2013,Nat Genet,DIAGNOSTIC,0.008837044892188053
1349,1,SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.,PUBMED,2017,Neuro Oncol,DIAGNOSTIC,0.008837044892188053
1350,1,Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.,PUBMED,1998,Cancer Res,DIAGNOSTIC,0.008837044892188053
1352,1,PTEN gene mutations are seen in high-grade but not in low-grade gliomas.,PUBMED,1997,Cancer Res,DIAGNOSTIC,0.008837044892188053
1353,1,Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.,PUBMED,1998,Cancer Res,DIAGNOSTIC,0.008837044892188053
1354,1,"Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.",PUBMED,1998,Int J Oncol,DIAGNOSTIC,0.008837044892188053
1355,1,Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.,PUBMED,1998,Cancer Res,ONCOGENIC,0.008837044892188053
2337,1,Diagnostic genetics at a distance: von hippel-lindau disease and a novel mutation.,PUBMED,2013,Genet Res Int,PREDISPOSING,0.008837044892188053
2339,1,Genetic characterization and protein stability analysis of a Chinese family with Von Hippel-Lindau disease.,PUBMED,2013,Chin Med J (Engl),PREDISPOSING,0.008837044892188053
1338,1,Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.,PUBMED,1994,Cancer Res,ONCOGENIC,0.008837044892188053
1339,1,Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.008837044892188053
1340,1,RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
1342,1,"Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.",PUBMED,2016,Cancer,PREDICTIVE,0.008837044892188053
1343,1,Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex.,PUBMED,2011,Hum Mutat,PREDISPOSING,0.008837044892188053
1344,1,Upregulation of AKT3 Confers Resistance to the AKT Inhibitor MK2206 in Breast Cancer.,PUBMED,2016,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2380,1,Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review.,PUBMED,2016,J Gastrointest Oncol,PREDICTIVE,0.008837044892188053
2381,1,Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion.,PUBMED,2017,J Gastrointest Oncol,PREDICTIVE,0.008837044892188053
2382,1,"Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan.",PUBMED,2016,J Gastrointest Cancer,PREDICTIVE,0.008837044892188053
2386,1,Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with sunitinib.,PUBMED,2015,Breast J,PREDICTIVE,0.008837044892188053
2390,1,PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2391,1,LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors.,PUBMED,2017,Ann Oncol,PROGNOSTIC,0.008837044892188053
2392,1,"Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
2394,1,A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.,PUBMED,2015,Blood Cancer J,PREDICTIVE,0.008837044892188053
1327,1,"Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.",PUBMED,1998,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
1333,1,Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.,PUBMED,2017,Blood,PROGNOSTIC,0.008837044892188053
1335,1,ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors.,PUBMED,2010,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2374,1,Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene.,PUBMED,1999,Am J Med Genet,PREDISPOSING,0.008837044892188053
2375,1,A germline mutation in the von Hippel-Lindau disease gene (L178Q) detected by denaturing gradient gel electrophoresis in a large Jewish-Yemenite family.,PUBMED,1999,Hum Mutat,PREDISPOSING,0.008837044892188053
2377,1,PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2378,1,SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2379,1,Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine.,PUBMED,2014,Ecancermedicalscience,PREDICTIVE,0.008837044892188053
1285,1,Clinical correlation of extensive-stage small-cell lung cancer genomics.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.008837044892188053
1291,1,A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.,PUBMED,2017,Cancer,PROGNOSTIC,0.008837044892188053
1292,1,A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.,PUBMED,2001,Blood,PREDISPOSING,0.008837044892188053
1294,1,A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia.,PUBMED,2002,Br J Haematol,PREDISPOSING,0.008837044892188053
1295,1,Recurrence and variability of germline EPCAM deletions in Lynch syndrome.,PUBMED,2011,Hum Mutat,PREDISPOSING,0.008837044892188053
1296,1,"Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
1306,1,CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.,PUBMED,2015,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
1310,1,Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.,PUBMED,2008,Eur J Hum Genet,PREDISPOSING,0.008837044892188053
2361,1,"Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
2362,1,KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.,PUBMED,2012,Br J Cancer,PROGNOSTIC,0.008837044892188053
2364,1,Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.,PUBMED,2017,BMC Cancer,PREDICTIVE,0.008837044892188053
2367,1,Low frequency of VHL gene mutations in young individuals with polycythemia and high serum erythropoietin.,PUBMED,2005,Haematologica,PREDISPOSING,0.008837044892188053
2368,1,Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.,PUBMED,2015,Hum Mutat,PREDISPOSING,0.008837044892188053
2370,1,VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.,PUBMED,1999,Neurology,PREDISPOSING,0.008837044892188053
1281,1,Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.,PUBMED,2016,J Clin Invest,PREDICTIVE,0.008837044892188053
1282,1,Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors.,PUBMED,2013,Lung Cancer,PREDICTIVE,0.008837044892188053
2432,1,"Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.",PUBMED,2009,J Thorac Oncol,PROGNOSTIC,0.008837044892188053
2434,1,Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.,PUBMED,2012,Cell,PROGNOSTIC,0.008837044892188053
2436,1,Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study.,PUBMED,2015,Biomed J,PREDICTIVE,0.008837044892188053
2437,1,Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.,PUBMED,2005,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2438,1,EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2439,1,Targeted Treatment of a Rare Vaginal Sarcoma With an Anaplastic Lymphoma Kinase Inhibitor.,PUBMED,2016,Obstet Gynecol,PREDICTIVE,0.008837044892188053
2440,1,"A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.",PUBMED,2014,Jpn J Clin Oncol,PREDICTIVE,0.008837044892188053
2441,1,"Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
2420,1,Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome.,PUBMED,2014,Sci Transl Med,PREDICTIVE,0.008837044892188053
2422,1,ATM Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma.,PUBMED,2017,Cancer Res,PREDICTIVE,0.008837044892188053
2423,1,TCTP as a therapeutic target in melanoma treatment.,PUBMED,2017,Br J Cancer,PREDICTIVE,0.008837044892188053
2424,1,Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.,PUBMED,2016,Nat Commun,PREDICTIVE,0.008837044892188053
2427,1,Targeting MYCN in neuroblastoma by BET bromodomain inhibition.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.008837044892188053
2428,1,Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2429,1,The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2430,1,CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.,PUBMED,2018,J Clin Invest,PREDICTIVE,0.008837044892188053
2410,1,Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.008837044892188053
2411,1,Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.,PUBMED,2012,Br J Cancer,PREDICTIVE,0.008837044892188053
2412,1,Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.,PUBMED,2004,Cancer Invest,PREDICTIVE,0.008837044892188053
2413,1,A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.,PUBMED,2017,Invest New Drugs,PREDICTIVE,0.008837044892188053
2415,1,A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.,PUBMED,2016,Cell Death Dis,PREDICTIVE,0.008837044892188053
2416,1,Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.,PUBMED,2009,Int J Cancer,PREDICTIVE,0.008837044892188053
2418,1,Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
2419,1,BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.,PUBMED,2015,Blood,PROGNOSTIC,0.008837044892188053
2395,1,EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis.,PUBMED,2017,J Investig Med,PREDICTIVE,0.008837044892188053
2398,1,KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.,PUBMED,2017,Blood,PREDICTIVE,0.008837044892188053
2399,1,Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.,PUBMED,2018,Cell,PREDICTIVE,0.008837044892188053
2400,1,SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.,PUBMED,2017,Nat Commun,PREDICTIVE,0.008837044892188053
2404,1,Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.,PUBMED,2011,Blood,PROGNOSTIC,0.008837044892188053
2407,1,"Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.",PUBMED,2011,Anticancer Res,PREDICTIVE,0.008837044892188053
2408,1,Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2409,1,Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.,PUBMED,2016,Sci Rep,PREDICTIVE,0.008837044892188053
2456,1,"Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor.",PUBMED,2002,Int J Mol Med,DIAGNOSTIC,0.008837044892188053
2457,1,Frequent association of beta-catenin and WT1 mutations in Wilms tumors.,PUBMED,2000,Cancer Res,DIAGNOSTIC,0.008837044892188053
2459,1,"Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.",PUBMED,2016,Cytokine Growth Factor Rev,PREDISPOSING,0.008837044892188053
2460,1,"Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.",PUBMED,2002,Oncogene,PREDICTIVE,0.008837044892188053
2461,1,"Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.",PUBMED,2015,Cancer Cell,PROGNOSTIC,0.008837044892188053
2463,1,Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.,PUBMED,2014,Cancer Res,ONCOGENIC,0.008837044892188053
2466,1,Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.008837044892188053
2469,1,Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.,PUBMED,2011,Brain Pathol,DIAGNOSTIC,0.008837044892188053
2447,1,Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.,PUBMED,1996,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
2449,1,Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma.,PUBMED,2007,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
2450,1,Genetic and chromosomal alterations in Kenyan Wilms Tumor.,PUBMED,2015,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
2451,1,Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.,PUBMED,2018,Haematologica,DIAGNOSTIC,0.008837044892188053
2452,1,Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL.,PUBMED,2017,J Exp Med,PREDISPOSING,0.008837044892188053
2453,1,Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation.,PUBMED,2007,J Med Genet,DIAGNOSTIC,0.008837044892188053
2454,1,Beta-catenin expression and mutation in adult and pediatric Wilms' tumors.,PUBMED,2008,APMIS,DIAGNOSTIC,0.008837044892188053
2455,1,Stratification of Wilms tumor by genetic and epigenetic analysis.,PUBMED,2012,Oncotarget,DIAGNOSTIC,0.008837044892188053
1257,1,"Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
1258,1,Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC.,PUBMED,1999,Hum Mutat,ONCOGENIC,0.008837044892188053
1265,1,Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis.,PUBMED,2016,Oncotarget,PREDISPOSING,0.008837044892188053
1266,1,Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.,PUBMED,2015,Blood Cancer J,PREDICTIVE,0.008837044892188053
1269,1,Molecular genetic characterization of the genomic ACTB-GLI fusion in pericytoma with t(7;12).,PUBMED,2004,Biochem Biophys Res Commun,DIAGNOSTIC,0.008837044892188053
1271,1,CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia.,PUBMED,2006,Leukemia,PROGNOSTIC,0.008837044892188053
1280,1,Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
2443,1,Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing.,PUBMED,2017,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
1237,1,Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.,PUBMED,2015,JAMA Oncol,PREDICTIVE,0.008837044892188053
1240,1,Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.,PUBMED,2014,Br J Haematol,PREDICTIVE,0.008837044892188053
1243,1,Fusion of the EWS and CHOP genes in myxoid liposarcoma.,PUBMED,1996,Oncogene,DIAGNOSTIC,0.008837044892188053
1245,1,Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.,PUBMED,1999,Cancer Res,DIAGNOSTIC,0.008837044892188053
1246,1,Selective inhibition of BET bromodomains.,PUBMED,2010,Nature,PREDICTIVE,0.008837044892188053
1248,1,CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis.,PUBMED,2013,PLoS One,PROGNOSTIC,0.008837044892188053
1249,1,Cytogenetic findings in liposarcoma correlate with histopathologic subtypes.,PUBMED,1992,Cancer,DIAGNOSTIC,0.008837044892188053
1254,1,Fusion events lead to truncation of FOS in epithelioid hemangioma of bone.,PUBMED,2015,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
1231,1,Does CDKN2A loss predict palbociclib benefit?,PUBMED,2015,Curr Oncol,PREDICTIVE,0.008837044892188053
1232,1,"Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.",PUBMED,2013,Br J Haematol,PREDICTIVE,0.008837044892188053
1234,1,Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.,PUBMED,2010,Hum Genet,PREDISPOSING,0.008837044892188053
1235,1,Disease pattern in Danish patients with Peutz-Jeghers syndrome.,PUBMED,2016,Int J Colorectal Dis,PREDISPOSING,0.008837044892188053
2476,1,SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.,PUBMED,2018,Cancer Res,PROGNOSTIC,0.008837044892188053
2481,1,PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.,PUBMED,2008,Breast Cancer Res,PREDICTIVE,0.008837044892188053
2482,1,Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.,PUBMED,2012,Blood,PREDICTIVE,0.008837044892188053
2485,1,Von Hippel-Lindau Disease: The Importance of Retinal Hemangioblastomas in Diagnosis.,PUBMED,2017,Turk J Ophthalmol,PREDISPOSING,0.008837044892188053
1212,1,Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).,PUBMED,1988,Cancer Genet Cytogenet,DIAGNOSTIC,0.008837044892188053
1215,1,Detection of t(11;22)(q24;q12) translocation of Ewing's sarcoma in paraffin embedded tissue by nested reverse transcription-polymerase chain reaction.,PUBMED,1998,J Korean Med Sci,DIAGNOSTIC,0.008837044892188053
1216,1,Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors.,PUBMED,2006,Mod Pathol,DIAGNOSTIC,0.008837044892188053
1217,1,High-speed biosensing strategy for non-invasive profiling of multiple cancer fusion genes in urine.,PUBMED,2017,Biosens Bioelectron,DIAGNOSTIC,0.008837044892188053
1218,1,MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai.,PUBMED,2016,Sci Rep,PREDISPOSING,0.008837044892188053
1221,1,A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.,PUBMED,2015,Am J Cancer Res,PREDICTIVE,0.008837044892188053
1224,1,The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.,PUBMED,2015,Cancer Epidemiol Biomarkers Prev,PREDISPOSING,0.008837044892188053
1229,1,Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.008837044892188053
1192,1,BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.,PUBMED,2014,Cell Rep,PREDICTIVE,0.008837044892188053
1193,1,Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.,PUBMED,2015,Sci Rep,PREDISPOSING,0.008837044892188053
1197,1,Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
1198,1,Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein.,PUBMED,2014,J Hematol Oncol,PREDICTIVE,0.008837044892188053
1203,1,Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.,PUBMED,2015,BMC Cancer,PROGNOSTIC,0.008837044892188053
1206,1,"Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
1207,1,"Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial.",PUBMED,2017,Lancet Respir Med,PREDICTIVE,0.008837044892188053
1211,1,The GADD45A (1506T>C) Polymorphism Is Associated with Ovarian Cancer Susceptibility and Prognosis.,PUBMED,2015,PLoS One,PREDISPOSING,0.008837044892188053
2470,1,Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature.,PUBMED,2012,Avicenna J Med,PREDICTIVE,0.008837044892188053
2471,1,Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.,PUBMED,2010,Head Neck Oncol,PREDICTIVE,0.008837044892188053
2472,1,Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.,PUBMED,2017,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
1185,1,Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.,PUBMED,2016,PLoS One,PREDICTIVE,0.008837044892188053
1186,1,Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.,PUBMED,2013,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
1188,1,Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.,PUBMED,2012,Hum Mol Genet,PROGNOSTIC,0.008837044892188053
1190,1,The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.,PUBMED,2016,Biomed Pharmacother,PROGNOSTIC,0.008837044892188053
1191,1,NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.008837044892188053
2540,1,Pharmacogenomics and gemcitabine.,PUBMED,2006,Ann Oncol,PREDICTIVE,0.008837044892188053
2541,1,Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.,PUBMED,2004,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2542,1,"Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.",PUBMED,2014,Asian Pac J Cancer Prev,PREDICTIVE,0.008837044892188053
2543,1,Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.,PUBMED,2004,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2545,1,Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer.,PUBMED,2017,Lung Cancer,PREDICTIVE,0.008837044892188053
2546,1,Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.,PUBMED,2007,Ann Oncol,PREDICTIVE,0.008837044892188053
2547,1,The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.,PUBMED,2017,Int J Mol Sci,PROGNOSTIC,0.008837044892188053
2548,1,STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.008837044892188053
2526,1,Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.,PUBMED,2014,Am J Hematol,PROGNOSTIC,0.008837044892188053
2528,1,Lipofibromatosis-like neural tumor: Case report of a unique infantile presentation.,PUBMED,2018,JAAD Case Rep,DIAGNOSTIC,0.008837044892188053
2531,1,Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.,PUBMED,2011,Cancer Discov,PREDICTIVE,0.008837044892188053
2532,1,"The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.",PUBMED,2012,J Transl Med,PREDICTIVE,0.008837044892188053
2533,1,ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade.,PUBMED,2018,Nat Med,PREDICTIVE,0.008837044892188053
2535,1,Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.,PUBMED,2013,Oncogene,PREDICTIVE,0.008837044892188053
2537,1,Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer.,PUBMED,2010,Med Oncol,PREDICTIVE,0.008837044892188053
2539,1,Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.,PUBMED,2003,Oncogene,PREDICTIVE,0.008837044892188053
2511,1,Concurrent bilateral pheochromocytoma and thoracic paraganglioma during pregnancy.,PUBMED,2010,Endocrine,PREDISPOSING,0.008837044892188053
2512,1,Contribution of endosonography in an uncommon case of pancreatic cysts.,PUBMED,2013,World J Gastrointest Endosc,PREDISPOSING,0.008837044892188053
2513,1,Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
2519,1,Activity of sunitinib in extraskeletal myxoid chondrosarcoma.,PUBMED,2014,Eur J Cancer,PREDICTIVE,0.008837044892188053
2520,1,The relative expression of Mig6 and EGFR is associated with resistance to EGFR kinase inhibitors.,PUBMED,2013,PLoS One,PREDICTIVE,0.008837044892188053
2521,1,The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.,PUBMED,2013,Blood,PREDICTIVE,0.008837044892188053
2522,1,Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.,PUBMED,2014,Leuk Res Rep,PREDICTIVE,0.008837044892188053
2524,1,"Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.",PUBMED,2014,Blood,PROGNOSTIC,0.008837044892188053
2487,1,Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up.,PUBMED,2017,Am J Case Rep,PREDISPOSING,0.008837044892188053
2491,1,Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice.,PUBMED,2009,Leukemia,PREDICTIVE,0.008837044892188053
2492,1,MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib.,PUBMED,2018,Sci Rep,PREDICTIVE,0.008837044892188053
2494,1,Gain-of-function mutations in interleukin-7 receptor-Œ± (IL7R) in childhood acute lymphoblastic leukemias.,PUBMED,2011,J Exp Med,ONCOGENIC,0.008837044892188053
2497,1,Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.,PUBMED,2011,Nat Genet,DIAGNOSTIC,0.008837044892188053
2500,1,Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.,PUBMED,2009,J Pathol,PROGNOSTIC,0.008837044892188053
2502,1,SPONTANEOUS RESOLUTION OF MACULAR EPIRETINAL MEMBRANES AFTER FLUORESCEIN POTENTIATED ARGON LASER TREATMENT OF VON HIPPEL-LINDAU ASSOCIATED RETINAL HEMANGIOMAS: CASE REPORT AND REVIEW OF LITERATURE.,PUBMED,2016,Retin Cases Brief Rep,PREDISPOSING,0.008837044892188053
2505,1,Cardiac Involvement in Von Hippel-Lindau Disease.,PUBMED,2016,Med Princ Pract,PREDISPOSING,0.008837044892188053
2577,1,Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.,PUBMED,2016,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
2578,1,NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.,PUBMED,2016,Cancer,PROGNOSTIC,0.008837044892188053
2579,1,Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma.,PUBMED,2017,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
2581,1,Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.,PUBMED,2007,Endocr Relat Cancer,PREDISPOSING,0.008837044892188053
1142,1,"Metastatic Extramammary Paget's Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature.",PUBMED,2015,Case Rep Oncol Med,PREDICTIVE,0.008837044892188053
1144,1,MEN1 mutations in H√ºrthle cell (oncocytic) thyroid carcinoma.,PUBMED,2015,J Clin Endocrinol Metab,DIAGNOSTIC,0.008837044892188053
1145,1,Mutational landscape of aggressive cutaneous squamous cell carcinoma.,PUBMED,2014,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
1146,1,The genomic landscape of pediatric Ewing sarcoma.,PUBMED,2014,Cancer Discov,PROGNOSTIC,0.008837044892188053
2567,1,Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma.,PUBMED,2015,Clin Mol Hepatol,PROGNOSTIC,0.008837044892188053
2568,1,High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.,PUBMED,2015,Int J Clin Exp Pathol,PROGNOSTIC,0.008837044892188053
2569,1,The prognostic value of Smad4 mRNA in patients with prostate cancer.,PUBMED,2014,Tumour Biol,PROGNOSTIC,0.008837044892188053
2571,1,EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2572,1,"Expression pattern of FGFR2, Grb2 and PlcŒ≥1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.",PUBMED,2015,Am J Cancer Res,PROGNOSTIC,0.008837044892188053
2573,1,A novel donor splice site mutation associated with two mRNAs in von Hippel-Lindau disease.,PUBMED,1994,Hum Mol Genet,PREDISPOSING,0.008837044892188053
2574,1,Advanced renal cell carcinoma associated with von Hippel-Lindau disease: A case report and review of the literature.,PUBMED,2015,Oncol Lett,PREDISPOSING,0.008837044892188053
2575,1,Altered cytokine profiles in patients with Chuvash polycythemia.,PUBMED,2009,Am J Hematol,PREDISPOSING,0.008837044892188053
2558,1,Somatic alterations of the DPC4 gene in human colorectal cancers in vivo.,PUBMED,1996,Gastroenterology,PROGNOSTIC,0.008837044892188053
2559,1,Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation.,PUBMED,2018,Pancreas,PROGNOSTIC,0.008837044892188053
2561,1,FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.,PUBMED,2017,Clin Transl Oncol,PROGNOSTIC,0.008837044892188053
2562,1,Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.,PUBMED,2017,Oncotarget,PROGNOSTIC,0.008837044892188053
2563,1,The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.,PUBMED,2010,Oncology,PROGNOSTIC,0.008837044892188053
2564,1,Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cells.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2565,1,Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.,PUBMED,2015,Anticancer Res,PROGNOSTIC,0.008837044892188053
2566,1,Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.,PUBMED,2016,Tumour Biol,PROGNOSTIC,0.008837044892188053
2549,1,Paraganglioma in a 13-year-old girl: a novel SDHB gene mutation in the family?,PUBMED,2010,Cancer Genet Cytogenet,PREDISPOSING,0.008837044892188053
2550,1,Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.,PUBMED,2015,Int J Gynecol Cancer,PROGNOSTIC,0.008837044892188053
2551,1,FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.,PUBMED,2017,Gynecol Oncol,PROGNOSTIC,0.008837044892188053
2552,1,Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis.,PUBMED,2016,Transl Oncol,PROGNOSTIC,0.008837044892188053
2553,1,"Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.",PUBMED,1998,Hum Mol Genet,PREDISPOSING,0.008837044892188053
2554,1,High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.,PUBMED,2014,Blood,PREDICTIVE,0.008837044892188053
2555,1,Clinical and genetic determinants of ovarian metastases from colorectal cancer.,PUBMED,2017,Cancer,PREDICTIVE,0.008837044892188053
2556,1,H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.,PUBMED,2013,Am J Clin Pathol,DIAGNOSTIC,0.008837044892188053
2591,1,A novel mutation in the von Hippel-Lindau tumor suppressor gene identified in a Japanese family with pheochromocytoma and hepatic hemangioma.,PUBMED,2006,Intern Med,PREDISPOSING,0.008837044892188053
2594,1,A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.,PUBMED,2008,Cancer Invest,PREDISPOSING,0.008837044892188053
2595,1,A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C.,PUBMED,2007,World J Surg Oncol,PREDISPOSING,0.008837044892188053
2596,1,A type 2B von Hippel-Lindau family masquerading as a metastatic sporadic renal cell carcinoma.,PUBMED,2003,BJU Int,PREDISPOSING,0.008837044892188053
2597,1,"A unique case of renal carcinoma with Xp11.2 translocations/ TFE3 gene fusions in a 3-year-old child, with coexistent von Hippel-Lindau gene mutation.",PUBMED,2004,Pediatr Dev Pathol,PREDISPOSING,0.008837044892188053
2598,1,A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.,PUBMED,2004,Int J Mol Med,PREDISPOSING,0.008837044892188053
2600,1,"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.",PUBMED,2009,Lancet Oncol,PREDISPOSING,0.008837044892188053
2601,1,Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.,PUBMED,2001,J Med Genet,PREDISPOSING,0.008837044892188053
1180,1,Effectiveness of Tyrosine Kinase Inhibitors in Japanese Patients with Non-small Cell Lung Cancer Harboring Minor Epidermal Growth Factor Receptor Mutations: Results from a Multicenter Retrospective Study (HANSHIN Oncology Group 0212).,PUBMED,2015,Anticancer Res,PREDICTIVE,0.008837044892188053
1181,1,Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.,PUBMED,2003,Br J Cancer,PREDISPOSING,0.008837044892188053
2583,1,Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.,PUBMED,2011,Blood,PREDISPOSING,0.008837044892188053
2584,1,Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry.,PUBMED,2003,Blood,PREDISPOSING,0.008837044892188053
2586,1,KMT2C mediates the estrogen dependence of breast cancer through regulation of ERŒ± enhancer function.,PUBMED,2018,Oncogene,PREDICTIVE,0.008837044892188053
2587,1,Clinical presentation of a patient with congenital polycythemia.,PUBMED,2006,Coll Antropol,PREDISPOSING,0.008837044892188053
2588,1,von Hippel-Lindau disease: renal tumors less than 3 cm. can metastasize.,PUBMED,2001,J Urol,PREDISPOSING,0.008837044892188053
2590,1,A novel mutation in the von Hippel-Lindau gene.,PUBMED,1994,Hum Mol Genet,PREDISPOSING,0.008837044892188053
1159,1,Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors.,PUBMED,2014,Adv Biomed Res,DIAGNOSTIC,0.008837044892188053
1164,1,Testing ERBB2 p.L755S kinase domain mutation as a druggable target in a patient with advanced colorectal cancer.,PUBMED,2016,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
1170,1,Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.008837044892188053
1171,1,"Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.",PUBMED,2016,Leukemia,PROGNOSTIC,0.008837044892188053
1172,1,"Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
1176,1,Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.008837044892188053
1177,1,Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
1178,1,Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1149,1,Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.,PUBMED,2016,Anticancer Drugs,PREDICTIVE,0.008837044892188053
1150,1,Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.,PUBMED,2012,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
1151,1,Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.,PUBMED,2007,J Clin Oncol,PREDICTIVE,0.008837044892188053
1152,1,Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.,PUBMED,2004,J Clin Oncol,PREDICTIVE,0.008837044892188053
1153,1,Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.,PUBMED,2014,Nature,PREDICTIVE,0.008837044892188053
1154,1,FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.,PUBMED,2016,Cancer Res,PREDICTIVE,0.008837044892188053
1155,1,Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.,PUBMED,2013,Nat Genet,PROGNOSTIC,0.008837044892188053
1157,1,Responses to Crizotinib Can Occur in High-Level MET-Amplified Non-Small Cell Lung Cancer Independent of MET Exon 14 Alterations.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1131,1,Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.,PUBMED,2015,J Neurooncol,PREDICTIVE,0.008837044892188053
1135,1,Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.,PUBMED,2008,Hum Mutat,PREDISPOSING,0.008837044892188053
1139,1,HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.,PUBMED,2013,Br J Cancer,PREDICTIVE,0.008837044892188053
1140,1,"Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
2615,1,Detecting circulating tumor DNA in renal cancer: An open challenge.,PUBMED,2017,Exp Mol Pathol,PREDISPOSING,0.008837044892188053
2618,1,Difficulties in the management of retinal capillary haemangiomas associated with von Hippel Lindau disease.,PUBMED,2017,Arch Soc Esp Oftalmol,PREDISPOSING,0.008837044892188053
2619,1,Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation.,PUBMED,2017,J Natl Compr Canc Netw,PREDISPOSING,0.008837044892188053
2623,1,Integrated molecular analysis of adult T cell leukemia/lymphoma.,PUBMED,2015,Nat Genet,DIAGNOSTIC,0.008837044892188053
1117,1,Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma.,PUBMED,2015,BMC Cancer,PREDICTIVE,0.008837044892188053
1118,1,CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.,PUBMED,2014,PLoS One,PROGNOSTIC,0.008837044892188053
1119,1,The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
1120,1,Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow.,PUBMED,2016,J Cell Biochem,PREDICTIVE,0.008837044892188053
1121,1,Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.,PUBMED,2015,PLoS One,PROGNOSTIC,0.008837044892188053
1122,1,Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.,PUBMED,2015,Tumour Biol,PROGNOSTIC,0.008837044892188053
1129,1,Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain.,PUBMED,2014,Pigment Cell Melanoma Res,PREDICTIVE,0.008837044892188053
1130,1,Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib.,PUBMED,2015,Pigment Cell Melanoma Res,PREDICTIVE,0.008837044892188053
1092,1,Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy.,PUBMED,2014,Endocr Relat Cancer,DIAGNOSTIC,0.008837044892188053
1093,1,ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.,PUBMED,2013,Acta Neuropathol,PREDICTIVE,0.008837044892188053
1094,1,ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.,PUBMED,2016,Sci Transl Med,PROGNOSTIC,0.008837044892188053
1106,1,FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.,PUBMED,2013,Hepatology,PREDICTIVE,0.008837044892188053
1113,1,CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients.,PUBMED,2014,Leukemia,PROGNOSTIC,0.008837044892188053
1114,1,Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.,PUBMED,2016,J Ovarian Res,PREDICTIVE,0.008837044892188053
1115,1,Lazarus-Type Response to Crizotinib in a Patient with Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1116,1,Acquired Resistance to Crizotinib in NSCLC with MET¬†Exon 14 Skipping.,PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2602,1,Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution.,PUBMED,1998,Genes Chromosomes Cancer,PREDISPOSING,0.008837044892188053
2603,1,Bilateral papillopathy as a presenting sign of pheochromocytoma associated with von Hippel-Lindau disease.,PUBMED,2014,Clin Ophthalmol,PREDISPOSING,0.008837044892188053
2604,1,Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.,PUBMED,2003,Am J Kidney Dis,PREDISPOSING,0.008837044892188053
2606,1,Case records of the Massachusetts General Hospital. Case 23-2006. A 36-year-old man with numbness in the left [corrected] hand and hypertension.,PUBMED,2006,N Engl J Med,PREDISPOSING,0.008837044892188053
2607,1,Cerebellar hemangioblastoma as a late manifestation of sporadic von Hippel-Lindau disease.,PUBMED,1999,J Urol,PREDISPOSING,0.008837044892188053
2613,1,Coexistence of VHL Disease and CPT2 Deficiency: A Case Report.,PUBMED,2016,Cancer Res Treat,PREDISPOSING,0.008837044892188053
2614,1,Clear cell neuroendocrine tumor of the pancreas in von Hippel-Lindau disease: a case report and literature review.,PUBMED,2017,Neuro Endocrinol Lett,PREDISPOSING,0.008837044892188053
1091,1,LRP1B deletion is associated with poor outcome for glioblastoma patients.,PUBMED,2015,J Neurol Sci,PROGNOSTIC,0.008837044892188053
1088,1,A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1089,1,A genomic case study of mixed fibrolamellar hepatocellular carcinoma.,PUBMED,2016,Ann Oncol,DIAGNOSTIC,0.008837044892188053
1090,1,SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer.,PUBMED,2002,Br J Cancer,PREDICTIVE,0.008837044892188053
2652,1,A malignant pheochromocytoma in a child with von Hippel-Lindau mutation.,PUBMED,2017,Clujul Med,PREDISPOSING,0.008837044892188053
2653,1,"The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.",PUBMED,2014,Pediatr Blood Cancer,PREDISPOSING,0.008837044892188053
2656,1,Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.,PUBMED,1994,Hum Mol Genet,PREDISPOSING,0.008837044892188053
2658,1,Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor.,PUBMED,2018,Eur J Cancer,PREDICTIVE,0.008837044892188053
2660,1,Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).,PUBMED,2011,BMC Cancer,PREDICTIVE,0.008837044892188053
1071,1,mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.,PUBMED,2009,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
1072,1,LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.,PUBMED,2015,Acta Pharmacol Sin,PREDICTIVE,0.008837044892188053
1077,1,Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma.,PUBMED,2014,Cancer Res,PREDICTIVE,0.008837044892188053
1079,1,FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
1080,1,FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.,PUBMED,2008,Science,PREDICTIVE,0.008837044892188053
1083,1,"Single Nucleotide Polymorphisms in CBLB, a¬†Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.",PUBMED,2016,Clin Lung Cancer,PROGNOSTIC,0.008837044892188053
1086,1,MYD88 L265P somatic mutation in Waldenstr√∂m's macroglobulinemia.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
1087,1,EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.,PUBMED,2016,Blood,PREDICTIVE,0.008837044892188053
1059,1,HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostat.,PUBMED,2016,J Pathol Clin Res,PREDICTIVE,0.008837044892188053
1061,1,Genome sequencing for nonsmall-cell lung cancer identifies a basis for nintedanib sensitivity.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.008837044892188053
1062,1,Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.008837044892188053
1063,1,Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.,PUBMED,2015,Eur Urol,PREDICTIVE,0.008837044892188053
1065,1,Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.008837044892188053
1068,1,Nivolumab plus ipilimumab in advanced melanoma.,PUBMED,2013,N Engl J Med,PREDICTIVE,0.008837044892188053
1069,1,mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.008837044892188053
1070,1,Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2630,1,Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation.,PUBMED,2016,J Heart Lung Transplant,PREDISPOSING,0.008837044892188053
2631,1,Primary Clear Cell Microcystic Adenoma of the Sinonasal Cavity: Pathological or Fortuitous Association?,PUBMED,2017,Case Rep Pathol,PREDISPOSING,0.008837044892188053
2635,1,"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.",PUBMED,1995,JAMA,PREDISPOSING,0.008837044892188053
2638,1,The N131S mutation in the von Hippel-Lindau gene in a Japanese family with pheochromocytoma and hemangioblastomas.,PUBMED,2006,Endocr J,PREDISPOSING,0.008837044892188053
2639,1,VHL gene alterations in Italian patients with isolated renal cell carcinomas.,PUBMED,2013,Int J Biol Markers,PREDISPOSING,0.008837044892188053
2641,1,In Silico Analysis Identification of a Novel Germ-Line VHL Mutation in a Patient of Malignant Pheochromocytoma.,PUBMED,2014,Endocr Pract,PREDISPOSING,0.008837044892188053
2643,1,Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.,PUBMED,2016,Cancer Biol Ther,PREDISPOSING,0.008837044892188053
1058,1,Toward the molecular dissection of peritoneal pseudomyxoma.,PUBMED,2016,Ann Oncol,PROGNOSTIC,0.008837044892188053
2706,1,PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.,PUBMED,2017,Cancer Discov,PREDICTIVE,0.008837044892188053
2707,1,Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity.,PUBMED,2016,Sci Rep,PREDICTIVE,0.008837044892188053
2708,1,Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.008837044892188053
2710,1,The MLL recombinome of acute leukemias in 2017.,PUBMED,2018,Leukemia,DIAGNOSTIC,0.008837044892188053
2711,1,Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.,PUBMED,2011,Cancer Cell,PREDICTIVE,0.008837044892188053
2712,1,Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.,PUBMED,2009,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2713,1,Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.,PUBMED,2013,Lancet Oncol,PREDICTIVE,0.008837044892188053
2714,1,Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.,PUBMED,2016,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
2694,1,Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
2695,1,PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.,PUBMED,2018,Blood,PREDICTIVE,0.008837044892188053
2696,1,"Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor.",PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2697,1,Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2698,1,NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.,PUBMED,2014,Cancer Res,PREDICTIVE,0.008837044892188053
2699,1,Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.,PUBMED,2018,Cancer Cell,PREDISPOSING,0.008837044892188053
2701,1,Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.,PUBMED,2018,Haematologica,PREDICTIVE,0.008837044892188053
2703,1,"Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.",PUBMED,2012,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
2685,1,Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo.,PUBMED,2009,Cancer Res,PROGNOSTIC,0.008837044892188053
2686,1,Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.008837044892188053
2687,1,Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.,PUBMED,2001,Blood,ONCOGENIC,0.008837044892188053
2688,1,Combination of vemurafenib and cobimetinib in patients with advanced BRAF(V600)-mutated melanoma: a phase 1b study.,PUBMED,2014,Lancet Oncol,PREDICTIVE,0.008837044892188053
2689,1,"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.",PUBMED,2003,Nat Genet,DIAGNOSTIC,0.008837044892188053
2690,1,Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.,PUBMED,2013,Nat Genet,DIAGNOSTIC,0.008837044892188053
2691,1,Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2693,1,Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion.,PUBMED,2013,Haematologica,PREDICTIVE,0.008837044892188053
2664,1,Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.,PUBMED,2018,Nat Med,PREDICTIVE,0.008837044892188053
2665,1,"TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.",PUBMED,2007,Cancer Genet Cytogenet,PROGNOSTIC,0.008837044892188053
2666,1,TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.,PUBMED,2013,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
2670,1,TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.,PUBMED,2013,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
2678,1,A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.008837044892188053
2679,1,Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.008837044892188053
2681,1,KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients.,PUBMED,2009,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
2684,1,TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.,PUBMED,2017,J Nucl Med,PREDICTIVE,0.008837044892188053
1055,1,"Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.",PUBMED,2015,Breast Cancer Res Treat,PROGNOSTIC,0.008837044892188053
1056,1,Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.,PUBMED,2013,Br J Cancer,PROGNOSTIC,0.008837044892188053
2723,1,"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.",PUBMED,2011,Lancet Oncol,PREDICTIVE,0.008837044892188053
2726,1,Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.,PUBMED,2004,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
2727,1,Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience.,PUBMED,2017,South Asian J Cancer,ONCOGENIC,0.008837044892188053
2730,1,A Novel EML6-ALK FBXO11-ALK Double Fusion¬†Variant in Lung Adenocarcinoma and Response to Crizotinib.,PUBMED,2018,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2732,1,Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.,PUBMED,2015,Lancet Oncol,PROGNOSTIC,0.008837044892188053
2733,1,ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation.,PUBMED,2014,Oncogene,PROGNOSTIC,0.008837044892188053
1044,1,Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance.,PUBMED,2015,Cell,PREDICTIVE,0.008837044892188053
1045,1,MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression.,PUBMED,2015,PLoS One,PREDICTIVE,0.008837044892188053
1046,1,"Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.",PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
1047,1,Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.,PUBMED,2013,Histopathology,PREDICTIVE,0.008837044892188053
1048,1,Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.,PUBMED,2016,Blood,PROGNOSTIC,0.008837044892188053
1049,1,DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.,PUBMED,2012,Leukemia,PREDICTIVE,0.008837044892188053
1051,1,Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.,PUBMED,2016,Blood,PROGNOSTIC,0.008837044892188053
1053,1,Osimertinib: First Global Approval.,PUBMED,2016,Drugs,PREDICTIVE,0.008837044892188053
1032,1,Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity.,PUBMED,2006,Blood,PREDICTIVE,0.008837044892188053
1033,1,Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.,PUBMED,1998,Cancer Res,PROGNOSTIC,0.008837044892188053
1034,1,Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.008837044892188053
1035,1,MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.008837044892188053
1038,1,Cetuximab for the treatment of colorectal cancer.,PUBMED,2007,N Engl J Med,PREDICTIVE,0.008837044892188053
1039,1,Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.,PUBMED,2007,N Engl J Med,PREDICTIVE,0.008837044892188053
1041,1,Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
1042,1,PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.,PUBMED,2016,N Engl J Med,PREDICTIVE,0.008837044892188053
2716,1,Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review.,PUBMED,2015,Sarcoma,DIAGNOSTIC,0.008837044892188053
2717,1,Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
2718,1,NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.,PUBMED,2008,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
2719,1,Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia.,PUBMED,2017,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
2720,1,Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation.,PUBMED,2012,Leukemia,PREDICTIVE,0.008837044892188053
1024,1,"The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
1029,1,RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.,PUBMED,2016,Leukemia,PROGNOSTIC,0.008837044892188053
1030,1,p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.,PUBMED,2012,Neuro Oncol,PREDICTIVE,0.008837044892188053
2787,1,Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis.,PUBMED,2013,Cell Death Differ,PREDISPOSING,0.008837044892188053
2788,1,Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.,PUBMED,2010,Biomed Res,ONCOGENIC,0.008837044892188053
2789,1,Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia.,PUBMED,2012,Leukemia,FUNCTIONAL,0.008837044892188053
2790,1,Germline BRCA1 mutations increase prostate cancer risk.,PUBMED,2012,Br J Cancer,PREDISPOSING,0.008837044892188053
2791,1,Neutron radiation can activate K-ras via a point mutation in codon 146 and induces a different spectrum of ras mutations than does gamma radiation.,PUBMED,1990,Mol Cell Biol,PREDISPOSING,0.008837044892188053
2792,1,Recurrent KRAS codon 146 mutations in human colorectal cancer.,PUBMED,2006,Cancer Biol Ther,ONCOGENIC,0.008837044892188053
2793,1,Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.,PUBMED,2015,JAMA Surg,DIAGNOSTIC,0.008837044892188053
2794,1,Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.,PUBMED,2005,Cancer Res,PREDISPOSING,0.008837044892188053
2774,1,Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report.,PUBMED,2018,Medicine (Baltimore),PREDISPOSING,0.008837044892188053
2775,1,Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.,PUBMED,2019,Haematologica,PREDICTIVE,0.008837044892188053
2776,1,CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.,PUBMED,2013,J Biol Chem,FUNCTIONAL,0.008837044892188053
2777,1,Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.,PUBMED,2010,J Med Genet,PREDISPOSING,0.008837044892188053
2781,1,CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.,PUBMED,2019,Nat Commun,PREDICTIVE,0.008837044892188053
2782,1,SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.,PUBMED,2019,Nat Commun,PREDICTIVE,0.008837044892188053
2785,1,BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis.,PUBMED,2013,Colorectal Dis,PROGNOSTIC,0.008837044892188053
2786,1,Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.,PUBMED,2018,Sci Rep,FUNCTIONAL,0.008837044892188053
2756,1,KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.,PUBMED,2013,Int J Cancer,PREDICTIVE,0.008837044892188053
2759,1,Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells.,PUBMED,1996,Cancer Res,FUNCTIONAL,0.008837044892188053
2765,1,Acute Lymphoblastic Leukemia Patient with Variant ATF7IP/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report.,PUBMED,2017,Am J Case Rep,PREDICTIVE,0.008837044892188053
2768,1,Functioning Mediastinal Paraganglioma Associated with a Germline Mutation of von Hippel-Lindau Gene.,PUBMED,2018,J Clin Med,PREDISPOSING,0.008837044892188053
2769,1,Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.,PUBMED,2014,Leukemia,PROGNOSTIC,0.008837044892188053
2770,1,Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.,PUBMED,2015,J Exp Clin Cancer Res,PREDICTIVE,0.008837044892188053
2772,1,CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2773,1,A pediatric case of pheochromocytoma without apparent hypertension associated with von Hippel-Lindau disease.,PUBMED,2018,Clin Pediatr Endocrinol,PREDISPOSING,0.008837044892188053
2734,1,Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies.,PUBMED,2017,J Clin Oncol,PREDICTIVE,0.008837044892188053
2735,1,Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.,PUBMED,2014,Nat Genet,PREDISPOSING,0.008837044892188053
2737,1,Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.,PUBMED,2014,Oncogene,ONCOGENIC,0.008837044892188053
2739,1,Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.,PUBMED,2009,Nat Genet,DIAGNOSTIC,0.008837044892188053
2743,1,Survival of patients with metastatic HER2 positive gastroesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on frontline chemotherapy plus trastuzumab.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl 4; abstr 69)",PREDICTIVE,0.008837044892188053
2753,1,Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.,PUBMED,2019,J Clin Oncol,PREDICTIVE,0.008837044892188053
2754,1,The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
2755,1,Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification.,PUBMED,2015,Case Rep Oncol,PREDICTIVE,0.008837044892188053
2834,1,Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.008837044892188053
2835,1,MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.,PUBMED,2006,PLoS Med,ONCOGENIC,0.008837044892188053
2837,1,Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.,PUBMED,2002,J Bone Miner Res,DIAGNOSTIC,0.008837044892188053
2838,1,The mitochondrial and autosomal mutation landscapes of prostate cancer.,PUBMED,2013,Eur Urol,DIAGNOSTIC,0.008837044892188053
2839,1,EphB2 SNPs and sporadic prostate cancer risk in African American men.,PUBMED,2011,PLoS One,DIAGNOSTIC,0.008837044892188053
2842,1,Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.,PUBMED,2004,Nat Genet,DIAGNOSTIC,0.008837044892188053
2843,1,Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.,PUBMED,1990,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
2844,1,Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.,PUBMED,2016,Cancer Cell,ONCOGENIC,0.008837044892188053
2822,1,Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas.,PUBMED,2013,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
2825,1,Frequent truncating mutations of STAG2 in bladder cancer.,PUBMED,2013,Nat Genet,PROGNOSTIC,0.008837044892188053
2826,1,NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.,PUBMED,2016,Haematologica,PREDICTIVE,0.008837044892188053
2827,1,Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.,PUBMED,2008,Genes Chromosomes Cancer,PROGNOSTIC,0.008837044892188053
2828,1,"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.",PUBMED,2009,Blood,FUNCTIONAL,0.008837044892188053
2829,1,Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.,PUBMED,2011,Mol Cancer Res,FUNCTIONAL,0.008837044892188053
2831,1,Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants.,PUBMED,2011,Blood,DIAGNOSTIC,0.008837044892188053
2832,1,Oncogenic Y641 mutations in EZH2 prevent Jak2/Œ≤-TrCP-mediated degradation.,PUBMED,2015,Oncogene,FUNCTIONAL,0.008837044892188053
2807,1,"Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer.",PUBMED,2012,Invest New Drugs,PREDICTIVE,0.008837044892188053
2808,1,Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.,PUBMED,2013,Cancer Cell,PREDICTIVE,0.008837044892188053
2809,1,Small molecule inhibition of the KRAS-PDEŒ¥ interaction impairs oncogenic KRAS signalling.,PUBMED,2013,Nature,PREDICTIVE,0.008837044892188053
2810,1,KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.,PUBMED,2014,Br J Cancer,PREDICTIVE,0.008837044892188053
2811,1,Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma.,PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2817,1,Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.,PUBMED,2017,Br J Cancer,PREDICTIVE,0.008837044892188053
2818,1,Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells.,PUBMED,2016,Exp Hematol,PREDICTIVE,0.008837044892188053
2820,1,BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.,PUBMED,2011,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
2795,1,Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.,PUBMED,2016,Proc Natl Acad Sci U S A,FUNCTIONAL,0.008837044892188053
2796,1,PTEN loss accelerates KrasG12D-induced pancreatic cancer development.,PUBMED,2010,Cancer Res,PROGNOSTIC,0.008837044892188053
2797,1,Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish.,PUBMED,2009,Zebrafish,PREDISPOSING,0.008837044892188053
2798,1,Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.,PUBMED,2000,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
2800,1,The consequence of oncomorphic TP53 mutations in ovarian cancer.,PUBMED,2013,Int J Mol Sci,PREDICTIVE,0.008837044892188053
2801,1,KRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencing.,PUBMED,2011,Clin Chim Acta,PREDICTIVE,0.008837044892188053
2802,1,MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells.,PUBMED,2014,Oncotarget,PREDICTIVE,0.008837044892188053
2803,1,"Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.",PUBMED,2011,J Clin Oncol,PROGNOSTIC,0.008837044892188053
2850,1,WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas.,PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2851,1,Targeting Wee1 for the treatment of pediatric high-grade gliomas.,PUBMED,2014,Neuro Oncol,PREDICTIVE,0.008837044892188053
2852,1,Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
2854,1,Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification.,PUBMED,2017,J Natl Compr Canc Netw,PREDICTIVE,0.008837044892188053
2856,1,Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.008837044892188053
2858,1,Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BINI) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC).,ASCO,2019,"J Clin Oncol 37, 2019 (suppl 4; abstr 688)",PREDICTIVE,0.008837044892188053
2860,1,Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with <i>BRAF</i> V600E&#x2013;mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl 4; abstr 187)",PREDICTIVE,0.008837044892188053
2861,1,Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas.,PUBMED,2018,Ecancermedicalscience,PREDICTIVE,0.008837044892188053
1017,1,Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.,PUBMED,2013,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
1019,1,Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.,PUBMED,2016,Exp Hematol,PREDICTIVE,0.008837044892188053
1022,1,Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.,PUBMED,2010,Oncogene,PREDICTIVE,0.008837044892188053
1023,1,Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.,PUBMED,2012,Blood,PREDICTIVE,0.008837044892188053
2845,1,"Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.",PUBMED,2015,Genes Cancer,PREDICTIVE,0.008837044892188053
2846,1,Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.,PUBMED,2014,Br J Cancer,PROGNOSTIC,0.008837044892188053
2847,1,The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk.,PUBMED,2005,Carcinogenesis,PREDISPOSING,0.008837044892188053
2848,1,Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.,PUBMED,2010,Clin Cancer Res,PREDICTIVE,0.008837044892188053
1007,1,Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib.,PUBMED,2015,Blood,PROGNOSTIC,0.008837044892188053
1008,1,MEK targeting in N-RAS mutated metastatic melanoma.,PUBMED,2014,Mol Cancer,PREDICTIVE,0.008837044892188053
1010,1,"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.",PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
1011,1,Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.,PUBMED,2010,Genome Biol,PREDICTIVE,0.008837044892188053
1012,1,Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.,PUBMED,2011,JAMA,PREDICTIVE,0.008837044892188053
1013,1,Personalized treatment of S√©zary syndrome by targeting a novel CTLA4:CD28 fusion.,PUBMED,2015,Mol Genet Genomic Med,PREDICTIVE,0.008837044892188053
1014,1,Integrative clinical genomics of advanced prostate cancer.,PUBMED,2015,Cell,PREDICTIVE,0.008837044892188053
1015,1,Feedback suppression of PI3KŒ± signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3KŒ≤.,PUBMED,2015,Cancer Cell,PREDICTIVE,0.008837044892188053
991,1,Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.,PUBMED,2011,J Clin Oncol,PROGNOSTIC,0.008837044892188053
993,1,Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.,PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
994,1,Clinical and molecular response to interferon-Œ± therapy in essential thrombocythemia patients with CALR mutations.,PUBMED,2015,Blood,PREDICTIVE,0.008837044892188053
998,1,"Targeting activated Akt with GDC-0068, a novel selective Akt inhibitor that is efficacious in multiple tumor models.",PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
999,1,Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.,PUBMED,2005,Gynecol Oncol,PREDICTIVE,0.008837044892188053
1000,1,Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer.,PUBMED,2005,Int J Cancer,PREDICTIVE,0.008837044892188053
1001,1,Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
1003,1,Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders.,PUBMED,2007,Blood,PREDICTIVE,0.008837044892188053
2903,1,Genetic and functional analysis of a Li Fraumeni syndrome family in China.,PUBMED,2016,Sci Rep,PREDISPOSING,0.008837044892188053
2905,1,Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).,ASCO,2017,"J Clin Oncol 35, 2017 (suppl; abstr 3505)",PREDICTIVE,0.008837044892188053
2906,1,Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma.,PUBMED,2009,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2907,1,Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.,PUBMED,2011,J Clin Oncol,PREDICTIVE,0.008837044892188053
2910,1,A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.,PUBMED,2019,Blood,PROGNOSTIC,0.008837044892188053
961,1,Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.,PUBMED,2011,Lancet Oncol,PREDICTIVE,0.008837044892188053
962,1,The MKK7 p.Glu116Lys Rare Variant Serves as a Predictor for Lung Cancer Risk and Prognosis in Chinese.,PUBMED,2016,PLoS Genet,PROGNOSTIC,0.008837044892188053
964,1,"Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib response.",PUBMED,2014,Oncotarget,PREDICTIVE,0.008837044892188053
2893,1,TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.008837044892188053
2895,1,Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.,PUBMED,2018,J Hepatol,PREDICTIVE,0.008837044892188053
2896,1,Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.,PUBMED,2019,Br J Cancer,PREDICTIVE,0.008837044892188053
2897,1,Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.,PUBMED,2016,Free Radic Biol Med,PREDICTIVE,0.008837044892188053
2899,1,NRAS destines tumor cells to the lungs.,PUBMED,2017,EMBO Mol Med,DIAGNOSTIC,0.008837044892188053
2900,1,Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.,PUBMED,2015,Sci Rep,PREDICTIVE,0.008837044892188053
2901,1,Specific TP53 mutation pattern in radiation-induced sarcomas.,PUBMED,2006,Carcinogenesis,FUNCTIONAL,0.008837044892188053
2902,1,Expression of C-terminal deleted p53 isoforms in neuroblastoma.,PUBMED,2006,Nucleic Acids Res,FUNCTIONAL,0.008837044892188053
2877,1,BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.,PUBMED,2019,Lab Med,PREDICTIVE,0.008837044892188053
2881,1,"Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
2883,1,"Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.",PUBMED,2019,Lancet,PREDICTIVE,0.008837044892188053
2884,1,Immunogenic neoantigens derived from gene fusions stimulate T cell responses.,PUBMED,2019,Nat Med,PREDICTIVE,0.008837044892188053
2885,1,KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma.,PUBMED,2018,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2887,1,Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2891,1,"Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).",PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2892,1,Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.,PUBMED,2017,Oral Oncol,PREDISPOSING,0.008837044892188053
2862,1,"SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).",ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 10503)",PREDICTIVE,0.008837044892188053
2864,1,Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High.,PUBMED,2019,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
2865,1,Tepotinib in patients with advanced non-small cell lung cancer (NSCLC) harboring <i>MET</i> exon 14-skipping mutations: Phase II trial.,ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 9016)",PREDICTIVE,0.008837044892188053
2866,1,"First report of safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 (AP32788) in non&#x2013;small cell lung cancer (NSCLC).",ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 9015)",PREDICTIVE,0.008837044892188053
2868,1,Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.,PUBMED,2018,N Engl J Med,PREDICTIVE,0.008837044892188053
2870,1,"Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.",PUBMED,2019,Ann Oncol,PREDICTIVE,0.008837044892188053
2872,1,"Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
2874,1,"Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.",PUBMED,2018,Lancet Oncol,PREDICTIVE,0.008837044892188053
2928,1,Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK228.,ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 9098)",PREDICTIVE,0.008837044892188053
2929,1,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",PUBMED,2014,Neuro Oncol,PREDICTIVE,0.008837044892188053
2930,1,"Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in breast cancer patients: Phase 1 dose escalation study.",ASCO,2018,"J Clin Oncol 36, 2018 (suppl; abstr 2512)",PREDICTIVE,0.008837044892188053
2931,1,Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.,PUBMED,2009,Mol Cancer,ONCOGENIC,0.008837044892188053
2932,1,p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3.,PUBMED,2007,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
2945,1,Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with <i>CDKN2A</i> alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 9041)",PREDICTIVE,0.008837044892188053
2946,1,Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.,PUBMED,1990,Cancer,PROGNOSTIC,0.008837044892188053
2947,1,Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 9085)",PREDICTIVE,0.008837044892188053
989,1,Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma.,PUBMED,2014,Melanoma Res,PREDICTIVE,0.008837044892188053
990,1,An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2912,1,DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2916,1,Direct Ras G12C inhibitors: crossing the rubicon.,PUBMED,2019,Br J Cancer,PREDICTIVE,0.008837044892188053
2919,1,Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs).,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
2920,1,"SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).",PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2922,1,Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.,PUBMED,2016,Leukemia,PROGNOSTIC,0.008837044892188053
2923,1,The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.,PUBMED,2014,Cancer Biomark,PROGNOSTIC,0.008837044892188053
975,1,ROS1 rearrangements define a unique molecular class of lung cancers.,PUBMED,2012,J Clin Oncol,PREDICTIVE,0.008837044892188053
976,1,Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.008837044892188053
978,1,p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.,PUBMED,1993,Blood,PROGNOSTIC,0.008837044892188053
979,1,Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.,PUBMED,2008,Blood,PROGNOSTIC,0.008837044892188053
980,1,TP53 mutation and survival in chronic lymphocytic leukemia.,PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.008837044892188053
981,1,"NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.",PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
983,1,"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.",PUBMED,2004,Cancer Cell,PREDICTIVE,0.008837044892188053
987,1,"Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.",PUBMED,2008,J Clin Oncol,PREDICTIVE,0.008837044892188053
967,1,Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
968,1,Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.,PUBMED,2013,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
969,1,BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
970,1,Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
971,1,Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
972,1,"Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.",PUBMED,2012,Lancet,PREDICTIVE,0.008837044892188053
973,1,RICTOR Amplification Defines a Novel Subset of Patients with Lung Cancer Who May Benefit from Treatment with mTORC1/2 Inhibitors.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.008837044892188053
974,1,Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.,PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
2957,1,Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in <i>BRCA1</i> and <i>BRCA2</i> wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3006)",PREDICTIVE,0.008837044892188053
2958,1,First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3007)",PREDICTIVE,0.008837044892188053
2960,1,Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a POLE Mutation.,PUBMED,2017,J Natl Compr Canc Netw,PREDICTIVE,0.008837044892188053
2962,1,TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 5005)",PREDICTIVE,0.008837044892188053
2968,1,Clinical activity of avapritinib in &#x2265; fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 11022)",PREDICTIVE,0.008837044892188053
2969,1,RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.008837044892188053
2970,1,Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer.,PUBMED,2015,Br J Cancer,PREDICTIVE,0.008837044892188053
2971,1,"ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.",PUBMED,2017,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
953,1,Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.008837044892188053
954,1,Improved survival with vemurafenib in melanoma with BRAF V600E mutation.,PUBMED,2011,N Engl J Med,PREDICTIVE,0.008837044892188053
956,1,DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
957,1,Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
958,1,Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.,PUBMED,2014,Case Rep Oncol,PREDICTIVE,0.008837044892188053
2952,1,Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.,PUBMED,2014,Blood,PROGNOSTIC,0.008837044892188053
2953,1,"Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.",ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3000)",PREDICTIVE,0.008837044892188053
2955,1,"Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule <i>KRAS<sup>G12C</sup></i> inhibitor, in advanced solid tumors.",ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 3003)",PREDICTIVE,0.008837044892188053
936,1,ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.,PUBMED,2013,Leukemia,PROGNOSTIC,0.008837044892188053
942,1,Ponatinib in refractory Philadelphia chromosome-positive leukemias.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
944,1,Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib.,PUBMED,2014,J Thorac Oncol,PREDICTIVE,0.008837044892188053
945,1,Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in exon 20 (S768I).,PUBMED,2010,Jpn J Clin Oncol,PREDICTIVE,0.008837044892188053
948,1,Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation.,PUBMED,2016,Case Rep Oncol Med,PREDICTIVE,0.008837044892188053
949,1,In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer.,PUBMED,2015,Anticancer Res,PREDICTIVE,0.008837044892188053
951,1,Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis.,PUBMED,2015,Eur J Cancer,PREDICTIVE,0.008837044892188053
952,1,Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
2948,1,Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study.,PUBMED,2019,Lancet Gastroenterol Hepatol,PREDICTIVE,0.008837044892188053
2949,1,Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive <i>IDH1</i> mutant gliomas.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 2004)",PREDICTIVE,0.008837044892188053
2950,1,"Biomarker driven phase II umbrella trial study of AZD1775, AZD2014, AZD2811 monotherapy in relapsed small cell lung cancer.",ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 8514)",PREDICTIVE,0.008837044892188053
2951,1,BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.,PUBMED,2013,Blood,PROGNOSTIC,0.008837044892188053
928,1,Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.,PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
930,1,"Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.",PUBMED,2005,Blood,PROGNOSTIC,0.008837044892188053
931,1,The effect of flavopiridol on the growth of p16+ and p16- melanoma cell lines.,PUBMED,2003,Melanoma Res,PREDICTIVE,0.008837044892188053
935,1,ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.,PUBMED,2011,Blood,PROGNOSTIC,0.008837044892188053
3016,1,Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.,PUBMED,2019,Cancers (Basel),DIAGNOSTIC,0.008837044892188053
3018,1,Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.,PUBMED,2018,Nat Commun,PREDICTIVE,0.008837044892188053
3019,1,Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
3020,1,Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
894,1,"ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.",PUBMED,2014,Mol Cancer Res,PREDICTIVE,0.008837044892188053
895,1,Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.,PUBMED,2007,Cancer Res,PREDISPOSING,0.008837044892188053
896,1,TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.,PUBMED,2003,Mutagenesis,PROGNOSTIC,0.008837044892188053
897,1,"TP53 polymorphism, HPV infection, and risk of cervical cancer.",PUBMED,2001,Cancer Epidemiol Biomarkers Prev,PROGNOSTIC,0.008837044892188053
3000,1,Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
3001,1,Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.,PUBMED,2019,PLoS One,PREDICTIVE,0.008837044892188053
3002,1,Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
3003,1,Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma.,PUBMED,2019,JAMA Oncol,PREDICTIVE,0.008837044892188053
3007,1,Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.,PUBMED,2018,EBioMedicine,PREDICTIVE,0.008837044892188053
3008,1,A phase I/II multiple expansion cohort trial of MRTX849 in patients with advanced solid tumors with <i>KRAS</i> G12C mutation.,ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr TPS3161)",PREDICTIVE,0.008837044892188053
3012,1,Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.,PUBMED,2019,J Clin Oncol,PREDICTIVE,0.008837044892188053
3015,1,Olaparib: A Novel Therapy for Metastatic Breast Cancer in Patients With a BRCA1/2 Mutation.,PUBMED,2019,J Adv Pract Oncol,PREDICTIVE,0.008837044892188053
2986,1,H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.,PUBMED,2017,Cancer Res,PREDICTIVE,0.008837044892188053
2987,1,FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.,PUBMED,2017,J Exp Clin Cancer Res,PREDICTIVE,0.008837044892188053
2991,1,Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia.,PUBMED,2004,Cancer Res,PREDICTIVE,0.008837044892188053
2993,1,Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.,PUBMED,2017,Ann Hematol,PROGNOSTIC,0.008837044892188053
2994,1,IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.,PUBMED,2013,Haematologica,PROGNOSTIC,0.008837044892188053
2995,1,"IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.",PUBMED,2015,Leukemia,PROGNOSTIC,0.008837044892188053
2997,1,Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001.,PUBMED,2018,Blood Adv,PROGNOSTIC,0.008837044892188053
2998,1,The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.,PUBMED,2019,Nat Commun,PREDICTIVE,0.008837044892188053
2972,1,Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.,PUBMED,2018,Clin Cancer Res,PREDICTIVE,0.008837044892188053
2974,1,"Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors.",PUBMED,2014,Ann Oncol,PREDICTIVE,0.008837044892188053
2976,1,A Case of Invasive Mucinous¬†Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
2977,1,EGFR and HER3 signaling blockade in invasive mucinous lung adenocarcinoma harboring an NRG1 fusion.,PUBMED,2018,Lung Cancer,PREDICTIVE,0.008837044892188053
2979,1,Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.,PUBMED,2019,Nat Genet,PREDISPOSING,0.008837044892188053
2980,1,MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation.,PUBMED,2019,Oncologist,PREDICTIVE,0.008837044892188053
2983,1,p53 inhibits mRNA 3' processing through its interaction with the CstF/BARD1 complex.,PUBMED,2011,Oncogene,FUNCTIONAL,0.008837044892188053
2985,1,NAB2-STAT6 Gene Fusion in Meningeal Hemangiopericytoma and Solitary Fibrous Tumor.,PUBMED,2016,J Neuropathol Exp Neurol,DIAGNOSTIC,0.008837044892188053
3034,1,Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.,PUBMED,1995,Hum Genet,PREDISPOSING,0.008837044892188053
3035,1,"Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
3036,1,"Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
3037,1,Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.008837044892188053
3038,1,A Randomized Phase 2 Study of Gefitinib With or Without Pemetrexed as First-line Treatment in Nonsquamous NSCLC With EGFR Mutation: Final Overall Survival and Biomarker Analysis.,PUBMED,2020,J Thorac Oncol,PREDICTIVE,0.008837044892188053
3042,1,Sensitivity of SNX2-ABL1 toward tyrosine kinase inhibitors distinct from that of BCR-ABL1.,PUBMED,2014,Leuk Res,PREDICTIVE,0.008837044892188053
3043,1,Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models.,PUBMED,2016,Cancer Res,PREDICTIVE,0.008837044892188053
3052,1,Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.,PUBMED,2004,Biochem J,FUNCTIONAL,0.008837044892188053
918,1,ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.,PUBMED,2014,Cancer Cell,PROGNOSTIC,0.008837044892188053
921,1,"Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.",PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
3022,1,Effect of intravitreal dexamethasone on macular edema in von Hippel-Lindau disease assessed using swept-source optical coherence tomography: a case report.,PUBMED,2018,J Med Case Rep,PREDISPOSING,0.008837044892188053
3024,1,A case of ALK-rearranged non-small cell lung cancer that responded to ceritinib after development of resistance to alectinib.,PUBMED,2018,Oncotarget,PREDICTIVE,0.008837044892188053
3027,1,First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.008837044892188053
3029,1,Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.,PUBMED,2010,J Clin Oncol,PREDISPOSING,0.008837044892188053
3030,1,Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma.,PUBMED,2019,NPJ Precis Oncol,PREDICTIVE,0.008837044892188053
3033,1,Efficacy and safety of crizotinib in patients (pts) with advanced <i>MET</i> exon 14-altered non-small cell lung cancer (NSCLC).,ASCO,2016,"J Clin Oncol 34, 2016 (suppl; abstr 108)",PREDICTIVE,0.008837044892188053
909,1,Penetrance analysis of the PALB2 c.1592delT founder mutation.,PUBMED,2008,Clin Cancer Res,DIAGNOSTIC,0.008837044892188053
910,1,A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.008837044892188053
912,1,Second- and third-generation ALK inhibitors for non-small cell lung cancer.,PUBMED,2016,J Hematol Oncol,PREDICTIVE,0.008837044892188053
913,1,Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis.,PUBMED,2002,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
914,1,Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
915,1,Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.,PUBMED,2016,J Cancer Res Clin Oncol,PREDICTIVE,0.008837044892188053
916,1,"Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.",PUBMED,2015,Cancer Chemother Pharmacol,PREDICTIVE,0.008837044892188053
917,1,Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.,PUBMED,2016,Sci Rep,PREDICTIVE,0.008837044892188053
898,1,Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.,PUBMED,2011,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
899,1,The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.,PUBMED,2001,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
901,1,Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
902,1,Somatic mutations in exocrine pancreatic tumors: association with patient survival.,PUBMED,2013,PLoS One,PROGNOSTIC,0.008837044892188053
903,1,Inherited Variants in SULT1E1 and Response to Abiraterone Acetate by Men with Metastatic Castration Refractory Prostate Cancer.,PUBMED,2016,J Urol,PREDICTIVE,0.008837044892188053
905,1,Predictive value of CHFR and MLH1 methylation in human gastric cancer.,PUBMED,2015,Gastric Cancer,PREDICTIVE,0.008837044892188053
906,1,SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.,PUBMED,2014,Int J Oncol,PROGNOSTIC,0.008837044892188053
907,1,XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.,PUBMED,2006,Gynecol Oncol,PREDICTIVE,0.008837044892188053
890,1,"Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.",PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
3060,1,"Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.",PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3062,1,VHL P25L is not a pathogenic von Hippel-Lindau mutation: a family study.,PUBMED,2006,Mol Diagn Ther,PREDISPOSING,0.008837044892188053
3063,1,Adrenal adenoma in von Hippel-Lindau syndrome: A case report with review of literature.,PUBMED,2019,J Cancer Res Ther,PREDISPOSING,0.008837044892188053
3064,1,Synonymous but Not Silent: A Synonymous VHL Variant in Exon 2 Confers Susceptibility to Familial Pheochromocytoma and von Hippel-Lindau Disease.,PUBMED,2019,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
3068,1,"Renal cell carcinoma in children and young adults: clinicopathological, immunohistochemical, and VHL gene analysis of 46 cases with follow-up.",PUBMED,2011,Int J Surg Pathol,PREDISPOSING,0.008837044892188053
3069,1,Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.,PUBMED,2013,Int J Surg Case Rep,PREDISPOSING,0.008837044892188053
3071,1,Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.,PUBMED,2020,Oncologist,PREDICTIVE,0.008837044892188053
878,1,"CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.",PUBMED,2013,Lancet Oncol,PREDICTIVE,0.008837044892188053
879,1,Rapid and dramatic response to alectinib in an anaplastic lymphoma kinase rearranged non-small-cell lung cancer patient who is critically ill.,PUBMED,2016,Anticancer Drugs,PREDICTIVE,0.008837044892188053
880,1,Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
881,1,PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
883,1,Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
884,1,Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.,PUBMED,2014,Lancet Oncol,PREDICTIVE,0.008837044892188053
886,1,"Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
888,1,Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.,PUBMED,2015,Pancreas,PROGNOSTIC,0.008837044892188053
865,1,Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report.,PUBMED,2016,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
871,1,Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.,PUBMED,2011,PLoS One,PREDICTIVE,0.008837044892188053
872,1,Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations.,PUBMED,2016,Blood Cancer J,PROGNOSTIC,0.008837044892188053
873,1,Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
874,1,Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response.,PUBMED,2014,Eur J Haematol,PREDICTIVE,0.008837044892188053
875,1,Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature.,PUBMED,2015,Int J Clin Exp Med,PREDICTIVE,0.008837044892188053
876,1,Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.,PUBMED,2012,Cancer,PREDICTIVE,0.008837044892188053
877,1,Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
3057,1,SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.,PUBMED,2017,Leuk Lymphoma,PROGNOSTIC,0.008837044892188053
3058,1,Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.,PUBMED,2018,Blood,DIAGNOSTIC,0.008837044892188053
3059,1,"Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
857,1,"Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.",PUBMED,2007,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
858,1,Crizotinib in anaplastic large-cell lymphoma.,PUBMED,2011,N Engl J Med,PREDICTIVE,0.008837044892188053
860,1,Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.,PUBMED,2012,Cancer J,PREDICTIVE,0.008837044892188053
861,1,Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.,PUBMED,2010,N Engl J Med,PREDICTIVE,0.008837044892188053
862,1,A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.,PUBMED,2014,Case Rep Oncol,PREDICTIVE,0.008837044892188053
3125,1,CDK4/6 inhibition is more active against the glioblastoma proneural subtype.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
3126,1,EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.,PUBMED,2008,Int J Cancer,PREDICTIVE,0.008837044892188053
3127,1,"Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway.",PUBMED,2007,Cancer Sci,PREDICTIVE,0.008837044892188053
3129,1,"Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3130,1,Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.008837044892188053
3132,1,A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.,PUBMED,2019,Cancer Cell,PREDICTIVE,0.008837044892188053
3135,1,In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.,PUBMED,2015,BMC Cancer,PREDICTIVE,0.008837044892188053
3137,1,Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.,PUBMED,2016,BJU Int,PREDICTIVE,0.008837044892188053
3113,1,IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.,PUBMED,2018,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3114,1,Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant.,PUBMED,2020,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
3115,1,"Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome.",PUBMED,2010,Leuk Lymphoma,PREDICTIVE,0.008837044892188053
3116,1,A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas.,PUBMED,2016,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3117,1,"A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer.",PUBMED,2018,Cancer Lett,PREDICTIVE,0.008837044892188053
3118,1,Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3121,1,Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing.,PUBMED,2018,Ann Oncol,PREDICTIVE,0.008837044892188053
3124,1,Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3097,1,Urothelial carcinoma with an NRF1-BRAF rearrangement and response to targeted therapy.,PUBMED,2019,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
3098,1,"Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3099,1,CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred.,PUBMED,2001,Genes Chromosomes Cancer,PREDISPOSING,0.008837044892188053
3102,1,Œ≤-Catenin mutation status and outcomes in sporadic desmoid tumors.,PUBMED,2013,Oncologist,PROGNOSTIC,0.008837044892188053
3107,1,The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.,PUBMED,1997,Nat Genet,FUNCTIONAL,0.008837044892188053
3108,1,BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.,PUBMED,2015,Mod Pathol,DIAGNOSTIC,0.008837044892188053
3110,1,BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.,PUBMED,2018,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
3112,1,EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma.,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3077,1,"Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
3082,1,Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.008837044892188053
3085,1,Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21).,PUBMED,2002,Cancer Genet Cytogenet,PREDISPOSING,0.008837044892188053
3086,1,Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution.,PUBMED,2014,Genome Biol,PREDISPOSING,0.008837044892188053
3087,1,Diagnosis at dusk: malignant hypertension and phaeochromocytoma in a 6-year-old girl.,PUBMED,2008,Emerg Med Australas,PREDISPOSING,0.008837044892188053
3091,1,Acute peripheral blood flow response induced by passive leg cycle exercise in people with spinal cord injury.,PUBMED,2007,Arch Phys Med Rehabil,PREDISPOSING,0.008837044892188053
3094,1,Surgical decision-making affected by clinical and genetic screening of a novel kindred with von Hippel-Lindau disease and pancreatic islet cell tumors.,PUBMED,1998,Ann Surg,PREDISPOSING,0.008837044892188053
3095,1,Giant Congenital Melanocytic Nevus Treated With Trametinib.,PUBMED,2019,Pediatrics,PREDICTIVE,0.008837044892188053
3185,1,Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors.,PUBMED,2016,Oncoscience,PREDICTIVE,0.008837044892188053
824,1,Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
825,1,EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
827,1,Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.,PUBMED,2013,N Engl J Med,PREDICTIVE,0.008837044892188053
828,1,First-line crizotinib versus chemotherapy in ALK-positive lung cancer.,PUBMED,2014,N Engl J Med,PREDICTIVE,0.008837044892188053
829,1,Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC.,PUBMED,2014,Ann Oncol,PREDICTIVE,0.008837044892188053
830,1,Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
831,1,"Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.",PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
3166,1,Mutations in CIC and FUBP1 contribute to human oligodendroglioma.,PUBMED,2011,Science,DIAGNOSTIC,0.008837044892188053
3169,1,Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.008837044892188053
3173,1,The Anti-tumor Effect of Cabozantinib on Ovarian Clear Cell Carcinoma In Vitro and In Vivo.,PUBMED,2017,Anticancer Res,PREDICTIVE,0.008837044892188053
3174,1,Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition.,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3175,1,Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.008837044892188053
3176,1,Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
3182,1,Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.,PUBMED,2005,Br J Cancer,PREDICTIVE,0.008837044892188053
3183,1,Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3150,1,CCNE1 amplification is associated with liver metastasis in gastric carcinoma.,PUBMED,2019,Pathol Res Pract,PROGNOSTIC,0.008837044892188053
3157,1,Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients.,PUBMED,2015,CNS Oncol,PREDICTIVE,0.008837044892188053
3158,1,Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
3159,1,PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models.,PUBMED,2017,Mol Cancer,PREDICTIVE,0.008837044892188053
3162,1,"Alectinib: A Review in Advanced, ALK-Positive NSCLC.",PUBMED,2018,Drugs,PREDICTIVE,0.008837044892188053
3163,1,"Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.",PUBMED,2011,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
3164,1,PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.,PUBMED,2017,Mol Cell,PREDICTIVE,0.008837044892188053
3165,1,"Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.",PUBMED,2005,Hum Mol Genet,FUNCTIONAL,0.008837044892188053
3138,1,Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.,PUBMED,2020,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
3139,1,Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.,PUBMED,2020,Nat Med,PREDICTIVE,0.008837044892188053
3140,1,Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells.,PUBMED,2011,Anticancer Res,PREDICTIVE,0.008837044892188053
3141,1,Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer.,PUBMED,2018,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
3142,1,"Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).",PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
3145,1,Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation.,PUBMED,2020,Lung Cancer,PREDICTIVE,0.008837044892188053
3148,1,NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.,PUBMED,2016,Nat Genet,PREDICTIVE,0.008837044892188053
3149,1,Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).,PUBMED,2019,Sarcoma,PREDICTIVE,0.008837044892188053
3200,1,"Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation.",PUBMED,2016,PLoS One,PREDICTIVE,0.008837044892188053
3202,1,Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.,PUBMED,2020,Proc Natl Acad Sci U S A,PREDISPOSING,0.008837044892188053
3211,1,Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.,PUBMED,2011,J Transl Med,PREDICTIVE,0.008837044892188053
3212,1,Amplification of chromosomal segment 4q12 in non-small cell lung cancer.,PUBMED,2009,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
3214,1,Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.,PUBMED,2003,Oncogene,PREDICTIVE,0.008837044892188053
3217,1,Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.,PUBMED,2020,Blood Adv,PREDICTIVE,0.008837044892188053
3218,1,"Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia.",PUBMED,2018,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
3224,1,Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.,PUBMED,2016,EBioMedicine,DIAGNOSTIC,0.008837044892188053
855,1,Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.,PUBMED,2016,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
3187,1,Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.,PUBMED,2017,PLoS One,PREDICTIVE,0.008837044892188053
3188,1,The novel ATP-competitive inhibitor of the MET hepatocyte growth factor receptor EMD1214063 displays inhibitory activity against selected MET-mutated variants.,PUBMED,2013,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
3189,1,Therapeutic Strategies for Hereditary Kidney Cancer.,PUBMED,2016,Curr Oncol Rep,PREDICTIVE,0.008837044892188053
3193,1,Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.,PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3194,1,Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.,PUBMED,2013,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3196,1,beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.,PUBMED,2005,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3197,1,Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.,PUBMED,2006,Cell Cycle,DIAGNOSTIC,0.008837044892188053
843,1,"Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.",PUBMED,2012,Lancet Oncol,PREDICTIVE,0.008837044892188053
845,1,"Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.",PUBMED,2011,J Clin Oncol,PREDICTIVE,0.008837044892188053
847,1,Sunitinib therapy for melanoma patients with KIT mutations.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.008837044892188053
848,1,PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel.,PUBMED,2015,Eur J Cancer,PREDICTIVE,0.008837044892188053
851,1,Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
852,1,Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).,PUBMED,2013,Eur Urol,PREDICTIVE,0.008837044892188053
853,1,Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.,PUBMED,2013,Target Oncol,PREDICTIVE,0.008837044892188053
854,1,Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
832,1,The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.,PUBMED,2011,Oncogene,PREDICTIVE,0.008837044892188053
833,1,Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.,PUBMED,2016,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
834,1,An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model.,PUBMED,2016,Genes Dev,PREDICTIVE,0.008837044892188053
837,1,Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
838,1,Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.,PUBMED,2012,Oncology,PROGNOSTIC,0.008837044892188053
839,1,The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.,PUBMED,2013,Cancer Genet,PREDICTIVE,0.008837044892188053
840,1,Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome.,PUBMED,2012,J Natl Cancer Inst,PROGNOSTIC,0.008837044892188053
842,1,Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.,PUBMED,2011,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
3273,1,Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer.,PUBMED,2013,Oncotarget,PREDICTIVE,0.008837044892188053
3274,1,"Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase.",PUBMED,2004,Cancer Res,PREDICTIVE,0.008837044892188053
3294,1,TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3304,1,FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.,PUBMED,2020,Onco Targets Ther,PREDICTIVE,0.008837044892188053
795,1,"Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
797,1,Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.,PUBMED,2014,Neuro Oncol,PREDICTIVE,0.008837044892188053
798,1,"Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.",PUBMED,2014,Lancet Oncol,PREDICTIVE,0.008837044892188053
799,1,Trastuzumab emtansine for HER2-positive advanced breast cancer.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
3264,1,U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer.,PUBMED,2018,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3265,1,"Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with &#x2265; 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.",ASCO,2019,"J Clin Oncol 37, 2019 (suppl; abstr 1002)",PREDICTIVE,0.008837044892188053
3266,1,"Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.",PUBMED,2017,Lancet Oncol,PREDICTIVE,0.008837044892188053
3267,1,Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.,PUBMED,2014,J Clin Oncol,PREDICTIVE,0.008837044892188053
3268,1,RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.,PUBMED,2019,Cancer Cell,PREDICTIVE,0.008837044892188053
3269,1,Targeting the Prion-like Aggregation of Mutant p53 to Combat Cancer.,PUBMED,2018,Acc Chem Res,PREDICTIVE,0.008837044892188053
3270,1,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,PUBMED,1999,Am J Pathol,DIAGNOSTIC,0.008837044892188053
3271,1,Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.,PUBMED,2011,J Neurosurg Spine,PREDISPOSING,0.008837044892188053
3256,1,JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL.,PUBMED,2019,Cancers (Basel),PROGNOSTIC,0.008837044892188053
3257,1,Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.,PUBMED,2016,Blood,PREDICTIVE,0.008837044892188053
3258,1,A role for PCNA ubiquitination in immunoglobulin hypermutation.,PUBMED,2006,PLoS Biol,PREDISPOSING,0.008837044892188053
3259,1,Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.,PUBMED,2009,Am J Clin Oncol,PROGNOSTIC,0.008837044892188053
3260,1,K-Ras(V14I) -induced Noonan syndrome predisposes to tumour development in mice.,PUBMED,2016,J Pathol,PREDISPOSING,0.008837044892188053
3261,1,Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.,PUBMED,2018,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
3262,1,A polymorphism rs6815464 in the macrophage erythroblast attacher gene is associated with low bone mineral density in postmenopausal Japanese women.,PUBMED,2019,Gene,DIAGNOSTIC,0.008837044892188053
3263,1,Variants in the GH-IGF axis confer susceptibility to lung cancer.,PUBMED,2006,Genome Res,PREDISPOSING,0.008837044892188053
3226,1,Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.,PUBMED,2020,Cancer Cell,PREDICTIVE,0.008837044892188053
3227,1,Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.,PUBMED,2020,Sci Rep,PROGNOSTIC,0.008837044892188053
3228,1,"The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.",PUBMED,2010,Eur J Cancer,PROGNOSTIC,0.008837044892188053
3229,1,"STUMP un""stumped"": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.",PUBMED,2015,J Hematol Oncol,PREDICTIVE,0.008837044892188053
3232,1,Overexpression of interleukin-33 is associated with poor prognosis of patients with glioma.,PUBMED,2017,Int J Neurosci,PROGNOSTIC,0.008837044892188053
3249,1,Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.,PUBMED,2020,Acta Haematol,PROGNOSTIC,0.008837044892188053
3251,1,"Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.",PUBMED,2020,Chin Med J (Engl),PROGNOSTIC,0.008837044892188053
3255,1,Targeting the cyclin-dependent kinase 5 in metastatic melanoma.,PUBMED,2020,Proc Natl Acad Sci U S A,PROGNOSTIC,0.008837044892188053
3383,1,Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease.,PUBMED,2001,Am J Kidney Dis,PREDISPOSING,0.008837044892188053
3385,1,Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.,PUBMED,2013,Virchows Arch,PREDISPOSING,0.008837044892188053
3387,1,Unintended diagnosis of Von Hippel Lindau syndrome using Array Comparative Genomic Hybridization (CGH): counseling challenges arising from unexpected information.,PUBMED,2013,J Genet Couns,PREDISPOSING,0.008837044892188053
3390,1,Pars plana vitrectomy for juxtapapillary capillary retinal angioma.,PUBMED,2006,Am J Ophthalmol,PREDISPOSING,0.008837044892188053
3392,1,B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.,PUBMED,2021,J Pediatr Hematol Oncol,PREDICTIVE,0.008837044892188053
3395,1,von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.,PUBMED,2003,Graefes Arch Clin Exp Ophthalmol,PREDISPOSING,0.008837044892188053
3396,1,Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster.,PUBMED,2006,Blood,PREDISPOSING,0.008837044892188053
3397,1,Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.,PUBMED,2008,J Endocrinol Invest,PREDISPOSING,0.008837044892188053
821,1,Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
822,1,KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer.,PUBMED,2016,Cureus,PREDICTIVE,0.008837044892188053
823,1,Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
3350,1,Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.,PUBMED,2016,Genome Med,PREDISPOSING,0.008837044892188053
3360,1,"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
3363,1,Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.,PUBMED,2018,PLoS One,PREDICTIVE,0.008837044892188053
3364,1,Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.,PUBMED,2019,Nat Med,PREDICTIVE,0.008837044892188053
3382,1,VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality.,PUBMED,2001,J Med Genet,PREDISPOSING,0.008837044892188053
810,1,Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.,PUBMED,2016,Cancer Discov,PREDICTIVE,0.008837044892188053
812,1,"Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
813,1,Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
814,1,Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.,PUBMED,2016,Eur J Cancer,PREDICTIVE,0.008837044892188053
815,1,KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.,PUBMED,2015,PLoS One,PREDICTIVE,0.008837044892188053
816,1,CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.,PUBMED,2016,PLoS One,PREDICTIVE,0.008837044892188053
817,1,Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.,PUBMED,2015,Genet Mol Res,PROGNOSTIC,0.008837044892188053
820,1,Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.,PUBMED,2007,Nature,PREDICTIVE,0.008837044892188053
800,1,High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
802,1,Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil‚Äìbased chemotherapy.,PUBMED,2014,Gastroenterology,PREDICTIVE,0.008837044892188053
804,1,PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
805,1,Association of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma.,PUBMED,2016,J Cancer,PROGNOSTIC,0.008837044892188053
806,1,Correlation of TP53 and MDM2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up.,PUBMED,2016,Int J Biol Markers,PROGNOSTIC,0.008837044892188053
807,1,TP53 mutational status is predictive of pazopanib response in advanced sarcomas.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.008837044892188053
808,1,Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.,PUBMED,2006,J Clin Invest,PREDICTIVE,0.008837044892188053
809,1,"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.",PUBMED,2016,Lancet,PREDICTIVE,0.008837044892188053
3413,1,Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.,PUBMED,2013,Blood,PREDICTIVE,0.008837044892188053
3416,1,Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).,PUBMED,2009,Mod Pathol,DIAGNOSTIC,0.008837044892188053
3417,1,Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors.,PUBMED,2019,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
3419,1,"Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.",PUBMED,2019,Ann Oncol,PREDICTIVE,0.008837044892188053
3421,1,"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
3423,1,Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma.,PUBMED,2018,Br J Cancer,PREDICTIVE,0.008837044892188053
3435,1,Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial.,PUBMED,2019,J Cancer,PREDICTIVE,0.008837044892188053
3436,1,Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.,PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
779,1,Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.008837044892188053
780,1,BRAF mutations in hairy-cell leukemia.,PUBMED,2011,N Engl J Med,DIAGNOSTIC,0.008837044892188053
781,1,Prognostic Subgroups among Patients with Stage II Colon Cancer.,PUBMED,2016,N Engl J Med,PROGNOSTIC,0.008837044892188053
782,1,A novel K-ras mutation in colorectal cancer. A case report and literature review.,PUBMED,2009,Anticancer Res,PREDICTIVE,0.008837044892188053
784,1,Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
786,1,Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
788,1,Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.,PUBMED,2014,Mol Cancer Res,PREDICTIVE,0.008837044892188053
789,1,KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials.,PUBMED,2013,Med Oncol,PREDICTIVE,0.008837044892188053
763,1,FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.,PUBMED,2010,Cancer Res,PREDICTIVE,0.008837044892188053
765,1,Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients.,PUBMED,2011,Korean J Hematol,PROGNOSTIC,0.008837044892188053
766,1,Breast cancer in a RAD51D mutation carrier: case report and review of the literature.,PUBMED,2015,Clin Breast Cancer,PREDISPOSING,0.008837044892188053
767,1,Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.,PUBMED,2014,Ann Hematol,PREDICTIVE,0.008837044892188053
768,1,"Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
770,1,HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.,PUBMED,2013,J Clin Invest,PROGNOSTIC,0.008837044892188053
776,1,A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene.,PUBMED,2012,BMC Cancer,PREDICTIVE,0.008837044892188053
777,1,Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.,PUBMED,2005,N Engl J Med,PREDICTIVE,0.008837044892188053
3399,1,Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia).,PUBMED,2012,Haematologica,PREDISPOSING,0.008837044892188053
3400,1,The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W).,PUBMED,2013,Haematologica,PREDISPOSING,0.008837044892188053
757,1,"Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.",PUBMED,2010,Gynecol Oncol,PREDICTIVE,0.008837044892188053
758,1,Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model.,PUBMED,2012,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
759,1,Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
760,1,Assessment of Minimal Residual Disease in Standard-Risk AML.,PUBMED,2016,N Engl J Med,PROGNOSTIC,0.008837044892188053
761,1,Pharmacological targeting of the Wdr5-MLL interaction in C/EBPŒ± N-terminal leukemia.,PUBMED,2015,Nat Chem Biol,PREDICTIVE,0.008837044892188053
762,1,PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.,PUBMED,2004,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
3516,1,Suprasellar hemangioblastoma in a patient with von Hippel-Lindau disease confirmed by germline mutation study: case report and review of the literature.,PUBMED,2001,Surg Neurol,PREDISPOSING,0.008837044892188053
3518,1,Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.,PUBMED,2019,Front Genet,PREDISPOSING,0.008837044892188053
3519,1,Von Hippel Lindau Disease.,PUBMED,2019,J Pediatr,PREDISPOSING,0.008837044892188053
3520,1,Robot-assisted cortical-sparing adrenalectomy in a patient with Von Hippel-Lindau disease and bilateral pheochromocytomas separated by 9 years.,PUBMED,2006,J Laparoendosc Adv Surg Tech A,PREDISPOSING,0.008837044892188053
3521,1,Von Hippel-Lindau disease: the clinical manifestations and genetic analysis results of two cases from a single family.,PUBMED,2015,Balkan J Med Genet,PREDISPOSING,0.008837044892188053
3523,1,"Von Hippel-Lindau ""Black Forest"" mutation inherited in a large Chinese family.",PUBMED,2019,Gland Surg,PREDISPOSING,0.008837044892188053
3524,1,Triple pancreatic lesion in a patient with Von Hippel-Lindau disease.,PUBMED,2018,Gastroenterol Hepatol,PREDISPOSING,0.008837044892188053
3526,1,Total pancreatectomy for multiple neuroendocrine tumors of the pancreas in a patient with von Hippel-Lindau disease.,PUBMED,2009,Clin J Gastroenterol,PREDISPOSING,0.008837044892188053
3486,1,A severely mentally and motor retarded girl with monosomy 3pter-->p25 and trisomy 8q24-->qter due to a familial reciprocal translocation t(3;8)(p25;q24).,PUBMED,2009,Genet Couns,PREDISPOSING,0.008837044892188053
3488,1,Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours.,PUBMED,2018,NPJ Genom Med,PREDISPOSING,0.008837044892188053
3499,1,Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.,PUBMED,2019,J Clin Invest,PREDICTIVE,0.008837044892188053
3500,1,Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.,PUBMED,2019,Nat Commun,PREDICTIVE,0.008837044892188053
3501,1,Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.,PUBMED,2018,Nat Commun,PREDICTIVE,0.008837044892188053
3510,1,The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes.,PUBMED,2013,J Pediatr Surg,PREDISPOSING,0.008837044892188053
3513,1,"Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online.",PUBMED,1998,Hum Mutat,PREDISPOSING,0.008837044892188053
3515,1,Second hit deletion size in von Hippel-Lindau disease.,PUBMED,2006,Ann Neurol,PREDISPOSING,0.008837044892188053
3461,1,Loss of BAP1 function leads to EZH2-dependent transformation.,PUBMED,2015,Nat Med,PREDICTIVE,0.008837044892188053
3475,1,GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.,PUBMED,2018,Blood Cancer J,PROGNOSTIC,0.008837044892188053
3476,1,Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.,PUBMED,2010,Nature,PROGNOSTIC,0.008837044892188053
3478,1,Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.,PUBMED,2018,Lancet Oncol,PREDISPOSING,0.008837044892188053
3479,1,Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.,PUBMED,2017,Lancet Oncol,PROGNOSTIC,0.008837044892188053
3480,1,Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.,PUBMED,2002,Blood,PROGNOSTIC,0.008837044892188053
3484,1,Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease. Case report and review of the literature.,PUBMED,2005,J Neurosurg Spine,PREDISPOSING,0.008837044892188053
3485,1,"A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.",PUBMED,2002,Endocr J,PREDISPOSING,0.008837044892188053
3442,1,Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1.,PUBMED,2020,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
3443,1,Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: A case report.,PUBMED,2020,Cancer Genet,PROGNOSTIC,0.008837044892188053
3444,1,Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (Comment to Tausch et al.).,PUBMED,2019,Haematologica,PREDICTIVE,0.008837044892188053
3448,1,The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.,PUBMED,2019,Histopathology,PROGNOSTIC,0.008837044892188053
3450,1,BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.,PUBMED,2020,Am J Cancer Res,PROGNOSTIC,0.008837044892188053
3454,1,A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.,PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3458,1,Spinal hemangioblastoma.,PUBMED,2011,Am J Med Sci,PREDISPOSING,0.008837044892188053
3459,1,Unusual ocular presentation of von Hippel-Lindau disease.,PUBMED,2005,Can J Ophthalmol,PREDISPOSING,0.008837044892188053
3535,1,Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease.,PUBMED,2000,Graefes Arch Clin Exp Ophthalmol,PREDISPOSING,0.008837044892188053
3536,1,Sporadic phaeochromocytoma in childhood: clinical and molecular variability.,PUBMED,2005,J Pediatr Endocrinol Metab,PREDISPOSING,0.008837044892188053
3537,1,Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.,PUBMED,2014,Hum Pathol,PREDISPOSING,0.008837044892188053
3538,1,Recurrent polytopic chromaffin paragangliomas in a 9-year-old boy resulting from a novel germline mutation in the von Hippel-Lindau gene.,PUBMED,2002,J Pediatr Hematol Oncol,PREDISPOSING,0.008837044892188053
3539,1,Recurrent Pheochromocytomas in a Child with Familial von Hippel-Lindau Syndrome.,PUBMED,2016,Indian J Pediatr,PREDISPOSING,0.008837044892188053
3540,1,Unsuspected Von Hippel-Lindau syndrome in acute-onset resistant hypertension.,PUBMED,2018,BMJ Case Rep,PREDISPOSING,0.008837044892188053
3541,1,Superior mediastinal paraganglioma associated with von Hippel-Lindau syndrome: report of a case.,PUBMED,2014,World J Surg Oncol,PREDISPOSING,0.008837044892188053
3544,1,When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma.,PUBMED,2018,Am J Med,PREDISPOSING,0.008837044892188053
749,1,The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.,PUBMED,1995,Haematologica,DIAGNOSTIC,0.008837044892188053
750,1,All trans retinoic acid in acute promyelocytic leukemia.,PUBMED,2001,Oncogene,PREDICTIVE,0.008837044892188053
751,1,Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia.,PUBMED,2013,Int J Hematol,PREDICTIVE,0.008837044892188053
755,1,Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.,PUBMED,2005,Am J Obstet Gynecol,PROGNOSTIC,0.008837044892188053
756,1,Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu.,PUBMED,2008,Int J Gynaecol Obstet,PREDICTIVE,0.008837044892188053
3530,1,Comorbid VHL and SCA2 mutations in a large kindred: confounding diagnosis of neurological dysfunction caused by CNS VHL vascular tumours versus SCA2 atrophic neurodegeneration.,PUBMED,2002,J Med Genet,PREDISPOSING,0.008837044892188053
3531,1,The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia.,PUBMED,2011,Haematologica,PREDISPOSING,0.008837044892188053
3532,1,DNA-based diagnosis of the von Hippel-Lindau syndrome.,PUBMED,2000,Am J Ophthalmol,PREDISPOSING,0.008837044892188053
734,1,High expression of HEF1 predicts a poorer prognosis of hepatocellular carcinoma: A retrospective study.,PUBMED,2016,Mol Clin Oncol,PROGNOSTIC,0.008837044892188053
735,1,A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
736,1,Downregulation of cytokeratin 18 is associated with paclitaxel‚Äëresistance and tumor aggressiveness in prostate cancer.,PUBMED,2016,Int J Oncol,PROGNOSTIC,0.008837044892188053
737,1,Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.,PUBMED,2016,Int J Cancer,PROGNOSTIC,0.008837044892188053
740,1,Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?,PUBMED,2000,Histopathology,DIAGNOSTIC,0.008837044892188053
743,1,"A novel fusion gene, SYT-SSX4, in synovial sarcoma.",PUBMED,1999,J Natl Cancer Inst,DIAGNOSTIC,0.008837044892188053
745,1,"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.",PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
748,1,Epidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based Therapy.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
3527,1,Ovarian Steroid Cell Tumor in an Adolescent With Von Hippel-Lindau Syndrome: A Case Report and Review of the Literature.,PUBMED,2020,Int J Gynecol Pathol,PREDISPOSING,0.008837044892188053
724,1,Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.,PUBMED,2004,Ann Oncol,PREDICTIVE,0.008837044892188053
725,1,Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial.,PUBMED,2004,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
726,1,Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.,PUBMED,2016,Ann Oncol,PREDICTIVE,0.008837044892188053
727,1,Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.008837044892188053
728,1,HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.008837044892188053
730,1,Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance.,PUBMED,2014,Mol Cancer,PREDICTIVE,0.008837044892188053
733,1,Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model.,PUBMED,2017,Mol Carcinog,PROGNOSTIC,0.008837044892188053
3603,1,Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801.,PUBMED,2020,Blood Adv,PREDICTIVE,0.008837044892188053
3604,1,Medullary hemangioblastoma in a child with von Hippel-Lindau disease: vascular tumor perfusion depicted by arterial spin labeling and dynamic contrast-enhanced imaging.,PUBMED,2015,J Neurosurg Pediatr,PREDISPOSING,0.008837044892188053
691,1,Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma.,PUBMED,2016,PLoS One,PREDICTIVE,0.008837044892188053
692,1,Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.,PUBMED,2016,Cancer Cell,PREDICTIVE,0.008837044892188053
693,1,Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.,PUBMED,2011,J Clin Invest,PREDICTIVE,0.008837044892188053
694,1,"Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.",PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
695,1,"Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.",PUBMED,2005,Oncogene,PREDICTIVE,0.008837044892188053
696,1,"Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.",PUBMED,2012,J Clin Oncol,PREDICTIVE,0.008837044892188053
3590,1,"Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.",PUBMED,1996,Hum Genet,PREDISPOSING,0.008837044892188053
3592,1,A family with hydrocephalus as a complication of cerebellar hemangioblastoma: identification of Pro157Leu mutation in the VHL gene.,PUBMED,2000,J Hum Genet,PREDISPOSING,0.008837044892188053
3593,1,Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.,PUBMED,2002,J Neurosurg,PREDISPOSING,0.008837044892188053
3594,1,Multiple lung adenocarcinomas associated with von hippel-lindau disease.,PUBMED,2014,Ann Thorac Surg,PREDISPOSING,0.008837044892188053
3595,1,A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.,PUBMED,2013,J Clin Neurosci,PREDISPOSING,0.008837044892188053
3599,1,Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation.,PUBMED,2015,Endocrine,PREDISPOSING,0.008837044892188053
3600,1,Somatic mosaicism in von Hippel-Lindau Disease.,PUBMED,2000,Hum Mutat,PREDISPOSING,0.008837044892188053
3601,1,Relaxing retinectomy for tractional retinal detachment with retinal capillary hemangiomas in genotypically confirmed von hippel-lindau disease.,PUBMED,2010,Retin Cases Brief Rep,PREDISPOSING,0.008837044892188053
3575,1,Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.,PUBMED,2018,J Clin Oncol,PREDISPOSING,0.008837044892188053
3577,1,Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.,PUBMED,2009,J Clin Endocrinol Metab,PREDISPOSING,0.008837044892188053
3578,1,The von Hippel-Lindau (VHL) germline mutation V84L manifests as early-onset bilateral pheochromocytoma.,PUBMED,2006,Am J Med Genet A,PREDISPOSING,0.008837044892188053
3582,1,Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?,PUBMED,2009,Eur J Endocrinol,PREDISPOSING,0.008837044892188053
3583,1,An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease.,PUBMED,2018,Intern Med,PREDISPOSING,0.008837044892188053
3584,1,Ruptured intracranial aneurysm associated with von Hippel-Lindau syndrome: a molecular link?,PUBMED,2006,J Neurosurg,PREDISPOSING,0.008837044892188053
3585,1,Unilateral Papillary Cystadenoma of the Epididymis as a First Presentation of Von Hippel-Lindau Disease.,PUBMED,2018,Urology,PREDISPOSING,0.008837044892188053
3589,1,"A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.",PUBMED,2001,Leukemia,DIAGNOSTIC,0.008837044892188053
3552,1,CREBBP mutations in relapsed acute lymphoblastic leukaemia.,PUBMED,2011,Nature,PREDICTIVE,0.008837044892188053
3558,1,Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.,PUBMED,2020,Cancer Res,FUNCTIONAL,0.008837044892188053
3561,1,Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421.,PUBMED,2013,Leukemia,PROGNOSTIC,0.008837044892188053
3567,1,Bilateral pheochromocytoma/intra-adrenal paraganglioma in von Hippel-Lindau patient causing acute myocardial infarction.,PUBMED,2014,Pol J Pathol,PREDISPOSING,0.008837044892188053
3568,1,Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.,PUBMED,2006,Cancer Res,PREDISPOSING,0.008837044892188053
3570,1,Detection of a novel germline mutation in the von Hippel-Lindau tumour-suppressor gene by fluorescence-labelled base excision sequence scanning (F-BESS).,PUBMED,1999,Clin Genet,PREDISPOSING,0.008837044892188053
3573,1,Identification of a VHL gene mutation in a Chinese family with Von Hippel‚ÄëLindau syndrome.,PUBMED,2018,Mol Med Rep,PREDISPOSING,0.008837044892188053
3574,1,A novel mutation in the VHL gene in a Chinese family with von Hippel-Lindau disease.,PUBMED,2018,BMC Med Genet,PREDISPOSING,0.008837044892188053
3635,1,Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target.,PUBMED,2017,Sci Rep,PREDISPOSING,0.008837044892188053
3636,1,CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.,PUBMED,2019,Neuropathol Appl Neurobiol,DIAGNOSTIC,0.008837044892188053
3637,1,"Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene.",PUBMED,2005,J Endocrinol Invest,PREDISPOSING,0.008837044892188053
3639,1,Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.,PUBMED,2014,PLoS One,FUNCTIONAL,0.008837044892188053
3640,1,"Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.",PUBMED,2017,Lancet,PREDICTIVE,0.008837044892188053
3642,1,Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type acute myeloid leukemia patients.,PUBMED,2020,Oncotarget,PREDICTIVE,0.008837044892188053
3644,1,"Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.",PUBMED,2006,Oncogene,DIAGNOSTIC,0.008837044892188053
3645,1,FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248).,PUBMED,2006,Leukemia,PREDICTIVE,0.008837044892188053
721,1,FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro.,PUBMED,2009,Cancer Res,PREDICTIVE,0.008837044892188053
723,1,Mutation and methylation analysis of TP53 in adrenal carcinogenesis.,PUBMED,2005,Eur J Surg Oncol,PROGNOSTIC,0.008837044892188053
3612,1,High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.,PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3613,1,Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.,PUBMED,2008,J Clin Oncol,PROGNOSTIC,0.008837044892188053
3614,1,Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.,PUBMED,2002,Lancet,PROGNOSTIC,0.008837044892188053
3621,1,Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.,PUBMED,2000,Clin Nephrol,PREDISPOSING,0.008837044892188053
3627,1,Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene.,PUBMED,2019,Cancer Med,PREDICTIVE,0.008837044892188053
3631,1,FGFR3S249C mutation promotes chemoresistance by activating Akt signaling in bladder cancer cells.,PUBMED,2019,Exp Ther Med,PREDICTIVE,0.008837044892188053
705,1,TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.,PUBMED,2016,Br J Haematol,PROGNOSTIC,0.008837044892188053
706,1,Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.,PUBMED,2013,Nat Med,PREDICTIVE,0.008837044892188053
709,1,"Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.",PUBMED,2014,J Clin Oncol,PREDICTIVE,0.008837044892188053
710,1,Detection of complete response to imatinib mesylate (Glivec/Gleevec) with 18F-FDG PET/CT for low-grade endometrial stromal sarcoma.,PUBMED,2009,Cancer Chemother Pharmacol,PREDICTIVE,0.008837044892188053
711,1,A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.,PUBMED,2006,Gynecol Oncol,PREDICTIVE,0.008837044892188053
715,1,Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.,PUBMED,2015,J Clin Oncol,PREDICTIVE,0.008837044892188053
716,1,Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
718,1,Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.,PUBMED,2006,Virchows Arch,PROGNOSTIC,0.008837044892188053
697,1,Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015.,PUBMED,2015,Breast,PREDICTIVE,0.008837044892188053
698,1,"Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.",PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
699,1,"Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
700,1,"Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.",PUBMED,2016,Lancet Oncol,PREDICTIVE,0.008837044892188053
701,1,Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
702,1,Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.,PUBMED,2012,Blood,PROGNOSTIC,0.008837044892188053
703,1,Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.,PUBMED,2015,Lancet Oncol,PROGNOSTIC,0.008837044892188053
704,1,Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.,PUBMED,2016,Cancer Med,PREDICTIVE,0.008837044892188053
683,1,Ibrutinib in previously treated Waldenstr√∂m's macroglobulinemia.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
684,1,Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases.,PUBMED,2015,Br J Cancer,PROGNOSTIC,0.008837044892188053
689,1,"Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.",PUBMED,2013,Lancet Oncol,PREDICTIVE,0.008837044892188053
3663,1,Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension.,PUBMED,2011,Blood,PREDISPOSING,0.008837044892188053
3672,1,"MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.",PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
3674,1,Molecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testing.,PUBMED,2007,Arq Bras Endocrinol Metabol,PREDISPOSING,0.008837044892188053
3675,1,[Genetic study of a new family with Hippel-Lindau type IIB disease].,PUBMED,1999,Med Clin (Barc),PREDISPOSING,0.008837044892188053
3678,1,Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.,PUBMED,2007,Oncogene,PREDICTIVE,0.008837044892188053
671,1,"A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.",PUBMED,2015,Neuro Oncol,PREDICTIVE,0.008837044892188053
673,1,Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.,PUBMED,2015,Am J Transl Res,PROGNOSTIC,0.008837044892188053
674,1,Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.,PUBMED,2016,Eur J Cancer,PROGNOSTIC,0.008837044892188053
676,1,Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.,PUBMED,2016,Anticancer Res,PREDICTIVE,0.008837044892188053
677,1,NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
680,1,"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
681,1,Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.,PUBMED,2016,Tumour Biol,PROGNOSTIC,0.008837044892188053
682,1,Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.,PUBMED,2016,Nat Commun,PREDICTIVE,0.008837044892188053
3660,1,Hypogonadotrophic hypogonadism due to intrasellar hemangioblastoma in von Hippel-Lindau syndrome.,PUBMED,2009,Am J Med Genet A,PREDISPOSING,0.008837044892188053
658,1,CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.,PUBMED,2016,N Engl J Med,PROGNOSTIC,0.008837044892188053
659,1,Somatic STAT3 mutations in large granular lymphocytic leukemia.,PUBMED,2012,N Engl J Med,DIAGNOSTIC,0.008837044892188053
660,1,"OCT4B1 promotes cell growth, migration and invasion suppressing sensitivity to Œøxaliplatin in colon cancer.",PUBMED,2015,Oncol Rep,PREDICTIVE,0.008837044892188053
664,1,"Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.",PUBMED,2016,Target Oncol,PREDICTIVE,0.008837044892188053
666,1,Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.,PUBMED,2015,Nat Med,PREDICTIVE,0.008837044892188053
668,1,Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib.,PUBMED,2016,JAMA Oncol,PREDICTIVE,0.008837044892188053
670,1,Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma.,PUBMED,2006,J Oral Pathol Med,PROGNOSTIC,0.008837044892188053
3648,1,Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
3651,1,"Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss.",PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3652,1,Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation.,PUBMED,2017,Case Rep Oncol,PREDICTIVE,0.008837044892188053
3653,1,Photodynamic therapy and vitrectomy for a large optic nerve hemangioma with neovascularization and retinal detachment: a clinicopathologic correlation.,PUBMED,2009,Retin Cases Brief Rep,PREDISPOSING,0.008837044892188053
3654,1,Germline mutation in the von Hippel-Lindau gene in Kuwait: a clinical and molecular study.,PUBMED,2008,Med Princ Pract,PREDISPOSING,0.008837044892188053
3655,1,Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.,PUBMED,2001,Arch Ophthalmol,PREDISPOSING,0.008837044892188053
3656,1,Laparoscopic partial adrenalectomy for recurrent pheochromocytoma after open partial adrenalectomy in von Hippel-Lindau disease.,PUBMED,2002,J Endourol,PREDISPOSING,0.008837044892188053
3659,1,Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
3764,1,Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine.,PUBMED,2020,Gynecol Oncol Rep,PREDICTIVE,0.008837044892188053
3765,1,Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report.,PUBMED,2019,Gynecol Oncol Rep,PREDICTIVE,0.008837044892188053
3767,1,Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysis.,PUBMED,2015,Genes Chromosomes Cancer,ONCOGENIC,0.008837044892188053
626,1,Class III Œ≤-tubulin counteracts the ability of paclitaxel to inhibit cell migration.,PUBMED,2011,Oncotarget,PREDICTIVE,0.008837044892188053
627,1,High expression of class III Œ≤-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer.,PUBMED,2013,Clin Breast Cancer,PREDICTIVE,0.008837044892188053
628,1,"Association between expression of thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase and efficacy of pemetrexed in advanced non-small cell lung cancer.",PUBMED,2012,Anticancer Res,PREDICTIVE,0.008837044892188053
629,1,Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR.,PUBMED,2012,J Exp Clin Cancer Res,PREDICTIVE,0.008837044892188053
630,1,Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.,PUBMED,2012,Eur J Cancer,PREDICTIVE,0.008837044892188053
3724,1,Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture.,PUBMED,2013,Leukemia,PREDICTIVE,0.008837044892188053
3729,1,Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib.,PUBMED,2020,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
3731,1,Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.,PUBMED,2013,Acta Haematol,PROGNOSTIC,0.008837044892188053
3733,1,A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia.,PUBMED,2005,Leukemia,ONCOGENIC,0.008837044892188053
3735,1,Myxoid Spindle Cell Sarcoma With LMNA-NTRK Fusion: Expanding the Morphologic Spectrum of NTRK-Rearranged Tumors.,PUBMED,2020,Int J Surg Pathol,PREDICTIVE,0.008837044892188053
3749,1,Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
3757,1,Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3-tyrosine kinase domain mutations.,PUBMED,2014,Cancer,PREDICTIVE,0.008837044892188053
3758,1,FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.,PUBMED,2004,Blood,PROGNOSTIC,0.008837044892188053
3701,1,FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.,PUBMED,2018,J Pathol,ONCOGENIC,0.008837044892188053
3707,1,Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.,PUBMED,2004,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
3710,1,Multifocal renal oncocytoma in a patient with Von Hippel-Lindau mutation.,PUBMED,2005,Urology,PREDISPOSING,0.008837044892188053
3712,1,Phaeochromocytoma associated with a de novo VHL mutation as form fruste of von Hippel-Lindau disease.,PUBMED,2001,Eur J Pediatr,PREDISPOSING,0.008837044892188053
3713,1,Molecular analysis as a tool in the differential diagnosis of VHL disease-related tumors.,PUBMED,2005,Diagn Mol Pathol,PREDISPOSING,0.008837044892188053
3715,1,Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib.,PUBMED,2019,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
3722,1,Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.,PUBMED,1998,Cell Growth Differ,FUNCTIONAL,0.008837044892188053
3723,1,"Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.",PUBMED,2001,Oncogene,ONCOGENIC,0.008837044892188053
3679,1,Frequent genetic changes in childhood pheochromocytomas.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.008837044892188053
3680,1,Pancreatic involvement in von Hippel-Lindau disease: report of two cases and review of the literature.,PUBMED,2006,Am J Gastroenterol,PREDISPOSING,0.008837044892188053
3681,1,Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations.,PUBMED,2008,Clin Endocrinol (Oxf),PREDISPOSING,0.008837044892188053
3682,1,Osteoporosis and amenorrhea in a young patient with von Hippel-Lindau disease.,PUBMED,2005,Isr Med Assoc J,PREDISPOSING,0.008837044892188053
3684,1,Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.,PUBMED,1999,J Pediatr Endocrinol Metab,PREDISPOSING,0.008837044892188053
3691,1,Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
3692,1,Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
3695,1,Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization.,PUBMED,2015,Biophys J,FUNCTIONAL,0.008837044892188053
3772,1,Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.,PUBMED,2011,Iran J Kidney Dis,PROGNOSTIC,0.008837044892188053
3773,1,Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.,PUBMED,1996,Nat Genet,FUNCTIONAL,0.008837044892188053
3777,1,Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.,PUBMED,2004,J Nephrol,PREDISPOSING,0.008837044892188053
3779,1,"A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.",PUBMED,2014,J Invest Dermatol,PREDICTIVE,0.008837044892188053
3781,1,Characterization of a novel complex BRAF mutation in a follicular variant papillary thyroid carcinoma.,PUBMED,2008,Eur J Endocrinol,FUNCTIONAL,0.008837044892188053
3789,1,Meningioma showing VHL gene inactivation in a patient with von Hippel-Lindau disease.,PUBMED,2003,Neurology,PREDISPOSING,0.008837044892188053
3791,1,Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene.,PUBMED,2008,J Paediatr Child Health,PREDISPOSING,0.008837044892188053
3792,1,Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.,PUBMED,2014,Clin Genet,PREDISPOSING,0.008837044892188053
651,1,"CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer.",PUBMED,2010,Anticancer Res,PREDICTIVE,0.008837044892188053
652,1,Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.,PUBMED,2010,Cancer Sci,PREDICTIVE,0.008837044892188053
653,1,Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
654,1,MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.,PUBMED,2008,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
655,1,"Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.",PUBMED,2006,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
656,1,"Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.",PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.008837044892188053
657,1,PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.,PUBMED,2006,Br J Cancer,PREDICTIVE,0.008837044892188053
3771,1,"AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib.",PUBMED,2021,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
639,1,BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.,PUBMED,2012,J Pathol,PREDICTIVE,0.008837044892188053
642,1,Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.,PUBMED,2012,J Cell Mol Med,PREDICTIVE,0.008837044892188053
644,1,BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.,PUBMED,2011,Gynecol Oncol,PREDICTIVE,0.008837044892188053
645,1,Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.008837044892188053
646,1,"ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.",PUBMED,2011,Respirology,PREDICTIVE,0.008837044892188053
647,1,Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer.,PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.008837044892188053
648,1,DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.,PUBMED,2011,Eur J Cancer,PREDICTIVE,0.008837044892188053
649,1,Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.,PUBMED,2011,Oncogene,PREDICTIVE,0.008837044892188053
631,1,Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.008837044892188053
632,1,Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.,PUBMED,2012,Br J Cancer,PREDICTIVE,0.008837044892188053
633,1,High expression of TIMP-1 in human breast cancer tissues is a predictive of resistance to paclitaxel-based chemotherapy.,PUBMED,2012,Med Oncol,PREDICTIVE,0.008837044892188053
634,1,FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.,PUBMED,2012,Ann Oncol,PREDICTIVE,0.008837044892188053
635,1,Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer.,PUBMED,2012,Int J Cancer,PREDICTIVE,0.008837044892188053
636,1,Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.,PUBMED,2012,Br J Cancer,PREDICTIVE,0.008837044892188053
637,1,Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.,PUBMED,2012,Br J Cancer,PREDICTIVE,0.008837044892188053
638,1,mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.,PUBMED,2012,Cell Cycle,PREDICTIVE,0.008837044892188053
3838,1,ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.,PUBMED,2018,Oral Oncol,PREDICTIVE,0.008837044892188053
3841,1,MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.,PUBMED,2013,PLoS One,PREDICTIVE,0.008837044892188053
3842,1,"Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A.",PUBMED,2011,Fam Cancer,PREDISPOSING,0.008837044892188053
3843,1,Familial pheochromocytomas and paragangliomas: stories from the sign-out room.,PUBMED,2006,Endocr Pathol,PREDISPOSING,0.008837044892188053
3844,1,High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.,PUBMED,2008,J Hypertens,PREDISPOSING,0.008837044892188053
3849,1,Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children-a novel health disparity.,PUBMED,2021,Leukemia,PROGNOSTIC,0.008837044892188053
3851,1,Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
3852,1,Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib.,PUBMED,2019,IJU Case Rep,PREDICTIVE,0.008837044892188053
3829,1,Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.,PUBMED,2011,Hum Mutat,FUNCTIONAL,0.008837044892188053
3830,1,Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
3831,1,"Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
3832,1,"A novel, germline, deactivating CBL variant p.L493F alters domain orientation and is associated with multiple childhood cancers.",PUBMED,2021,Cancer Genet,PREDISPOSING,0.008837044892188053
3833,1,Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.,PUBMED,2020,Blood,PROGNOSTIC,0.008837044892188053
3834,1,Characterization of leukemias with ETV6-ABL1 fusion.,PUBMED,2016,Haematologica,DIAGNOSTIC,0.008837044892188053
3836,1,Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial.,PUBMED,2018,Haematologica,PREDICTIVE,0.008837044892188053
3837,1,MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.,PUBMED,2010,Cancer Res,PREDICTIVE,0.008837044892188053
3808,1,Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.,PUBMED,2010,Lancet,PREDICTIVE,0.008837044892188053
3811,1,Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.,PUBMED,2018,Cell Death Dis,PREDICTIVE,0.008837044892188053
3816,1,"Endolymphatic sac tumours and von Hippel-Lindau disease - case report, molecular analysis and histopathological characterization.",PUBMED,2009,Folia Neuropathol,PREDISPOSING,0.008837044892188053
3817,1,Large deletion causing von Hippel-Lindau disease and hereditary breast cancer syndrome.,PUBMED,2014,Hered Cancer Clin Pract,PREDISPOSING,0.008837044892188053
3818,1,Neuroendocrine tumor of the pancreas and bilateral adrenal pheochromocytomas. A rare manifestation of von Hippel-Lindau disease in childhood.,PUBMED,2007,J Pediatr Surg,PREDISPOSING,0.008837044892188053
3819,1,Obstructive jaundice due to von Hippel-Lindau disease-associated pancreatic lesions: A case report.,PUBMED,2014,Oncol Lett,PREDISPOSING,0.008837044892188053
3822,1,Establishment and characterization of a renal cell carcinoma line from a patient with von Hippel-Lindau syndrome.,PUBMED,1997,Cancer Genet Cytogenet,PREDISPOSING,0.008837044892188053
3825,1,Plasma proteome profiling of von Hippel-Lindau disease after total and subtotal nephrectomy: a preliminary study.,PUBMED,2010,Clin Biochem,PREDISPOSING,0.008837044892188053
3794,1,First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
3795,1,MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma.,PUBMED,2020,Oncotarget,PREDICTIVE,0.008837044892188053
3796,1,Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial.,PUBMED,2021,JAMA Oncol,PREDICTIVE,0.008837044892188053
3802,1,Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.,PUBMED,2016,Invest New Drugs,PREDICTIVE,0.008837044892188053
3803,1,Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).,PUBMED,2018,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
3804,1,"Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).",PUBMED,2018,J Clin Oncol,PREDICTIVE,0.008837044892188053
3805,1,Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.,PUBMED,2017,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
3807,1,Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.,PUBMED,2021,J Clin Oncol,PREDICTIVE,0.008837044892188053
3897,1,Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.,PUBMED,2002,Mol Cell Biol,FUNCTIONAL,0.008837044892188053
596,1,Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.,PUBMED,2014,Br J Cancer,PREDICTIVE,0.008837044892188053
597,1,"A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer.",PUBMED,2015,Clin Breast Cancer,PREDICTIVE,0.008837044892188053
598,1,Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.,PUBMED,2014,Scand J Gastroenterol,PREDICTIVE,0.008837044892188053
599,1,p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.,PUBMED,2014,Oral Oncol,PREDICTIVE,0.008837044892188053
600,1,"Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.",PUBMED,2014,Lung Cancer,PREDICTIVE,0.008837044892188053
601,1,AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.,PUBMED,2013,Dis Markers,PREDICTIVE,0.008837044892188053
603,1,"HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab.",PUBMED,2013,Ann Oncol,PREDICTIVE,0.008837044892188053
3886,1,A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.,PUBMED,2007,Leukemia,DIAGNOSTIC,0.008837044892188053
3888,1,RCSD1-ABL1 Translocation Associated with IKZF1 Gene Deletion in B-Cell Acute Lymphoblastic Leukemia.,PUBMED,2015,Case Rep Hematol,PREDICTIVE,0.008837044892188053
3889,1,RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.,PUBMED,2011,Int J Hematol,PREDICTIVE,0.008837044892188053
3890,1,Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.,PUBMED,2013,Leukemia,DIAGNOSTIC,0.008837044892188053
3891,1,Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.,PUBMED,2017,Haematologica,PREDICTIVE,0.008837044892188053
3892,1,Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).,PUBMED,2017,Leuk Lymphoma,PREDICTIVE,0.008837044892188053
3893,1,BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.,PUBMED,2005,J Clin Endocrinol Metab,PROGNOSTIC,0.008837044892188053
3896,1,Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.,PUBMED,2019,J Pediatr Hematol Oncol,PREDICTIVE,0.008837044892188053
3864,1,HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.,PUBMED,2017,Am J Cancer Res,PREDICTIVE,0.008837044892188053
3877,1,Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia.,PUBMED,2012,Blood,PREDICTIVE,0.008837044892188053
3878,1,Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.,PUBMED,2008,Leukemia,ONCOGENIC,0.008837044892188053
3880,1,Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.,PUBMED,2015,Haematologica,PROGNOSTIC,0.008837044892188053
3882,1,"The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.",PUBMED,2011,Leuk Res,ONCOGENIC,0.008837044892188053
3883,1,SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.,PUBMED,2020,Genes Chromosomes Cancer,PREDICTIVE,0.008837044892188053
3884,1,t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.,PUBMED,2017,Acta Haematol,DIAGNOSTIC,0.008837044892188053
3885,1,The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1.,PUBMED,2008,Genes Chromosomes Cancer,ONCOGENIC,0.008837044892188053
3853,1,Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.,PUBMED,2017,Eur J Cancer,PREDICTIVE,0.008837044892188053
3854,1,Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer.,PUBMED,2018,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3856,1,Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study.,PUBMED,2010,Acta Neurol Scand,PREDISPOSING,0.008837044892188053
3857,1,Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene.,PUBMED,2004,Am J Hypertens,PREDISPOSING,0.008837044892188053
3858,1,Mosaicism in von Hippel-Lindau disease: an event important to recognize.,PUBMED,2007,J Cell Mol Med,PREDISPOSING,0.008837044892188053
3859,1,Functioning carotid paraganglioma in the von Hippel-Lindau syndrome.,PUBMED,1998,Am J Med Genet,PREDISPOSING,0.008837044892188053
3860,1,Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.,PUBMED,2008,Pathol Res Pract,PREDISPOSING,0.008837044892188053
3861,1,Incidence of von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998.,PUBMED,2001,Acta Neurochir (Wien),PREDISPOSING,0.008837044892188053
3917,1,Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas.,PUBMED,1997,Am J Clin Pathol,PREDISPOSING,0.008837044892188053
3918,1,Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions.,PUBMED,2009,Hum Reprod,PREDISPOSING,0.008837044892188053
3920,1,The Highly Recurrent PP2A AŒ±-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.,PUBMED,2019,Cancer Res,FUNCTIONAL,0.008837044892188053
3927,1,"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.",PUBMED,2012,Nat Genet,FUNCTIONAL,0.008837044892188053
3936,1,"Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML.",PUBMED,2020,Invest New Drugs,PREDICTIVE,0.008837044892188053
3943,1,Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,PUBMED,2017,Cancer,ONCOGENIC,0.008837044892188053
3944,1,Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor.,PUBMED,2019,Cold Spring Harb Mol Case Stud,ONCOGENIC,0.008837044892188053
3948,1,Revealing the impact of structural variants in multiple myeloma.,PUBMED,2020,Blood Cancer Discov,ONCOGENIC,0.008837044892188053
621,1,The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer.,PUBMED,2013,Int J Cancer,PREDICTIVE,0.008837044892188053
622,1,PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.,PUBMED,2013,J Cancer Res Clin Oncol,PREDICTIVE,0.008837044892188053
624,1,Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.,PUBMED,2013,Cancer Lett,PREDICTIVE,0.008837044892188053
625,1,"A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.",PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
3899,1,Functional characterization of a novel somatic oncogenic mutation of PIK3CB.,PUBMED,2017,Signal Transduct Target Ther,FUNCTIONAL,0.008837044892188053
3900,1,Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.,PUBMED,2012,Hum Mutat,FUNCTIONAL,0.008837044892188053
3901,1,The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.,PUBMED,2018,Cancer Cell,FUNCTIONAL,0.008837044892188053
3913,1,Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.,PUBMED,2015,Cancer,PREDICTIVE,0.008837044892188053
613,1,Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.,PUBMED,2013,Ann Surg Oncol,PREDICTIVE,0.008837044892188053
614,1,Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.,PUBMED,2011,Lung Cancer,PREDICTIVE,0.008837044892188053
615,1,A practical approach to aid physician interpretation of clinically actionable predictive biomarker results in a multi-platform tumor profiling service.,PUBMED,2014,Front Pharmacol,PREDICTIVE,0.008837044892188053
616,1,Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.,PUBMED,2004,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
617,1,Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.,PUBMED,2010,Bone Marrow Transplant,PREDICTIVE,0.008837044892188053
618,1,Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: a fluorescent in situ hybridization study.,PUBMED,2008,Clin Cancer Res,PREDICTIVE,0.008837044892188053
619,1,Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.,PUBMED,2009,BMC Cancer,PREDICTIVE,0.008837044892188053
620,1,Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.,PUBMED,2013,Am J Pathol,PREDICTIVE,0.008837044892188053
604,1,Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.,PUBMED,2013,Digestion,PREDICTIVE,0.008837044892188053
605,1,Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.,PUBMED,2013,Clin Cancer Res,PREDICTIVE,0.008837044892188053
606,1,EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.,PUBMED,2013,PLoS One,PREDICTIVE,0.008837044892188053
608,1,TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.,PUBMED,2013,Tumour Biol,PREDICTIVE,0.008837044892188053
609,1,Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells.,PUBMED,2013,J Clin Invest,PREDICTIVE,0.008837044892188053
610,1,Thymidylate synthase gene copy number as a predictive marker for response to pemetrexed treatment of lung adenocarcinoma.,PUBMED,2013,Anticancer Res,PREDICTIVE,0.008837044892188053
611,1,Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.,PUBMED,2013,Cell Oncol (Dordr),PREDICTIVE,0.008837044892188053
612,1,Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.,PUBMED,2013,Med Oncol,PREDICTIVE,0.008837044892188053
3994,1,Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.,PUBMED,2015,Leukemia,PREDICTIVE,0.008837044892188053
3996,1,BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.,PUBMED,2013,Oncotarget,PREDICTIVE,0.008837044892188053
3997,1,Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination.,PUBMED,2018,Science,FUNCTIONAL,0.008837044892188053
562,1,Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer.,PUBMED,2015,BMC Pulm Med,PREDICTIVE,0.008837044892188053
563,1,TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
564,1,"Response to Crizotinib Observed in Lung Adenocarcinoma with MET Copy Number Gain but without a High-Level MET/CEP7 Ratio, MET Overexpression, or Exon 14 Splicing Mutations.",PUBMED,2016,J Thorac Oncol,PREDICTIVE,0.008837044892188053
569,1,Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
571,1,EGFR gene copy number as a predictive biomarker for resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer treatment: a meta-analysis.,PUBMED,2014,Chin J Cancer Res,PREDICTIVE,0.008837044892188053
3982,1,Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.,PUBMED,2014,Clin Breast Cancer,PREDICTIVE,0.008837044892188053
3984,1,"Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.",PUBMED,2021,Lancet Oncol,PREDICTIVE,0.008837044892188053
3987,1,Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.,PUBMED,2013,Br J Cancer,PREDICTIVE,0.008837044892188053
3989,1,"Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.",PUBMED,2013,Lancet Oncol,PREDICTIVE,0.008837044892188053
3990,1,Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.,PUBMED,2017,Eur J Cancer,PREDICTIVE,0.008837044892188053
3991,1,AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
3992,1,Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
3993,1,Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma.,PUBMED,2019,Cancers (Basel),PREDICTIVE,0.008837044892188053
3962,1,TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.,PUBMED,2015,Oncotarget,DIAGNOSTIC,0.008837044892188053
3963,1,"Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.",PUBMED,2016,Oncotarget,DIAGNOSTIC,0.008837044892188053
3964,1,Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors.,PUBMED,2017,Oncogenesis,PREDICTIVE,0.008837044892188053
3967,1,Independent segregation of von Hippel-Lindau disease and cerebral cavernomas.,PUBMED,1997,J Neurol Neurosurg Psychiatry,PREDISPOSING,0.008837044892188053
3970,1,Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.,PUBMED,2005,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
3976,1,A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.,PUBMED,2011,Leuk Res,FUNCTIONAL,0.008837044892188053
3977,1,"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
3981,1,"VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.",PUBMED,2008,Br J Cancer,PREDICTIVE,0.008837044892188053
3950,1,VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis.,PUBMED,2015,Breast Cancer Res Treat,PREDICTIVE,0.008837044892188053
3951,1,Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
3952,1,Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia.,PUBMED,2018,J Hematol Oncol,ONCOGENIC,0.008837044892188053
3953,1,Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo.,PUBMED,2019,Front Pharmacol,PREDICTIVE,0.008837044892188053
3954,1,FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.,PUBMED,2018,Cancer Lett,PREDICTIVE,0.008837044892188053
3955,1,Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival.,PUBMED,2021,Appl Immunohistochem Mol Morphol,PROGNOSTIC,0.008837044892188053
3957,1,Loss of Atrx sensitizes cells to DNA damaging agents through p53-mediated death pathways.,PUBMED,2012,PLoS One,PREDICTIVE,0.008837044892188053
3958,1,HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.,PUBMED,2008,Int J Oncol,DIAGNOSTIC,0.008837044892188053
4023,1,Bilateral adrenal incidentalomas: a case report and review of diagnostic challenges.,PUBMED,2013,Case Rep Endocrinol,PREDISPOSING,0.008837044892188053
4024,1,Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.,PUBMED,2015,PLoS One,PROGNOSTIC,0.008837044892188053
4025,1,Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.,PUBMED,2018,BMC Cancer,PROGNOSTIC,0.008837044892188053
4028,1,"Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.",PUBMED,2004,J Neurosurg,PREDISPOSING,0.008837044892188053
4030,1,"Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.",PUBMED,2021,Lancet Oncol,PREDICTIVE,0.008837044892188053
4031,1,Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.,PUBMED,2021,Clin Cancer Res,ONCOGENIC,0.008837044892188053
4032,1,Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.,PUBMED,2018,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
4033,1,The mutationally activated Met receptor mediates motility and metastasis.,PUBMED,1998,Proc Natl Acad Sci U S A,FUNCTIONAL,0.008837044892188053
593,1,Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion.,PUBMED,2015,Anticancer Res,PREDICTIVE,0.008837044892188053
4011,1,Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).,PUBMED,2003,Hum Genet,PREDISPOSING,0.008837044892188053
4012,1,"Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas.",PUBMED,2009,Endocrine,PREDISPOSING,0.008837044892188053
4013,1,Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.,PUBMED,2014,Int J Clin Exp Pathol,PREDISPOSING,0.008837044892188053
4014,1,Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.,PUBMED,2009,Eur J Clin Invest,PREDISPOSING,0.008837044892188053
4015,1,Electronic clinical challenges and images in GI. Gastroenterology referral for retinal detachment.,PUBMED,2010,Gastroenterology,PREDISPOSING,0.008837044892188053
4017,1,A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).,PUBMED,2009,Haematologica,PREDICTIVE,0.008837044892188053
4021,1,Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.,PUBMED,2017,Sci Rep,PROGNOSTIC,0.008837044892188053
584,1,Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.,PUBMED,2014,Anticancer Drugs,PREDICTIVE,0.008837044892188053
585,1,Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis.,PUBMED,2014,J Transl Med,PREDICTIVE,0.008837044892188053
586,1,A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.,PUBMED,2014,Ann Oncol,PREDICTIVE,0.008837044892188053
587,1,The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.,PUBMED,2014,Cancer Res,PREDICTIVE,0.008837044892188053
588,1,Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.,PUBMED,2014,Med Oncol,PREDICTIVE,0.008837044892188053
589,1,TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial.,PUBMED,2014,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
590,1,Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
591,1,Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.,PUBMED,2014,Cell Cycle,PREDICTIVE,0.008837044892188053
572,1,"Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.",PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
573,1,Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.,PUBMED,2004,Br J Cancer,PREDICTIVE,0.008837044892188053
575,1,Activation of AR sensitizes breast carcinomas to NVP-BEZ235's therapeutic effect mediated by PTEN and KLLN upregulation.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
576,1,Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy.,PUBMED,2014,Oncotarget,PREDICTIVE,0.008837044892188053
579,1,PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.,PUBMED,2015,Oncology,PREDICTIVE,0.008837044892188053
580,1,HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.,PUBMED,2014,Oncotarget,PREDICTIVE,0.008837044892188053
581,1,UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespib.,PUBMED,2014,Cell Death Dis,PREDICTIVE,0.008837044892188053
583,1,Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.,PUBMED,2015,Cell Cycle,PREDICTIVE,0.008837044892188053
4076,1,NTRK1 fusion in glioblastoma multiforme.,PUBMED,2014,PLoS One,ONCOGENIC,0.008837044892188053
4078,1,Characterization of p53 mutants identified in human tumors with a missense mutation in the tetramerization domain.,PUBMED,1998,Int J Cancer,FUNCTIONAL,0.008837044892188053
4080,1,Sotorasib for Lung Cancers with KRAS p.G12C Mutation.,PUBMED,2021,N Engl J Med,PREDICTIVE,0.008837044892188053
4081,1,"Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
4082,1,Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.,PUBMED,2019,J Clin Oncol,PREDICTIVE,0.008837044892188053
4083,1,Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer.,PUBMED,2018,Eur Urol,PREDICTIVE,0.008837044892188053
4084,1,"Clinical factors associated with AR-V7 detection in ARMOR3-SV, a randomized trial of galeterone (Gal) vs enzalutamide (Enz) in men with AR-V7+ metastatic castration-resistant prostate cancer (mCRPC).",ASCO,2017,"J Clin Oncol 35, 2017 (suppl; abstr 5005)",PREDICTIVE,0.008837044892188053
4085,1,Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells.,PUBMED,2015,Eur Urol,PREDICTIVE,0.008837044892188053
4061,1,Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.,PUBMED,2015,Eur J Paediatr Neurol,PREDISPOSING,0.008837044892188053
4063,1,High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.,PUBMED,2013,J Med Genet,PREDISPOSING,0.008837044892188053
4066,1,CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.,PUBMED,2001,Gynecol Oncol,PREDICTIVE,0.008837044892188053
4067,1,"A germline MTOR mutation in Aboriginal Australian siblings with intellectual disability, dysmorphism, macrocephaly, and small thoraces.",PUBMED,2015,Am J Med Genet A,PREDICTIVE,0.008837044892188053
4068,1,VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma.,PUBMED,2018,BMC Cancer,PREDICTIVE,0.008837044892188053
4073,1,A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer.,PUBMED,2017,PLoS Genet,FUNCTIONAL,0.008837044892188053
4074,1,TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.,PUBMED,2002,Oncogene,FUNCTIONAL,0.008837044892188053
4075,1,Leukemogenic potency of the novel FLT3-N676K mutant.,PUBMED,2016,Ann Hematol,ONCOGENIC,0.008837044892188053
4047,1,Recurrent lobular capillary hemangiomas in a patient with neurofibromatosis type 1 (NF1) and von Hippel-Lindau syndrome (VHL).,PUBMED,2015,JAAD Case Rep,PREDISPOSING,0.008837044892188053
4048,1,Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells.,PUBMED,2020,Cancers (Basel),PREDICTIVE,0.008837044892188053
4050,1,Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.,PUBMED,2004,J Cancer Res Clin Oncol,PROGNOSTIC,0.008837044892188053
4051,1,CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.,PUBMED,2014,Diagn Pathol,PROGNOSTIC,0.008837044892188053
4052,1,CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients.,PUBMED,2020,Heliyon,PREDICTIVE,0.008837044892188053
4053,1,CD44 variant isoforms in head and neck squamous cell carcinoma progression.,PUBMED,2009,Laryngoscope,PROGNOSTIC,0.008837044892188053
4054,1,Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells.,PUBMED,2020,Cancers (Basel),PREDICTIVE,0.008837044892188053
4060,1,Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.,PUBMED,2017,Oncogene,FUNCTIONAL,0.008837044892188053
4034,1,Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.,PUBMED,2015,Pigment Cell Melanoma Res,PROGNOSTIC,0.008837044892188053
4035,1,CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis.,PUBMED,2015,Clin Res Hepatol Gastroenterol,PROGNOSTIC,0.008837044892188053
4036,1,CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis.,PUBMED,2016,Medicine (Baltimore),PROGNOSTIC,0.008837044892188053
4040,1,Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.,PUBMED,2010,Proc Natl Acad Sci U S A,FUNCTIONAL,0.008837044892188053
4041,1,von Hippel-Lindau disease and familial polyposis coli in the same family.,PUBMED,1996,Arch Ophthalmol,PREDISPOSING,0.008837044892188053
4043,1,Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity.,PUBMED,2013,Cancer Res,FUNCTIONAL,0.008837044892188053
4044,1,"Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.",PUBMED,2009,Hum Mutat,FUNCTIONAL,0.008837044892188053
4045,1,Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.,PUBMED,2017,Br J Cancer,PROGNOSTIC,0.008837044892188053
4112,1,"ERŒ≤1: characterization, prognosis, and evaluation of treatment strategies in ERŒ±-positive and -negative breast cancer.",PUBMED,2014,BMC Cancer,PROGNOSTIC,0.008837044892188053
4113,1,ERŒ≤1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.,PUBMED,2015,Breast Cancer Res Treat,PROGNOSTIC,0.008837044892188053
4114,1,ERŒ≤ splice variant expression in four large cohorts of human breast cancer patient tumors.,PUBMED,2014,Breast Cancer Res Treat,PROGNOSTIC,0.008837044892188053
4115,1,Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.,PUBMED,2019,BMC Cancer,PROGNOSTIC,0.008837044892188053
4116,1,A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.,PUBMED,2011,BMC Cancer,PROGNOSTIC,0.008837044892188053
4117,1,Full-length LGR5-positive cells have chemoresistant characteristics in colorectal cancer.,PUBMED,2016,Br J Cancer,PREDICTIVE,0.008837044892188053
4118,1,Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.,PUBMED,2015,Cancer Immunol Immunother,PREDICTIVE,0.008837044892188053
4119,1,A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.,PUBMED,2019,Cancer Immunol Immunother,PREDICTIVE,0.008837044892188053
4104,1,High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.,PUBMED,2020,Ann Surg Oncol,PROGNOSTIC,0.008837044892188053
4105,1,Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer.,PUBMED,2011,Int J Cancer,PROGNOSTIC,0.008837044892188053
4106,1,CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.,PUBMED,2014,Ann Surg Oncol,PROGNOSTIC,0.008837044892188053
4107,1,CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.,PUBMED,2017,J Surg Res,PROGNOSTIC,0.008837044892188053
4108,1,"Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.",PUBMED,2004,J Mol Endocrinol,PROGNOSTIC,0.008837044892188053
4109,1,Prognostic and predictive value of ERŒ≤1 and ERŒ≤2 in the Intergroup Exemestane Study (IES)-first results from PathIES‚Ä†.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
4110,1,High Estrogen Receptor Œ≤ Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.,PUBMED,2017,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
4111,1,"Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.",PUBMED,2010,Endocr Relat Cancer,PROGNOSTIC,0.008837044892188053
4094,1,AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel.,PUBMED,2019,Mol Oncol,PROGNOSTIC,0.008837044892188053
4095,1,TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4096,1,Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4097,1,Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.,PUBMED,2008,J Med Genet,FUNCTIONAL,0.008837044892188053
4098,1,"BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.",PUBMED,2018,Int J Mol Sci,PROGNOSTIC,0.008837044892188053
4100,1,Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.,PUBMED,2019,Int J Cancer,PROGNOSTIC,0.008837044892188053
4101,1,Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.,PUBMED,2018,BMC Bioinformatics,PROGNOSTIC,0.008837044892188053
4103,1,Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.,PUBMED,2010,Biol Pharm Bull,PREDICTIVE,0.008837044892188053
4086,1,Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.,PUBMED,2017,J Clin Oncol,PREDICTIVE,0.008837044892188053
4087,1,Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer.,PUBMED,2015,Eur Urol,PREDICTIVE,0.008837044892188053
4088,1,Detecting predictive androgen receptor modifications in circulating prostate cancer cells.,PUBMED,2019,Oncotarget,PREDICTIVE,0.008837044892188053
4089,1,KLF4K409Q-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment.,PUBMED,2020,Acta Neuropathol Commun,FUNCTIONAL,0.008837044892188053
4090,1,Genetic landscape of esophageal squamous cell carcinoma.,PUBMED,2014,Nat Genet,ONCOGENIC,0.008837044892188053
4091,1,Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.,PUBMED,2016,Cancer Discov,FUNCTIONAL,0.008837044892188053
4092,1,"A Phase Ib Study of Alpelisib (BYL719), a PI3KŒ±-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.",PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4093,1,Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.,PUBMED,2015,JAMA Oncol,PREDICTIVE,0.008837044892188053
4162,1,STAT5 contributes to interferon resistance of melanoma cells.,PUBMED,2005,Curr Biol,PREDICTIVE,0.008837044892188053
4163,1,Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study.,PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
4165,1,The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220.,PUBMED,2012,Haematologica,PREDICTIVE,0.008837044892188053
529,1,A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma.,PUBMED,2010,Cancer Cell,PREDICTIVE,0.008837044892188053
530,1,Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
531,1,Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.008837044892188053
532,1,Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.,PUBMED,2016,Target Oncol,PROGNOSTIC,0.008837044892188053
533,1,FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.,PUBMED,2015,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4149,1,Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer.,PUBMED,2020,Front Oncol,PREDISPOSING,0.008837044892188053
4150,1,Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer.,PUBMED,2020,Front Oncol,PREDISPOSING,0.008837044892188053
4153,1,A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.,PUBMED,2021,Cancer Res,FUNCTIONAL,0.008837044892188053
4154,1,High FGFR1-4 mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer.,PUBMED,2022,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4157,1,A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia.,PUBMED,2021,J Hematol Oncol,PREDICTIVE,0.008837044892188053
4158,1,RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.,PUBMED,2015,Leuk Lymphoma,DIAGNOSTIC,0.008837044892188053
4159,1,Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.,PUBMED,2017,Blood Adv,FUNCTIONAL,0.008837044892188053
4161,1,A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.,PUBMED,2018,Haematologica,PROGNOSTIC,0.008837044892188053
4135,1,Ratio of Autoantibodies of Tumor Suppressor AIMP2 and Its Oncogenic Variant Is Associated with Clinical Outcome in Lung Cancer.,PUBMED,2017,J Cancer,PROGNOSTIC,0.008837044892188053
4137,1,"The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population.",PUBMED,2011,J Clin Pathol,DIAGNOSTIC,0.008837044892188053
4138,1,Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
4139,1,Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.,PUBMED,2015,Cancer Discov,PREDICTIVE,0.008837044892188053
4140,1,The BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.,PUBMED,2014,Nat Med,PREDICTIVE,0.008837044892188053
4144,1,Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.,PUBMED,2016,Cytogenet Genome Res,DIAGNOSTIC,0.008837044892188053
4146,1,Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.,PUBMED,2012,Am J Clin Pathol,PROGNOSTIC,0.008837044892188053
4148,1,A functional dissection of PTEN N-terminus: implications in PTEN subcellular targeting and tumor suppressor activity.,PUBMED,2015,PLoS One,FUNCTIONAL,0.008837044892188053
4120,1,Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses.,PUBMED,2014,Cancer Immunol Res,PREDICTIVE,0.008837044892188053
4123,1,Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.,PUBMED,2012,J Biol Chem,FUNCTIONAL,0.008837044892188053
4124,1,"A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS Mutations.",PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4125,1,Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.,PUBMED,2021,J Clin Oncol,PREDICTIVE,0.008837044892188053
4128,1,The Novel C-terminal Truncated 90-kDa Isoform of Topoisomerase IIŒ± (TOP2Œ±/90) Is a Determinant of Etoposide Resistance in K562 Leukemia Cells via Heterodimerization with the TOP2Œ±/170 Isoform.,PUBMED,2018,Mol Pharmacol,PREDICTIVE,0.008837044892188053
4130,1,CRISPR/Cas9 Genome Editing of the Human Topoisomerase IIŒ± Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells.,PUBMED,2021,Mol Pharmacol,PREDICTIVE,0.008837044892188053
4133,1,The BRCA1-Œî11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.,PUBMED,2016,Cancer Res,PREDICTIVE,0.008837044892188053
4134,1,Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer.,PUBMED,2019,J Exp Med,PREDICTIVE,0.008837044892188053
4184,1,Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.,PUBMED,2019,Hemasphere,PREDICTIVE,0.008837044892188053
4187,1,How I treat double-hit lymphoma.,PUBMED,2017,Blood,PROGNOSTIC,0.008837044892188053
4188,1,"Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
4191,1,Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing.,PUBMED,2019,Front Genet,PREDISPOSING,0.008837044892188053
4192,1,A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.,PUBMED,2016,Mol Oncol,FUNCTIONAL,0.008837044892188053
4193,1,AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing.,PUBMED,2020,Cell Death Discov,PREDICTIVE,0.008837044892188053
4194,1,Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.,PUBMED,2016,Sci Rep,PREDICTIVE,0.008837044892188053
4195,1,Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.,PUBMED,2016,Int J Cancer,PREDICTIVE,0.008837044892188053
555,1,Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
557,1,Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.,PUBMED,2016,J Oral Pathol Med,PREDICTIVE,0.008837044892188053
559,1,Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib.,PUBMED,2015,Onco Targets Ther,PREDICTIVE,0.008837044892188053
560,1,Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.,PUBMED,2015,Oncotarget,PROGNOSTIC,0.008837044892188053
561,1,Caspase-8 expression is predictive of tumour response to death receptor 5 agonist antibody in Ewing's sarcoma.,PUBMED,2015,Br J Cancer,PREDICTIVE,0.008837044892188053
4170,1,Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.,PUBMED,2015,Ann Surg Oncol,PROGNOSTIC,0.008837044892188053
4171,1,Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with BRAF p.T599dup mutation.,PUBMED,2021,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
4174,1,H3 K27M Mutation in Gangliogliomas can be Associated with Poor Prognosis.,PUBMED,2017,Brain Pathol,DIAGNOSTIC,0.008837044892188053
546,1,WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.,PUBMED,2015,Sci Rep,PREDICTIVE,0.008837044892188053
547,1,The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.,PUBMED,2015,Br J Clin Pharmacol,PREDICTIVE,0.008837044892188053
548,1,Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer.,PUBMED,2015,Br J Cancer,PREDICTIVE,0.008837044892188053
549,1,Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.,PUBMED,2016,Oncogene,PREDICTIVE,0.008837044892188053
550,1,Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.,PUBMED,2015,Int J Clin Exp Pathol,PREDICTIVE,0.008837044892188053
552,1,Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4.,PUBMED,2015,J Proteome Res,PREDICTIVE,0.008837044892188053
553,1,The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.,PUBMED,2015,Neuro Oncol,PREDICTIVE,0.008837044892188053
554,1,TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.,PUBMED,2015,Endocr Relat Cancer,PREDICTIVE,0.008837044892188053
534,1,Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.,PUBMED,2015,Anticancer Res,PREDICTIVE,0.008837044892188053
536,1,Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.,PUBMED,2009,Cancer Res,PREDICTIVE,0.008837044892188053
538,1,p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.,PUBMED,2014,J Clin Oncol,PROGNOSTIC,0.008837044892188053
539,1,"Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.",PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
540,1,Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.,PUBMED,2015,Mol Clin Oncol,PREDICTIVE,0.008837044892188053
541,1,Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.,PUBMED,2015,PLoS One,PREDICTIVE,0.008837044892188053
542,1,Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer.,PUBMED,2015,Onco Targets Ther,PREDICTIVE,0.008837044892188053
545,1,"Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer.",PUBMED,2015,EBioMedicine,PREDICTIVE,0.008837044892188053
4246,1,COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients.,PUBMED,2018,Anticancer Res,PREDICTIVE,0.008837044892188053
4247,1,Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.,PUBMED,2013,Cell Rep,PREDICTIVE,0.008837044892188053
4251,1,Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.,PUBMED,2021,Haematologica,DIAGNOSTIC,0.008837044892188053
4253,1,G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL.,PUBMED,2022,Blood Adv,ONCOGENIC,0.008837044892188053
4259,1,A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).,PUBMED,2014,Neuro Oncol,PREDICTIVE,0.008837044892188053
4260,1,Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.,PUBMED,2016,Br J Cancer,PREDICTIVE,0.008837044892188053
4262,1,Gene symbol: VHL. Disease: pancreatic cancer.,PUBMED,2000,Hum Genet,PREDISPOSING,0.008837044892188053
4263,1,Gene symbol: VHL. Disease: Von-Hippel-Lindau syndrome.,PUBMED,2000,Hum Genet,PREDISPOSING,0.008837044892188053
4231,1,Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.,PUBMED,2022,N Engl J Med,PREDICTIVE,0.008837044892188053
4232,1,ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma.,PUBMED,2019,Commun Biol,PREDICTIVE,0.008837044892188053
4234,1,Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma.,PUBMED,2012,Gastroenterology,PREDICTIVE,0.008837044892188053
4235,1,ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.,PUBMED,2019,Gynecol Oncol,PREDICTIVE,0.008837044892188053
4241,1,HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma.,PUBMED,2020,Onco Targets Ther,PREDICTIVE,0.008837044892188053
4243,1,KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.,PUBMED,2016,Oncotarget,PREDICTIVE,0.008837044892188053
4244,1,"Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.",PUBMED,2017,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4245,1,Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.,PUBMED,2019,Gastroenterology,PREDICTIVE,0.008837044892188053
4215,1,"Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
4217,1,Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.,PUBMED,2016,Nat Genet,ONCOGENIC,0.008837044892188053
4219,1,Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).,PUBMED,2019,Cancer Genet,PROGNOSTIC,0.008837044892188053
4220,1,GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial.,PUBMED,2022,Hepatol Int,PROGNOSTIC,0.008837044892188053
4226,1,KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
4227,1,Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.,PUBMED,2006,Hum Mol Genet,ONCOGENIC,0.008837044892188053
4228,1,Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors.,PUBMED,2022,Cancer Res,PREDICTIVE,0.008837044892188053
4230,1,The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis.,PUBMED,2016,Mol Oncol,PREDICTIVE,0.008837044892188053
4196,1,AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.,PUBMED,2019,Drug Des Devel Ther,PREDICTIVE,0.008837044892188053
4197,1,The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.,PUBMED,2018,Cell Biochem Funct,PREDICTIVE,0.008837044892188053
4203,1,Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment.,PUBMED,2014,Cancer Cell,ONCOGENIC,0.008837044892188053
4205,1,ASPL-TFE3 Oncoprotein Regulates Cell Cycle Progression and Induces Cellular Senescence by Up-Regulating p21.,PUBMED,2016,Neoplasia,ONCOGENIC,0.008837044892188053
4206,1,Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.,PUBMED,2019,Front Immunol,PREDICTIVE,0.008837044892188053
4207,1,"Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.",PUBMED,2018,Lancet,PREDICTIVE,0.008837044892188053
4208,1,Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.,PUBMED,2022,J Clin Oncol,PREDICTIVE,0.008837044892188053
4214,1,"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.",PUBMED,2001,Oncogene,DIAGNOSTIC,0.008837044892188053
4296,1,Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.,PUBMED,2005,J Clin Oncol,PREDICTIVE,0.008837044892188053
4297,1,Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.,PUBMED,2013,Clin Sarcoma Res,PREDICTIVE,0.008837044892188053
4298,1,The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.,PUBMED,1999,Cancer Res,PREDICTIVE,0.008837044892188053
4299,1,Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.,PUBMED,2001,Int J Cancer,PREDICTIVE,0.008837044892188053
496,1,Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer.,PUBMED,2017,Oncotarget,PROGNOSTIC,0.008837044892188053
497,1,Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38.,PUBMED,2015,Autophagy,PREDICTIVE,0.008837044892188053
498,1,Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.,PUBMED,2015,Cancer Cell,PREDICTIVE,0.008837044892188053
499,1,Unique genomic profile of fibrolamellar hepatocellular carcinoma.,PUBMED,2015,Gastroenterology,DIAGNOSTIC,0.008837044892188053
4286,1,Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.,PUBMED,2022,N Engl J Med,PREDICTIVE,0.008837044892188053
4287,1,Molecular and clinicopathologic features of gliomas harboring NTRK fusions.,PUBMED,2020,Acta Neuropathol Commun,DIAGNOSTIC,0.008837044892188053
4288,1,Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.,PUBMED,2005,Cancer Immunol Immunother,PROGNOSTIC,0.008837044892188053
4290,1,ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4291,1,Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4292,1,Sustained Response to the Mitogen-Activated Extracellular Kinase Inhibitor Trametinib in a Spindle Cell Sarcoma Harboring a QKI-RAF1 Gene Fusion.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4293,1,Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4295,1,Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.,PUBMED,2009,Arch Dermatol,PREDICTIVE,0.008837044892188053
4274,1,The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.,PUBMED,2014,Oncotarget,FUNCTIONAL,0.008837044892188053
4275,1,Formation of a stable heterodimer between Smad2 and Smad4.,PUBMED,2001,J Biol Chem,FUNCTIONAL,0.008837044892188053
4280,1,The genomic landscape of schwannoma.,PUBMED,2016,Nat Genet,DIAGNOSTIC,0.008837044892188053
4281,1,"Case Report: A Unique Case of Pediatric Central Nervous System Embryonal Tumor Harboring the CIC-LEUTX Fusion, Germline NBN Variant and Somatic TSC2 Mutation: Expanding the Spectrum of CIC-Rearranged Neoplasia.",PUBMED,2020,Front Oncol,DIAGNOSTIC,0.008837044892188053
4282,1,"Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",PUBMED,2021,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
4283,1,Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.,PUBMED,2019,Nat Med,FUNCTIONAL,0.008837044892188053
4284,1,"Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans.",PUBMED,2005,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
4285,1,Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans.,PUBMED,2007,Mod Pathol,ONCOGENIC,0.008837044892188053
4264,1,Familial pheochromocytoma due to mutant von Hippel-Lindau disease gene.,PUBMED,1997,Arch Intern Med,PREDISPOSING,0.008837044892188053
4265,1,Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors.,PUBMED,2015,Endocr Relat Cancer,PREDICTIVE,0.008837044892188053
4266,1,Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.,PUBMED,2011,Proc Natl Acad Sci U S A,DIAGNOSTIC,0.008837044892188053
4268,1,The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.,PUBMED,2009,J Biol Chem,FUNCTIONAL,0.008837044892188053
4269,1,Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.,PUBMED,2007,Cancer Lett,FUNCTIONAL,0.008837044892188053
4270,1,A novel 3' splice site recognition by the two zinc fingers in the U2AF small subunit.,PUBMED,2015,Genes Dev,FUNCTIONAL,0.008837044892188053
4272,1,The Application of Digital Design Combined with 3D Printing Technology in Skin Flap Transplantation for Fingertip Defects during the COVID-19 Epidemic.,PUBMED,2021,Biomed Res Int,PREDICTIVE,0.008837044892188053
4273,1,Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.,PUBMED,2013,Hum Mutat,FUNCTIONAL,0.008837044892188053
4310,1,Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.,PUBMED,2020,Leuk Res,ONCOGENIC,0.008837044892188053
4311,1,Clinical features of DDX41 mutation-related diseases: a systematic review with individual patient data.,PUBMED,2021,Ther Adv Hematol,ONCOGENIC,0.008837044892188053
4312,1,Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12).,PUBMED,1988,Hum Genet,PREDISPOSING,0.008837044892188053
4313,1,Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas.,PUBMED,1989,Int J Cancer,PREDISPOSING,0.008837044892188053
4314,1,Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population.,PUBMED,2017,Onco Targets Ther,PROGNOSTIC,0.008837044892188053
4315,1,"Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan.",PUBMED,2014,J Gastroenterol Hepatol,PROGNOSTIC,0.008837044892188053
4316,1,Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling.,PUBMED,2021,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4317,1,Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 Fusion.,PUBMED,2021,Oncologist,PREDICTIVE,0.008837044892188053
4300,1,Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.,PUBMED,2010,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4302,1,COSMIC: the Catalogue Of Somatic Mutations In Cancer.,PUBMED,2019,Nucleic Acids Res,ONCOGENIC,0.008837044892188053
4303,1,Myeloid neoplasms with germline DDX41 mutation.,PUBMED,2017,Int J Hematol,ONCOGENIC,0.008837044892188053
4304,1,DDX41-related myeloid neoplasia.,PUBMED,2017,Semin Hematol,PREDISPOSING,0.008837044892188053
4305,1,A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report.,PUBMED,2022,BMC Med Genomics,PREDISPOSING,0.008837044892188053
4306,1,Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.,PUBMED,2021,Br J Haematol,ONCOGENIC,0.008837044892188053
4308,1,Germline DDX41 mutations define a significant entity within adult MDS/AML patients.,PUBMED,2019,Blood,ONCOGENIC,0.008837044892188053
4309,1,Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.,PUBMED,2020,Front Oncol,ONCOGENIC,0.008837044892188053
516,1,"Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.",PUBMED,2015,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
517,1,Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.,PUBMED,2011,Cancer Cell,PREDICTIVE,0.008837044892188053
518,1,Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab.,PUBMED,2011,Sci Transl Med,PREDICTIVE,0.008837044892188053
519,1,An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells.,PUBMED,2010,Cancer Cell,PREDICTIVE,0.008837044892188053
520,1,Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancer.,PUBMED,2013,Sci Transl Med,PREDICTIVE,0.008837044892188053
526,1,Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.,PUBMED,2012,Cancer Discov,PREDICTIVE,0.008837044892188053
527,1,FGFR1 is an adverse outcome indicator for luminal A breast cancers.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
528,1,"Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.",PUBMED,2014,Nat Med,PREDICTIVE,0.008837044892188053
501,1,Human papillomavirus and survival of patients with oropharyngeal cancer.,PUBMED,2010,N Engl J Med,PROGNOSTIC,0.008837044892188053
502,1,Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.,PUBMED,2016,J Clin Oncol,PREDICTIVE,0.008837044892188053
503,1,Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.,PUBMED,2008,PLoS One,PREDICTIVE,0.008837044892188053
504,1,"Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer.",PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
505,1,Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.008837044892188053
509,1,Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.,PUBMED,2009,Nat Genet,PREDICTIVE,0.008837044892188053
510,1,"Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.",PUBMED,2015,Int J Cancer,PREDICTIVE,0.008837044892188053
515,1,"Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.",PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
4370,1,"Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.",PUBMED,2020,Brain Pathol,DIAGNOSTIC,0.008837044892188053
4371,1,More than It Meets the Eye! Vision Loss as a Presenting Symptom of von Hippel-Lindau Disease.,PUBMED,2020,J Pediatr Neurosci,PREDISPOSING,0.008837044892188053
4372,1,TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.,PUBMED,2022,Curr Oncol,PREDICTIVE,0.008837044892188053
464,1,Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.,PUBMED,2012,Int J Oncol,PREDICTIVE,0.008837044892188053
466,1,Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors.,PUBMED,2015,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
467,1,Inhibition of PI3KŒ≤ signaling with AZD8186 inhibits growth of PTEN-deficient breast and prostate tumors alone and in combination with docetaxel.,PUBMED,2015,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
469,1,Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.,PUBMED,2015,Cancer Chemother Pharmacol,PREDICTIVE,0.008837044892188053
470,1,Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer.,PUBMED,2015,Ann Oncol,PREDICTIVE,0.008837044892188053
4359,1,Functional Analysis of Cancer-Associated DNA Polymerase Œµ Variants in Saccharomyces cerevisiae.,PUBMED,2018,G3 (Bethesda),FUNCTIONAL,0.008837044892188053
4362,1,A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.,PUBMED,2017,Cancer Res,ONCOGENIC,0.008837044892188053
4363,1,The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.,PUBMED,2012,Cancer Discov,DIAGNOSTIC,0.008837044892188053
4364,1,Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation.,PUBMED,2013,Structure,FUNCTIONAL,0.008837044892188053
4365,1,Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.,PUBMED,2013,PLoS One,FUNCTIONAL,0.008837044892188053
4366,1,KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases.,PUBMED,2021,JCO Precis Oncol,PROGNOSTIC,0.008837044892188053
4367,1,Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile.,PUBMED,2018,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
4368,1,YES1 Is a Druggable Oncogenic Target in SCLC.,PUBMED,2022,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4339,1,TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.,PUBMED,2019,Am J Surg Pathol,PROGNOSTIC,0.008837044892188053
4341,1,Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.,PUBMED,2007,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4343,1,ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.,PUBMED,2021,Lung Cancer,ONCOGENIC,0.008837044892188053
4344,1,Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.,PUBMED,2005,Hum Mol Genet,FUNCTIONAL,0.008837044892188053
4346,1,EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review.,PUBMED,2022,Front Med (Lausanne),ONCOGENIC,0.008837044892188053
4347,1,Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature.,PUBMED,2023,J Clin Pathol,ONCOGENIC,0.008837044892188053
4357,1,Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome‚Äìassociated Sos1 mutation.,PUBMED,2010,J Clin Invest,FUNCTIONAL,0.008837044892188053
4358,1,Enhanced polymerase activity permits efficient synthesis by cancer-associated DNA polymerase œµ variants at low dNTP levels.,PUBMED,2022,Nucleic Acids Res,FUNCTIONAL,0.008837044892188053
4320,1,Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.,PUBMED,2020,Blood Adv,PREDICTIVE,0.008837044892188053
4321,1,Activation of FGF receptors by mutations in the transmembrane domain.,PUBMED,1997,Oncogene,FUNCTIONAL,0.008837044892188053
4323,1,The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.,PUBMED,2001,Blood,ONCOGENIC,0.008837044892188053
4327,1,Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells.,PUBMED,2000,J Bone Miner Res,FUNCTIONAL,0.008837044892188053
4331,1,Mechanism of FGF receptor dimerization and activation.,PUBMED,2016,Nat Commun,FUNCTIONAL,0.008837044892188053
4332,1,Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.,PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
4335,1,Familial nonsyndromic pheochromocytoma.,PUBMED,2006,Ann N Y Acad Sci,PREDISPOSING,0.008837044892188053
4336,1,"Physical basis behind achondroplasia, the most common form of human dwarfism.",PUBMED,2010,J Biol Chem,FUNCTIONAL,0.008837044892188053
4395,1,Lost in translation: returning germline genetic results in genome-scale cancer research.,PUBMED,2017,Genome Med,PREDISPOSING,0.008837044892188053
4396,1,Next-generation sequencing in familial breast cancer patients from Lebanon.,PUBMED,2017,BMC Med Genomics,PREDISPOSING,0.008837044892188053
4399,1,Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation.,PUBMED,2017,Endocr Relat Cancer,PREDISPOSING,0.008837044892188053
4401,1,TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes.,PUBMED,2016,Sci Rep,PREDISPOSING,0.008837044892188053
4403,1,"Synchronous and multiple renal cell carcinoma, clear cell and papillary: An approach to clinically significant genetic abnormalities.",PUBMED,2020,Int Braz J Urol,PREDISPOSING,0.008837044892188053
4405,1,Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.,PUBMED,2022,Ann Oncol,PREDICTIVE,0.008837044892188053
4406,1,"Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab.",PUBMED,2020,Case Rep Oncol,PREDICTIVE,0.008837044892188053
4407,1,Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.,PUBMED,2022,Lab Invest,PREDICTIVE,0.008837044892188053
4379,1,Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations.,PUBMED,2020,Kidney Int Rep,PREDISPOSING,0.008837044892188053
4380,1,Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.,PUBMED,2020,Biomed Res Int,PREDISPOSING,0.008837044892188053
4381,1,Robotic adrenalectomy in the pediatric population: initial experience case series from a tertiary center.,PUBMED,2020,BMC Urol,PREDISPOSING,0.008837044892188053
4382,1,Targeted sequencing of crucial cancer causing genes of breast cancer in Saudi patients.,PUBMED,2020,Saudi J Biol Sci,PREDISPOSING,0.008837044892188053
4383,1,Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?,PUBMED,2020,BMJ Case Rep,PREDISPOSING,0.008837044892188053
4388,1,Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting.,PUBMED,2020,J Med Genet,PREDISPOSING,0.008837044892188053
4390,1,VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3Œ≤ signaling.,PUBMED,2020,J Exp Clin Cancer Res,PREDISPOSING,0.008837044892188053
4393,1,SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice.,PUBMED,2019,Sci Rep,PREDISPOSING,0.008837044892188053
484,1,MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor.,PUBMED,2015,Lung Cancer,PREDICTIVE,0.008837044892188053
485,1,Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer.,PUBMED,2015,Oncotarget,PREDICTIVE,0.008837044892188053
486,1,Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.,PUBMED,2016,Cancer Res Treat,PREDICTIVE,0.008837044892188053
487,1,Response to Idelalisib in a Patient with Stage IV Merkel-Cell Carcinoma.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
489,1,Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.,PUBMED,2015,Int J Clin Exp Pathol,PROGNOSTIC,0.008837044892188053
491,1,Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.,PUBMED,2015,Sci Transl Med,PREDICTIVE,0.008837044892188053
492,1,Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.,PUBMED,2009,Science,PREDICTIVE,0.008837044892188053
4373,1,Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel-Lindau Disease.,PUBMED,2021,Gastroenterology,PREDISPOSING,0.008837044892188053
471,1,Convergent loss of PTEN leads to clinical resistance to a PI(3)KŒ± inhibitor.,PUBMED,2015,Nature,PREDICTIVE,0.008837044892188053
474,1,Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.,PUBMED,2015,Cancer Biol Ther,PREDICTIVE,0.008837044892188053
477,1,Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
479,1,Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
480,1,New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.,PUBMED,2015,Nat Chem Biol,PREDICTIVE,0.008837044892188053
481,1,MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.,PUBMED,2007,Science,PREDICTIVE,0.008837044892188053
482,1,Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.,PUBMED,2016,Tumour Biol,PREDICTIVE,0.008837044892188053
483,1,"Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.",PUBMED,2011,J Thorac Oncol,PREDICTIVE,0.008837044892188053
429,1,Influence of MDR1 gene codon 3435 polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancer.,PUBMED,2011,Asian Pac J Cancer Prev,PREDICTIVE,0.008837044892188053
430,1,Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.,PUBMED,2009,Pharmacogenomics J,PREDICTIVE,0.008837044892188053
431,1,Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
432,1,UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.,PUBMED,2010,Br J Cancer,PREDICTIVE,0.008837044892188053
433,1,LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.,PUBMED,2012,Cancer Res,PREDICTIVE,0.008837044892188053
434,1,Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.,PUBMED,2010,Sci Transl Med,PREDICTIVE,0.008837044892188053
435,1,"FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.",PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
436,1,Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.,PUBMED,2013,J Clin Oncol,PROGNOSTIC,0.008837044892188053
4443,1,A Case of Von Hippel-Lindau Disease with Bilateral Pheochromocytoma and Ectopic Hypersecretion of Intact Parathyroid Hormone in an Adolescent Girl.,PUBMED,2020,Case Rep Endocrinol,PREDISPOSING,0.008837044892188053
4444,1,"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.",PUBMED,2006,J Biol Chem,FUNCTIONAL,0.008837044892188053
4446,1,Gefitinib Combined with Cetuximab for the Treatment of Lung Adenocarcinoma Harboring the EGFR-Intergenic Region (SEC61G) Fusion and EGFR Amplification.,PUBMED,2021,Oncologist,PREDICTIVE,0.008837044892188053
4447,1,A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3-SCAPER gene fusion.,PUBMED,2020,J Cutan Pathol,ONCOGENIC,0.008837044892188053
4448,1,"Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients.",PUBMED,2020,Ann Oncol,ONCOGENIC,0.008837044892188053
426,1,"Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.",PUBMED,2012,Gynecol Oncol,PROGNOSTIC,0.008837044892188053
427,1,Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.,PUBMED,2012,J Thorac Oncol,PROGNOSTIC,0.008837044892188053
428,1,mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4429,1,Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case report.,PUBMED,2011,Urol Oncol,PREDISPOSING,0.008837044892188053
4430,1,Germline VHL Mutation Discovered in Association with EGFR-Positive Lung Cancer and Metachronous Hepatocellular Carcinoma: A Case Report.,PUBMED,2021,Case Rep Oncol,PREDISPOSING,0.008837044892188053
4432,1,Clinical and Laboratory Characteristics of a Large Iranian Kindred Afflicted with Von Hippel Lindau Disease.,PUBMED,2021,Int J Endocrinol Metab,PREDISPOSING,0.008837044892188053
4434,1,A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.,PUBMED,2022,Nat Cancer,PREDICTIVE,0.008837044892188053
4435,1,Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review.,PUBMED,2021,Front Oncol,PREDISPOSING,0.008837044892188053
4437,1,Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient.,PUBMED,2021,Bol Med Hosp Infant Mex,PREDISPOSING,0.008837044892188053
4440,1,"Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial.",PUBMED,2021,Lancet,PREDICTIVE,0.008837044892188053
4441,1,Anorexia as the first clinical manifestation of von Hippel-Lindau syndrome.,PUBMED,2020,Mol Clin Oncol,PREDISPOSING,0.008837044892188053
4411,1,"High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.",PUBMED,2020,Brain Pathol,DIAGNOSTIC,0.008837044892188053
4413,1,Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4415,1,A long-term survivor of metachronous liver metastases of pancreatic serous cystic neoplasm associated with von Hippel-Lindau disease.,PUBMED,2021,Surg Case Rep,PREDISPOSING,0.008837044892188053
4418,1,Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma.,PUBMED,2022,Cancer Res,PREDICTIVE,0.008837044892188053
4420,1,Novel deletion of exon 3 in TYR¬†gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations.,PUBMED,2022,BMC Med Genomics,DIAGNOSTIC,0.008837044892188053
4421,1,Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas.,PUBMED,2005,Int J Cancer,FUNCTIONAL,0.008837044892188053
4422,1,Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.,PUBMED,2018,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
4428,1,Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype-phenotype correlation and gene therapy perspective.,PUBMED,2021,Cancer Cell Int,PREDISPOSING,0.008837044892188053
4464,1,Novel gene mutation in von Hippel-Lindau disease - a report of two cases.,PUBMED,2019,BMC Med Genet,PREDISPOSING,0.008837044892188053
4465,1,Overexpression of EGFR and TGFŒ± in von Hippel-Lindau-Related Central Nervous System Hemangioblastomas.,PUBMED,2020,Front Oncol,PREDISPOSING,0.008837044892188053
4467,1,Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.,PUBMED,2018,Cell Rep,ONCOGENIC,0.008837044892188053
4468,1,Pediatric pheochromocytoma in association with Von Hippel-Lindau disease: Focus on screening strategies.,PUBMED,2020,Arch Pediatr,PREDISPOSING,0.008837044892188053
4469,1,Familial multiple sclerosis in patients with Von Hippel-Lindau disease.,PUBMED,2022,BMC Neurol,PREDISPOSING,0.008837044892188053
4472,1,Intravitreal Triamcinolone Acetonide in Von Hippel-Lindau Patient with Novel Mutation.,PUBMED,2020,Middle East Afr J Ophthalmol,PREDISPOSING,0.008837044892188053
4474,1,Biochemically normal adrenal pheochromocytoma following extensive central necrosis in a child with von Hippel-Lindau (VHL) gene mutation.,PUBMED,2021,BMJ Case Rep,PREDISPOSING,0.008837044892188053
4476,1,Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings.,PUBMED,2022,Fam Cancer,PREDISPOSING,0.008837044892188053
4449,1,Neurotrophic receptor tyrosine kinase (NTRK) fusions and their role in cancer.,PUBMED,2020,Cancer Cytopathol,ONCOGENIC,0.008837044892188053
4450,1,Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.,PUBMED,2017,Cancer Res,PREDICTIVE,0.008837044892188053
4452,1,ISOLATED PARAGANGLIOMA IN A PATIENT WITH VHL P.L163F MUTATION.,PUBMED,2020,AACE Clin Case Rep,PREDISPOSING,0.008837044892188053
4453,1,"Case report: a synonymous VHL mutation (c.414A‚Äâ>‚ÄâG, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.",PUBMED,2020,BMC Med Genet,PREDISPOSING,0.008837044892188053
4455,1,"von Hippel-Lindau Syndrome: Genetic Study of Case With a Rare Pathogenic Variant With Optic Nerve Hemangioblastoma, a Rare Phenotypic Expression.",PUBMED,2020,Front Oncol,PREDISPOSING,0.008837044892188053
4456,1,Clear cell chondrosarcoma in Von Hippel-Lindau disease.,PUBMED,2020,Fam Cancer,PREDISPOSING,0.008837044892188053
4460,1,Identification of a Novel Icotinib-Sensitive EGFR-SEPTIN14 Fusion Variant in Lung Adenocarcinoma by¬†Next-Generation Sequencing.,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4461,1,Detection of EGFR-SEPT14 fusion in cell-free DNA of a patient with advanced gastric cancer: A case report.,PUBMED,2021,World J Clin Cases,ONCOGENIC,0.008837044892188053
451,1,Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: analysis of data from the EXTREME and CRYSTAL studies.,PUBMED,2013,Eur J Cancer,PREDICTIVE,0.008837044892188053
452,1,EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.,PUBMED,2012,Lancet Oncol,PREDICTIVE,0.008837044892188053
453,1,Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.,PUBMED,2014,Ann Oncol,PREDICTIVE,0.008837044892188053
454,1,Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.,PUBMED,2014,Ann Oncol,PROGNOSTIC,0.008837044892188053
456,1,Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.,PUBMED,2014,Cell Death Dis,PREDICTIVE,0.008837044892188053
459,1,Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.,PUBMED,2015,Onco Targets Ther,PROGNOSTIC,0.008837044892188053
460,1,PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.,PUBMED,2015,PLoS One,PROGNOSTIC,0.008837044892188053
461,1,Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.,PUBMED,2016,Oncotarget,PROGNOSTIC,0.008837044892188053
437,1,FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.,PUBMED,2014,Virchows Arch,PROGNOSTIC,0.008837044892188053
438,1,Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.,PUBMED,2013,Lung Cancer,PROGNOSTIC,0.008837044892188053
439,1,Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.,PUBMED,2014,PLoS One,PROGNOSTIC,0.008837044892188053
440,1,Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.,PUBMED,2011,PLoS One,PREDICTIVE,0.008837044892188053
441,1,FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.,PUBMED,2015,Lung Cancer,PROGNOSTIC,0.008837044892188053
448,1,Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence.,PUBMED,2011,Cancer Discov,PREDICTIVE,0.008837044892188053
449,1,ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
450,1,Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.,PUBMED,2011,Ann Oncol,PREDICTIVE,0.008837044892188053
4525,1,MET 14 Deletion in Sarcomatoid Non-Small-Cell Lung Cancer Detected by Next-Generation Sequencing and Successfully Treated with a MET Inhibitor.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4529,1,Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity.,PUBMED,2014,Oncotarget,FUNCTIONAL,0.008837044892188053
4532,1,"EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains.",PUBMED,2019,Nat Genet,PREDICTIVE,0.008837044892188053
387,1,IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.,PUBMED,2014,Blood,PROGNOSTIC,0.008837044892188053
388,1,IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
389,1,IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.,PUBMED,2010,Leukemia,PROGNOSTIC,0.008837044892188053
390,1,IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.,PUBMED,2015,Blood,PROGNOSTIC,0.008837044892188053
391,1,IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.,PUBMED,2012,Blood,DIAGNOSTIC,0.008837044892188053
4507,1,Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
4508,1,EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.,PUBMED,2022,Lung Cancer,PREDICTIVE,0.008837044892188053
4509,1,Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma.,PUBMED,2022,J Clin Invest,PREDICTIVE,0.008837044892188053
4511,1,Somatic mutations lead to an oncogenic deletion of met in lung cancer.,PUBMED,2006,Cancer Res,ONCOGENIC,0.008837044892188053
4513,1,c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.,PUBMED,2003,Cancer Res,ONCOGENIC,0.008837044892188053
4514,1,Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.,PUBMED,2005,Cancer Res,DIAGNOSTIC,0.008837044892188053
4522,1,A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case Report.,PUBMED,2021,Onco Targets Ther,PREDICTIVE,0.008837044892188053
4523,1,MET-Mutated NSCLC with Major Response to Crizotinib.,PUBMED,2015,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4492,1,Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.,PUBMED,2014,PLoS One,PREDICTIVE,0.008837044892188053
4494,1,Complete remission in leptomeningeal metastasis of NSCLC with rare EGFR-SEPT14 fusion treated with osimertinib combined with intrathecal chemotherapy with pemetrexed.,PUBMED,2022,Anticancer Drugs,ONCOGENIC,0.008837044892188053
4499,1,Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.,PUBMED,2016,Blood,FUNCTIONAL,0.008837044892188053
4500,1,Classification and Personalized Prognosis in Myeloproliferative Neoplasms.,PUBMED,2018,N Engl J Med,ONCOGENIC,0.008837044892188053
4501,1,Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.,PUBMED,2016,Blood,FUNCTIONAL,0.008837044892188053
4502,1,VHL mosaicism: the added value of multi-tissue analysis.,PUBMED,2022,NPJ Genom Med,PREDISPOSING,0.008837044892188053
4504,1,Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).,PUBMED,2016,Ann Surg Oncol,PREDICTIVE,0.008837044892188053
4505,1,Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.,PUBMED,2019,Mod Pathol,ONCOGENIC,0.008837044892188053
4477,1,Bilateral Scrotal Masses as a Clue to Diagnosis of Genetic Disease.,PUBMED,2020,Am J Med Sci,PREDISPOSING,0.008837044892188053
4478,1,Arterial Hypertension in a 10-Year-Old Girl.,PUBMED,2021,Am J Kidney Dis,PREDISPOSING,0.008837044892188053
4480,1,Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors.,PUBMED,2020,Neoplasma,PREDISPOSING,0.008837044892188053
4481,1,Sinonasal renal cell-like adenocarcinoma arising in von Hippel Lindau (VHL) syndrome.,PUBMED,2022,Oral Oncol,PREDISPOSING,0.008837044892188053
4482,1,Vestibular Function in Children With Von Hippel-Lindau Disease.,PUBMED,2021,J Int Adv Otol,PREDISPOSING,0.008837044892188053
4483,1,Von Hippel-Lindau syndrome and renal tumours: radiological diagnostic and treatment options. A case report and literature review.,PUBMED,2020,Acta Med Litu,PREDISPOSING,0.008837044892188053
4490,1,Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.,PUBMED,2020,Medicine (Baltimore),PREDICTIVE,0.008837044892188053
4491,1,A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau.,PUBMED,2022,J Med Genet,PREDISPOSING,0.008837044892188053
4543,1,MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.,PUBMED,2016,Nat Genet,DIAGNOSTIC,0.008837044892188053
4545,1,Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4546,1,Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4547,1,Refractory infantile high-grade glioma containing TRK-fusion responds to larotrectinib.,PUBMED,2021,Pediatr Blood Cancer,PREDICTIVE,0.008837044892188053
4549,1,Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.,PUBMED,2021,NPJ Precis Oncol,ONCOGENIC,0.008837044892188053
4553,1,EZH2 mutations are frequent and represent an early event in follicular lymphoma.,PUBMED,2013,Blood,DIAGNOSTIC,0.008837044892188053
4554,1,Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study.,PUBMED,2022,Clin Lymphoma Myeloma Leuk,PREDICTIVE,0.008837044892188053
4558,1,Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.,PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
422,1,A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.,PUBMED,2011,Oncogene,DIAGNOSTIC,0.008837044892188053
423,1,An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.,PUBMED,2012,Ann Oncol,PROGNOSTIC,0.008837044892188053
424,1,The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.,PUBMED,2009,Cancer Chemother Pharmacol,PREDICTIVE,0.008837044892188053
425,1,Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.,PUBMED,2010,Cancer Sci,PREDICTIVE,0.008837044892188053
4534,1,A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.,PUBMED,2023,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4535,1,"SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.",PUBMED,2013,Cancer Res,FUNCTIONAL,0.008837044892188053
4539,1,EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL.,PUBMED,2017,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
4542,1,Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.,PUBMED,2023,Cold Spring Harb Mol Case Stud,PREDICTIVE,0.008837044892188053
407,1,PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation.,PUBMED,2013,Br J Cancer,PREDICTIVE,0.008837044892188053
408,1,Rociletinib in EGFR-mutated non-small-cell lung cancer.,PUBMED,2015,N Engl J Med,PREDICTIVE,0.008837044892188053
410,1,Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.,PUBMED,2015,PLoS One,PREDICTIVE,0.008837044892188053
416,1,Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients.,PUBMED,2009,Lung Cancer,PREDICTIVE,0.008837044892188053
417,1,Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.,PUBMED,2014,Br J Cancer,PREDICTIVE,0.008837044892188053
418,1,Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.,PUBMED,2013,Tumour Biol,PREDICTIVE,0.008837044892188053
419,1,Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.,PUBMED,2013,Carcinogenesis,PREDICTIVE,0.008837044892188053
421,1,A common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy.,PUBMED,2015,Genes Dev,PROGNOSTIC,0.008837044892188053
392,1,Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.,PUBMED,2014,Blood,PROGNOSTIC,0.008837044892188053
400,1,Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors.,PUBMED,2008,Blood,PREDICTIVE,0.008837044892188053
401,1,Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.,PUBMED,2013,PLoS One,PREDICTIVE,0.008837044892188053
402,1,Resistant mutations in CML and Ph(+)ALL - role of ponatinib.,PUBMED,2014,Biologics,PREDICTIVE,0.008837044892188053
403,1,Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.,PUBMED,2011,J Clin Oncol,PROGNOSTIC,0.008837044892188053
404,1,Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.,PUBMED,2003,Oral Oncol,PROGNOSTIC,0.008837044892188053
405,1,The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.,PUBMED,2008,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
406,1,Therapeutic targeting of cancers with loss of PTEN function.,PUBMED,2014,Curr Drug Targets,PREDICTIVE,0.008837044892188053
4575,1,"Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.",PUBMED,2023,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
4578,1,Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.,PUBMED,2011,J Neurosurg,ONCOGENIC,0.008837044892188053
4580,1,Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.,PUBMED,2020,Neuro Oncol,DIAGNOSTIC,0.008837044892188053
4584,1,"First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.",PUBMED,2017,Lancet,PREDICTIVE,0.008837044892188053
4587,1,Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study.,PUBMED,2022,J Clin Oncol,PREDICTIVE,0.008837044892188053
4588,1,"Subgroup-specific structural variation across 1,000 medulloblastoma genomes.",PUBMED,2012,Nature,DIAGNOSTIC,0.008837044892188053
4589,1,Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
4592,1,A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.,PUBMED,2004,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
364,1,Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma.,PUBMED,2014,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
367,1,Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.,PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
375,1,Midline carcinoma of children and young adults with NUT rearrangement.,PUBMED,2004,J Clin Oncol,DIAGNOSTIC,0.008837044892188053
378,1,A patient with lung adenocarcinoma and RET fusion treated with vandetanib.,PUBMED,2013,J Thorac Oncol,PREDICTIVE,0.008837044892188053
386,1,Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.,PUBMED,2014,Cancer Res,PREDICTIVE,0.008837044892188053
4572,1,SMARCB1/INI1 inactivation in renal medullary carcinoma.,PUBMED,2012,Histopathology,DIAGNOSTIC,0.008837044892188053
4573,1,Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.,PUBMED,2017,Clin Genitourin Cancer,DIAGNOSTIC,0.008837044892188053
4574,1,"Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.",PUBMED,2020,Nat Med,ONCOGENIC,0.008837044892188053
327,1,Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.,PUBMED,2009,J Cell Mol Med,PROGNOSTIC,0.008837044892188053
328,1,Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.,PUBMED,2001,N Engl J Med,PREDICTIVE,0.008837044892188053
329,1,Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.,PUBMED,2005,J Clin Oncol,PREDICTIVE,0.008837044892188053
331,1,Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.,PUBMED,1999,Science,PREDISPOSING,0.008837044892188053
335,1,Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.,PUBMED,2012,Clin Cancer Res,PREDICTIVE,0.008837044892188053
341,1,Genetic predictors of MEK dependence in non-small cell lung cancer.,PUBMED,2008,Cancer Res,PREDICTIVE,0.008837044892188053
348,1,Targeted therapy for BRAFV600E malignant astrocytoma.,PUBMED,2011,Clin Cancer Res,PREDICTIVE,0.008837044892188053
360,1,Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.,PUBMED,2013,J Clin Oncol,PREDICTIVE,0.008837044892188053
4563,1,Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.,PUBMED,2018,J Thorac Oncol,PROGNOSTIC,0.008837044892188053
4565,1,Glioblastomas harboring gene fusions detected by next-generation sequencing.,PUBMED,2020,Brain Tumor Pathol,ONCOGENIC,0.008837044892188053
4566,1,CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data.,PUBMED,2020,Genome Biol,ONCOGENIC,0.008837044892188053
4569,1,Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.,PUBMED,2017,Oncotarget,PREDICTIVE,0.008837044892188053
4570,1,Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review.,PUBMED,2021,Front Oncol,PREDICTIVE,0.008837044892188053
322,1,p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.,PUBMED,2010,Ann Surg Oncol,PROGNOSTIC,0.008837044892188053
323,1,Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.,PUBMED,2014,Leuk Res,PROGNOSTIC,0.008837044892188053
324,1,Clinical significance of TP53 mutation in myeloma.,PUBMED,2007,Leukemia,PROGNOSTIC,0.008837044892188053
4637,1,Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.,PUBMED,2002,N Engl J Med,PREDICTIVE,0.008837044892188053
4639,1,Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.,PUBMED,2006,Lancet,PREDICTIVE,0.008837044892188053
4640,1,Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors.,PUBMED,2014,Blood,PREDICTIVE,0.008837044892188053
4641,1,Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.,PUBMED,2006,N Engl J Med,PREDICTIVE,0.008837044892188053
4642,1,Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.,PUBMED,2020,Urology,PREDICTIVE,0.008837044892188053
4643,1,Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.,PUBMED,2020,Anticancer Drugs,PREDICTIVE,0.008837044892188053
4644,1,Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report.,PUBMED,2017,Am J Case Rep,PREDICTIVE,0.008837044892188053
4648,1,Single-agent dabrafenib for BRAFV600E-mutated histiocytosis.,PUBMED,2018,Haematologica,PREDICTIVE,0.008837044892188053
4625,1,"Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.",PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
4629,1,A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer.,PUBMED,2016,Br J Cancer,PREDICTIVE,0.008837044892188053
4631,1,Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study.,PUBMED,2008,Br J Haematol,PREDICTIVE,0.008837044892188053
4632,1,Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.,PUBMED,2021,Nat Med,PREDICTIVE,0.008837044892188053
4633,1,Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.,PUBMED,2000,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4634,1,Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.,PUBMED,2001,Am J Clin Pathol,DIAGNOSTIC,0.008837044892188053
4635,1,Real-World Experience of NTRK Fusion-Positive Thyroid Cancer.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4636,1,Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.,PUBMED,2016,Pathology,DIAGNOSTIC,0.008837044892188053
4611,1,Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.,PUBMED,2021,JAMA Oncol,PREDICTIVE,0.008837044892188053
4612,1,"Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.",PUBMED,2021,Lancet Gastroenterol Hepatol,PREDICTIVE,0.008837044892188053
4615,1,CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL),ASH,2017,Blood,PREDICTIVE,0.008837044892188053
4617,1,"Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.",PUBMED,2020,Lancet,PREDICTIVE,0.008837044892188053
4619,1,"Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.",PUBMED,2019,Lancet Oncol,PREDICTIVE,0.008837044892188053
4620,1,"First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study.",PUBMED,2014,Br J Cancer,PREDICTIVE,0.008837044892188053
4623,1,Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.,PUBMED,2009,J Clin Oncol,PREDICTIVE,0.008837044892188053
4624,1,Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.,PUBMED,2021,JAMA Oncol,PREDICTIVE,0.008837044892188053
4593,1,Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4599,1,Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.,PUBMED,2023,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4600,1,Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
4604,1,"A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.",PUBMED,2021,Blood,PREDICTIVE,0.008837044892188053
4606,1,Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.,PUBMED,2018,J Clin Oncol,PREDICTIVE,0.008837044892188053
4607,1,Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.,PUBMED,2019,N Engl J Med,PREDICTIVE,0.008837044892188053
4608,1,"Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.",PUBMED,2021,Blood,PREDICTIVE,0.008837044892188053
4610,1,Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.,PUBMED,2021,J Clin Oncol,PREDICTIVE,0.008837044892188053
4686,1,Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib.,PUBMED,2019,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
4687,1,Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation.,PUBMED,2019,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
4690,1,MET Y1003S point mutation shows sensitivity to crizotinib in a patient with lung adenocarcinoma.,PUBMED,2019,Lung Cancer,PREDICTIVE,0.008837044892188053
4691,1,Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping.,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4693,1,"Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants.",PUBMED,1998,J Clin Oncol,DIAGNOSTIC,0.008837044892188053
4694,1,Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.,PUBMED,1995,Proc Natl Acad Sci U S A,DIAGNOSTIC,0.008837044892188053
4695,1,Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.,PUBMED,1994,Cancer Res,DIAGNOSTIC,0.008837044892188053
4696,1,Intracranial Activity of Gefitinib and Capmatinib in¬†a¬†Patient with Previously Treated Non-Small Cell Lung Cancer Harboring a Concurrent EGFR Mutation and MET Amplification.,PUBMED,2020,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4674,1,Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.,PUBMED,2008,Haematologica,PREDICTIVE,0.008837044892188053
4675,1,Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report.,PUBMED,2016,Medicine (Baltimore),PREDICTIVE,0.008837044892188053
4677,1,A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.,PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
4681,1,Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4682,1,Intracranial Activity of Cabozantinib in MET Exon 14-Positive NSCLC with Brain Metastases.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4683,1,Response and acquired resistance to crizotinib in Chinese patients with lung adenocarcinomas harboring MET Exon 14 splicing alternations.,PUBMED,2016,Lung Cancer,PREDICTIVE,0.008837044892188053
4684,1,Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping.,PUBMED,2017,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4685,1,Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation: A case report.,PUBMED,2017,Medicine (Baltimore),PREDICTIVE,0.008837044892188053
4660,1,"Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.",PUBMED,2017,J Clin Oncol,PREDICTIVE,0.008837044892188053
4661,1,High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.,PUBMED,2018,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
4662,1,Immunologic Correlates of the Abscopal Effect in a SMARCB1/INI1-negative Poorly Differentiated Chordoma after EZH2 Inhibition and Radiotherapy.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4663,1,Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.,PUBMED,2015,Am J Hematol,PREDICTIVE,0.008837044892188053
4664,1,Molecular characteristics of poorly differentiated chordoma.,PUBMED,2019,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
4665,1,Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study.,PUBMED,2007,Blood,PREDICTIVE,0.008837044892188053
4670,1,Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.,PUBMED,2017,Mod Pathol,DIAGNOSTIC,0.008837044892188053
4671,1,The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.,PUBMED,2018,Cancer Discov,PREDICTIVE,0.008837044892188053
4650,1,Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.,PUBMED,2022,Eur J Cancer,PREDICTIVE,0.008837044892188053
4651,1,Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma.,PUBMED,2020,J Clin Pharm Ther,PREDICTIVE,0.008837044892188053
4652,1,Dabrafenib and trametinib in BRAFV600E mutated glioma.,PUBMED,2017,CNS Oncol,PREDICTIVE,0.008837044892188053
4653,1,Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma.,PUBMED,2018,Neurology,PREDICTIVE,0.008837044892188053
4654,1,Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.,PUBMED,2023,J Clin Oncol,PREDICTIVE,0.008837044892188053
4655,1,Rapid Response of a BRCA2/TP53/PTEN-Deleted Metastatic Uterine Leiomyosarcoma to Olaparib: A Case Report.,PUBMED,2021,Perm J,PREDICTIVE,0.008837044892188053
4656,1,Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer.,PUBMED,2017,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
4659,1,Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.,PUBMED,2012,Invest New Drugs,PREDICTIVE,0.008837044892188053
4732,1,Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-Œ∫B signaling pathway.,PUBMED,2014,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
287,1,Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.,PUBMED,2006,J Clin Oncol,PROGNOSTIC,0.008837044892188053
288,1,Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.,PUBMED,2003,Cancer Res,PROGNOSTIC,0.008837044892188053
291,1,FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.,PUBMED,2010,Cancer Epidemiol,DIAGNOSTIC,0.008837044892188053
292,1,The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.,PUBMED,2010,Mod Pathol,DIAGNOSTIC,0.008837044892188053
295,1,"The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians.",PUBMED,2006,Leukemia,DIAGNOSTIC,0.008837044892188053
298,1,MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
301,1,Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.,PUBMED,2012,Blood,PROGNOSTIC,0.008837044892188053
4721,1,The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.,PUBMED,2022,Blood,ONCOGENIC,0.008837044892188053
4722,1,Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.,PUBMED,2023,Blood,ONCOGENIC,0.008837044892188053
4723,1,Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation.,PUBMED,2021,J Neuropathol Exp Neurol,ONCOGENIC,0.008837044892188053
4726,1,A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-Œ∫B.,PUBMED,2018,Cell Rep,ONCOGENIC,0.008837044892188053
4728,1,"Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study.",PUBMED,2023,Lancet Oncol,PREDICTIVE,0.008837044892188053
4729,1,A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma.,PUBMED,2023,Neurooncol Adv,PROGNOSTIC,0.008837044892188053
4730,1,CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort.,PUBMED,2020,Acta Neuropathol,PROGNOSTIC,0.008837044892188053
4731,1,Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.,PUBMED,2019,Neuro Oncol,PROGNOSTIC,0.008837044892188053
4706,1,Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis.,PUBMED,2022,Onco Targets Ther,PREDICTIVE,0.008837044892188053
4707,1,Osimertinib and Capmatinib Combination Therapy to Overcome MET Y1003N-Mediated Resistance in EGFR-Mutant NSCLC: A Case Report.,PUBMED,2022,JTO Clin Res Rep,PREDICTIVE,0.008837044892188053
4708,1,Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ‚â•50% (GFPC 01-20 Study).,PUBMED,2022,Clin Lung Cancer,PREDICTIVE,0.008837044892188053
4710,1,"Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study.",PUBMED,2023,BMC Cancer,PREDICTIVE,0.008837044892188053
4711,1,Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney.,PUBMED,2015,Nat Genet,DIAGNOSTIC,0.008837044892188053
4712,1,Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney.,PUBMED,2015,Oncotarget,DIAGNOSTIC,0.008837044892188053
4716,1,Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
4720,1,Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.,PUBMED,2022,Blood,ONCOGENIC,0.008837044892188053
4697,1,Interstitial lung disease associated with capmatinib therapy in a patient with non-small cell lung cancer harboring a skipping mutation of MET exon 14.,PUBMED,2021,Thorac Cancer,PREDICTIVE,0.008837044892188053
4698,1,Responses to crizotinib and cabozantinib in patient with lung adenocarcinoma harboring mesenchymal-epithelial transition factor exon 14 skipping mutation: A case report.,PUBMED,2021,Medicine (Baltimore),PREDICTIVE,0.008837044892188053
4699,1,Rapid Disease Progression in a Patient with Advanced NSCLC Harboring a Germline MET Exon 14 Skipping Mutation: A Case Report.,PUBMED,2021,Onco Targets Ther,PROGNOSTIC,0.008837044892188053
4700,1,Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edema.,PUBMED,2021,Thorac Cancer,PREDICTIVE,0.008837044892188053
4701,1,Overcoming Acquired Resistance Mutation MET D1228N to Crizotinib With Cabozantinib in NSCLC With MET Exon 14 Skipping Mutation.,PUBMED,2021,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4702,1,Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report.,PUBMED,2022,Clin Med Insights Oncol,PREDICTIVE,0.008837044892188053
4704,1,Tepotinib Improves Prognosis in an Elderly Patient with Poor Performance Status and MET Exon 14 Skipping Mutation-positive Non-small Cell Lung Cancer.,PUBMED,2022,Tokai J Exp Clin Med,PREDICTIVE,0.008837044892188053
4705,1,"Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience.",PUBMED,2022,Oncology,PREDICTIVE,0.008837044892188053
4745,1,Identification of a Novel MET Exon 14 Skipping Variant Coexistent with EGFR Mutation in Lung Adenocarcinoma Sensitive to Combined Treatment with Afatinib and Crizotinib.,PUBMED,2019,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4748,1,Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4749,1,Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4750,1,Transient asymptomatic pulmonary opacities in a patient with MET exon 14 skipping non-small cell lung cancer: A case report.,PUBMED,2023,Thorac Cancer,PREDICTIVE,0.008837044892188053
4751,1,Successful tepotinib treatment of adenocarcinoma with MET exon 14 skipping and discordant results between Oncomine Dx target test and ArcherMET: A case report.,PUBMED,2023,Mol Clin Oncol,PREDICTIVE,0.008837044892188053
4753,1,DICER1 hot-spot mutations in ovarian gynandroblastoma.,PUBMED,2018,Histopathology,DIAGNOSTIC,0.008837044892188053
4754,1,Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.,PUBMED,2014,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
4755,1,Clinical Outcomes and Complications of Pituitary Blastoma.,PUBMED,2021,J Clin Endocrinol Metab,DIAGNOSTIC,0.008837044892188053
4736,1,"Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.",PUBMED,2020,Lancet Respir Med,PREDICTIVE,0.008837044892188053
4737,1,Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a¬†case report.,PUBMED,2022,J Med Case Rep,PREDICTIVE,0.008837044892188053
4738,1,A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor.,PUBMED,2021,J Thorac Oncol,PREDICTIVE,0.008837044892188053
4739,1,Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case Report.,PUBMED,2022,Am J Kidney Dis,PREDICTIVE,0.008837044892188053
4740,1,Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation: Case Report.,PUBMED,2022,JTO Clin Res Rep,PREDICTIVE,0.008837044892188053
4742,1,Lazarus Response to Tepotinib for Leptomeningeal Metastases in a Patient With MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma: Case Report.,PUBMED,2021,JTO Clin Res Rep,PREDICTIVE,0.008837044892188053
4743,1,Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation.,PUBMED,2021,Thorac Cancer,PREDICTIVE,0.008837044892188053
4744,1,Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.,PUBMED,2021,Cancer Commun (Lond),PREDICTIVE,0.008837044892188053
313,1,RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.,PUBMED,2012,J Clin Oncol,PROGNOSTIC,0.008837044892188053
314,1,SF3B1 mutations in chronic lymphocytic leukemia.,PUBMED,2013,Blood,PROGNOSTIC,0.008837044892188053
315,1,SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.,PUBMED,2009,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
317,1,TERT gene amplification is associated with poor outcome in acral lentiginous melanoma.,PUBMED,2014,J Am Acad Dermatol,PROGNOSTIC,0.008837044892188053
318,1,TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.,PUBMED,2014,J Natl Cancer Inst,PROGNOSTIC,0.008837044892188053
320,1,TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.,PUBMED,2012,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
321,1,p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.,PUBMED,1996,J Natl Cancer Inst,PROGNOSTIC,0.008837044892188053
4735,1,Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.,PUBMED,2017,Ann Oncol,PREDICTIVE,0.008837044892188053
302,1,Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.,PUBMED,2011,J Exp Med,PROGNOSTIC,0.008837044892188053
304,1,RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.,PUBMED,2003,J Clin Endocrinol Metab,DIAGNOSTIC,0.008837044892188053
305,1,Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.,PUBMED,2013,Lancet Oncol,PROGNOSTIC,0.008837044892188053
306,1,"Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.",PUBMED,2006,Ann Oncol,PROGNOSTIC,0.008837044892188053
307,1,Biomarkers for the clinical management of breast cancer: international perspective.,PUBMED,2013,Int J Cancer,PREDICTIVE,0.008837044892188053
309,1,Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.,PUBMED,2012,BMC Cancer,PROGNOSTIC,0.008837044892188053
311,1,"KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.",PUBMED,2011,Lancet Oncol,PREDICTIVE,0.008837044892188053
312,1,Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.,PUBMED,2001,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
4810,1,A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.,PUBMED,2010,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4812,1,Distinct histologic and genetic characteristics of round cell sarcoma with CIC-DUX4 fusion and comparison with ewing sarcoma.,PUBMED,2022,Pathol Res Pract,DIAGNOSTIC,0.008837044892188053
4813,1,High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.,PUBMED,2012,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
255,1,EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.,PUBMED,1998,J Clin Oncol,PROGNOSTIC,0.008837044892188053
260,1,DNAJB1-PRKACA is specific for fibrolamellar carcinoma.,PUBMED,2015,Mod Pathol,DIAGNOSTIC,0.008837044892188053
261,1,A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.,PUBMED,2014,Cancer Discov,PREDICTIVE,0.008837044892188053
263,1,A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.,PUBMED,2012,Cancer Res,PREDICTIVE,0.008837044892188053
264,1,A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.,PUBMED,2013,Cancer Res,PREDICTIVE,0.008837044892188053
4791,1,"Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.",PUBMED,2005,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4792,1,"Activity of osimertinib in a patient with stage IV non-small cell lung cancer harboring HER2 exon 19, p.L755P mutation: case report.",PUBMED,2023,Transl Lung Cancer Res,PREDICTIVE,0.008837044892188053
4794,1,Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing.,PUBMED,2022,Endocr Connect,PREDISPOSING,0.008837044892188053
4797,1,"Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese Population.",PUBMED,2019,J Thorac Oncol,ONCOGENIC,0.008837044892188053
4802,1,An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.,PUBMED,2022,Eur J Endocrinol,PREDICTIVE,0.008837044892188053
4803,1,LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.,PUBMED,2021,J Cutan Pathol,DIAGNOSTIC,0.008837044892188053
4805,1,CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.,PUBMED,2018,Brain Pathol,DIAGNOSTIC,0.008837044892188053
4807,1,MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.,PUBMED,2019,Mod Pathol,PROGNOSTIC,0.008837044892188053
4777,1,Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney.,PUBMED,2016,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4778,1,Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study.,PUBMED,2020,Mod Pathol,DIAGNOSTIC,0.008837044892188053
4781,1,Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.,PUBMED,2021,Acta Neuropathol Commun,DIAGNOSTIC,0.008837044892188053
4783,1,Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.,PUBMED,2012,Hum Pathol,DIAGNOSTIC,0.008837044892188053
4784,1,Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.,PUBMED,2001,Am J Pathol,DIAGNOSTIC,0.008837044892188053
4787,1,"Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.",PUBMED,2012,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4788,1,Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.,PUBMED,2013,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
4789,1,Cytopathologic features of epithelioid hemangioendothelioma including touch imprints for rapid on-site evaluation.,PUBMED,2023,Cytojournal,DIAGNOSTIC,0.008837044892188053
4756,1,Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.,PUBMED,2021,Cancer Med,DIAGNOSTIC,0.008837044892188053
4757,1,Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.,PUBMED,2018,Cancer,ONCOGENIC,0.008837044892188053
4758,1,Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
4759,1,Durable Response to Chemoimmunotherapy of a Lung Adenocarcinoma Harboring a MET Exon 14 Skipping Mutation.,PUBMED,2023,Cureus,PREDICTIVE,0.008837044892188053
4771,1,Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.,PUBMED,2021,NPJ Precis Oncol,ONCOGENIC,0.008837044892188053
4772,1,Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers.,PUBMED,2023,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
4773,1,Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.,PUBMED,2019,Mol Genet Genomic Med,PREDISPOSING,0.008837044892188053
4774,1,PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.,PUBMED,2019,Blood,DIAGNOSTIC,0.008837044892188053
4830,1,Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.,PUBMED,2020,Target Oncol,PREDICTIVE,0.008837044892188053
4832,1,Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4833,1,Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.,PUBMED,2022,NPJ Precis Oncol,PREDICTIVE,0.008837044892188053
4834,1,Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
4835,1,"Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.",PUBMED,2023,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4836,1,Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors.,PUBMED,2021,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4838,1,Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.,PUBMED,2020,J Clin Oncol,PREDICTIVE,0.008837044892188053
4839,1,Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.,PUBMED,2022,J Clin Oncol,PREDICTIVE,0.008837044892188053
4818,1,Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
4819,1,Efficacy and safety of vismodegib in advanced basal-cell carcinoma.,PUBMED,2012,N Engl J Med,PREDICTIVE,0.008837044892188053
4820,1,Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.,PUBMED,2018,J Eur Acad Dermatol Venereol,PREDICTIVE,0.008837044892188053
4822,1,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,PUBMED,2020,N Engl J Med,PREDICTIVE,0.008837044892188053
4824,1,An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification.,PUBMED,2020,Pathol Res Pract,DIAGNOSTIC,0.008837044892188053
4827,1,Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations.,PUBMED,2020,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4828,1,Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.,PUBMED,2020,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4829,1,Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study.,PUBMED,2023,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
277,1,Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.,PUBMED,2005,J Clin Invest,DIAGNOSTIC,0.008837044892188053
278,1,Targeting the BRAF V600E mutation in multiple myeloma.,PUBMED,2013,Cancer Discov,PROGNOSTIC,0.008837044892188053
280,1,Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer.,PUBMED,2010,Cancer,PROGNOSTIC,0.008837044892188053
281,1,Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.,PUBMED,2009,Blood,PROGNOSTIC,0.008837044892188053
282,1,Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.,PUBMED,2014,Blood Cancer J,PROGNOSTIC,0.008837044892188053
284,1,Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.,PUBMED,2010,Histopathology,PROGNOSTIC,0.008837044892188053
285,1,"EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.",PUBMED,2011,Br J Cancer,PROGNOSTIC,0.008837044892188053
286,1,Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.,PUBMED,2007,J Clin Oncol,PROGNOSTIC,0.008837044892188053
265,1,A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.008837044892188053
266,1,Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.,PUBMED,2003,Cancer Res,PREDICTIVE,0.008837044892188053
268,1,ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia.,PUBMED,2015,Leuk Lymphoma,PROGNOSTIC,0.008837044892188053
270,1,Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors.,PUBMED,2013,Sci Transl Med,PREDICTIVE,0.008837044892188053
271,1,The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.,PUBMED,2010,Blood,PREDICTIVE,0.008837044892188053
273,1,"AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.",PUBMED,2003,Cancer Cell,PREDICTIVE,0.008837044892188053
274,1,Prognostic parameters in uveal melanoma and their association with BAP1 expression.,PUBMED,2014,Br J Ophthalmol,PROGNOSTIC,0.008837044892188053
276,1,Comprehensive molecular characterization of clear cell renal cell carcinoma.,PUBMED,2013,Nature,PROGNOSTIC,0.008837044892188053
4882,1,Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.,PUBMED,2023,J Clin Oncol,PREDICTIVE,0.008837044892188053
4883,1,"Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial.",PUBMED,2021,Lancet Respir Med,PREDICTIVE,0.008837044892188053
4885,1,"Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma.",PUBMED,2021,Invest New Drugs,PREDICTIVE,0.008837044892188053
4887,1,Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.,PUBMED,2021,Br J Cancer,PREDICTIVE,0.008837044892188053
4888,1,A rare case of recurrent ovarian cancer with TPM3-NTRK1 gene rearrangement: A case report.,PUBMED,2022,Mol Clin Oncol,PREDICTIVE,0.008837044892188053
4889,1,TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.,PUBMED,2021,Cancer Discov,PREDICTIVE,0.008837044892188053
218,1,Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.,PUBMED,2005,Int J Exp Pathol,PROGNOSTIC,0.008837044892188053
219,1,Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.,PUBMED,2007,Nat Rev Cancer,PROGNOSTIC,0.008837044892188053
4871,1,Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.,PUBMED,2022,Br J Dermatol,DIAGNOSTIC,0.008837044892188053
4872,1,Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing.,PUBMED,2023,Front Oncol,ONCOGENIC,0.008837044892188053
4873,1,B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.,PUBMED,2010,Leuk Res,ONCOGENIC,0.008837044892188053
4874,1,"Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues.",PUBMED,2020,Cancer Biol Ther,FUNCTIONAL,0.008837044892188053
4875,1,Systematic Characterization of the Clinical and Pathological Features of Schwannomas Harboring SH3PXD2A::HTRA1 Fusion.,PUBMED,2024,Mod Pathol,DIAGNOSTIC,0.008837044892188053
4876,1,Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer.,PUBMED,2022,Cell Death Dis,PREDICTIVE,0.008837044892188053
4878,1,Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.,PUBMED,2019,Mod Pathol,DIAGNOSTIC,0.008837044892188053
4880,1,Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.,PUBMED,2018,Mod Pathol,DIAGNOSTIC,0.008837044892188053
4856,1,TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics.,PUBMED,2016,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
4857,1,The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.,PUBMED,2023,Nat Commun,PREDICTIVE,0.008837044892188053
4861,1,The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ‚âà0.6% of healthy newborns.,PUBMED,2019,Blood,ONCOGENIC,0.008837044892188053
4863,1,The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.,PUBMED,1991,Blood,DIAGNOSTIC,0.008837044892188053
4864,1,Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.,PUBMED,2009,Leukemia,PREDICTIVE,0.008837044892188053
4865,1,Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.,PUBMED,2021,Leuk Lymphoma,PREDICTIVE,0.008837044892188053
4866,1,Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.,PUBMED,2023,Nat Commun,PREDICTIVE,0.008837044892188053
4869,1,Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.,PUBMED,2016,Cancer Sci,FUNCTIONAL,0.008837044892188053
4840,1,Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.,PUBMED,2022,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4842,1,Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.,PUBMED,2009,Clin Cancer Res,DIAGNOSTIC,0.008837044892188053
4845,1,"Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor.",PUBMED,2023,Gynecol Oncol,PREDICTIVE,0.008837044892188053
4846,1,Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.,PUBMED,2023,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
4847,1,Presence of MET exon 14 skipping and fusion as mechanism of osimertinb resistance in a lung adenocarcinoma with an EGFR exon 19 deletion that responds to combination of capmatinib and osimertinb: A case report.,PUBMED,2023,Heliyon,PREDICTIVE,0.008837044892188053
4848,1,First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression.,PUBMED,2023,Drug Target Insights,PREDICTIVE,0.008837044892188053
4853,1,"A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications.",PUBMED,2021,Int J Surg Pathol,ONCOGENIC,0.008837044892188053
4854,1,Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy.,PUBMED,2022,Cureus,PREDICTIVE,0.008837044892188053
4898,1,Measurement of FGFR3 signaling at the cell membrane via total internal reflection fluorescence microscopy to compare the activation of FGFR3 mutants.,PUBMED,2023,J Biol Chem,FUNCTIONAL,0.008837044892188053
4899,1,"Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.",PUBMED,1994,J Clin Oncol,DIAGNOSTIC,0.008837044892188053
4902,1,Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).,PUBMED,2020,Oncotarget,PREDICTIVE,0.008837044892188053
4903,1,The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.,PUBMED,2022,Leukemia,DIAGNOSTIC,0.008837044892188053
4908,1,Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney.,PUBMED,2012,J Pathol,DIAGNOSTIC,0.008837044892188053
4909,1,Immunophenotype-Genotype Correlations in Clear Cell Sarcoma of Kidney-An Evaluation of Diagnostic Ancillary Studies.,PUBMED,2020,Pediatr Dev Pathol,DIAGNOSTIC,0.008837044892188053
4910,1,Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.,PUBMED,2016,J Pathol,DIAGNOSTIC,0.008837044892188053
4911,1,A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.,PUBMED,2014,J Pathol,DIAGNOSTIC,0.008837044892188053
4890,1,"NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.",PUBMED,2021,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4891,1,A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib.,PUBMED,2022,Pathobiology,PREDICTIVE,0.008837044892188053
4892,1,NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.,PUBMED,2021,J Clin Invest,PREDICTIVE,0.008837044892188053
4893,1,Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.,PUBMED,2017,Sci Transl Med,PREDICTIVE,0.008837044892188053
4894,1,Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.,PUBMED,2018,Cancer Cell,PREDICTIVE,0.008837044892188053
4895,1,Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.,PUBMED,2023,JAMA Oncol,PREDICTIVE,0.008837044892188053
4896,1,RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics.,PUBMED,2021,J Clin Invest,PREDICTIVE,0.008837044892188053
4897,1,Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.,PUBMED,2019,Blood Adv,PREDICTIVE,0.008837044892188053
240,1,Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.,PUBMED,2008,Proc Natl Acad Sci U S A,DIAGNOSTIC,0.008837044892188053
243,1,Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.,PUBMED,2006,Clin Cancer Res,PREDICTIVE,0.008837044892188053
246,1,Aurora kinases as prognostic biomarkers in ovarian carcinoma.,PUBMED,2009,Hum Pathol,PROGNOSTIC,0.008837044892188053
247,1,TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).,PUBMED,2009,Blood,PROGNOSTIC,0.008837044892188053
248,1,Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.,PUBMED,2008,Int J Cancer,PROGNOSTIC,0.008837044892188053
252,1,Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.,PUBMED,2010,Nat Genet,PROGNOSTIC,0.008837044892188053
253,1,TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.,PUBMED,2011,Blood,PROGNOSTIC,0.008837044892188053
254,1,"VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.",PUBMED,2002,J Pathol,PROGNOSTIC,0.008837044892188053
221,1,Cyclin E and survival in patients with breast cancer.,PUBMED,2002,N Engl J Med,PROGNOSTIC,0.008837044892188053
224,1,The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysis.,PUBMED,2014,Onco Targets Ther,PROGNOSTIC,0.008837044892188053
225,1,Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients.,PUBMED,2014,Onco Targets Ther,PROGNOSTIC,0.008837044892188053
226,1,Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.,PUBMED,2001,Cancer Res,PROGNOSTIC,0.008837044892188053
227,1,FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.,PUBMED,2008,Blood,PROGNOSTIC,0.008837044892188053
228,1,IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.,PUBMED,2010,Haematologica,PROGNOSTIC,0.008837044892188053
230,1,The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.,PUBMED,2005,Br J Cancer,PROGNOSTIC,0.008837044892188053
237,1,RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.,PUBMED,2014,Leukemia,PREDICTIVE,0.008837044892188053
4944,1,Loss of signalling via GŒ±13 in germinal centre B-cell-derived lymphoma.,PUBMED,2014,Nature,ONCOGENIC,0.008837044892188053
4947,1,"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.",PUBMED,2012,Nat Genet,ONCOGENIC,0.008837044892188053
4948,1,Mantle cell lymphoma is characterized by inactivation of the ATM gene.,PUBMED,2000,Proc Natl Acad Sci U S A,ONCOGENIC,0.008837044892188053
4950,1,Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations.,PUBMED,2016,Oncotarget,ONCOGENIC,0.008837044892188053
4955,1,"Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt.",PUBMED,1992,Blood,DIAGNOSTIC,0.008837044892188053
4956,1,Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.,PUBMED,1992,Blood,DIAGNOSTIC,0.008837044892188053
4957,1,Morphological subtyping of acute myeloid leukemia with maturation (AML-M2): homogeneous pink-colored cytoplasm of mature neutrophils is most characteristic of AML-M2 with t(8;21).,PUBMED,1997,Leukemia,DIAGNOSTIC,0.008837044892188053
182,1,Clinical predictors of response to EGFR tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.,PUBMED,2014,Oncology,PREDICTIVE,0.008837044892188053
4933,1,The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases.,PUBMED,2018,Sci Signal,ONCOGENIC,0.008837044892188053
4934,1,Transforming fusions of FGFR and TACC genes in human glioblastoma.,PUBMED,2012,Science,ONCOGENIC,0.008837044892188053
4935,1,Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation.,PUBMED,1998,J Biol Chem,ONCOGENIC,0.008837044892188053
4936,1,Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer.,PUBMED,1987,N Engl J Med,DIAGNOSTIC,0.008837044892188053
4940,1,A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.,PUBMED,2020,Cancer Cell,DIAGNOSTIC,0.008837044892188053
4941,1,Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.,PUBMED,2023,Blood,ONCOGENIC,0.008837044892188053
4942,1,Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.,PUBMED,2012,Nature,ONCOGENIC,0.008837044892188053
4943,1,The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.,PUBMED,2015,Genes Chromosomes Cancer,ONCOGENIC,0.008837044892188053
4925,1,Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.,PUBMED,2014,Cancer Biol Ther,ONCOGENIC,0.008837044892188053
4926,1,FGFR3 has tumor suppressor properties in cells with epithelial phenotype.,PUBMED,2013,Mol Cancer,ONCOGENIC,0.008837044892188053
4927,1,Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.,PUBMED,2018,Oncogenesis,ONCOGENIC,0.008837044892188053
4928,1,Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3-BAIAP2L1.,PUBMED,2015,Mol Cancer Ther,ONCOGENIC,0.008837044892188053
4929,1,Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage.,PUBMED,2008,PLoS One,ONCOGENIC,0.008837044892188053
4930,1,A metabolic function of FGFR3-TACC3 gene fusions in cancer.,PUBMED,2018,Nature,ONCOGENIC,0.008837044892188053
4931,1,Fibroblast growth factor receptor 3 interacts with and activates TGFŒ≤-activated kinase 1 tyrosine phosphorylation and NFŒ∫B signaling in multiple myeloma and bladder cancer.,PUBMED,2014,PLoS One,ONCOGENIC,0.008837044892188053
4932,1,A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.,PUBMED,2009,Hum Mol Genet,ONCOGENIC,0.008837044892188053
4912,1,Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.,PUBMED,2020,Virchows Arch,DIAGNOSTIC,0.008837044892188053
4913,1,FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma.,PUBMED,2020,Cancer Genomics Proteomics,DIAGNOSTIC,0.008837044892188053
4917,1,"A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.",PUBMED,2023,Gynecol Oncol,PREDICTIVE,0.008837044892188053
4920,1,Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.,PUBMED,2005,J Clin Oncol,DIAGNOSTIC,0.008837044892188053
4921,1,Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.,PUBMED,2004,J Clin Oncol,DIAGNOSTIC,0.008837044892188053
4922,1,Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.,PUBMED,1983,N Engl J Med,DIAGNOSTIC,0.008837044892188053
4923,1,Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.,PUBMED,2018,Blood,PROGNOSTIC,0.008837044892188053
4924,1,A frequent PLCŒ≥1 mutation in adult T-cell leukemia/lymphoma determines functional properties of the malignant cells.,PUBMED,2023,Biochim Biophys Acta Mol Basis Dis,ONCOGENIC,0.008837044892188053
4969,1,Recurrent targets of aberrant somatic hypermutation in lymphoma.,PUBMED,2012,Oncotarget,ONCOGENIC,0.008837044892188053
4971,1,Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.,PUBMED,2013,Blood,ONCOGENIC,0.008837044892188053
4972,1,Characterization of DLBCL with a PMBL gene expression signature.,PUBMED,2021,Blood,ONCOGENIC,0.008837044892188053
4974,1,Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.,PUBMED,2019,PLoS One,ONCOGENIC,0.008837044892188053
4975,1,Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.,PUBMED,2009,Blood,ONCOGENIC,0.008837044892188053
4976,1,STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.,PUBMED,2014,Haematologica,ONCOGENIC,0.008837044892188053
4977,1,Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.,PUBMED,2016,Clin Cancer Res,ONCOGENIC,0.008837044892188053
4979,1,Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.,PUBMED,2009,Nature,ONCOGENIC,0.008837044892188053
213,1,"Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancer.",PUBMED,2014,J Thorac Oncol,PROGNOSTIC,0.008837044892188053
214,1,IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.,PUBMED,2009,Neurology,PROGNOSTIC,0.008837044892188053
215,1,The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.,PUBMED,2010,Acta Neuropathol,PROGNOSTIC,0.008837044892188053
4959,1,Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.,PUBMED,2012,J Exp Med,DIAGNOSTIC,0.008837044892188053
4961,1,"Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.",PUBMED,2019,Brain Pathol,DIAGNOSTIC,0.008837044892188053
4962,1,Supratentorial ependymoma with YAP1:FAM118B fusion: A case report.,PUBMED,2021,Neuropathology,DIAGNOSTIC,0.008837044892188053
4963,1,Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene.,PUBMED,2019,Cancer Discov,PREDICTIVE,0.008837044892188053
4966,1,TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.,PUBMED,2020,Nat Med,PREDICTIVE,0.008837044892188053
201,1,Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.,PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.008837044892188053
203,1,Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.,PUBMED,2010,Blood,PROGNOSTIC,0.008837044892188053
205,1,Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.,PUBMED,2012,Leukemia,PROGNOSTIC,0.008837044892188053
206,1,KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size.,PUBMED,2002,Am J Pathol,PROGNOSTIC,0.008837044892188053
207,1,Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.,PUBMED,2004,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
208,1,KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.,PUBMED,2009,Clin Cancer Res,PROGNOSTIC,0.008837044892188053
209,1,Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.,PUBMED,2001,J Clin Oncol,PROGNOSTIC,0.008837044892188053
211,1,Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.,PUBMED,2012,PLoS One,PROGNOSTIC,0.008837044892188053
183,1,Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC.,PUBMED,2014,Lung Cancer,PREDICTIVE,0.008837044892188053
184,1,A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity.,PUBMED,2014,Amino Acids,PREDICTIVE,0.008837044892188053
187,1,"Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.",PUBMED,2004,Blood,PREDICTIVE,0.008837044892188053
188,1,Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.,PUBMED,2002,Leukemia,PREDICTIVE,0.008837044892188053
190,1,Major response to imatinib mesylate in KIT-mutated melanoma.,PUBMED,2008,J Clin Oncol,PREDICTIVE,0.008837044892188053
196,1,Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.,PUBMED,2005,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
197,1,Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.,PUBMED,1996,Cancer Res,PREDICTIVE,0.008837044892188053
198,1,The PI3K pathway as drug target in human cancer.,PUBMED,2010,J Clin Oncol,PREDICTIVE,0.008837044892188053
5013,1,Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.,PUBMED,2000,Br J Surg,PROGNOSTIC,0.008837044892188053
5015,1,Plasma versus tissue tumor mutational burden as biomarkers of durvalumab plus tremelimumab response in patients with metastatic colorectal cancer in the CO.26 trial.,PUBMED,2024,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5016,1,Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.,PUBMED,2007,Am J Clin Pathol,DIAGNOSTIC,0.008837044892188053
5017,1,Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.,PUBMED,1996,Haematologica,DIAGNOSTIC,0.008837044892188053
5019,1,NUT carcinoma in children and adults: A multicenter retrospective study.,PUBMED,2017,Pediatr Blood Cancer,DIAGNOSTIC,0.008837044892188053
5020,1,An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.,PUBMED,2020,JNCI Cancer Spectr,DIAGNOSTIC,0.008837044892188053
5021,1,EGFR/ERBB2 Amplifications and Alterations Associated With Resistance to Lenvatinib in Hepatocellular Carcinoma.,PUBMED,2023,Gastroenterology,PREDICTIVE,0.008837044892188053
5022,1,Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial.,PUBMED,2021,Nat Med,PREDICTIVE,0.008837044892188053
5003,1,Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes.,PUBMED,2021,J Clin Oncol,PREDICTIVE,0.008837044892188053
5004,1,Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.,PUBMED,2019,Nat Commun,DIAGNOSTIC,0.008837044892188053
5005,1,KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumors.,PUBMED,2020,Biomark Res,PREDICTIVE,0.008837044892188053
5007,1,"Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.",PUBMED,2021,Nat Commun,PREDICTIVE,0.008837044892188053
5008,1,Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.,PUBMED,2022,ESMO Open,PREDICTIVE,0.008837044892188053
5009,1,Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.,PUBMED,2022,Neurooncol Adv,PREDICTIVE,0.008837044892188053
5010,1,Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.,PUBMED,2015,Science,PREDICTIVE,0.008837044892188053
5012,1,"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.",PUBMED,2019,Blood,PROGNOSTIC,0.008837044892188053
4989,1,Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
4990,1,Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
4992,1,Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.,PUBMED,2011,Sci Transl Med,DIAGNOSTIC,0.008837044892188053
4993,1,"Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases.",PUBMED,2014,Diagn Pathol,DIAGNOSTIC,0.008837044892188053
4996,1,"Nirogacestat, a Œ≥-Secretase Inhibitor for Desmoid Tumors.",PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
4998,1,Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.,PUBMED,2024,Clin Cancer Res,PREDICTIVE,0.008837044892188053
4999,1,Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.,PUBMED,2024,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
5000,1,"Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.",PUBMED,2023,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
4980,1,Enhancing knowledge discovery from cancer genomics data with Galaxy.,PUBMED,2017,Gigascience,ONCOGENIC,0.008837044892188053
4981,1,"Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion.",PUBMED,2018,Histopathology,DIAGNOSTIC,0.008837044892188053
4982,1,BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.,PUBMED,2020,Pediatr Blood Cancer,DIAGNOSTIC,0.008837044892188053
4983,1,"Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues.",PUBMED,2017,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4984,1,Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight.,PUBMED,2020,Front Oncol,FUNCTIONAL,0.008837044892188053
4985,1,NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.,PUBMED,2018,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
4987,1,Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.,PUBMED,2024,N Engl J Med,PREDICTIVE,0.008837044892188053
4988,1,Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.,PUBMED,2024,J Clin Oncol,PREDICTIVE,0.008837044892188053
5052,1,Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.,PUBMED,2024,Cancer Res Commun,PREDICTIVE,0.008837044892188053
5055,1,MN1 rearrangement in astroblastoma: study of eight cases and review of literature.,PUBMED,2019,Brain Tumor Pathol,DIAGNOSTIC,0.008837044892188053
5056,1,MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.,PUBMED,2023,BMC Cancer,DIAGNOSTIC,0.008837044892188053
5057,1,"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.",PUBMED,2020,Lancet Oncol,PREDICTIVE,0.008837044892188053
5059,1,Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.,PUBMED,1996,J Natl Cancer Inst,PROGNOSTIC,0.008837044892188053
5060,1,Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNA.,PUBMED,1995,J Virol,ONCOGENIC,0.008837044892188053
5061,1,Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.,PUBMED,2024,Cancer Immunol Immunother,PREDICTIVE,0.008837044892188053
5062,1,Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia.,PUBMED,1986,Blood,DIAGNOSTIC,0.008837044892188053
5029,1,"Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.",PUBMED,2006,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5031,1,Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.,PUBMED,2024,Cancer Discov,PREDICTIVE,0.008837044892188053
5032,1,Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.,PUBMED,2021,Nat Commun,PREDICTIVE,0.008837044892188053
5033,1,A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.,PUBMED,2022,Nat Commun,PREDISPOSING,0.008837044892188053
5034,1,Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M-positive: Case report and literature review.,PUBMED,2023,Thorac Cancer,PREDICTIVE,0.008837044892188053
5035,1,Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.,PUBMED,2021,NPJ Precis Oncol,PREDICTIVE,0.008837044892188053
5047,1,"Kataegis Expression Signature in Breast Cancer Is Associated with Late Onset, Better Prognosis, and Higher HER2 Levels.",PUBMED,2016,Cell Rep,PROGNOSTIC,0.008837044892188053
5051,1,Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial.,PUBMED,2019,JAMA Oncol,PREDICTIVE,0.008837044892188053
162,1,Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.,PUBMED,2014,J Thorac Oncol,PREDICTIVE,0.008837044892188053
167,1,EGFR T790M resistance mutation in non small-cell lung carcinoma.,PUBMED,2015,Clin Chim Acta,PREDICTIVE,0.008837044892188053
168,1,EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.,PUBMED,2005,N Engl J Med,PREDICTIVE,0.008837044892188053
169,1,Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.,PUBMED,2011,Sci Transl Med,PREDICTIVE,0.008837044892188053
175,1,Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.,PUBMED,2009,Neoplasia,PREDICTIVE,0.008837044892188053
177,1,Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.,PUBMED,2012,Cancer Cell,PREDICTIVE,0.008837044892188053
180,1,The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.,PUBMED,2006,Cancer Cell,PREDICTIVE,0.008837044892188053
5028,1,Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.,PUBMED,2007,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5023,1,"Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.",PUBMED,2020,JNCI Cancer Spectr,PREDICTIVE,0.008837044892188053
5024,1,,ASCO,,,PREDICTIVE,0.008837044892188053
5026,1,In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.,PUBMED,2017,Clin Cancer Res,DIAGNOSTIC,0.008837044892188053
5027,1,A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.,PUBMED,2015,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
151,1,Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.,PUBMED,2014,Leukemia,DIAGNOSTIC,0.008837044892188053
153,1,Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.,PUBMED,2008,Clin Cancer Res,DIAGNOSTIC,0.008837044892188053
155,1,Promoter methylation of cyclin D2 gene in gastric carcinoma.,PUBMED,2003,Int J Oncol,DIAGNOSTIC,0.008837044892188053
158,1,Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.,PUBMED,2010,Leukemia,DIAGNOSTIC,0.008837044892188053
5093,1,Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a¬†secondary analysis from MARIPOSA.,PUBMED,2024,Ann Oncol,PREDICTIVE,0.008837044892188053
5094,1,"Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).",PUBMED,2023,J Thorac Oncol,PREDICTIVE,0.008837044892188053
5095,1,"Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.",PUBMED,2022,Lancet Oncol,PREDICTIVE,0.008837044892188053
5096,1,Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial.,PUBMED,2021,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5098,1,Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer.,PUBMED,2023,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
5100,1,MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.,PUBMED,2018,Cell Res,PREDICTIVE,0.008837044892188053
5101,1,Loss of IFN-Œ≥ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.,PUBMED,2016,Cell,PREDICTIVE,0.008837044892188053
5103,1,Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.,PUBMED,2024,N Engl J Med,PREDICTIVE,0.008837044892188053
5083,1,Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects.,PUBMED,2023,Cancer Res,FUNCTIONAL,0.008837044892188053
5084,1,Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification.,PUBMED,2020,Oncologist,PREDICTIVE,0.008837044892188053
5085,1,Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer.,PUBMED,2017,DNA Cell Biol,PREDICTIVE,0.008837044892188053
5086,1,"Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.",PUBMED,2024,Lancet,PREDICTIVE,0.008837044892188053
5087,1,"Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.",PUBMED,2007,Mod Pathol,DIAGNOSTIC,0.008837044892188053
5090,1,t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.,PUBMED,2014,Haematologica,DIAGNOSTIC,0.008837044892188053
5091,1,Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.,PUBMED,2019,Blood Adv,DIAGNOSTIC,0.008837044892188053
5092,1,A new genomic framework to categorize pediatric acute myeloid leukemia.,PUBMED,2024,Nat Genet,DIAGNOSTIC,0.008837044892188053
5073,1,HER2 as a target in invasive urothelial carcinoma.,PUBMED,2015,Cancer Med,FUNCTIONAL,0.008837044892188053
5074,1,HER2 missense mutations have distinct effects on oncogenic signaling and migration.,PUBMED,2015,Proc Natl Acad Sci U S A,FUNCTIONAL,0.008837044892188053
5076,1,Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.,PUBMED,2002,Am J Pathol,DIAGNOSTIC,0.008837044892188053
5077,1,Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.,PUBMED,2001,Cancer Res,DIAGNOSTIC,0.008837044892188053
5078,1,Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.,PUBMED,2005,Acta Neuropathol,DIAGNOSTIC,0.008837044892188053
5079,1,Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.,PUBMED,2014,Nat Genet,DIAGNOSTIC,0.008837044892188053
5080,1,Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.,PUBMED,2016,Acta Neuropathol Commun,DIAGNOSTIC,0.008837044892188053
5081,1,High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.,PUBMED,2010,Br J Cancer,DIAGNOSTIC,0.008837044892188053
5063,1,Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.,PUBMED,1999,Leuk Lymphoma,DIAGNOSTIC,0.008837044892188053
5064,1,Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.,PUBMED,1991,Blood,DIAGNOSTIC,0.008837044892188053
5065,1,t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.,PUBMED,2001,Leukemia,DIAGNOSTIC,0.008837044892188053
5066,1,"High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.",PUBMED,2006,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
5067,1,Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.,PUBMED,2018,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
5068,1,YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.,PUBMED,2018,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
5070,1,Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.,PUBMED,2004,Proc Natl Acad Sci U S A,PREDICTIVE,0.008837044892188053
5071,1,Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy.,PUBMED,2010,Eur J Cancer,PREDICTIVE,0.008837044892188053
5121,1,"ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance.",PUBMED,2020,Front Mol Biosci,PREDICTIVE,0.008837044892188053
5122,1,"Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.",PUBMED,2020,Cancer Lett,PREDICTIVE,0.008837044892188053
5123,1,"A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin.",PUBMED,2023,Case Rep Oncol,PREDICTIVE,0.008837044892188053
5124,1,TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.,PUBMED,2023,Int J Lab Hematol,DIAGNOSTIC,0.008837044892188053
5125,1,Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.,PUBMED,2015,Nat Genet,DIAGNOSTIC,0.008837044892188053
5127,1,CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.,PUBMED,2022,Blood,DIAGNOSTIC,0.008837044892188053
5128,1,Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.,PUBMED,2022,Blood Adv,DIAGNOSTIC,0.008837044892188053
5131,1,"Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.",PUBMED,2019,Haematologica,DIAGNOSTIC,0.008837044892188053
5111,1,"Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.",PUBMED,2013,Blood,DIAGNOSTIC,0.008837044892188053
5112,1,A novel specific signature of pediatric MOZ-CBP acute myeloid leukemia.,PUBMED,2010,Leuk Res,DIAGNOSTIC,0.008837044892188053
5113,1,FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.,PUBMED,2017,Pediatr Blood Cancer,DIAGNOSTIC,0.008837044892188053
5114,1,Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.,PUBMED,2024,Ann Oncol,PREDICTIVE,0.008837044892188053
5115,1,Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
5116,1,"First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration.",PUBMED,2024,Ann Oncol,PREDICTIVE,0.008837044892188053
5118,1,Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.,PUBMED,2023,Nat Med,PREDICTIVE,0.008837044892188053
5119,1,Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma.,PUBMED,2023,J Clin Oncol,PREDICTIVE,0.008837044892188053
131,1,TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.,PUBMED,2010,Oncogene,PREDICTIVE,0.008837044892188053
135,1,IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.,PUBMED,2010,Blood,PROGNOSTIC,0.008837044892188053
138,1,Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.,PUBMED,2008,Blood,PROGNOSTIC,0.008837044892188053
140,1,Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.,PUBMED,2009,J Clin Oncol,PROGNOSTIC,0.008837044892188053
143,1,Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.,PUBMED,2010,J Clin Oncol,PROGNOSTIC,0.008837044892188053
145,1,"Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.",PUBMED,2014,Ann Hematol,PROGNOSTIC,0.008837044892188053
146,1,Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML.,PUBMED,2009,Blood,PROGNOSTIC,0.008837044892188053
147,1,TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.,PUBMED,2014,Int J Hematol,PROGNOSTIC,0.008837044892188053
5104,1,Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.,PUBMED,2017,Immunity,PREDICTIVE,0.008837044892188053
5105,1,Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an RAF1 Fusion.,PUBMED,2018,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
5106,1,Poly (ADP-Ribose) Polymerase inhibitors (PARPi) therapy response in an acral melanoma patient with EMSY gene amplification.,PUBMED,2024,JAAD Case Rep,PREDICTIVE,0.008837044892188053
5107,1,High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.,PUBMED,2019,Cancer,PREDICTIVE,0.008837044892188053
5108,1,B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy.,PUBMED,2022,J Immunother,PREDICTIVE,0.008837044892188053
5109,1,B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy.,PUBMED,2021,Immunology,PREDICTIVE,0.008837044892188053
5110,1,Resistance to checkpoint blockade therapy through inactivation of antigen presentation.,PUBMED,2017,Nat Commun,PREDICTIVE,0.008837044892188053
127,1,Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.,PUBMED,2014,Blood,PREDICTIVE,0.008837044892188053
5162,1,"Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.",PUBMED,2001,Nat Genet,DIAGNOSTIC,0.008837044892188053
5163,1,Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.,PUBMED,2015,Blood,DIAGNOSTIC,0.008837044892188053
5164,1,Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.,PUBMED,2018,Cancer Cell,PREDICTIVE,0.008837044892188053
5166,1,Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
5170,1,"Acute promyelocytic leukemia with PML/RARA (bcr1, bcr2 and bcr3) transcripts in a pediatric patient.",PUBMED,2024,Oncol Lett,DIAGNOSTIC,0.008837044892188053
5171,1,Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia.,PUBMED,2007,Acta Haematol,DIAGNOSTIC,0.008837044892188053
5173,1,CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.,PUBMED,2024,Br J Haematol,PREDICTIVE,0.008837044892188053
5174,1,Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.,PUBMED,2020,Cancer Discov,PREDICTIVE,0.008837044892188053
5153,1,The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene.,PUBMED,1989,Blood,DIAGNOSTIC,0.008837044892188053
5154,1,Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.,PUBMED,2016,Nat Genet,DIAGNOSTIC,0.008837044892188053
5155,1,Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.,PUBMED,2016,Nat Commun,DIAGNOSTIC,0.008837044892188053
5156,1,LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.,PUBMED,2021,J Immunother Cancer,PREDICTIVE,0.008837044892188053
5157,1,Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.,PUBMED,2011,Blood,DIAGNOSTIC,0.008837044892188053
5158,1,Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.,PUBMED,2020,Br J Haematol,DIAGNOSTIC,0.008837044892188053
5159,1,Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.,PUBMED,2020,Blood,DIAGNOSTIC,0.008837044892188053
5161,1,Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.,PUBMED,2009,Cancer Res,ONCOGENIC,0.008837044892188053
5144,1,"Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.",PUBMED,2023,Lancet,PREDICTIVE,0.008837044892188053
5145,1,Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion.,PUBMED,2022,Pathol Oncol Res,PREDICTIVE,0.008837044892188053
5146,1,TumorFusions: an integrative resource for cancer-associated transcript fusions.,PUBMED,2018,Nucleic Acids Res,ONCOGENIC,0.008837044892188053
5148,1,NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.,PUBMED,2019,Haematologica,DIAGNOSTIC,0.008837044892188053
5149,1,Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.,PUBMED,2021,Leukemia,DIAGNOSTIC,0.008837044892188053
5150,1,Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.,PUBMED,2021,Blood,DIAGNOSTIC,0.008837044892188053
5151,1,B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL.,PUBMED,2019,Front Oncol,DIAGNOSTIC,0.008837044892188053
5152,1,Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.,PUBMED,2021,Ann Diagn Pathol,DIAGNOSTIC,0.008837044892188053
5132,1,Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.,PUBMED,2022,Blood Cancer Discov,PROGNOSTIC,0.008837044892188053
5133,1,Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.,PUBMED,2024,Cell Res,PREDICTIVE,0.008837044892188053
5136,1,ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.,PUBMED,2014,Int J Clin Exp Pathol,PROGNOSTIC,0.008837044892188053
5138,1,Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma.,PUBMED,2020,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
5140,1,Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.,PUBMED,2024,N Engl J Med,PREDICTIVE,0.008837044892188053
5141,1,Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).,PUBMED,2024,J Clin Oncol,PREDICTIVE,0.008837044892188053
5142,1,"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.",PUBMED,2023,Lancet,PREDICTIVE,0.008837044892188053
5143,1,"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.",PUBMED,2023,Nat Med,PREDICTIVE,0.008837044892188053
5212,1,Adenocarcinoma Harboring EGFR-RAD51 Fusion Treated With Osimertinib: A Case Report.,PUBMED,2024,JTO Clin Res Rep,PREDICTIVE,0.008837044892188053
5213,1,Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring an EGFR::ERBB4 Fusion Through Use of EGFR Tyrosine Kinase Inhibitors.,PUBMED,2024,JCO Precis Oncol,PREDICTIVE,0.008837044892188053
5214,1,The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.,PUBMED,1995,Blood,PREDICTIVE,0.008837044892188053
5215,1,TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.,PUBMED,1995,Leukemia,DIAGNOSTIC,0.008837044892188053
5217,1,Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.,PUBMED,2023,Haematologica,DIAGNOSTIC,0.008837044892188053
5218,1,IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.,PUBMED,2018,Blood,DIAGNOSTIC,0.008837044892188053
5219,1,B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.,PUBMED,2018,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5220,1,Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.,PUBMED,2022,Cancer Rep (Hoboken),DIAGNOSTIC,0.008837044892188053
5200,1,Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.,PUBMED,2023,N Engl J Med,PREDICTIVE,0.008837044892188053
5201,1,Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.,PUBMED,2024,Ann Oncol,PREDICTIVE,0.008837044892188053
5202,1,"ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer.",PUBMED,2024,Ann Oncol,PREDICTIVE,0.008837044892188053
5204,1,PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment.,PUBMED,2022,J Immunother Cancer,PREDICTIVE,0.008837044892188053
5205,1,The landscape of kinase fusions in cancer.,PUBMED,2014,Nat Commun,ONCOGENIC,0.008837044892188053
5208,1,KIF5B-EGFR Fusion: A Novel EGFR Mutation in Lung Adenocarcinoma.,PUBMED,2020,Onco Targets Ther,PREDICTIVE,0.008837044892188053
5209,1,,ASCO,,,PREDICTIVE,0.008837044892188053
5210,1,EGFR-RAD51 Fusion: A Targetable Partnership Originated from the Tumor Evolution?,PUBMED,2018,J Thorac Oncol,PREDICTIVE,0.008837044892188053
5191,1,Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis.,PUBMED,2009,J Neuropathol Exp Neurol,DIAGNOSTIC,0.008837044892188053
5192,1,High-Resolution Genomic Analysis of Cribriform Neuroepithelial Tumors of the Central Nervous System.,PUBMED,2015,J Neuropathol Exp Neurol,DIAGNOSTIC,0.008837044892188053
5193,1,Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.,PUBMED,2017,Brain Pathol,DIAGNOSTIC,0.008837044892188053
5194,1,The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.,PUBMED,1990,Nature,DIAGNOSTIC,0.008837044892188053
5195,1,Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias.,PUBMED,1990,J Exp Med,DIAGNOSTIC,0.008837044892188053
5196,1,A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.,PUBMED,2020,Mod Pathol,DIAGNOSTIC,0.008837044892188053
5197,1,Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.,PUBMED,2022,Mod Pathol,DIAGNOSTIC,0.008837044892188053
5198,1,Morphologic and Ancillary Studies of Pediatric Acinic Cell Carcinoma: A Single Institute Experience.,PUBMED,2023,Head Neck Pathol,DIAGNOSTIC,0.008837044892188053
5176,1,Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.,PUBMED,2015,Eur J Haematol,PREDICTIVE,0.008837044892188053
5178,1,Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.,PUBMED,2019,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
5179,1,Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-M√ºnster Study Group.,PUBMED,1997,Blood,DIAGNOSTIC,0.008837044892188053
5180,1,Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.,PUBMED,2019,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5184,1,Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.,PUBMED,1997,Blood,DIAGNOSTIC,0.008837044892188053
5185,1,Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.,PUBMED,2018,Blood,DIAGNOSTIC,0.008837044892188053
5186,1,Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG.,PUBMED,2018,Ann Hematol,DIAGNOSTIC,0.008837044892188053
5190,1,Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.,PUBMED,2018,Histopathology,DIAGNOSTIC,0.008837044892188053
5275,1,Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.,PUBMED,2011,Hum Pathol,DIAGNOSTIC,0.008837044892188053
5276,1,EGFR Amplification in Metastatic Colorectal Cancer.,PUBMED,2021,J Natl Cancer Inst,PREDICTIVE,0.008837044892188053
5277,1,Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.,PUBMED,2023,Blood,PREDICTIVE,0.008837044892188053
5278,1,Rare germline variant contributions to myeloid malignancy susceptibility.,PUBMED,2020,Leukemia,PREDISPOSING,0.008837044892188053
83,1,RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.,PUBMED,2005,Blood,PROGNOSTIC,0.008837044892188053
84,1,Implications of NRAS mutations in AML: a study of 2502 patients.,PUBMED,2006,Blood,PROGNOSTIC,0.008837044892188053
87,1,NRAS mutation status is an independent prognostic factor in metastatic melanoma.,PUBMED,2012,Cancer,PROGNOSTIC,0.008837044892188053
88,1,Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.,PUBMED,2012,J Hematol Oncol,PREDICTIVE,0.008837044892188053
5260,1,Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).,PUBMED,2012,Proc Natl Acad Sci U S A,ONCOGENIC,0.008837044892188053
5261,1,Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.,PUBMED,2019,J Immunother Cancer,PREDICTIVE,0.008837044892188053
5268,1,Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production.,PUBMED,2020,Haematologica,ONCOGENIC,0.008837044892188053
5270,1,Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia.,PUBMED,2019,Oncogenesis,ONCOGENIC,0.008837044892188053
5271,1,Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition.,PUBMED,2012,Cancer Res,PREDICTIVE,0.008837044892188053
5272,1,Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.,PUBMED,2024,Blood Adv,DIAGNOSTIC,0.008837044892188053
5273,1,The KMT2A recombinome of acute leukemias in 2023.,PUBMED,2023,Leukemia,DIAGNOSTIC,0.008837044892188053
5274,1,COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22).,PUBMED,2006,Cancer Genet Cytogenet,DIAGNOSTIC,0.008837044892188053
5236,1,From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion.,PUBMED,2020,Ann Diagn Pathol,DIAGNOSTIC,0.008837044892188053
5237,1,3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.,PUBMED,2023,Cancers (Basel),DIAGNOSTIC,0.008837044892188053
5238,1,Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.,PUBMED,2016,Genes Chromosomes Cancer,DIAGNOSTIC,0.008837044892188053
5239,1,Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.,PUBMED,2020,Blood,DIAGNOSTIC,0.008837044892188053
5240,1,NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma.,PUBMED,2020,Cancer Genomics Proteomics,DIAGNOSTIC,0.008837044892188053
5243,1,Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer.,PUBMED,2020,Clin Cancer Res,ONCOGENIC,0.008837044892188053
5256,1,Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.,PUBMED,2024,Br J Haematol,PROGNOSTIC,0.008837044892188053
5259,1,EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.,PUBMED,2013,Cancer Cell,ONCOGENIC,0.008837044892188053
5221,1,Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin.,PUBMED,2022,Front Oncol,PREDICTIVE,0.008837044892188053
5226,1,Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.,PUBMED,2019,Nat Commun,PREDICTIVE,0.008837044892188053
5228,1,Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis.,PUBMED,2025,Cancer Genet,PROGNOSTIC,0.008837044892188053
5229,1,Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.,PUBMED,2009,Cancer Cell,DIAGNOSTIC,0.008837044892188053
5230,1,Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.,PUBMED,2014,Nat Genet,DIAGNOSTIC,0.008837044892188053
5231,1,The molecular landscape of ETMR at diagnosis and relapse.,PUBMED,2019,Nature,DIAGNOSTIC,0.008837044892188053
5232,1,A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma.,PUBMED,2023,Genes Chromosomes Cancer,PROGNOSTIC,0.008837044892188053
5235,1,Concurrent EPOR::IGH fusion gene and numerous cytoplasmic granules in BCR::ABL1-like B-lymphoblastic leukemia.,PUBMED,2024,Pediatr Blood Cancer,DIAGNOSTIC,0.008837044892188053
5382,1,Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer.,PUBMED,2025,J Transl Med,PREDICTIVE,0.008837044892188053
5383,1,BCOR-CCNB3 Undifferentiated Sarcoma-Does Immunohistochemistry Help in the Identification?,PUBMED,2017,Pediatr Dev Pathol,DIAGNOSTIC,0.008837044892188053
5384,1,The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma.,PUBMED,2023,Cell Death Discov,FUNCTIONAL,0.008837044892188053
5385,1,Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.,PUBMED,2014,J Pathol,PREDICTIVE,0.008837044892188053
5386,1,Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.,PUBMED,2024,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5387,1,Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.,PUBMED,2025,J Clin Oncol,PREDICTIVE,0.008837044892188053
5388,1,Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.,PUBMED,2019,Ann Oncol,PREDICTIVE,0.008837044892188053
64,1,High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a.,PUBMED,2006,Blood,PREDICTIVE,0.008837044892188053
5374,1,Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5375,1,Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.,PUBMED,2010,J Pathol,ONCOGENIC,0.008837044892188053
33,1,Identification of targetable FGFR gene fusions in diverse cancers.,PUBMED,2013,Cancer Discov,PREDICTIVE,0.008837044892188053
5377,1,FIP1L1::PDGFRA Fusion in a Pediatric Patient Presenting With B-Cell Lymphoblastic Leukemia.,PUBMED,2025,Genes Chromosomes Cancer,PREDICTIVE,0.008837044892188053
5378,1,Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.,PUBMED,2024,N Engl J Med,PREDICTIVE,0.008837044892188053
5379,1,"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.",PUBMED,2025,Lancet,PREDICTIVE,0.008837044892188053
5380,1,Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma.,PUBMED,2022,Front Pediatr,PREDICTIVE,0.008837044892188053
5381,1,CDK12: an emerging therapeutic target for cancer.,PUBMED,2018,J Clin Pathol,ONCOGENIC,0.008837044892188053
5326,1,Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.,PUBMED,2020,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5328,1,The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts.,PUBMED,1999,Blood,ONCOGENIC,0.008837044892188053
5329,1,"A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation.",PUBMED,2000,Blood,ONCOGENIC,0.008837044892188053
5330,1,Identification of an ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a T-cell acute lymphoblastic leukaemia cell line.,PUBMED,2002,Br J Haematol,ONCOGENIC,0.008837044892188053
5331,1,Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.,PUBMED,2012,Ann Hematol,ONCOGENIC,0.008837044892188053
5367,1,Inactivating CUX1 mutations promote tumorigenesis.,PUBMED,2014,Nat Genet,PREDICTIVE,0.008837044892188053
5368,1,Galiximab signals B-NHL cells and inhibits the activities of NF-Œ∫B-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.,PUBMED,2012,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
5369,1,Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer.,PUBMED,2024,Cell Death Discov,PREDICTIVE,0.008837044892188053
5309,1,Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.,PUBMED,2016,Nat Genet,ONCOGENIC,0.008837044892188053
5310,1,"Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.",PUBMED,2017,Breast Cancer Res,PREDICTIVE,0.008837044892188053
5314,1,,ASH,,,PREDICTIVE,0.008837044892188053
5319,1,"SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.",PUBMED,2015,Mol Cell Biol,ONCOGENIC,0.008837044892188053
5320,1,PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse.,PUBMED,2012,Nucleic Acids Res,ONCOGENIC,0.008837044892188053
5321,1,"Phase Ib Trial of Fulvestrant, Palbociclib and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.",PUBMED,2025,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5323,1,Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.,PUBMED,2021,J Natl Cancer Inst,PROGNOSTIC,0.008837044892188053
5325,1,Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.,PUBMED,2020,Breast Cancer Res Treat,PROGNOSTIC,0.008837044892188053
5357,1,Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival.,PUBMED,2020,Cancers (Basel),PROGNOSTIC,0.008837044892188053
5359,1,FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy.,PUBMED,2025,bioRxiv,PREDICTIVE,0.008837044892188053
5360,1,Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.,PUBMED,2024,Nat Med,PREDICTIVE,0.008837044892188053
5361,1,"Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.",PUBMED,2015,Lancet Oncol,PREDICTIVE,0.008837044892188053
5363,1,Efficacy of Trabectedin in Patients with Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.,PUBMED,2017,Oncologist,PREDICTIVE,0.008837044892188053
5364,1,Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.,PUBMED,2016,BMC Cancer,PREDICTIVE,0.008837044892188053
5365,1,CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.,PUBMED,2021,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5366,1,Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.,PUBMED,2020,Cancer Res,PREDICTIVE,0.008837044892188053
5346,1,[SRF-rearranged cellular perivascular myoid tumor: a clinicopathological analysis of two cases].,PUBMED,2024,Zhonghua Bing Li Xue Za Zhi,DIAGNOSTIC,0.008837044892188053
5347,1,Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.,PUBMED,2023,Clin Epigenetics,DIAGNOSTIC,0.008837044892188053
5348,1,Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.,PUBMED,2025,J Clin Oncol,PREDICTIVE,0.008837044892188053
5349,1,"Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.",PUBMED,2025,J Clin Oncol,PREDICTIVE,0.008837044892188053
5350,1,Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome.,PUBMED,2024,NPJ Precis Oncol,ONCOGENIC,0.008837044892188053
5351,1,Polymerase epsilon mutations and concomitant Œ≤2-microglobulin mutations in cancer.,PUBMED,2018,Gene,ONCOGENIC,0.008837044892188053
5352,1,Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.,PUBMED,2017,Oncotarget,DIAGNOSTIC,0.008837044892188053
5353,1,Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for NTRK3 fusion.,PUBMED,2025,Front Oncol,PREDICTIVE,0.008837044892188053
5337,1,Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years.,PUBMED,2021,Leuk Lymphoma,ONCOGENIC,0.008837044892188053
5338,1,The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.,PUBMED,2021,Cancers (Basel),ONCOGENIC,0.008837044892188053
5340,1,A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer.,PUBMED,2025,NPJ Precis Oncol,PREDICTIVE,0.008837044892188053
5341,1,Comparison of Molecular Testing Methodologies for CIC-Rearranged Sarcomas.,PUBMED,2025,Arch Pathol Lab Med,DIAGNOSTIC,0.008837044892188053
5342,1,Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth.,PUBMED,2014,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5343,1,Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.,PUBMED,2017,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5344,1,SRF Fusions Other Than With RELA Expand the Molecular Definition of SRF-fused Perivascular Tumors.,PUBMED,2020,Am J Surg Pathol,DIAGNOSTIC,0.008837044892188053
5345,1,Cellular myofibromas with SRF fusions: clinicopathological and molecular study of 3 cases of a rare entity and a potential mimic of sarcoma.,PUBMED,2023,Hum Pathol,DIAGNOSTIC,0.008837044892188053
65,1,"Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.",PUBMED,2008,Cancer Cell,PREDICTIVE,0.008837044892188053
66,1,BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors.,PUBMED,2008,Mol Cancer Ther,PREDICTIVE,0.008837044892188053
69,1,Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.,PUBMED,2006,Blood,PROGNOSTIC,0.008837044892188053
70,1,"The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.",PUBMED,2014,Acta Oncol,PROGNOSTIC,0.008837044892188053
71,1,Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.,PUBMED,2011,Br J Dermatol,DIAGNOSTIC,0.008837044892188053
75,1,KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.,PUBMED,2005,PLoS Med,PREDICTIVE,0.008837044892188053
5333,1,FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.,PUBMED,2019,Clin Cancer Res,PREDICTIVE,0.008837044892188053
5335,1,Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain.,PUBMED,2025,Blood Neoplasia,PREDICTIVE,0.008837044892188053
